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Assessing and understanding governance at all levels of the health system is crucial to 
improve the way in which the system is steered and managed and thus might positively 
affect (among other things) its performance, and ultimately, health outcomes. This 
association needs to be further explored by more research in order to confirm the type of 
relationship between governance and health outcomes, but first we need to define it and 
assess it in a pragmatic way. Previously, several assessments tools for health governance 
were proposed; but, due to a range of reasons, they are not being widely employed. Thus, 
there is a need for a new assessment tool to address some of the limitations of the existing 
ones (one that is specific to the health sector, practical, and capable of assessing change 
and progress over time) and help fill some of the gaps in knowledge (such as 
supplementing conceptual depth to the governance principles covered). Additionally, 
policymakers require a diagnostic tool to identify deficiencies in governance that need to 
be addressed. 
This research involved the development of a valid generic tool, suitable for assessing the 
principles and practices of governance in health policymaking, as well as providing a 
structured opportunity to policymakers to critically reflect on good practices. The 
assessment/guidance instrument covers five fundamental principles of good governance 
(GG) as yet insufficiently explored within the literature on health governance or 
systematically operationalised. These are participation, transparency, accountability, use of 
information, and responsiveness. The tool was developed over five steps (three stages). 
Stage one focused on the conceptualisation of the five selected principles based on a 
review of the available literature, with the aim to compile concepts/characteristics of GG 
under each of these principles and operationalise them into a list of questions, which 
comprised the initial tool. In stage two, the tool was refined by conducting three rounds of 
online Delphi consultations with 25 experts from 16 countries. These consultations helped 
attain consensus on the most important characteristics of the governance principles and 
explored new attributes that were not identified through the literature search. Moreover, the 
tool was reviewed by seven high-level policymakers from seven different countries, mainly 
to consider its practical application in the health context. Stage three pertained to pilot 
testing the refined tool with regard to a new national policy on mental health in Lebanon in 
order to identify GG practices as well as possible gaps in its formulation. The results of the 
assessment were presented with recommendations to the relevant policymakers.  
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In conclusion, the end product of this research is a Health Policymaking Governance 
Guidance Tool (HP-GGT) that can be readily used by policymakers at the Ministry of 
Health level and/or by health authorities. It offers guidance concerning a list of "good 




Introduction and Research Question 
This chapter introduces the general implication of governance, including commonly 
employed definitions of health system governance (HSG) that are used, its importance, 
levels of health system in which governance has a role, the salience of assessing HSG, the 
principles of GG, as well as the available assessment tools, their limitations, and gaps. 
Subsequently, the need for and importance of bridging some of the gaps in previous and 
current work concerning the operationalisation and implementation of HSG assessment is 
considered. Drawing on the existing literature, the necessity for a new governance tool is 
proposed and the expectations from this new tool in terms of what it can and cannot 
achieve are addressed. The chapter concludes with a proposal of the research question this 
research will address.  
 
1.1 Introduction 
1.1.1 What is Governance? 
Governance is considered a relatively new field in the development agenda, although the 
underlying concepts and principles of governance date back to early human civilisation 
(Mailk, 2002), with references to these present in many religions, including Christianity 
and Islam (Saltman and Davis, 2000). Governance is recognised by many policymakers 
and researchers as a fundamental ingredient for development across various policy fields 
(Kaufmann and Kraay, 2008). Accordingly, the improvement of “governance” and 
promotion of "good governance"  have become subjects of interest for policymakers and 
scholars alike (Fryatt, Bennett and Soucat, 2017).  
This concept was developed and expanded on in the fields of political science, social 
sciences, public policy, and economics (Kaufmann and Kraay, 2008). This implies that the 
concept emerged from different disciplines (Pyone, Smoth and Broek, 2017), which 
rendered reaching a consensus regarding its conceptualisation a difficult task (Barbaza and 
Tello, 2014). Governance has several implications (Laurance et al., 2000; Dodgson, Lee 
and Drager, 2002; Lewis and Pettersson, 2009; Veillard et al., 2011; Savedoff, 2011; 
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Emerson, Nabatchi and Balogh, 2011) that has resulted in the problematisation of the 
concept, leaving questions as to whether the different conceptualisations and definitions 
have enough in common to enable their use in research and policymaking. According to 
Bovaird and Loffler (2003), the "vagueness" associated with governance has led to the 
concept’s "popularity" and resulted in the drive to assess it.  
Governance is a generic term that has been used across all sectors (Leadership, 
Management and Governance Project (LMG) 2012). and entails both managerial as well as 
political aspects (United Nations Development Program (UNDP), 1997). Despite some key 
conceptualisations of governance as an issue of organisation management and decision-
making in the private corporate sector, these are now widely applied in the public sector as 
well (Ruhanen, Scott, Ritchie, and Tkacznaki, 2010). Corporate governance is defined as 
"a set of relationships between a company’s management, its board, its shareholders and 
other stakeholders" (OECD, 2004). It provides the structure through which a company’s 
objectives are set, and the means of attaining those objectives and monitoring performance 
are determined (OECD, 2004). In other words, governance pertains to the political and 
administrative activities of creating, organising, and delivering a policy/product (UNDP, 
1997). According to UNDP (1997), governance in the public sector concerns the "exercise 
of political, economic and administrative authority in management of a country’s affairs at 
all levels". In turn, GG, in general, is defined as the "exercise of power through institutions 
to steer society for public good" (UNDP, 1997). It has been claimed that this is likely to 
result in processes and outputs that are inclusive, responsive, and fair and will also increase 
public trust in the social system (Huss, Green, Sudayshan, Karpagam, Ramani, Thomas, 
and Gerein, 2010). Hence, governance is commonly used to "refer to all patterns of rule to 
coordinate the relationship between different actors and organizations" (Bevir, 2008). This 
refers to the normative form of governance, the form this research will focus on in the 
context of the health sector.  
Regarding the health sector, the World Health Organization (WHO) first suggested the 
term stewardship in health in its World Health Report in 2000, where it defined the 
government’s role towards its citizens in the health sector as comprising a special type of 
governance (Saltman and Davis, 2000). The World Health Report (2000) defined 
stewardship as "careful and responsible management of the well-being of the population" 
(WHO, 2000). Subsequently, the term stewardship was replaced by governance to facilitate 
understanding and imply the regulation, management, and organisation of the system 
rather than merely focusing on the ethical and moral values that should be practised in the 
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management of a health system (WHO, 2007). The WHO offered another definition for 
governance in 2007, "ensuring strategic policy frameworks exist and are combined with 
effective oversight, coalition-building, provision of appropriate regulations and incentives, 
attention to system-design, and accountability" (WHO, 2007). USAID defined health 
governance as the "process of competently directing health system resources, performance 
and stakeholder participation toward the goal of saving lives and doing so in ways that are 
open, transparent, accountable, equitable and responsive to the needs of the people" 
(USAID, 2008). Since governance is considered a function of the health system (WHO, 
2010), it is required to ensure the achievement of health system goals through fair and 
ethical management (to reflect ethical values required for public health) of the health sector 
through national health ministries or governments (Veillard, Brown, Baris, Permanand, and 
Klazinga, 2011).  
When the general definitions of governance and those of health governance are considered, 
they can be perceived as being broad and abstract (UNDP, 197; WHO, 2007). While it can 
be concluded that the various definitions regarding the health sector (as in other fields) 
share a certain degree of similarity in terms of the government’s role of steering the system 
towards what is beneficial for its people, there is no agreement as to a common worldwide 
definition that should be followed (Barbaza and Tello, 2014). This could be explained by 
the fact that governance is a relatively new concept as well as a highly political one 
(Lopez, Wyss and Savigny, 2011). In addition, different perspectives concerning the 
meaning of governance are not only caused due to issues at the conceptual level but also 
due to differences in the language used to define the term (WHO, 2007; Veillard et al., 
2011).  
 
1.1.2 Different Levels at Which Governance Has a Role Within the Health Sector 
Governance is involved horizontally in several fields within the health sector and at all 
levels vertically (WHO, 2010). Therefore, for instance, reference is made to "Global 
Health Governance": the international platforms and processes for coordination and 
collaboration between countries and international organisations to protect their 
populations’ health against public health threats (Dodgson, Lee, and Drager, 2002).  
In contrast, at the national level, within a country, the governance of health system plays a 
role in the way in which structures, actors, and processes shape the overall political 
direction, level of financing, type of healthcare system organisation, as well as financing 
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and service delivery of the health system (Siddiqi, Masud, Nishat, Peters, Sabri, Bile and 
Jama, 2009). These processes of governance within the health sector regarding spending 
money, determination of general health goals, and provision of healthcare are usually 
influenced by the parliaments and the political parties, which consult with the respective 
ministries of health (MoHs) (Savedoff, 2011) and are hence dependent on the country’s 
governance style (Siddiqi et al., 2009).  
Ministries of health continue to be the principal governing bodies of health system 
(Veillard et al., 2011), holding a mandate for health policymaking, operational practices, 
organisation, financing, and service delivery, which also includes oversights and 
regulations (Siddiqqi et al., 2009). At this level, the focus of HSG is mainly on the process 
of policymaking and ensuring that evidence-based policies and procedures are formulated 
and implemented in a transparent and accountable manner, involving all stakeholders, 
being responsive and inclusive to the population’s needs, thereby reflecting normative 
principles that guide GG (WHO, 2009). This implies that it is the MoHs’ responsibility to 
ensure that the characteristics of  GG, as defined by international organisations, such as 
transparency, accountability, participation, among others, are established and implemented 
at the level of policymaking. Focusing on the HSG at the MoH level does not exclude the 
importance of other factors, such as economic development, public expenditure, inequality, 
and others, that might affect policymaking in the health sector.  
HSG exists at the service delivery level, with the aim to improve practices and services 
provided, including clinical governance, among other things, that focus on the quality and 
standard of care of health services offered (Savedoff, 2011). In investigating health 
governance, it is important to specify the level of focus, as different issues emerge as 
important depending on the targeted level of governance. 
 
1.1.3 Importance of Health System Governance  
Governance is considered one of the core components of health systems (WHO, 2010). 
According to the WHO, "a health system is sum total of all organizations, institutions and 
resources whose primary purpose is to improve health", and there are six building blocks 
for any health system, namely, service delivery, health workforce, information regarding 
medical products, vaccines and technologies, financing, and leadership/governance (WHO, 
2010). The governance’s role is to provide the required infrastructure for overall policy and 
regulation of all other building blocks (WHO, 2010).  
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"Improving" HSG was perceived by UNDP (1997) and the WHO (2009) as a major factor 
for the achievement of health millennium goals, social developmental goals (SDGs) 
(Siddiqi et al., 2009), as well as universal health coverage (Fryatt et al., 2017). Although 
there is no conclusive evidence that indicates a causal link between GG and enhanced 
performance of the health system and health outcomes, the existing literature suggests a 
positive association. In theory, the enhancement of performance and health outcomes is 
related to the improvement of the health system’s governance as this can exert a positive 
influence on all other health system functions and building blocks (Siddiqi et al., 2009). 
The literature suggests a positive correlation (to be further confirmed) between GG and the 
health system’s performance improvement, which might lead in turn to improved outcomes 
(Lewis and Pettersson, 2009). Hence, governance can be considered as one of the 
indicators (among others) for any health system’s performance (Alliance for Health Policy 
and Systems Research (HPSR), 2008). This, however, does not consider the influence of 
the other factors (within and beyond the health sector) that influence these system’s 
performance and health outcomes, nor confirms the type of relationship between HSG and 
system’s performance and health outcomes.  
Ciccone,  Vian, Maurer and Bradley (2014) conducted a review of literature in low- and 
middle-income countries (LMICs) to ascertain whether there is a link between health 
governance and health outcomes in these countries. They identified 30 peer-reviewed 
studies, and 18 of those demonstrated a positive effect in one way or another (Ciccone et 
al., 2014). According to Ciccone (2014), the effect of governance on health outcomes was 
found to be either a direct positive effect, an indirect positive effect (modified by 
contextual factors), or a moderating positive effect. The other 12 studies presented mixed 
findings concerning the association, showing no association or inconclusive results 
(Ciccone et al., 2014). The authors concluded that further research is required to 
understand the relationship between governance and health outcomes; however, 
meanwhile, policymakers are encouraged to apply GG in their practice: "building upon 
what we already know about the relationship between governance and health can catalyse 
new understanding and innovation for a better functioning health system" (Ciccone et al., 
2014, p.94). Ciccone et al. (2014) highlighted four key governance mechanisms that affect 
health outcomes: responsiveness to people’s needs, empowering diverse stakeholders’ 
participation in the health sector, enhancement of community engagement, and enabling 
citizens to hold providers/policymakers accountable (Ciccone et al., 2014). Health 
outcomes that are impacted by governance mechanisms included infants’ nutrition status, 
under-five mortality rates, service utilisation rates, immunisation rates, introduction of new 
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vaccines, life expectancy at birth, maternal mortality rates, as well as awareness about 
contraceptives and their use, according to these authors (Ciccone et al., 2014). 
Conversely, it has been reported that poor governance in the health sector might contribute 
to poor performance, among other problems, and might lead to poor health outcomes in 
LMICs (LMG, 2012), this is also to be confirmed in future research. For instance, lack of 
standards, information, and accountability can cause any health system to perform poorly 
(Lewis and Pettersson, 2009). Siddiqqi et al. (2009) also drew attention to the fact that poor 
governance pertains to poor accountability and transparency, weak responsiveness, limited 
engagement of various stakeholders, and lack of data and evidence. This is relevant 
especially in contexts with limited resources, in which effective, fair, and transparent 
resource utilisation and distribution can significantly affect the quality and access of 
services provided, which, in turn, can affect health outcomes (Siddiqi et al., 2009).  
The application of GG may lead to the strengthening of the health system (Pyon et al., 
2017) and can consequently improve health outcomes in those countries (Ciccone et al., 
2014). The influence of HSG on health outcomes is indirect as the process involves several 
intermediary steps involved. Improving one step might have a role in improving the 
outcomes but this cannot be guaranteed. For example, if resource allocation and health 
expenditure is performed in a more accountable and transparent manner, this might result 
in more effective public expenditure on lowering child mortality (Lazarova, 2006) and/or 
increasing life expectancy (Makuta and O'Hare, 2015), given that other factors such as the 
level of bureaucracy and corruption are also enhanced (Haan and Komp, 2008). In 
addition, international organisations have reported that weaknesses in HSG can threaten 
the effective utilisation of external funds (USAID, 2008) through wastage and leakage 
(Siddiqi et al., 2009). Hence, these organisations impose strict requirements on 
governments to improve HSG as a means to facilitate the management of limited resources 
and deliver transparent funding, thereby demonstrating accountability towards donor 
organisations (Alliance HPSR, 2008; Lopez et al., 2011). It is believed that LMICs are the 
countries that will gain the maximum benefits from enhanced quality of governance as 
problems at all levels of governance have been reported to affect the level of development 
(Ruhanen et al., 2010). In general, poor governance was reported as one of the reasons 
behind governmental inefficiency in LMICs (Andrews, 2008), with inefficiency in health 
systems, in particular, being attributed to the predominance of a hierarchical system in the 
management of this sector (Lewis and Pettersson, 2009; Siddiqi and Jabbour, 2012).  
It has been reported that the number of publications on health governance in LMICs is 
limited (Alliance HPSR, 2008) and that assessment efforts so far have been inadequate 
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(Siddiqqi and Jabbour, 2012), which reflect on poor practices of GG in real settings and 
thus require further attention.  
However, health governance has become a high priority in LMICs due to the emergent 
demand to enhance accountability and regulation within this sector in order to promote 
transparency of MoHs as well as engage various stakeholders in the decision-making 
process (USAID, 2008; Siddiqi and Jabbour, 2012). Accordingly, policymakers, donors, 
and researchers need to assess and understand the way in which governance operates in 
these countries at all levels of the health sector (Alliance HPSR, 2008). These stakeholders 
may have different interests, such as a desire to improve HSG as one of the means to 
contribute to the improvement of performance and thus the possibility to enhanced 
outcomes (Lopez et al., 2011), a wish to monitor aid effectiveness as a demand of donors 
(Lopez et al., 2011; Siddiq et al., 2009), or simply, to expand the body of knowledge 
regarding governance (Pyon et al., 2017). Regardless of the aim, it is evident that providing 
a better understanding of the way in which different aspects of governance are 
operationalised in the context of LMICs presents a worthwhile endeavour.  
HSG represents a complex phenomenon (Pyone et al., 2017), being one of the least 
understood aspects  compared to other foundational blocks of the health system (Siddiqi et 
al., 2009), despite the claims regarding its importance (Ciccicone et al., 2014; Fryatt et al., 
2017; Barbaza and Tello, 2014). Scholarship in this field is under developed and the reason 
for its delayed development could be the fact that governance in the health system forms a 
complex, sensitive, and consequently, challenging topic to research (Alliance HPSR, 
2008).  
The reason behind HSG’s complexity is the diversity of the stakeholders involved, who 
have different agendas, interests, beliefs, power, and authority, in addition to external 
factors’ influence on these stakeholders (USAID, 2008). Health governance is also 
considered a sensitive subject as it has a political dimension that exceeds the health sector 
(Kaufman and Kraay, 2008). Governance is generally associated with battling corruption, 
though it entails considerably more than that (WHO, 2009). In addition, health governance 
is also under researched due to limited funding due to lack of interest to fund governance 




In a recent article by Fryatt et al. (2017), the authors addressed the question: “Health sector 
governance: Should we be investing more?”. They presented the argument that despite 
ongoing issues with regard to the implication of governance and its influence on health 
being a debatable issue owing to conflicting evidence, the important thing is improving 
HSG; however, the interventions need to be "realistic" (Fryatt et al., 2017).  
 
1.1.4 Importance of Assessing Health System Governance  
In order to improve something, it first needs to be assessed for deficiencies in practice as 
well as to lacunae the knowledge concerning ways to enhance it (Siddiqi et al., 2009). The 
importance of assessing HSG is rooted in the necessity to detect weaknesses in the practice 
of GG. This, in turn, can sensitise policymakers and researchers concerning the need to 
devise possible approaches and interventions to effect this enhancement (Lopez et al,, 
2011; Baez-Camargo and Jacobs, 2011). Additionally, this pursuit in one country can also 
lead to the documentation of such success, which can then be utilised by other countries as 
a model of GG (Pyone et al., 2017).  
Research efforts for understanding/assessing governance issues in various fields have 
concentrated on developing the theoretical understanding of the consequences of 
governance on growth and development at all levels, in all sectors (Al-Marhubi, 2004). 
Extensive work has been undertaken in high income countries to develop indicators for 
governance, in general, which have been mainly used by donors and the private sector to 
decide on the level of economic development and public policy governance for a given 
country in order to predict investment potential (Mailk, 2002). In addition, international 
donors put a pre-requisite to giving funding that is documented GG practices at the 
national level in general and in specific the sector to receive the funding (Bovarid, 2005). 
However, still no consensus on a universal measurement exists (Smith, Anell, Busse, 
Grivelli, Healy, Lindahl, Westert and Kere, 2012).  
Governance cannot be defined or assessed without defining GG, which is defined, as 
"institutional barriers to corruption and the requirements for a functioning system" (Bevir, 
2009,p.26) being in place. GG in the context of health refers to the "formulation and 
implementation of appropriate policies and procedures that ensure effective, efficient and 
ethical management of all aspects of health systems, in a manner that is transparent, 
accountable, follows rule of law and minimizes corruption" (WHO, 2009, p.3). 
MoHs/health authorities and other relevant bodies could utilise this definition as a general 
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benchmark to understand the extent to which their policies reflect the standards for GG 
(Kaufmann and Kraay, 1999).  
The assessment of governance, in general, should facilitate policymakers’ understanding of 
the complex and multidimensional concept in the absence of a consolidated definition.  
So, how can policymakers assess HSG, a "conceptually rich" notion that has no unified 
definition or standardised criteria against which it can be measured? 
Recognising the various unclear and abstract definitions of governance, most international 
organisations have adopted a strongly normative approach towards understanding this 
phenomenon, suggesting lists of principles constituting GG (UNDP, 1997; Kaufman and 
Kraay, 1998; WHO, 2000; USAID, 2009; Lopez et al., 2009). However, agreeing on core 
principles of GG has resulted in the application of numerous lists of principles by different 
organisations. Ruhanen et al. (2010) conducted a meta-analysis and found 40 different 
principles across different fields in the literature; even within a specific field, such as the 
health sector, a variety of lists of principles exist. Table 1 below summarises the findings 
regarding the principles of governance as understood by various organisations and 
institutions dealing with the health sector. 
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Table 1: Principles of Governance According to Various Institutions that Deal with the 
Health Sector 
Organization Principles of Governance 
UNDP, 1997 
• Participation 
• Rule of law 
• Transparency 
• Responsiveness 
• Consensus orientation 
• Equity 
• Effectiveness and efficiency 
• Accountability 
• Strategic vision 
World Bank, 1999 
• Voice and accountability 
• Political stability and absence of violence 
• Government effectiveness 
• Regulatory quality 
• Rule of law 
• Control of corruption 
WHO, Stewardship Domains, 2001 
• Generation of intelligence 
• Formulating strategic policy direction 
• Ensuring tools for implementation; power, sanctions, 
and incentives 
• Building coalition/partnership 
• Ensuring a fit between policy objectives and 
organizational structure and culture 




• Legitimate exercise of voice 
• Institutional checks and balances 
• Accountability 
• Transparency 
• Evidence-based policymaking 
• Efficient and effective service provision 
WHO ,Siddiqi Framework, 2009 
• Participation and consensus orientation 




• Effectiveness and efficiency 
• Accountability 
• Strategic vision 
• Ethics 
• Information and intelligence  
Lopez, Wyss and Savigny, 2011 
• Addressing corruption 
• Being transparent 
• Being accountable 
• Participation and consensus orientation 
• Strategic vision and policy design 
The most common principles/dimensions across different organisations have been 
highlighted in red in the above table, while variations can also be observed. These 
variations demonstrate the necessity for a more systematic approach to defining (not 
merely listing) the most important principles of governance for the health sector. Equally 
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important is the assessment of their relevance for a particular level of governance within 
the health system, as discussed earlier. The WHO has attempted to define GG in the health 
sector in terms of its core principles through Siddiqi et al.’s (2009) work, in which, ten 
principles were proposed for HSG based on the UNDP principles (which are widely 
accepted by most stakeholders, although not universally [USAID, 2008]), allowing slight 
adjustment to enable them to be more relevant to health systems. This implies that Siddiqi 
et al. (2009) merged participation with consensus orientation, while also adding the 
elements of intelligence, information, and ethics. The decision to include these ten 
principles to define GG in the health sector was made after an extensive consultation led 
by the WHO Eastern Mediterranean Regional office (EMRO), and these were 
acknowledged by others as well (Kirigia and Kirigia, 2011; Lopez et al., 2011).  
Therefore, after the key principles of GG in the health sector had been defined, the 
following step was to conceptualise the selected principles based on the literature and 
determine ways to operationalise them in order to assess HSG in practical terms. 
 
1.1.5 Available Assessment Tools and Gaps When Assessing HSG 
Governance partly comprises a "qualitative phenomenon" (Mailk, 2002) as the factors that 
affect its quality are context-specific, depending on the political, social, and economic 
context, level of corruption, rule of law, in addition to several other factors that are 
considered country-specific (Kaufmann and Kraay, 2008; Siddiqi et al., 2009). Despite the 
fact that this major work, as mentioned before, has been undertaken by international 
organisations, such as the World Bank (WB), to develop indicators on governance as a way 
to track progress and change over time, it is not possible to accomplish this with qualitative 
indicators (Kaufmann and Kraay, 2008). These indicators range from process to 
performance, subjective to objective, rule-based to outcome-based, single to aggregated, 
among other indicators (Savedoff, 2011). All of these are widely applied but with some 
valid critique (Apaza, 2009). 
Most of these indicators are employed by international organisations and others to serve 
their agenda of improving governance based on the assumption that boosting economic 
development, social development, and/or health outcomes is the most important aspect 
(UNDP, 1997; Kaufman and Kraay, 2008). This is the reason behind the emergence of the 
need for indicators to assess different aspects of governance (Baez-Camargo and Jacobs, 
2011), despite the political nature of the issues related to it. The indicators developed to 
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assess governance in various fields are broad as the definition of the term (Mailk, 2002). 
These broad indicators are based on the abstract concept of governance, resulting in their 
limited application (Lopez et al., 2011; Pyone et al, 2017). Consequently, there is a need 
for further in-depth assessment of governance based on "identified" key principles in order 
to promote a common understanding of the phenomenon, its principles and role among 
public officers and policymakers across all fields (Siddiqqi and Jabbour, 2012). 
Table 2 given below summarises the characteristics and limitations of the available 
assessment tools, currently employed for HSG by international organisations and some 
researchers. 
Table 2: Characteristics and Limitations of Existing Assessment Tools for HSG 
Framework/Assessment Focus of Assessment Characteristics Limitations 
UNDP Governance 
Assessment, 1997 
Principles of GG Wide acceptance of 
principles 






performance at the 
national level 
Results are expressed as 
summary measures 
employed to rank and 
compare countries 
General and not specific to 
the health sector 
WHO GG for medicine, 
2009 
Transparency Combines quantitative 
and qualitative 
indicators 
Specific to the 
pharmaceutical sector 
WHO toolkit to monitor 
governance as a building 
block, 2010 
Disease specific 10 rules-based indicators Does not reflect the quality 
of HSG as a whole 
Siddiqi Framework, 
2009 
10 principles of GG 








Governance Index, 2011 
Based on Siddiqi’s 
framework 
Governance index based 
on 42 arithmetic indices 
Complex and time 
consuming data collection 
process 
Lopez Framework, 2011 Six building blocks 
and five selected GG 
principles; problem-
driven approach 
Qualitative indicators No tracking of progress; no 
list of standard indicators; 
need to identify the problem 





governance at the 
national level 
Qualitative indicators No tracking of progress of 
governance over time; 
limited focus on leadership 
 
Several frameworks have been developed for assessing HSG; however, these are not 
widely used still (Lopez et al., 2011). Pyone et al. (2017), in their systematic review, 
identified 16 frameworks for the assessment of governance in health systems (including 
accountability assessments as well). The authors found that only five of these have been 
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applied in practice as the others were found to be lacking  the practicality needed or failed 
to achieve consensus with regard to their content. They concluded that there are gaps in the 
understanding of HSG, a lack of evidence as to the way in which it could be assessed in 
different settings, as well as a shortage of practical assessments.  
Some assessments have been criticised for being overly general, for instance, those 
developed by the UNDP and WB, which have been designed to assess governance in 
general rather than the health sector particularly (Kirigia and Kirigia, 2011; Kaufmann and 
Kraay, 1999), thereby overlooking the specificity of health systems (Siddiqqi et al., 2009). 
While other assessments are specific, such as the GG for Medicine (GGM) assessment, this 
was developed by the WHO to assess governance in the pharmaceutical sector alone 
(WHO, 2009). Other assessments concentrate on a single aspect of governance, such as the 
degree of corruption (Lopez et al., 2011), neglecting other key principles such as 
participation, transparency, and accountability, among others that have been theoretically 
identified as significant. Furthermore, some frameworks that assess overall governance 
within health systems are designed to be disease-specific or to evaluate vertical 
programmes such as HIV/AIDS, as in the case of the WHO toolkit, which was developed 
in 2010 (WHO, 2010; Lopez et al., 2011). Lopez et al. (2011) assessed HSG using the 
problem-driven approach, collecting qualitative data for specific problems that prevent 
health systems from performing well (for example, workforce absenteeism). Hence, a 
limitation of this framework is that assessment has to begin from a weakness in governance 
that has been diagnosed beforehand (Kirigia and Kirigia, 2011). Though evaluating the 
specific weakness suggested by the tool can offer a focused appraisal of the limitation, 
other issues in governance remain unaddressed (Kirigia and Kirigia, 2011). Moreover, with 
its orientation towards problem-solving, a pre-identified weakness signifies that this 
framework does not contain a standard list of indicators or established criteria that could be 
applied consistently across different policy areas and that would thus allow accounting for 
multiple dimensions of HSG (Lopez et al., 2011).  
According to Kirigia and Kirigia (2011), the "most comprehensive" framework to assess 
HSG to date is the one developed by Siddiqi et al. (2009). This framework, as mentioned 
previously, is organised around ten principles (Siddiqi et al, 2009). Despite its strengths, 
this assessment does not track progress or change, thus rendering comparisons between 
countries and assessment of improvement in governance over time within a given country 
difficult (Siddiqi et al., 2009). The authors suggested some modifications to the Siddiqi 
framework, in relation to the inclusion of a scoring system for inter-country comparison 
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with a proposed health development governance index (Kirigia and Kirigia, 2011). This 
index would contain the mean of 42 arithmetic indices. However, the calculation of these 
indices entails a complex and time-consuming process, necessitating the conduction of at 
least five national surveys, interviews with high officials in the focal country, as well as 
reviews and analyses of more than 20 national reports. Although it is important to have an 
assessment that can allow the assessment of changes over time, a practical assessment is as 
important as a meaningful and useful one. 
 
1.1.6 Need for a New Assessment Tool 
However, due to the limitations of the existing tools of health governance (Pyone et al., 
2017), there is a lack of simple and practical assessments to assess HSG in different 
contexts. In this regard, various organisations/institutions assess HSG differently owing to 
their dissimilar definitions of it. Hence, there is a need for a new tool to address some of 
the limitations and help bridge some of the gaps in the existing knowledge. In addition, 
policymakers also need to use the tool as a diagnostic aid to signal deficiencies in 
governance that require to be addressed. According to the theoretical perspective, tackling 
HSG deficiencies might result in enhancement in the management of the health system, 
that might have a possible positive impact on its performance. Furthermore, it might also 
allow the effective exploitation of resources in contexts in which their availability is 
particularly limited.  
In contexts in which governance in general and HSG in particular are perceived as 
important aspects of economic and social development (UNDP, 1997; Kaufman and 
Kraay, 2008), both in theory and as parts of the reporting mechanisms for international 
institutions and donors (Lopez et al., 2011; Siddiqi et al., 2009), robust and practical tools 
that facilitate the collection and evaluation of empirical evidence are vital to facilitate the 
understanding of HSG’s operation in practice (Pyone et al., 2017). Hence, this research 
concentrates on the development of a SMART governance tool, capable of analysing health 
governance, in a Specific, Measurable, Achievable, Realistic, and Timely manner (Bell, 
2004). 
The rationale behind the inclusion of a SMART tool (the same behind SMART objectives) 
is to offer users of the tool a specific scope, which is clear, simple, and consistent. This 
would enable the assessment of governance principles in a concrete manner with available 
data sources to achieve the tool’s objective in a realistic manner, without the necessity for a 
30 
large amount of resources (human, skills, and financial) and one that can be done in an 
acceptable time frame (Mannion, 1995). 
As HSG represents a multidimensional concept (Barbaza and Tello, 2014), as discussed 
above, one way to assess it is performing an in-depth analysis of specific principles (Fryatt 
et al., 2017). Thus, the tool should assess good practices to reflect on good “enough” 
governance that should be in place to reflect on GG (Grindle, 2004) in the health system. 
Good practices "are actions, methods, initiatives or innovative practices that might 
contribute to and help enable improving the performance of a given process within the 
health sector. It can serve as a model/example that other countries can become familiar 
with, adapt to their context and use" (USAID, 2007,p.17). The suggested application of the 
tool will be discussed in detail in the following chapters.  
The tool developed in this research will not be able to bridge all the gaps in theory and 
practice regarding HSG. This implies that it will cover only selected principles of 
governance, namely participation, transparency, accountability, use of information, and 
responsiveness (the following chapter will explain the reasons behind the selection of these 
principles). 
Thus, a baseline non-exhaustive list of questions will be included to identify the most 
important aspects of these principles constituting GG. Although existing research suggests 
a positive association between HSG and systems’ performance and health outcomes, this 
research considers what those selected GG principles would be and what would they mean 
for health systems seeking to adopt GG practices. 
 
1.2 Research Question 
How can the abstract principles of GG for health policy be rendered practically relevant to 
allow MoHs to assess their policymaking practices? 
In order to address this question, this research has focused on the development of a tool 
that can be employed as a part of policymakers’ repertoire. It is believed that it would 
enable them to learn about and reflect on existing practices in relation to the processes of 
governance.  
To summarise, HSG entails a cross-cutting function that has been often neglected, partly 
because there has been no consents with regard to its definition. Consequently, existing 
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assessment tools fail to provide effective practicable means to determine what GG entails 
in the health sector. This research concentrates on the designing and development of a new 
tool to assess HSG as well as testing its practicality for use by policymakers in health 
authorities.  
In chapter two, I present the research aim and objectives, purpose, and scope of the tool. 
Furthermore, I present the research design, which is in-line with the research objectives, 
with justifications for the approach selected.  
Subsequently, in chapter three, I will offer a description of the way in which the selected 
principles were conceptualised through an examination of the literature for their key 
characteristics, their definitions, and the way in which they were operationalised into the 
first draft of the tool, by providing examples.  
Furthermore, in chapter four, I explain the refinement and the development of the initial 
tool achieved through the Delphi consultations with experts conducted online. This would 
contain an explanation of the way in which the experts were identified and recruited, along 
with a description of the processes followed and how these experts refined the tool and 
their contribution to the content. In the last section in the chapter, I describe the review of 
the tool, undertaken by policymakers during a face-to-face consultation meeting and the 
importance of this feedback for modifying the methodology so as to enhance the tools’ 
practicality and to enable the presentation of its results in a meaningful manner.  
In chapter five, I discuss the pilot testing that was conducted to test the tool in a real 
setting. I provide the findings and recommendations presented to the national policymakers 
as well as the way in which the pilot demonstrated the tool’s usefulness and its impact on 
the final adjustments in the tool. 
In chapter six, I conclude with a reflection on the process that was followed to develop the 
tool, its contribution to the research, limitations, along with suggestions for future research.  
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Chapter Two 
Aim, Objectives, Scope and Research Design 
This chapter presents the aim, objectives, and the end product of the research. It includes 
the scope as well as justification for this research, the purpose of the proposed tool, its 
possible contributions and the context in which the tool can be employed. Moreover, this 
chapter outlines the initial planned research design and associates it with the objectives. 
The chapter concludes with a section concerning ethical issues that were considered and 
the ethical approvals that were secured.  
 
2.1 Aim, Objectives, and End Product of the Research 
2.1.1 Aim of the Research 
The aim of this research is to address the research question presented in the previous 
chapter through the development of a SMART tool to assess HSG, i.e., in a Specific, 
Measurable, Achievable, Realistic and Timely manner (Bell, 2004), which can be utilised 
by policymakers to identify whether or not the characteristics of the selected governance 
principles (participation, transparency, accountability, use of information and 
responsiveness) are present, and if they do, the way in which they are reflected in 
policymakers’ current practices in MoHs at the level of policy formulation.  
 
2.1.2 Specific Objectives  
1. To identify "key" GG principles and highlight their significance in health systems 
2. To identify, based on the literature, the way in which these key principles were 
conceptualised and their primary characteristics  
3. To operationalise these characteristics as they are applied in health policy 
formulation in a governance tool  
4. To refine and further develop the tool using the Delphi method to gain consensus 
on key characteristics that need to be assessed and obtain policymakers’ feedback 
to ensure practical application by end users. 
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5. To pilot test the developed tool with regard to its feasibility and practicality in 
collection of necessary data, usefulness of the results, and the recommendations to 
be generated.  
 
2.1.3 End Product of the Research 
The primary end product of this research is the Health Policymaking Governance Guidance 
Tool (HP-GGT). The secondary end product would be the methodological approach 
followed to develop a valid and practical tool that can be adopted by policymakers to 
assess HSG. 
 
2.2 Scope of the HP-GGT 
In light of the different levels of the health system in which governance plays a role, the 
several gaps involved in the assessment of HSG, and the difficulties entailed in addressing 
all these gaps in a single research study, the focused scope of this research in terms of level 
and unit of analysis, type of assessment, and the area of assessment has been presented in 
the following section. 
 
2.2.1 Level of Analysis 
The proposed tool is intended to assess "key" principles at the level of policymaking in 
health . Hence, the analysis of governance in policymaking in the health sector will take 
place at the national level. The decision to assess principles of governance at the level of 
national policymaking is founded on policymaking’s role in shaping the population’s 
health and as a major practice of MoHs in governance (LMG, 2012). This implies that 
health policy "constitutes those courses of action proposed or taken by governments that 
affect the health of their populations" (Blank and Burau, 2010, p.2). It refers to "all formal 
written documents, rules, and guidelines that present policymakers’ decisions about what 
actions are deemed legitimate and necessary to strengthen the health system and improve 
health" (Blank and Burau, 2010, p.2). 
The process of policymaking has been traditionally conceptualised according to different 
models and frameworks (Schlager et al., 2013). While many theories, models, and 
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frameworks describe the process, all of them share one aim, the simplification and 
explanation of the process’s complexity to facilitate its understanding (Schlager and 
Weible, 2013). These different approaches have considered the policy process from 
different aspects, with the earliest work identifying the different stages the process 
undergoes (Hill and Varone, 2016). Others investigated the actors involved, inputs, 
outputs, outcomes, and the interactions of all these elements (Nowlin, 2011). Other 
researchers have investigated the structure, including the context, institutions involved, the 
rules, norms, and strategies that regulate these institutions and their impact on policy 
outcomes. Furthermore, others have also analysed the events or problems that led to the 
creation of policy processes or hindered them, or they considered a combination of aspects 
related to these matters (Schlager et al., 2013; Nowlin, 2011; Hill and Varone, 2016). 
Finally, other researchers have described the policy process as a consequence of a learning 
experience from the past or an external shock received by the system (Nowlin, 2011), with 
strong external drivers and an emphasis on contingency and politics in shaping the 
windows of opportunities for policy change (Nowlin, 2011; Mintrom  and Norman, 2009). 
Each theory highlights important aspects, components of the policymaking process, 
excluding a lot more. These frameworks entail a matter of deciding or highlighting the 
aspects that need to be prioritised. However, this does not imply that other excluded 
aspects are unimportant. This is done as no framework can take into account all aspects. 
Accordingly, one model of policy process had to be included in the proposed framework, 
and the policy cycle was selected. This model is the most widely used one for describing 
the policy process; it provided the baseline for other frameworks that emerged afterwards 
(Jann and Wegrich, 2006). It has served as the starting point for a considerable amount of 
research focused on policymaking (Jann and Wegrich, 2006). Specifically, the policy 
process cycle framework describes the chronological order of the different policy stages, 
including agenda setting based on the prioritisation of policy issues (including problem 
recognition and issue selection), policy formulation of health policies and decision making, 
policy implementation in practice, and monitoring and evaluation of the policy (Anderson, 
1975). This framework provided a logical and "ideal" process, reflecting a 
continuous/circular and continuous policy process (Anderson, 1975). However, these 
assumptions concerning the policy process are not always true; often, there is no defined 
beginning or ending, and the stages overlap most of the times. Furthermore, sometimes, 
some stages are skipped as well, such as monitoring and evaluation, for instance Jann and 
Wegrich (2006). In the real world, different policy stages are not always distinct; they 
interact, overlap, and sometimes, even contradict each other in a complex and 
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unpredictable manner (Hallsworth and Rutter, 2011). Thus, despite its wide application and 
acceptance, the policy process cycle has received some criticism mainly in relation to it 
being a simplified and unrealistic model that does not specify actors, institutions, or 
problems involved in the policy process (Knoepfel et al., 2007). However, the policy 
stages model was used by other researchers as it was found to be relevant for assessing 
HSG at the national health policymaking level whether at the formulation or 
implementation stage (Siddiqqi et al., 2009; Kirigia et al., 2011). 
The proposed tool will focus only on the policy formulation stage of the health policy 
process (implementation was included in the original plan and was subsequently removed 
as it was thought that its inclusion would make the research too extensive given the 
mandated size of the thesis). It is acknowledged here that in real practice, it is difficult to 
separate formulation from implementation due to the overlapping of these steps and the 
actors involved; furthermore, a key limitation of the tool is that it is not linked to other 
stages of the policy cycle. However, it is not uncommon to focus on a particular stage of 
the policy process rather than on the whole policy cycle (Howlett, 2011). Concentrating on 
a single stage of the policy cycle was found to be useful for improved understanding of that 
stage as it offers details concerning its importance, as a prerequisite to other stages as well 
as its influence on subsequent stages and policy outcomes (Warghade, 2015; Sidney, 
2006). This does not imply that the other stages are not as important as a given stage. 
However, the stages of agenda setting, implementation, evaluation, and monitoring fall 
beyond the scope of this research and can be assessed in future research.  
The policy formulation process is a complex and essential stage in the policy process as it 
concerns transforming all issues prioritised during the agenda setting stage into a 
policy/plan or a programme to be implemented (Turnpenny et al., 2015; Jann et al., 2006). 
Policy formulation involves determining the objectives of the policy and the way in which 
these objectives can be achieved, whether formally, in terms of relevant legislation and 
regulatory frameworks, or informally (Sidney, 2006). It also includes the collection and 
analysis of relevant information, using evidence, building networks with all relevant 
stakeholders, and resolving any conflict that may arise between the different actors who are 
affected by the policy, whether in a positive or negative manner (Hill, 2013). Thus, policy 
formulation constitutes “a critical phase of the policy process” (Sidney, 2006). Moreover, 
policy outcomes most likely depend on the process that was followed to formulate the 
policy in question (Sidney, 2006). If policies fail, the consequences might be substantial 
with respect to health outcomes and people’s trust towards their governments (Hallsworth 
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and Rutter, 2011). Assessing the policy formulation phase using policy formulation tools 
can help improve the future policymaking process (Sidney, 2006). Thus, following a good 
policymaking process should be an aim in itself for policymakers (Hallsworth and Rutter, 
2011), who usually do not acknowledge the importance of the quality of the process 
(Hallsworth and Rutter, 2011). Moreover, limited research has been undertaken to evaluate 
the way in which policies are formulated (Howlett , Tan, Migone, Wellstead and Evans, 
2015).  
Practising GG at the policy formulation level is essential because it has the potential to 
impact all other stages of the policymaking process (Howlett et al., 2015), given that all 
other factors that might affect the policy process remain unchanged. This research 
approaches the policy formulation as a matter of simple incremental analysis, a limited 
analysis of one policy stage (or it could be an analysis of a single policy goal, alternative, 
or consequence) (Lindblom, 1979). The incremental analysis is usually employed when the 
aim is to understand a complex subject that entails a large number of processes and factors 
focusing on partial or one aspect of the process under evaluation, which is a common 
practice (Lindblom, 1979). This is true for this research, which focuses only on policy 
formulation and the five principles of GG.  
Policy formulation tools are generally employed to assess practices and processes at the 
policy formulation level to help policymakers identify strengths and weaknesses and thus 
improve future policy formulation processes (Howlett et al., 2015). The policy formulation 
tools used in the health sector and in other fields range from brainstorming, consultation 
exercises, expert judgments, focus groups (extremely flexible methods with no 
standardised processes), to risk analysis, checklists, scenario analysis, cost-benefit analysis, 
and cost-effectiveness analysis (based on rigid structures, standardised methods, and 
equations) (Howlett et al., 2015). This research involves the introduction of a "new" policy 
tool, namely the HP-GGT. I would classify the HP-GGT as falling between these two 
categories of tools as it combines expert opinion and is also based on checklists (this will 
be discussed in detail in the section below). This implies that it is a practical tool, yet it is 
based on a list of GG/good quality policymaking characteristics developed by drawing on 
the literature and experts’ consensus.  
The intention was to design a tool that was sufficiently flexible to allow the analysis of the 
governance processes involved in the policymaking of any type of health policy, which has 
been recently formulated and implemented in a country. The tool is generic in terms of the 
policy type, and it will focus on the policy process and not the content of the policy or its 
37 
technical capacities; it concerns assessing the policy formulation process from the 
perspective of governance. It is not claimed that the tool is universally applicable; 
however, it is sufficiently flexible to allow a few adjustments so as to make it relevant to 
the context of the country it will be used in. The tool needs to be deployed in different 
countries with different contexts to ascertain whether it is practical and applicable. It can 
be used to initiate change (Mintrom and Norman, 2009), identify weaknesses if there are 
any, and thus, facilitate the improvement of the policy process (Mintrom and Norman, 
2009). It can help inform policymakers about ways to improve the policymaking process, 
but it cannot control the context in which the policy formulation takes place. This tool can 
be employed as an instrument for reflection, that is, it is recommended that policymakers 
reflect on the way they take actions; reflexivity is necessary on the part of policymakers, 
yet it is rarely exercised (Hallsworth and Rutter, 2011). In sum, the tool will help 
policymakers consider their policymaking practices and their relation to the list of "good 
practices" contained in it.  
The complexity involved in processes of health-related policymaking and improving the 
policy formulation process has been recognised (Hallsworth and Rutter, 2011). However, 
the betterment of one aspect (governance structure at the policy formulation level) can lead 
to the enhancement of the other aspects as well as the process itself and can thus contribute 
to improved outcomes in implementation (Knoepfel et al., 2011; Fryatt et al., 2017). 
 
2.2.2 Unit of Analysis 
MoHs or health authorities should play the most important role in governance in the health 
sector. Health governance is related to MoH or health authorities’ capacity to formulate 
and implement policies effectively (WHO, 2009), oversee the overall health system, 
encourage stakeholder participation, be responsive to the population’s needs, as well as 
ensure regulations, accountability, and transparency (USAID, 2012). MoHs/health 
authorities are responsible for promoting and maintaining the well-being of the population 
through their role in the regulation and policymaking (Veillard et al., 2011). Hence, the 
unit of analysis for this study will be the MoH or health authority (whether at the central or 
the peripheral level in decentralised systems) in a given country. This assessment will 
evaluate MoHs or health authorities’ ability to fulfil their function in health governance in 
practising GG in the formulation of health policies. It will assess MoH or health authority-
led policymaking processes. The influence of contextual factors (discussed below) on 
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policy formulation cannot be overlooked, especially in developing countries (Warghade, 
2015), and thus, it will be covered  through perception-based questions (also discussed 
below).  
As stated here, the scope of the tool entails focussing on the way in which MoHs or health 
authorities facilitate and steer the policymaking process, which signifies paying attention to 
their procedural capabilities (processes and inputs) (Fukuyama, 2013) and not performance 
(output/content of the policy) (Rotberg, 2014). Furthermore, Fukuyama (2013) suggested 
that there are four approaches to assess governance in the domain of public policy, and 
these are procedural measures, capacity measures, output measures, and bureaucratic 
autonomy. The study of procedural capacity aims to shift the attention from measuring 
only the health system’s performance and service delivery outcomes (for which, an 
enormous number of assessments are available (OECD, 1998; 1999; AHCPR, 1999; 
Knowles, Leightan and Stinson, 1999; Murray and Frenk, 1999)). The evaluation of the 
"execution" process and health authorities’ ability to perform one of their essential 
functions, policymaking (Fukuyama, 2013; Rotberg, 2014), has not been given much 
attention by international organisations.  
This assessment will be used as a guidance tool to identify the strengths as well as 
weaknesses in the practise of governance, prioritise key areas for improvement, and offer 
practical recommendations for the institutional strengthening of MoHs/health authorities to 
enable them to perform their function. The tool can be utilised by policymakers in LMICs 
or by international organisations interested in improving the governance of policymaking 
at the national level as a step toward the enhancement of HSG in practice. In conclusion, 
the potential targeted users of this tool are policymakers in the government sector, 
specifically, those within MoHs or health authorities.  
 
2.2.3 Context of the Analysis 
Since the level of analysis involves the national policymaking process, contextual factors 
and the policy environment that affects the health policymaking process should be closely 
examined. These contextual factors include political, economic, social, cultural, historical, 
local, regional, national, and international factors (Walt and Gilson, 1994; Buse, Mays and 
Walt, 2012). These factors affect the environment in which HSG operates and render the 
policymaking process complex (Buse et al., 2012). In general, LMICs are known for their 
political instability or uncertainty, disrupted operation of the health sector (due to wars and 
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natural disasters), constant reforms, state bureaucracy, economic constraints, strong 
cultural influence, weak institutional capacities, weak regulatory and legislative systems, 
strong private sector, inter-dependency of international funding and technical cooperation, 
influence of global threats, foreign policy, relationship between administrative (civil 
servants) and political decision makers, power struggles between "winners and losers" due 
to the policy, and lack of evidence-based information to inform policy (Walt and Gilson, 
1994; Gilson and Raphaely, 2008; Walt , Shiffman, Schneider, Murray, Brugha, and 
Gilson, 2008; Buse et al., 2012; Hill et al., 2016). ` the same policymaking and governance 
style. These contextual factors can affect the policy making process positively or 
negatively (May and Jochim, 203) and thus should be taken into consideration (by both 
researchers developing governance assessment tools and policymakers who wish to assess 
it) in the evaluation of the policy processes and HSG as they reflect on the reality of HSG’s 
application. In this research, I suggest that the tool can be applied in more than one context 
and by different countries. 
 
2.2.4 Type of Assessment  
It is important to track progress and improvement in the quality of governance over time 
(Buckingham, 2004). This is necessary to enable the identification of the elements that are 
present or absent or practised or not practiced in relation to governance. However, this 
assessment  would offer only a crude analysis of the complex phenomenon that requires 
further exploration. Taking into account the contextual factors (discussed above) that will 
affect the environment in which HSG processes are realised is essential in any assessment 
of governance to complement our understanding of the way in which  things work in 
practice (Reeves et al., 2008; Bryman, 2016). The assessment tool is designed to track 
progress and improvement over time as well as offer an explanation of factors that 
contribute to the quality of governance, based on checklists after interviewing 
knowledgeable key informants (KIs) regarding these practices and their responses, which 
would be validated by supporting evidence. The tool will be based on evidence collected 
through relevant document analysis, and the list of documents reviewed will be included in 
the final report of the assessment to offer a verification of the findings/conclusions if 
required (for instance, by donors to ensure that the claims of GG practices are valid). This 
will provide context-free summaries of governance practices, thus allowing the tracking of 
change over time. Using simple tools that include checklists and questionnaires (such as 
HP-GGT) for policy formulation analysis is a common practice (Turnpenny et al., 2015). 
40 
Furthermore, the tool will also be able to capture the context in which HSG operates by 
asking the same KIs regarding their perceptions of the governance process and factors that 
affect policymaking.  
 
2.2.5 What Will Be Assessed?  
According to the framework developed by Siddiqqi et al. (2009) (the most comprehensive 
one to date, as discussed in chapter one), there are 10 principles (also mentioned there) 
relevant to health sector. This framework has undergone international peer review and thus 
enjoys a high level of conceptual agreement among experts in the field (Siddiqqi and 
Jabbour, 2012). The thoroughness of this framework and its principles have been 
documented by others (Kirigia and Kirigia, 2011; Lopez et al., 2011). Hence, it forms a 
logical starting point for this research  . However, this research will focus on only five key 
principles of governance: participation, transparency, accountability, use of information, 
and responsiveness. In this subsection, the rationale behind the selection of these five 
principles has been given.  
This decision was made, primarily, for reasons of practicality: I had to determine an 
"acceptable" number of principles to focus on while ensuring that the scope of the tool was 
not too narrow or wide. Certainly, other studies have reported the average number of 
principles investigated as five (Ruhanen et al., 2010). Second, I decided to focus on "key" 
principles based on their importance in the health sector as reported in literature. 
According to Siddiqi and Jabbour (2012), the key principles of governance in a health 
system include participation, transparency, and accountability. Nearly all the existing 
assessments acknowledge the importance of these three principles for HSG (Barbaza and 
Tello, 2014). Participation is believed to enable citizens to influence decisions that concern 
the health services they receive and consequently their health, which can result in 
improved health outcomes in the long run (Labonte, 2010). Transparency is considered an 
important component of any reform as it is critical to policymaking, resource allocation, 
health performance, and increased accountability (NAO, 2012). Accountability has been 
found to be an issue that needs to be addressed in public health governance since it is 
usually neglected despite that fact that it has direct implications in the performance of 
health systems (Marks, Cave and Hunter, 2010). Increasing accountability within the 
health system will ensure the proper utilisation of resources, leading to improved service 
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delivery (Brinkerhoff, 2004). The presence or absence of these principles itself serves as an 
indicator of other governance principles (Barbaza and Tello, 2014).  
Ciccone et al. (2014), based on a literature review concerning the possible association of 
governance mechanisms to health outcomes, concluded that "encouraging participation and 
applying accountability at all levels of the health system may be more likely to improve 
health" (Ciccone et al., 2014, p.94). This assumption regarding the association needs to be 
further explored by more research in order to confirm the type of relationship between 
governance principles and health outcomes.  
The generation and use of information allows transparency in addition to the promotion of 
evidence-based practices (Lavis , Posada, Hanines and Osei,2004). Hence, the assessment 
of the utility of information within the health systems is as important as the assessment of 
transparency as the former is considered a part of the latter. In addition, the organisational 
capacity to collect and disseminate information is essential for any policy formulation 
process to produce evidence-based policies (Howlett and Ramesh, 2016). According to 
Fryatt et al. (2017), particular attention should be given to the generation and 
dissemination of information due to the asymmetry of information among all stakeholders 
in the health sector, policymakers, the private sector, and the public (WHO, 2009). 
Responsiveness is considered a basic human right, indicating that by catering to the 
legitimate needs of people will help improve their well-being, which is a goal of health 
stewardship (Gostin, Hadge and Valentine, 2003), one that is not frequently assessed 
(Darby, Valentine, Murray and Desilva, 2000, p.2). 
Apart from the assumption that improving governance might have a positive influence on 
the health system’ performance and its outcomes eventually, it also might have a positive 
effect on the policymaking process itself. According to the Institute for Government’s 
report on "Making Policy Better", seven elements are essential for an effective policy 
formulation process: proper engagement, setting roles and accountability mechanisms, 
transparent goals and ideas (Hallsworth and Rutter, 2011). Encouraging participation in the 
policy process might facilitate building public trust in the process and the subsequent 
decisions (Bevir, 2008). Accountability, transparency, responsiveness to the public’s 
needs, and consensus of all involved contribute to the quality of public policymaking 
(Bevir, 2008). Additionally, the public policy process should be open and based on 
evidence (Hallsworth and Rutter et al., 2011). Evidence-based policymaking involves the 
collection as well as the dissemination of information that will be used in the formulation, 
implementation, and evaluation of policies (Howlett et al., 2016). Applying these 
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principles at the policymaking level might result in improved policymaking (Hallswarch et 
al., 2011). Furthermore, practising GG at the policymaking level might result in an 
enhanced policymaking process, which is valuable for the policymakers themselves, even 
if it does not lead to in better health outcomes.  
Again, focusing exclusively on the application of these principles in policymaking does not 
imply the constraints of practical implementation and the role of politics in policymaking 
has been left unacknowledged; it has been done to gain a simplified perspective in order to 
have a starting point for improving the quality of health governance at the national level. 
Hence, the five principles (participation, transparency, accountability, use of information 
and responsiveness) were selected after conducting the literature review, in which these 
presented the most emphasised ones. This fulfilled objective one of the research which is 
to identify key GG principles and highlight their significance within the health system. 
According to Bovarid (2005, p.223), "all GG principles are important, however, they are 
not all equally important to all stakeholders in all contexts". Additionally, it is not 
necessary that all of these principles will lead to the resolution of all governance problems 
because in practise, they do not work in isolation, in the absence of other GG principles 
that have not been discussed in this research (such as rule of law, ethics, and other 
principles).  
As discussed in chapter one in relation to the definition of GG in terms of its principles and 
the approaches adopted by various organisations to "list" what constitutes governance, I 
decided to take this approach a step further in this research to explain the selected 
principles in further depth to facilitate assessment and understanding. This result is 
consistent with the recommendation of the systematic review conducted by Pyone et al. 
(2017), which stated that there is a need to explore the principles of GG extensively to gain 
a better understanding of HSG.  
Not all questions included in the tool will be relevant or applicable to all different countries 
as it has been developed as a generic tool and can be adjusted based on the context. The 
aim is not to have a perfect tool but a good, usable and useful tool. The tool will cover only 
a sub-level (health policymaking at the MoH level) in  which health governance has a role, 
as discussed in this chapter. 
This study can be considered as a pilot for the development and construction of an 
assessment of the five focal principles; the same approach can be adopted to develop 
assessment tools for the remaining principles at a later point. 
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2.3 Purpose of the Tool: Its Contributions and Implications 
The purpose of the research is to offer a practical tool that can be employed to assess the 
way in which MoHs or health authorities are governing the health policymaking process as 
well as offer a roadmap regarding ways to improve the process. This tool will be useful for 
policymakers in identifying the weaknesses, detecting changes, and demonstrating 
progress (WHO, 2010). 
The use of such a tool can be perceived as a starting point for creating a policy dialogue 
between policymakers and other stakeholders regarding an important, sensitive issue , with 
the aim to promote GG/practices, initiate and enable change, as well as offer a learning 
opportunity for all involved (WHO, 2009).  
The contribution of the tool is a focus on selected key governance principles and their 
major characteristics identified in the literature, which are aimed at promoting a common 
understanding of governance principles and their major characteristics. Specifically, a 
literature review was performed to determine the major characteristics and relevant 
concepts of the selected governance principles, which are directly relevant to the health 
sector, to gain a better understanding of the way in which these principles can contribute to 
the quality of HSG at all levels (a summary of the findings from the literature search will 
be presented in chapter three). The purpose of this step was to go beyond the traditional 
approach of merely listing the relevant principles of governance, by exploring their 
primary characteristics and components for better conceptualisation. The main 
characteristics of the principles are readily available in the literature; however, they are not 
employed comprehensively in other health governance assessments. This research 
attempted to compile the central characteristics that need to be validated during the Delphi 
consultations (discussed in chapter four). The characteristics identified for each 
governance principle provided a definition of that principle and was thus utilised as a 
guideline for best practices to be followed to achieve GG (see chapter three). 
It is expected that the use of the tool will encourage participation, transparency, 
accountability, and use of evidence. It will facilitate the identification of critical 
weaknesses and gaps that need to be addressed and improved at later stages. Furthermore, 
it should be considered as a guidance tool as well as an instrument for assessment. It does 
not only evaluate whether GG principles are practiced or not but also offers guidance 
regarding a list of "good practices" that can be followed to improve the quality of HSG at 
the policy formulation level. In conclusion, the developed tool is based on a checklist of 
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good practices that can be followed to enhance the quality of governance, and it is 
expected that it will produce evidence regarding the way in which policymaking processes 
are realised (Warghade, 2015). 
 
2. 4 Research Design  
The research design involved a step-wise approach, focusing on the development and 


































Figure 1: Research Design 
 
Development and Testing 
of Assessment Tool 
1. Conceptualisation 
- Exploring Main Characteristics of Selected HSG Principles 
- Development of Checklists of Characteristics of Principles 
 
2. Operationalisation 
Development of Analysis Tool/Indices 
- Selection of Items to be Assessed 
- Determination of the Type of Questions 
- Question Weighing  
- Deciding on the Final Length of Indices 
 
3. efining the Developed Tool  
- Delphi Method Consultation with Experts 
- Validity Testing 
 
4. Pilot Testing 
 
5. Final Feedback from Policymakers on the Tool 
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The following subsection contains an outline of the initial planned research steps, which is 
accompanied by justification for these, the following chapters will comprise detailed 
description of the methodology in detail. 
The initial study design included five steps that have been grouped into three stages. 
 
2.4.1 Conceptualisation of the Principles of HSG 
The diversity of the definitions of governance renders it a "conceptually rich" subject. 
Moreover, governance cannot be measured directly due to the lack of tangible criteria that 
can be included for comparison (Andrews, 2008). However, various agencies/organisations 
that deal with governance have identified different lists of principles that contribute to its 
quality and the reason behind it being classified as "good governance" (UNDP, 19; 
USAID, 2008; WHO, 2009). Governance has been defined as a set of interrelated 
principles. Detailed knowledge regarding governance and its principles forms an essential 
step in the development of a valid and usable assessment tool (Devellis, 2003). 
Conceptualisation is a standard step employed in the social sciences, especially with 
concepts that are abstract and ill-defined (Mueller, 2004), such as governance.  
I decided to work on the conceptualisation of the principles due to the lack of a common 
understanding of what each principle entails in practical terms and the way in which they 
can be applied at the level of health policymaking. This step was critical to this research to 
identify the central characteristics and aspects of the key principles. This step is required to 
fulfil the second objective, understanding  from the existing literature the way in which 




The step following the conceptualisation was focussing on the operationalisation of these 
principles in a manner that would enable their assessment (Devellis, 2003). 
Operationalisation of governance and its principles should reflect a theoretical 
understanding of these concepts, thus advancing from abstract concepts to assessable 
variables (Mueller, 2004). In order to operationalise the principles that need to be assessed, 
appropriate questions should be developed for inclusion in the tool.  
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Since governance is a multidimensional concept and its principles, in turn, have various 
defining characteristics, it cannot be assessed with a single measure; rather, 
multiple/composite measures are required, which can supply rigour to the analysis 
(Mueller, 2004). Accordingly, an index was required for each of the governance principles 
selected. Each index would comprise a list of questions that cover the primary 
characteristics/key elements of these principles, which are summarized in the checklists 
developed as a part of the conceptualisation step (further details are provided in chapter 
three) (Devellis, 2003). This operationalisation step enabled the proposal of an initial draft 
for the tool, thus fulfilling objective number three, the operationalisation of these 
characteristics as applicable in health policy formulation to facilitate assessment.  
 
2.4.3 Refinement and Further Development of the Tool  
The Delphi method was identified as the most suitable way to refine and validate the tool; 
it forms a recommended research approach in concept/framework development (Okali and 
Pawlowski, 2004), which is the case in this research. The Delphi method was introduced in 
the 1950s as a technique when experts’ consensus was required on a complex issue 
(Hasson, Keeney and Mckenna, 2000; Okali and Pawlowski, 2004). It has been utilised in 
many fields, including business and management, information systems and technology, 
defence, industry and commerce, education, medicine, as well as, nursing and health 
(Kirigia, 1997; Kalaian and Kasim, 2012). It constitutes a suitable research method for 
studying complex subjects that have a limited number of experts (Okali and Pawlowski, 
2004), such as governance, and maximising the content validity of a newly developed tool 
(Devellis, 2003). It is considered a flexible and appropriate method that does not require a 
face-to-face meetings of expert panels;  discussions can be conducted virtually (Okali and 
Pawlowski, 2004).  
This method is employed to seek experts’ opinions in order to gain a better understanding 
of the concepts (Okali and Pawlowski, 2004) underpinning the topic under study and other 
useful information. Since there is a lack of standard assessment tools and no consensus on 
the normative principles of HSG, I decided to further refine my initial tool through this 
method. The Delphi method was also selected due to other reasons. First, it allowed 
gaining consensus regarding what constitute good practices for the principles of 
governance. Second, it could provide insights regarding the way in which these principles 
relate to policymaking processes and practices (Okali and Pawlowski, 2004). Third, the 
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choice of the Delphi method over other means of face-to-face discussions or interviews 
was made with the aim to involve as many governance experts as possible from all around 
the world at the minimal possible cost. The detailed Delphi process will be discussed in 
Chapter Four.  
Developed assessment tools should be valid and reliable (Mueller, 2004). The individual 
questions as well as the tool as a whole require to be valid and reliable in different 
contexts. We needed to test if the conceptualisation appears meaningful to others. 
 
• Validity Testing 
The developed assessment tool should correctly capture the concepts it is intended to 
assess with minimum bias possible (Mueller, 2004). The developed tool was subjected to a 
series of validity tests, including face validity, content validity, and construct validity 
(which will be discussed in Chapter Four).  
 
2.4.4 Pilot Testing 
Pilot testing of the developed tool represents an important step, conducted to assess its 
feasibility in practice, in terms of consistency, ease, and speed of data collection, among 
other things (Campbell et al., 2003), and it pertains to fulfilling objective five of this 
research. Piloting is a key test for the tool’s applicability/utility in real settings (Campbell 
et al., 2003). It was conducted in Lebanon, which is classified as a middle-income country, 
and where, as a resident and worker in the health field, it was practical to conduct this test. 
Details of the pilot testing have been offered in Chapter Five.  
 
• Reliability Testing 
A reliable tool is one that produces the same results when repeated with minimum error 
(Mueller, 2004). To be reliable, a tool should exhibit internal consistency (Devellis, 2003). 
In other words, the questions included in the tool should be homogenous and inter-
correlated to each other (Devellis, 2003). The questions should be causing each other or 
have a common root cause to prove that they assess the same principle (Devellis, 2003). 
There are several methods to test reliability, which should be ascertained as a part of the 
pilot phase, as explained in chapter five. Other factors such as acceptability and the opinion 
of KIs were also tested (Campbell et al., 2003) during the pilot test. 
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2.4.5 Final Feedback on the Tool 
A consultation meeting was conducted in the presence of some of the Delphi experts who 
were consulted in the initial research and others in order to present the final tool. This is 
known as the RAND method, which involves combining Delphi consultations with a 
subsequent face-to-face panel meeting for the final evaluation of newly developed 
assessment tools in order to ensure quality (Campbell, Braspenning, Hutchinson and 
Marshall,2003). The details of the consultation meeting will be discussed in Chapter Four.  
 
2.5 Ethical Considerations and Approvals  
As mentioned earlier, the study involved consultations with Delphi experts during the 
refinement phase of the tool, data collection through a desk-based review of pertinent 
documents and interviews with relevant stakeholder KIs in the health sector as part of the 
pilot testing phase. Hence, no significant ethical issues were anticipated. Although the 
Delphi experts were told the names of other experts who were willing to participate, their 
responses were kept anonymous, and hence, quasi-anonymity was maintained. The 
experts’ consent to these measures and whether their names could be published in the final 
thesis was requested through email. They were also informed that even if they agreed to 
participate, they were free to withdraw at any time during the Delphi process.  
Additionally, the research included interviews with relevant KIs as part of the pilot. An 
official letter or email was sent to these potential participants for permission for an 
interview with an explanation of the purpose behind the test. The letter included a request 
for informed consent to participate in the pilot. It also stated that confidentiality and data 
protection would be respected throughout the study.  
At the beginning of each interview (during the pilot test), the participants were asked to 
read and sign an informed consent form. They were assured of confidentiality and were 
informed about the right to withdraw at any time during the interview. Permission was 
requested to record the interview on tape. Furthermore, consent was requested from each 
participant to contact them in the future if necessary for further clarification or 
triangulation of the results obtained. The participants were also informed about the way in 
which the data would be stored and used. In this regard, the questionnaires, signed 
consents, audios, and other field/interview notes were physically stored in a secure manner, 
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and only the principal investigator had access to them. The other study documents will be 
stored for at least three years after the end of the study. The answers of KIs were coded, 
and no identifiable information related to the participants was recorded. Hence, no link can 
be made between identifiable information and participants’ coded responses.  
The study involved obtaining and processing personal data related to the participants, (e.g. 
recording interviews with them), and hence, the Data Protection Act 1998 had to be 
adhered to throughout the research. Lastly, the results reported in this document and any 
other publications were guaranteed to be anonymised. 
Lebanon does not have a formal national-level ethical committee for research approval. 
Hence, a proposal was submitted to the Lebanese MoH, and the approval to conduct study 
was obtained in writing. An application for ethical approval was also submitted to the 
School Research Ethics Approval Panel (SREAP) at Bath University and was secured as 
well.  
To summarise, this chapter has presented the aim, objectives, and purpose of the research, 
the scope of the proposed tool, as well as an explanation of the research design.  
In the following chapters, chapters Three, Four and Five, I discuss the five steps and 
explain the way in which the research design was executed as a three-stage process. 
Furthermore, a description of the way in which the different research phase contributed to 
the tool in terms of content, structure, and methodology to conduct the tool. 
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Chapter Three  
Developing the Assessment Tool 
This chapter explains the purpose of the first phase of the research, the conceptualisation of 
the governance principles and the way in which this was accomplished through the 
literature review. Additionally, this chapter includes descriptive summaries of the findings 
of the literature review rather than a critical analysis. It also includes the checklists and the 
framework proposed, both of which guided the operationalisation of the principles and 
their component elements as well as the way in which they were transformed into concrete 
questions that formed the first draft of the tool. 
 
3.1 Conceptualisation of the Principles of Health System Governance  
This chapter identifies the concepts and characteristics found in the wide range of literature 
that covers governance principles as a first step towards achieving a better understanding 
of the principles that constitute GG. Detailed or in-depth conceptualisation of the concepts 
under study can strengthen the tool’s validity (Mueller, 2004). Not only is governance a 
broad and relatively abstract term, its principles can have different implications (Barbaza 
and Tello, 2014), that is, their application can signify different things to different people, 
which presents a major challenge in the development of a tool to assess these principles. 
As discussed in Chapter One, the primary characteristics of the principles are readily 
available in the literature; however, they are not explored in depth nor used extensively in 
the health governance literature. A literature review, conducted to compile and summarise 
the findings, included searching for the concept of governance and its selected individual 
principles in the literature on health and other fields in general as well as considering 
health policymaking specifically.  
 
3.1.1 Search Strategy Employed 
The search was limited to articles written in the English language, and the following 
databases were searched: PubMed, Scopus, Embase, Web of Science, Social & Political 
Policy, Cochrane Library, and Google Scholar. The literature review was conducted using 
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different terms for governance, including governance, governing, stewardship, and 
leadership. 
First, a search was conducted with governance-related terms in combination with 
definitions, frameworks, models, assessment, measurements, and indicators; the aim was to 
identify articles from different fields. Then, these were combined with terms related to the 
health sector, such as health system, healthcare, health reform, health system 
strengthening, health system performance, and health policymaking. Subsequently, the 
governance terms were combined with relevant terms related to principles, including 
elements, components, concepts, attributes, aspects, accounts, domains, and dimensions. 
Various combinations of key words were utilised with "AND, OR". 
After nearly a year of researching on governance in general, I decided to focus the tool 
around the five principles mentioned earlier (based on reasons discussed in Chapter Two), 
and thus, the literature search was further expanded to include term. The search terms used 
were:  
• For participation: Participation, engagement, representativeness, active citizen, 
community participation, multi-disciplinary participation, partnership, citizen 
voice, consensus orientation, stakeholders, interest groups, involvement, 
collaboration, inclusive, and coalition building;  
• For transparency: Transparency, openness, and disclosure;  
• For accountability: Accountability, oversight, answerability, and sanctions; 
• For use of information: Information, intelligence, research/research-informed, 
research utilisation, evidence-based, knowledge management, and knowledge 
translation;  
• For responsiveness: Responsiveness, responsive, population/public requirements, 
and legitimate requirements.  
 
Furthermore, the search terms employed were combined with governance (as well as other 
relevant terms), health (combined with other relevant terms), as well as the terms policy, 
policymaking, and policy formulation.  
The websites of international organisations were searched, including those of WHO, 
UNDP, WB, and USAID. Finally, a manual search for citations of the identified articles 
was conducted. Based on this search, the conceptualisation of the principles and their 
characteristics were identified and have been detailed below.  
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In the following section, I have summarised the findings from the literature concerning 
different aspects of governance principles that I found relevant to health policymaking. 
The characteristics/components outlined below represent the "ideal" norms of governance 
principles that should be promoted to achieve GG. These characteristics/components 
cannot be easily implemented in real-world practice due to a lack of understanding 
concerning exactly what and the way in which they contribute to the quality of governance, 
difficulties involved in the application of abstract concepts in practical terms, and the 
negative aspects that may be associated with their application. The negative aspects have 
been discussed at the end of each principle’s coverage. This research involves 
conceptualising these characteristics/components in a simplified manner to allow their 
assessment and enable policymakers to implement them to the extent possible. The 
summaries given below does not emphasise what is more important, more central, or vital 
out of these aspects for inclusion in the assessment. The critical analysis of the different 




Participation is all about empowering communities/citizens to exercise a role in decisions 
that affect their lives and in the policymaking process to reach common goals (Labonte, 
2010). It involves the ability to work together effectively and create a space in which 
groups with varied interests and roles have an opportunity to participate, voice their 
position, and negotiate policies (Dieleman, Shaw and Zwankkon, 2011). Siddiqi et al. 
(2009,p.18) stated that "all men and women should have a voice in decision-making for 
health, either directly or through legitimate intermediate institutions that represent their 
interests. Participation is associated with freedom of association and speech, as well as 
abilities to participate constructively when possible on health policies and procedures". 
• Types of Participant 
It is important to identify the potential participants in policymaking before describing the 
participation process and the factors that affect it. Since the assessment will be concerned 
with governance at the level of health policymaking (formulation phase), theoretically, all 
actors involved in this sector should participate in the process. Mutale, Mwanamwenge, 
Balabanova, Spicer and Ayles (2013) wrote about three major categories of actors in any 
health system: government/state actors, providers, and beneficiaries/clients. USAID (2008) 
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further clarified these three categories. State actors include politicians, policymakers, and 
other government officials (including high and middle-level officials), in addition to public 
health sector agencies such as MoHs, health and social insurance agencies, as well as 
public pharmaceutical procurement and distribution entities (USAID 2008; WHO, 2009). 
Other public sector actors apart from the health sector include parliamentary health 
committees, regulatory bodies, ministries of finance, various oversight and accountability 
entities, and the judicial system (USAID, 2008; Labonte, 2010). Health service providers 
include a mix of public, private, and voluntary sector providers working in a variety of 
institutions, such as hospitals, clinics, laboratories, and educational institutions in addition 
to other organisations such as insurance companies, health maintenance organisations, 
pharmaceutical industry, equipment manufacturers, and suppliers (USAID, 2008). 
Beneficiaries are service users/patients, guardians of patients, and the general public 
(Brinkerhoff and Bossert, 2008; Mitton, Smith, Peacock, Evoy and Abelson, 2009), 
laypersons, and taxpayers (Papadopoulos and Warin, 2007). Other diverse groups of actors 
who can contribute to policymaking include journalists (media), academia/researchers, 
think tanks, champions, non-governmental organisations, advocacy groups, and interest 
groups (who are directly or indirectly affected by a given policy) (Brugha and 
Varvasovszky, 2000; Bennette, Corluka and Aikins, 2012; Smith and Katikiredali, 2013). 
Further people who may have a role in the health sector, as mentioned in the literature, 
includes donors/funders, who might have a role in policymaking process at the national 
level (Dieleman, Shaw and Zwankkon, 2011), vulnerable groups (poor and marginalised 
factions of the society) (Brinkerhoff and Bossert, 2008), and women.  
Thus, the proposed tool needs to identify the types of participants, for policymakers and 
health authorities, that need to partake the process. However, an assertion of prominence 
among participants and the various roles that they might play in the process of 
policymaking is beyond the scope of the tool.  
• Benefits of Participation 
The importance of participation with regard to different aspects of health for policymakers 
and other stakeholders has been reported in the literature (Monza and Cook, 2002; 
Papadopoulous and Warin, 2007; Labonte, 2010; Dieleman, Shaw and Zwankkon, 2011). 
It allows participation in the health sector, in general, and in the policymaking process, in 
particular, with numerous advantages. Dieleman et al., (2011) assert that it ensures the 
ownership of policies and promotes a sense of responsibility to influence the policymaking 
process and play an active role in the implementation phase later on. This view is further 
supported by Manza and Cook (2002) and Labonte (2010), who suggest that participation 
54 
accords citizens their right to influence policies that can affect their health and can thus 
result in improved health outcomes. Papadopoulos and Warin (2007) further add that 
participation might result in a more efficient policymaking process due to the contribution 
made by knowledgeable actors regarding the policy concern, which will result in enhanced 
policy decisions and actions that may lead to more effective outcomes due to the 
involvement of concerned stakeholders. Hence, by increasing the effectiveness and 
efficiency of the health policy process, a population’s health can be positively affected 
(Matthews, Pulver and Ring 2008; Smith and Katikiredeli, 2013). However, while the 
participation of a broad group of stakeholders is usually accepted as a potentially beneficial 
aspect, it is rarely encouraged in practise (Mutale et al., 2013). 
A top-down approach in policymaking can possibly result in the failure in implementation 
of the determined course of action (Papadopoulos and Warin, 2007). The top-down 
approach implies that not all policy actors are involved or consulted and indicates a lack of 
proper representation, consultation, and communication in the formulation of policies 
(Matthews, Pulver and Ring, 2008). A lack of participation might obstruct the policy cycle 
as it can slowdown the implementation with resistance to change, which can emerge from 
health professionals, service providers, unions, and others, factions who were not included 
in the process (Dieleman et al., 2011). Stakeholder participation can increase the level of 
policy acceptance by health professionals (Papadopoulos and Warin, 2007). Additionally, 
including the public in policymaking is considered a tenet of democracy (Papadopoulos 
and Warin, 2007; Bishop, Vicary, Browne and Guard, 2009). In conclusion, governments 
can benefits in numerous ways by encouraging the participation of various stakeholders, 
which include increased knowledge regarding the concerned policy issues, certainty of 
having sufficient expertise and capacity required in the implementation phase, as well as 
assured compliance of all relevant stakeholders (Papadopoulos and Wein, 2007).  
• Mechanisms to Enable Participation 
However, given the advantages, the way in which MoHs can engage and encourage the 
participation of various stakeholders remains a challenge as it calls for proper planning and 
resources (Lavis et al., 2004). Currently, some countries are applying innovative 
participatory tools for policymaking, including public inquiries, the right to know 
legislation, citizen juries, policy dialogues, impact assessment with public comment, 
regulatory negotiation, mediation, and other kinds of third-party facilitated conflict 
resolution (Papadopoulos and Warin, 2007). The efforts of governments to promote 
participation also include partnership, contracts, roundtables, inter-governmental 
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conferences, and committees (Papadopoulos and Warin, 2007). Furthermore, offering 
incentives for participation can also be adopted as a strategy (Brinkerhoff and Bossert, 
2008). Again, the aim was not to determine superior mechanisms or to present the 
advantages and disadvantages of each; rather, the aim was to highlight some mechanisms 
that can enable participation that can be utilised, whether formal or informal. 
• Factors that Influence Participation 
There are several factors that can affect (positively or negatively) the various stakeholders 
preparedness to participate in the policymaking process as well as affect the "ideal" 
participation in the process itself. These factors can become obstacles or facilitators to 
participation, depending on the context and situation. Policymakers need to be sensitised 
regarding these factors and reflect on them to be able to plan ways to overcome any 
difficulties. For example, political support to develop and implement a health policy can 
facilitate and even accelerate its formulation, while the absence of political influence can 
hinder the process (Smith and Katikireddi, 2013). The list below summarises various 
factors, which can be obstacles or facilitators for participation depending on the context 
and the type of the policy, mentioned in the literature:  
• Political competition, power struggle, values and ethics, evidence, access to 
information, financial pressure, trust in the policymaking process, and public 
satisfaction with the implementation of policies (Smith and Katikireddi, 2013); 
• Political will, commitment, and the availability of resources to implement policies 
(Matthews, Pulver and Ring, 2008); 
• Level of interest, power, influence, relationships, and competition between 
stakeholders (Dieleman, Shaw and Zwankkon, 2001; Brugha and Varvasovszky, 
2000; Brinkerhoff and Bossert, 2008); 
• Supportive policy environment, governance and financing’s independence, and 
strong associations with policymakers (Bennett, Corluka and Aikins, 2012). 
 
The following factors are important to identify with the tool to build on facilitating factors 
and find ways to overcome the barriers to assessment in the policymaking process: 
• Presence of a legal framework to enable participants’ involvement in the decision-
making process (Cornwall, Lucas and Pasteur, 2000); 
• Institutional and technical capacity and leadership to bring participants together 
(Emerson, Nabatchi and Balogh, 2011).  
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• Criteria for Effective/Meaningful Participation 
Given the obstacles to "effective" or "ideal" participation, numerous studies have 
attempted to identify key criteria to interpret the scope, level, and quality of participation in 
decision-making. In particular, Gaventa (2002) asserted that for effective and meaningful 
participation, consensus has to exist with regard to the orientation process (which considers 
the voices and positions of various stakeholders and does not merely allow free expression 
of opinion). Emerson, Nabatchi and Balogh (2011) added that well-informed participants, 
existence of standard operating procedures, by-laws, decision-related rules, a conflict 
resolution mechanism, as well as transparency in roles and responsibilities, shared 
commitment, motivation, and a shared set of values and goals are important to ensure the 
complete practise of effective participation.  
Issues of representation (such as who is representing whom, how representatives are 
selected, among others) should also be considered in the context of participation (USAID, 
2008). It is important to have the right balance between policymakers and the private 
sector, professionals and public/patients, and between men and women (Martin, Abelson 
and Singer, 2002).  
The long list of the main characteristics and the concepts of participation constitute an 
ideal state of good governance. The tool will offer a practical assessment of these 
characteristics and will highlight them for policymakers, to drive them to consider these 
issues in a simplified manner.  
At the same time, it is important to acknowledge the negative impact of participation as 
well, as reported in the literature and to highlight the difficulties involved in the application 
of GG practices by policymakers so that they can make informed decisions regarding their 
implementation.  
• Negative Impact of Participation 
The literature reports the following potential negatives impact of participation: a poorly 
designed process, time-consuming process, possible production of ambiguous data, broadly 
defined groups, need for financial resources, conflict of interests, power struggles, and 
representation imbalance, all which can affect the legitimacy of the representation and can 
result in the exercise of informal influence, silencing the stakeholder’s voice (Lavis, 
Posoda, Haines and Osei, 2004; Lopez et al., 2011).  
In addition, it is claimed that enabling complete participation of all stakeholders in the 
policy process will reduce its efficiency of the process and can result in some participants 
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dominating the decision-making process (Bovaird, 2005). It has also been contended that 
the process might cause public dissatisfaction instead of increasing public trust (Irvin and 
Stansbury, 2004). In conclusion, negative impacts should be taken into account when 




Transparency is defined as active disclosure of information regarding the formulation of 
decisions (Vian, 2008). A "free flow of information within the health sector as processes, 
institutions, and information should be directly accessible to those concerned with them, 
and enough information is provided to understand and monitor health matters" (Siddiqi et 
al., 2009,p.18). It also signifies "bringing previously opaque information or processes into 
public domain" (Joshi, 2013, p.s29).  
• Criteria for Transparency 
In order to have real "ideal" transparency in place, certain criteria need to be considered, 
and the quality of the data, the speed of making these available (NAO, 2012; Vian, 2008), 
and ease of access are important factors in effecting complete transparency (WHO, 2009). 
Additionally, there should be a mandate to disclose government information (Vian, 2008; 
WHO, 2009) and encourage cyber transparency (e-transparency) (Otenyo and Lind, 2004). 
Information regarding the way in which policies are formulated, even if they were based 
on evidence alone, other factors that may have affected policy formulation, as well as 
information regarding the progress of implementation and evaluation stages, among other 
things, should be available (Vian, 2008). This information should be disseminated to the 
public, different policy actors, participants in the policymaking process, and the media 
(Otenyo and Lind, 2004) to encourage participation as well as to promote accountability 
(Siddiqi et al., 2009). The availability of written documents on policies is a sign of 
transparency (Otenyo and Lind, 2004; Lopez et al., 2011).  
• Benefits of Transparency 
Arguments in favour of enhancing transparency include increasing public accountability by 
publishing data and information, increasing public trust as well as respect for government 
decisions and policies; furthermore, it is essential to citizens’ compliance and acceptance 
of those decisions (NAO, 2012; WHO, 2009; Osborne, 2004; Licht, 2014). Disseminating 
good quality information is a critical element in effective management (NAO, 2012). 
Transparency can enhance the quality of decision-making during the policymaking process 
(Magraw and Amerasinghe, 2009) as it is considered a "golden tool in policymaking" 
(Licht, 2014, p.362). Additionally, transparency is an important component of any reform, 
and access to public sector information is a public right (NAO, 2012; Vian, 2008) as well 
as a salient requirement for donor agencies (Otenyo and Lind, 2004; Siddiqi and Jabbour, 
2012).  
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• Mechanisms of Transparency 
Mechanisms that are required to institutionalise the concept of transparency include 
existence of access to information law, e-government (the existence of an official website, 
availability of publications online, and online services), freedom of press (Relly and 
Sabharwal, 2009), availability of written standards on operating procedures, an effective 
decision-making process, and minutes of meetings, accompanied by appropriate 
communication strategies (Oxman, Leewin, Lavis, and Fretheim, 2009). Assessing the 
further for implementation of these mechanisms, for instance, it needs to be assessed 
whether written standards are adhered to or not, minutes of meetings are sufficiently clear 
to disclose information rather than hide it, and freedom of the press is utilised to aid 
effective decision-making rather than merely create a scandal, is beyond the scope of the 
tool. However, both policymakers and health authorities need to be aware of these 
mechanisms and the importance of their implementation in order to have a transparent 
system.  
• Strategies to Improve Transparency 
Institutional capacity and strategies are required to enhance ministries’ transparency 
(Oxman et al., 2009). Different scholars have suggested different strategies to increase 
transparency, which include the publication of public service reports, release of 
government documents or decisions through websites, public databases, public meetings, 
and publication of reports on financial monitoring through different dissemination channels 
(Vian, 2008; Joshi, 2013; Osborne, 2004; Licht, 2014; WHO, 2009). What a policymaker 
may perceive as high level of transparency may be perceived as opacity by a stakeholder 
and inaccessibility by a citizen. Hence, a standardised list of "good practices" based on the 
literature and validated by experts is an absolute necessity. The proposed tool aims to help 
alert policymakers regarding practices and processes that might be valuable in improving 
transparency from a practical viewpoint. This list of characteristics of "real" transparency 
is a presumed normative ideal drawn from the literature. It is essential to acknowledge the 
complexities when one aims to achieve this state of "ideal" transparency (Meijer, 2013), 
sensitivity of introducing transparency into practices, and the difficulties in its actual 
assessment. 
• Negative Aspects of Transparency 
The implementation of full transparency also entails disadvantages similar to applying real 
participation. Increased transparency has been reported to be associated with increased 
administrative costs as the process of making relevant information easily accessible 
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necessities institutional as well as cultural changes (Magraw and Amerasinghe, 2009; 
Osborne, 2004). Making the information publicly available in a user friendly manner can 
be a time consuming process and can result in delays (Magraw et al., 2009). Moreover, 
transparency with regard to decision-making can also lead to increased disappointment 
with government decisions (Licht, 2014). Moreover, increasing access to information in an 
effort to improve transparency can cause overloading and confusion if the information 
released is complicated (Licht, 2014). Finally, transparency can easily impinge on 




Accountability is defined "as the obligation of individuals or agencies to provide 
information about, or justifications for, their actions to actors along with imposition of 
sanctions for failure to comply or to engage in appropriate action" (Brinkerhoff, 2004, 
p.371). It concerns assuring that "those who are responsible for designing and 
implementing policies are held accountable for their performance and about having the 
right checks and balances put in place" (Dieleman et al., 2011, p.11).  
• Benefits of Accountability 
Accountability is needed in the health sector to control the misuse and abuse of resources 
and/or authority, ensure that resources are used effectively, ascertain that authority is 
exercised based on legal procedures, professional standards, and social values, as well as 
enhance management of health services through monitoring and evaluation (Brinkerhoff, 
2004; Savedoff, 2011).  
• Types of Accountability 
Several types of accountability have been described in the literature: financial 
accountability, performance accountability, and political/democratic accountability 
(Brinkerhoff, 2004; Tuohy, 2003; Baez-Camargo and Jacobs, 2011). These accountability 
types were identified in relation to service delivery in the health sector; however, all of 
them might not be applicable to the health policymaking process. Thus, experts during the 
Delphi consultations needed to decide on the most relevant types that should be assessed.  
Financial accountability refers to compliance with laws and regulations regarding financial 
issues (Brinkerhoff, 2004) and might be more applicable to policy implementation, unless 
it is related to resource allocation. Performance accountability includes performance 
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measurement and evaluation as well as service delivery improvement, and these should be 
outlined in the formulation plans of policies and when applied during implementing 
policies and strategies (Brinkerhoff, 2004;  Baez-Camargo and Jacobs, 2011). Performance 
accountability also concerns enhancing citizen participation, regulations, resource 
allocation, transparency, responsiveness, and trust building (Brinkerhoff, 2004; Savedoff, 
2011). Improving this type of accountability, through the creation and strengthening of 
incentives for health policymakers to respond to citizens’ needs and demands, is essential 
(Kirigia and  Kirigia, 2011; Brinkerhoff, 2004). This type of accountability is most 
applicable to policymaking process. Political/ democratic accountability pertains to 
focusing on the relationship between government and citizens, checking whether the 
former is acting in line with set standards, ethics, and principles of integrity (Brinkerhoff, 
2004). However, this accountability type is beyond the scope of consideration for the 
health sector unless health professionals/health policymakers are elected for their positions 
in the government (Baez-Camargo and Jacobs, 2011).  
In addition to the strong emphasis on public health sector accountability (with questions of 
private sector accountability addressed less directly), Murthy (2008) suggested that there is 
a gap in the enforcement of accountability, especially at the policymaking level, leading to 
negative consequences and the lack of "ideal/real" accountability. Further, he advises that 
accountability should be exercised prior to the formulation of a health policy as well as at 
different stages, before, during, and after the implementation of a programme (Murthy, 
2008), through any of the accountability types mentioned above, if they are applicable. In 
conclusion, health authorities should be aware of the different kinds of accountability that 
can be applied at all levels of the health system.  
• Actors for Accountability 
All stakeholders involved in the health sector should be accountable to the public, and 
these include decision-makers in government, the private sector, civil society 
organisations, and institutional stakeholders. Further, it should also be observed that 
"accountability differs depending on the organisation and whether the decision is internal 
or external to an organisation" (Siddiqi et al., 2009, p.18). Furthermore, accountability is 
required at multiple levels; it can comprise internal reporting to a higher authority within 
the health sector (Murthy, 2008). For instance, within the state, parliaments can hold MoH 
officials accountable, in addition to other state audit and anticorruption agencies 
(Brinkerhoff and Bossert, 2008). It can also be external in relation to citizen groups or 
independent bodies (Murthy, 2008). Thus, it is essential to identify who is answerable to 
62 
whom and for what in the assessment of accountability; this will reflect whether internal 
and/or external accountability is being practised in the concerned sector (Baez-Camargo 
and Jacobs, 2011).  
• Components of Accountability 
In order to have complete and real accountability, three components or aspects of 
accountability are defined and should be in place: answerability/justification, sanctions, 
and enforcement (Brinkerhoff, 2004; Murthy; 2008; Joshi, 2013). Answerability itself 
covers two issues, monitoring (in which facts and figures/information regarding budget, 
descriptions of activities or outputs are given by the accountable actor to the overseeing 
one) and demanding justification for actions (Brinkerhoff, 2004; Baez et al., 2011). The 
presence of the three components together is essential to practise accountability in its 
totality (Joshi, 2013). Answerability can reveal illegal or inappropriate actions and 
behaviours that should be followed by sanctions, while enforcement concerns ensuring 
compliance with sanction decisions (Brinkerhoff, 2004; Murthy, 2008). This is because 
answerability without sanctions as well as sanctions that are not enforced will serve to 
weaken accountability (Murthy, 2008). Inconsistency between the sanctions that exist "on 
paper" and the capacity to enforce them can result in serious accountability problems 
(Brinkerhoff, 2004). Brinkerhoff (2004) highlighted the importance of identifying actors 
who are in a position to demand information and impose sanctions as well as those who are 
charged with supplying information and are subject to accountability within the health 
sector.  
• Types of Sanctions 
Brinkerhoff (2004) suggested sanctions that can be utilised to have accountability in place, 
including legal sanctions, regulatory sanctions, as well as licensing and accreditation 
standards, quality assurance guidelines, and compliance mechanisms and a code of 
conduct. Other softer sanctions include negative publicity, which can damage accountable 
actors’ reputation or status (Vian, 2008). Healthcare providers are subject to professional 
codes of conduct (Ebrahim, 2003; Brinkerhoff, 2004; Vian, 2008); thus, it is essential for 
policymakers to know about the types of sanctions that can be applied in light of their 
mandate and authority.  
Proper incentives and rewards for good performance are as important as sanctions; this 
aspect of accountability is commonly neglected (Brinkerhoff, 2004) and should thus be 
highlighted to policymakers (Ebrahim, 2003). 
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• Mechanisms to Foster Accountability 
Accountability can be enhanced by an information system and the dissemination of 
information to the public and actors with oversight responsibility and capacity, 
encouraging watchdog organisations and non-governmental organisations (NGOs) can play 
this role, establishing whistle-blowing mechanisms, forming health boards or other civil 
organisations to demand explanation for results, providing performance incentives for 
good performance, setting clear procedural rules and using authority to enforce those rules, 
as well as creating citizen oversight that can take several forms (Saltman, 1997; Ebrahim, 
2003; Vian, 2008; Brinkerhoff and Bossert, 2008; Murthy, 2008). 
Policymakers should be aware of these mechanisms that can enhance accountability, their 
components as well as the types of accountability and sanctions. In order to have a 
complete picture, the potential negative effects of their use should also be considered. 
• Negative Aspects of Accountability 
Applying accountability requires time and monetary resources,  and often, major 
institutional changes as well (Osborne, 2004). High levels of extensive checks and 
balances as part of exercising and practising  accountability can also delay the policy 
process (Osborne, 2004). Moreover, it can result in power being accorded to certain 
stakeholders over others, which can thus discourage participation (Joshi, 2013). Workload 
has also been reported as another issue, whereby, as a result of the elaborate documentation 
and reporting required, public officials avoid accountability (Osborne, 2004).  
 
3.1.5 Use of Information 
•  Definitions 
"Information is essential for a good understanding of a health system, without which it is 
not possible to provide evidence for informed decisions that influence the behaviour of 
different interest groups that support, or at least do not conflict with, the strategic vision for 
health" (Siddiqi et al., 2009, p.18). It includes the processes of information generation, 
collection, analysis, as well as dissemination (Siddiqi et al., 2009; Kirigia et al., 2011). 
Information and intelligence also signify the use of research to inform policy (Siddiqi et 
al., 2009).  
The focus with regard to this principle is twofold: the willingness and ability to generate 
evidence-based, research-generated, up-to-date, and locally relevant information (Orem et 
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al., 2012) as well as on using this information/evidence to inform policymaking and 
information dissemination (Siddiqi et al, 2009).  
• Benefits of Information Generation and Use  
The generation and use of information is essential in the health sector. GG requires useful 
"good information" and appropriate health intelligence (Policy Innovation for Health 
(PIH), Ch. 2). Not all organisations acknowledge the use of information as a principle of 
GG (as indicted by the list in chapter one). However, most individuals working in the 
health sector acknowledge its importance as a GG practice, essential in policymaking in 
particular (WHO, 2000; USAID, 2008; Siddiqi et al., 2009) as it is a sector specific aspect 
(WHO, 2009). Moreover, research can play a role at almost all levels of the policy process: 
agenda setting, formulation, implementation, as well as evaluation (Hanney, Gonzalez, 
Buxton and Kogan, 2003). In policy formulation, research findings can be utilised to create 
briefs to inform arguments, demonstrate the best way to implement policy, inform 
decisions, and provide justification for the policy to generate the required financial 
resources, political commitment, and/or to gain public support (Hanney et al., 2003).  
Public policymakers face several challenges in finding solutions to health problems in the 
optimum way possible within a complex health system and the best methods to changes in 
health systems (Oxman, 2009). Research can help answer these questions and find 
practical solutions that are cost-effective (Lavis et al., 2004). Using high-quality and 
locally applicable research can significantly contribute to the policymaking process (Lavis 
et al., 2004). It is the responsibility of the MoHs to encourage, commit, and link evidence 
to policymaking (Oxman, 2009; WHO, 2010).  
Informing policy with research can facilitate the production of better policies than would 
be possible otherwise (Hallsworth and Rutter, 2011). Moreover, research often enables 
policies that have a technically well-informed foundation (Hanney et al., 2003). The 
generation and use of evidence in health policymaking plays an important role in guiding 
investment decisions (given the budget constraints) towards improving service delivery 
and consequently health outcomes (Orem et al., 2012). Accordingly, new policies must be 
evidence-based, founded on data, statistics, and other indicators (PIH, Ch. 2). In reality, 
research evidence competes with other factors, such as financial resource availability and 
legal issues, with values, public opinion, influence of the private sector, among others), 
visibility, as well as other interests (Lavis, 2006). These need to be identified in order to 
improve the uptake of evidence into policies.  
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• How Information Can Be Used in Policymaking 
There are three primary ways in which information can be utilised in policymaking: data 
and findings, ideas and criticism, or briefs and arguments for action, with their application 
in policymaking being instrumental, conceptual, or symbolic (Hanney et al., 2003). 
Instrumental application implies employing research findings as they are in policy 
formulation, while the conceptual aspect refers to utilising them as a way of informing or 
guiding, a symbolic means, using these findings to support a position already taken, for 
example, continue with existing policies (Hanney et al., 2003).  
• Factors that Affect the Use of Information 
This rather straightforward description of the use of information should not, however, 
overlook the practical complexities of the way in which knowledge/information can and is 
exploited in policymaking (Oxman et al., 2009). These complexities are the result of 
several obstacles to the use of information in policymaking as there are other factors that 
can increase information use (Hanney et al., 2003). According to the literature, there are 
four groups of factors that influence evidence’s uptake by decision makers: external, 
context, type of evidence, and stakeholders (Orem et al., 2012), which are described below: 
a. External influence: This includes encouragement and influence of donors and 
international agencies by supporting national and regional efforts to undertake 
research that can inform policies and assessing their local applicability (Lavis et al., 
2004) and the existence of global evidence regarding their use (WHO, 2010). 
b. Context: This includes consistency with the governing party’s political views (Lavis 
et al., 2004), politics, economic resources, incentives for researchers and 
policymakers, opinions of the mass media and public, demand for an evidence base, 
ways of knowledge transfer/translation, knowledge brokers, publicly funded research, 
government encouragement and commitment to linking evidence with policy (WHO, 
2010), as well as institutional capacity for research analysis and policy formulation 
along with the urgency to have a policy in place (Orem et al., 2012). 
c. Type of evidence: This includes technical content and quality (reliability, timeliness, 
specificity, comprehensiveness), practicality, issue complexity, the way in which 
results are communicated (summaries, through media ), feasibility of applying the 
evidence-based recommendations, administrative capacities, financial situation, their 
acceptability to key health system stakeholders (civil society groups, patient groups, 
professional associations, NGOs, private business, donors and international agencies), 
and national significance (Lavis et al., 2004; Hanney et al., 2003).  
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d. Stakeholders: These include the relationships between researchers and policymakers, 
acceptability to key stakeholders, public engagement, power of pressure groups, 
successful advocacy, partnership, synergy and coordination with academia/research 
centres (Lavis et al., 2004; Hanney et al., 2003; Davis et al., 1996; Orem et al., 2012; 
Siddiqi et al., 2012). It is extremely important to explore the relationship between 
policy/policymakers and research/researchers in real life. It is considered as one 
involving exchange, in which, policymakers usually act as receptors/recipients of 
research (Hanney et al., 2003).  
Scientists can benefit from publicly funded research (Choi, Pang, Lin, Puska, 
Sherman, Goddaed, Ackland, Sainsbury, Stachenko, Morrison and Clottey, 2005). 
Their goal is to advance science and their major output is research papers (to 
contribute to the body of knowledge), while policymakers’ goal is to secure practical 
support to implement policies (Choi et al., 2005). Since there is a gap between data 
production and data use, there is a need for a partnership between government policy 
bodies and experienced academic/research organisations(Choi et al., 2005).  
The most common facilitating factors for the transfer of evidence to policymakers 
include personal contacts, time-based relevance, the inclusion of summaries with 
policy recommendations, good quality research, community pressure/demand for 
research, and media reports (Travis et al., 2002; Choi et al., 2005; Lewis and 
Pettersson, 2009; Siddiqqi et al., 2009; Jansen et al., 2010). While barriers to the use 
of evidence are lack of personal contact, delay in releasing research findings, lack of 
trust, limited budgets, poor quality of research, and political instability (Choi et al., 
2005; Veillard et al., 2011; Savedoff, 2011), to overcome some of these barriers and to 
facilitate the use of information and evidence by policymakers, it is essential to invest 
in institutional strengthening. This can be accomplished through continuing education 
programmes for public policymakers to promote the value of evidence use and 
increase their capacity to access, adapt, and apply research evidence (Lavis, 2006). 
• Negative Aspects of Information Use 
The collection, analysis, generation, and dissemination of information entails financial 
costs and also requires professional expertise that might not be available all the time for 
public policymaking (Bao, Wang, Larsen and Morgan, 2012). Additionally, the production 
of quality information is a time-consuming process (Jansen et al., 2010).  
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3.1.6 Responsiveness 
Responsiveness is classified as both a principle of GG and its outcome. Unlike other 
outcomes such as equity, efficiency, and effectiveness that might be the result of other 
factors that work together in addition to GG, responsiveness forms a direct outcome. The 
WHO identified responsiveness as one of three intrinsic goals of a health system’s 
performance, with the other two being health services and fair financing (Darby et al., 
2000). Furthermore, according to the WHO, responsiveness addresses the people’s 
legitimate expectations, which forms the core of health systems’ stewardship function 
(WHO, 2000). It is a fundamental aspect because it is related to basic human rights. Health 
systems’ responsiveness can be enhanced without large investments as it does not 
necessarily require new legislation for its authorisation (Darby et al., 2000). Finally, 
responsiveness can be improved at a considerably faster pace than health, that is, it can 
improve people’s well-being, irrespective of improvement in their health (Gostin, Hadge 
and Valentine, 2003). Thus, by ensuring that people are treated in ways that correspond to 
their needs, they can be empowered to lead healthier lives (Gostin, Hadge and Valentine, 
2003).  
Despite the importance of responsiveness, it has not been adequately developed as a 
concept, thus making its evaluation difficult. I have labelled it as an "orphan principle" as 
all papers identified in the literature on responsiveness deal with it in terms the service 
delivery level (Darby et al., 2000; Gostin et al., 2003). That is, I was not able to find 
research relevant to responsiveness at the health policymaking process level. Thus, under 
this principle, I will present the findings from the literature in relation to health service 
delivery and make the link for the health policymaking process. 
• Definitions 
Responsiveness is defined as "how well health system meets the legitimate expectations of 
population for non-health enhancing aspects/dimensions of their interaction with the health 
system" (Darby et al., 2000). Siddiqi et al. (2009, p.18) explained it as "institutions and 
processes should try to serve all stakeholders to ensure that the policies and programs are 
responsive to the health and non-health needs of its users". Governments/MoHs are obliged 
to listen to the needs of their citizens, act on their concerns, and respond to their 
expectations in developing policies (Siddiqi et al., 2009; Ura and Ellis, 2008). Thus, 
responsiveness is an important aspect of governance that requires to be assessed in order to 
be improved. 
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To develop the tool, I start from the most advanced/elaborated conceptualisations of 
responsiveness in the health sector proposed by Darby et al. (2000) and Gostin et al. (2003) 
in collaboration with the WHO. They defined seven domains for health responsiveness at 
the service delivery level: respect for dignity of persons, confidentiality, autonomy to 
participate in health-related decisions, prompt attention, access to basic amenities of 
adequate quality of care, choice of healthcare provider, and communication (Darby et al., 
2000; Gostin et al., 2003). 
The responsiveness domains were further elaborated and defined based on the work of 
Gostin et al. (2003), and they were associated with health policymaking as follows: 
• Dignity: All individuals should be treated with respect, with no discrimination based 
on race, sex, religion, ethnicity, and other aspects (Gostin et al., 2003), that is, any 
health policy should be based on respect for the dignity of patients/public.  
• Autonomy to participate in health-related decisions and to select the healthcare 
provider: This concerns the freedom to seek, receive, and impart information, as 
well as the right to free, meaningful, and effective participation in decisions that 
affect one’s life (Gostin et al., 2003). In addition, each individual has the right to 
select the healthcare provider they want (Gostin et al., 2003). Therefore, health 
policies should be based on allowing patients and the public a say in the formulation 
of such policies as well as empowering them to make decisions related to their health.  
• Privacy and confidentiality: Respect for persons in the health care context includes 
the duty to maintain a patient’s medical information as private and confidential 
(Gostin el al., 2003). Linking this domain to the formulation of health policies related 
to providing health services, respecting patients’ and public’s confidentiality when it 
comes to their medical information should be a part of every health policy.  
• Prompt attention: This refers to offering timely service to avoid potential anxiety 
and inconvenience due to delays in giving attention or care (Gostin et al., 2003). 
Accordingly, health policies should be formulated with the obligation to ensure that 
the health system is responsive in a timely manner and services are accessible and 
provided without any delays.  
• Access to adequate quality of basic amenities: This is connected with al 
individuals’ right to an adequate standard quality health service (Gostin et al., 2003). 
Thus, any health policy should include the specific entitlement to the health services 
to be provided.  
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• Communication: Patients should be given the right to seek, receive, and impart 
information related to their health (Gostin et al., 2003).  
Adhering to all these elements of responsiveness in the formulation of health policies will 
make it possible to hold policymakers and other actors accountable (Gostin et al., 2003; 
Powell, 2004). In order to use responsiveness as a principle of GG at the health 
policymaking level, the  tool’s application will highlight these elements/domains of 
responsiveness and the fact that they should be a constituent of any health policy to be 
developed. 
It is important for policymakers to understand people’s perception regarding the 
responsiveness of a health system to their needs and assess factors that contribute to this 
perception in order to address them appropriately (Siddiqi et al., 2009). In most cases, this 
is not done, as the population’s health needs are usually determined by health professionals 
with little involvement of the public (Gostin et al., 2003).  
Factors that influence a government’s responsiveness to the needs of its people include the 
following: "National mood", nature of the policy issue, the urgency of the issue and the 
degree of seriousness/level of priority, costs of being responsive, involvement in changing 
an old established policy, media coverage, informed public, informed policymakers, social 
movements and pressure, availability of "open window of opportunity", influence of elites, 
contradictory public opinion, timing, government’s commitment towards responsiveness, 
and inequality in representation (Manza, 2002; Powell, 2004; Ura, 2008; Wlezien, 2009). 
• Mechanisms to Enhance Responsiveness  
These include institutional changes to enable the collection of public preferences, 
responding to media reports, enabling participation along with public polls, and surveys 
(Gaventa, 2002). All the positive characteristics and the concepts identified for the five 
principles discussed above represent the "ideal" situation in the application of GG 
principles. However, applying these may prove to be a burden to the efficiency of the 
policymaking process (Bovaird, 2005). That is, it is not possible to achieve all these 
characteristics/good practices at the same time (Bovaird, 2005), and thus, it is necessary to 
be realistic about what can and/or must be included for improvements (Fryatt et al., 2017). 
The disadvantages of GG principles that can obstruct or delay the policy formulation 
process can be minimised, if planning is done carefully (Irvin and Stansbury, 2004; 
Magraw et al., 2009). The advantages of GG practices and their contribution to the quality 
of health policymaking process and their possible influence on the health system 
performance outweighs all the potential disadvantages. 
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3.1.7 The Interrelationships Between the Principles 
The literature suggests there is an interrelationship between the various GG principles, and 
in some cases, there is also an overlap (Papadopoulos et al., 2007; Labonte, 2010; Mutale 
et al., 2013). However, no empirical evidence is available regarding this; there are only 
theories regarding the potential relationships. Effective participation can be enhanced by 
increasing access to information, whereby participants will be empowered by access to 
relevant information (Mutale et al., 2013). Moreover, participation will lead to increased 
visibility and transparency of the procedures followed during the policymaking process 
(Papadopoulos et al., 2007), and the opposite is also true; conversely, the lack of 
transparency may discourage participation (Labonte, 2010). Civil society’s participation 
can play a vital role in establishing research priorities and the data that should be generated 
and the way in which it will be presented (Choi et al., 2005). In addition, enabling the 
participation of all stakeholders will allow the public to voice their needs and thus 
encourage the government to be responsive to those needs (Darby et al., 2000).  
Transparency is considered a tool to enhance accountability (Otenyo et al., 2004), whereby 
providing information to the public will increase its demand (Joshi, 2013). In addition, it is 
a pre-requisite for participation as it can encourage stakeholders to play an active role 
(Magraw and Amerasinghe, 2009). In general, the use of information (including generation 
and dissemination) is essential for real transparency (Lavis et al., 2004). Transparency 
regarding the process and the decisions taken during policymaking through proper 
communication channels will allow the public to know whether the government is 
responsive to their needs (Gostin et al., 2003). 
Despite theories that signify the presence of interrelationships between GG principles, it is 
important that they are assessed separately within the tool and the characteristics are 
labelled under the relevant principle. This will help expand the understanding of the 
meanings of each of the principles and the way in which they constitute GG practices.  
The subsequent phases of the research (the Delphi and the pilot), with the tool devised, 
helped remove any overlaps, to the extent possible, among the principles. 
This research does not explore these relationships in any way but acknowledges their 
presence.  
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3.1.8 Development of Checklists 
In order to finalise the conceptualisation step, I had to group the characteristics that needed 
to be covered under each principle. Accordingly, a checklist was developed that 
summarised what the tool should cover in terms of the characteristics of the five 
governance principles. This checklist guided the tool’s operationalisation. Devellis (2003) 
stated that "the boundaries of a phenomenon must be recognised so the content of the scale 
does not inadvertently drift into unintended domains". Hence, I employed the 
components/characteristics of each governance principle to define that principle and used it 
as a guideline/indicator for "good practices" that needs to be followed in order to achieve 
GG (Andrews, 2008).  
The level of specificity or generality of the tool requires to be determined before the tool is 
developed (Foa and Tanner, 2011; Devellis, 2003). Thus, this research attempted to 
explore into details regarding governance principles in order to capture the maximum 
amount of information as to the way in which these governance principles can be enacted 
in practice. Table three offers a summary of the primary main characterises of the five 
principles identified in the literature review. These concepts were added if they appeared 
several times in the literature, if convincing arguments regarding their importance were 
presented, and based on my own judgment concerning their relevance to the health policy 
process.  
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Table 3: Checklists of the Major Characteristics of HSG Principles 




Types of Participants 
• State actors 












• Quality of data 
• Speed of 
publishing data 




Useful Information  
Elements of 
Responsiveness 
• Respect for dignity 
• Autonomy to 
participate in 
decisions 
• Confidentiality  
• Prompt attention 







Benefits of Participation 
• Ownership 
• Human right 
• Knowledgeable people 
• Democracy 







• Internal against 
Eternal 




• Law to disclose 
• E-Transparency 
• Freedom of press 
• Written SOPs and 
Minutes of 
Meetings 










• Benefits of Responsiveness 
• Human right 
• Improve wellbeing  
• Goal of health system 
performance 
• Direct outcome 
of governance  
 
Negative Impact of 
Participation 
• Time consuming 




• Control misuse 
and abuse 








• Increase public 
accountability 






• Empower citizens 
• Prerequisite for 
donors 
Factors Affecting 
Use of Information: 
• External factors 
• Context 








• "National Mood" and 
timing  
• Nature of the policy 
issue 
•  Level of priority 
• media coverage 
• Social movements 
and pressure  




commitment to be 
responsive to the 





• Political will 
• Power struggle 
• Financial resources 
• Context 
 
Actors in Accountability 
• Policymakers 
• Private Sector 
• Civil societies 
• Public  
 
Strategies to Enhance 
Transparency 








Generation and Use 
of Information 
 
Criteria for Effective 
Participation 
• Consensus orientation 
• Transparency 
• Available information 
• SOPs 
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Mechanisms to Enhance 
Participation 
• Public inquires 
• Policy dialogue 





Types of Sanctions  
• Legal sanctions 
• Regulatory 
Sanctions 
• Negative publicity 
• Soft sanctions 
   
 
The checklists offer indications as to what the tool should cover under each of the five 
principles. In order to assess whether there is an "effective" participatory policy process, it 
is necessary to identify all kinds of participants involved in the policymaking process, the 
benefits and negative impact of participation, barriers as well as facilitating factors, 
mechanisms and methods applied to enhance participation, along with the criteria for 
effective participation and consensus process, as well as representation. For enhanced 
accountability, the presence of its various components including procedures, methods, 
types, and levels of accountability, needs to be assessed. Moreover, the actors involved 
require to be identified along with the benefits of accountability at the policymaking level. 
For a transparent policymaking process, the relevant criteria, namely benefits, methods, 
and levels also need to be considered. With regard to the use of information, the ability of 
MOHs to generate information as well as the use of information in policymaking requires 
to be assessed. Consequently, it is important to examine the generation, publication, and 
dissemination of health-related information, types of information collected and used, 
criteria and factors involved in the use of information in policy, and benefits of generation 
and use of information at the policy level. For a health policy to be responsive to the needs 
of the population, the various elements of responsiveness, its benefits, and factors need to 
be considered in order to effectively enhance it.  
Before the development of a framework for the tool, it was essential to decide what this 
framework should include. It was recognised that the framework required to reflect the 
scope of the tool, i. e., assess the five principles at the health policymaking level. After 
unpacking the principles, a decision had to be made regarding the way in which the 




3.2 Development of a Conceptual Framework 
A conceptual framework/model of the selected GG principles and their characteristics is 
required to reflect reality and offer clarity before any attempt can be made to assess HSG 
(Andrews, 2008; Emerson, Nabatchi and Bologh, 2011). According to Andrews (2008, 
p.380), "Models are stories by which we connect certain elements and characteristics with 
certain realities and often take shape of structural designs for others to emulate." The 
developed framework was utilised as a roadmap to develop the tool that would enable 
policymakers and stakeholders to assess health governance in practice (Charles and de 
Maio, 1993; Emerson, Nabatchi and Bologh, 2011). 
In the proposed framework (Figure 2), the first diagram organises the five key principles of 
governance (participation, transparency, accountability, use of information, and 
responsiveness) into multi-graphics and suggests a link/interrelationship between them; 
however, it offers no explicit proposition as to how the interaction is realised. The arrows 
between the five principles point in both directions, and a box next to each principle 
summarises its main characteristics. The second diagram depicts the policy cycle stages 
(agenda setting, policy formulation, policy implementation, evaluation, and monitoring). 
The two diagrams represent "moving wheels", in which all the governance principles 
interact with all the policy stages. However, the framework will not illustrate the way in 
which the principles interact with the different policy stages nor how they impact each 
stage. Although the framework presents all the policy cycle stages, this research will 
concentrate only on assessing the five principles for policy formulation. It is suggested that 
the interaction of the governance principles and the policy stages is also affected by the 
contextual factors that affect the health sector in particular and the country in general. 
The suggested framework can be utilised as a broad map to facilitate understanding, 
development, and evaluation of theories related to the enhancement of the health 
policymaking process through the application of GG principles in practice (Charles and de 
Maio, 1993; Emerson, Nabatchi and Bologh, 2011).  
I understand that the five principles are interconnected and act as precursors to each other, 
thus enhancing each other. Furthermore, I also understand that not all these principles 
contribute equally to the quality of governance; however, exploring these issues is beyond 
the scope of this research. Thus, further research is required to test and explain the possible 
causal relationships between the principles on the one hand and the magnitude of their 
























































- Generation, analysis, 
Publication, 
Dissemination 
- Types of Information 
- Benefits 
- Factors that affect use 
of information  
- Components 
- Types 
- Benefits  
- Actors 
- Mechanisms  
-Sanctions/Rewards  
- Criteria  
- Mechanisms 
- Benefits 
- Strategies  
- COI 
- Types of participants 
-Benefits 
- Barriers/Facilitators 
- Criteria for effective 
participation 
- Mechanisms -  
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3.3 Operationalisation of the Principles of HSG 
Considering the scope of the research, the tool will focus on assessing processes and not 
measures of output/performance (Fukuyama, 2013; Rotberg, 2014). Operationalisation was 
defined in Chapter Two as a process that is commonly employed in the social sciences 
(Tucker, 2012) along with topics that are considered complex and are constantly discussed, 
with consensus over their meaning being elusive, as is the case with health governance 
(Fukuyama, 2013). The operationalisation of concepts we want to assess requires a strong 
theoretical foundation (Devellis, 2003) to facilitate the process (Covell and Sidani, 2012).  
In simple terms, operationalisation entails the translation of concepts into measures (in this 
case, questions) (Saris and Gallhofer, 2004), and each concept can be translated into one or 
more relevant questions (Buckingham and Saunders, 2004, Ch.3). These questions 
concerning the mechanisms followed to adhere to principles of GG are addressed to policy 
stakeholders. Once the theoretical definitions and descriptions of the various principles and 
their characteristics have been identified (the conceptualisation phase explained above), the 
subsequent logical step is to transform these into useful descriptions and applications 
(operationalisation) (Tucker, 2012) in order to enable their assessment in a practical and 
meaningful manner, and this can be through the development of a tool comprising several 
indices.  
 
3.3.1 Development of Assessment Tool/Indices 
Since a concrete definition of governance is associated with several principles , it should 
be accessed through multiple measures or composite indices (Carmines and Woods, 
2004b).  
An index refers to "a composite of several items assuming that all reflect on the underlying 
construct" (Carmines and Woods, 2004b, p.486). A composite index is widely employed 
by international organisations and the academia (Foa and Tanner, 2011; NCAER, paper no. 
83) for assessing broad social science concepts such as governance, human development, 
and social development, which has been found to be an acceptable way of assessing 
governmental agencies (OECD, 2005).  
The use of an index offers the advantage of summarising characteristics/concepts 
associated with each of the GG principles in a simple manner (Fao and Tanner, 2011); it 
also serves as a checklist of good practices. However, their inability to confirm whether 
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progress observed is exclusively due to change in governance practices (WHO, 2010) 
rather external factors  is a limitation that might affect the assessment’s usefulness 
(Veillard et al., 2011; Rotberg, 2014). Hence, external factors that might affect the 
governance process require to be taken into consideration in any attempt to assess health 
governance. A separate index for each of the five principles will not allow the evaluation 
of the overlapping nature of the relationship between the principles (Nyhan and Woolcock, 
2012). However, this is beyond the scope of this tool. One particular challenge presented 
by the use of an index is its conceptualisation and operationalisation, for if this is poorly 
pursued, a poorly developed index will be formed (Develis, 2003). In other words, if some 
major concepts related to the governance principles are excluded or if the individual 
questions that constitute the index are ill-developed, the assessment of the principles will 
remain incomplete (Develis, 2003). In conclusion, the conceptualisation of governance 
principles should be sufficiently inclusive of all the relevant concepts, and 
operationalisation of the composite tool should be undertaken carefully so as to completely 
capture what it aims to assess (Diamantopoulos and Winklhofer, 2001).  
As mentioned above, as a part of the operationalisation step, an index was developed for 
each of the five governance principles to be assessed. Each index comprised a list of 
questions concerning the main characteristics of these principles.  
Developing the proposed tool was accomplished by following a methodology adapted by 
Develis’ (2003) work, which included a five-step process as indicated below: 
• a. Item Generation and Selection of Items to Be Assessed 
All concepts in the checklists above were included in the tool, and then, each concept 
within the checklists was translated into one or more questions (Buckingham and 
Saunders, 2004, Ch.3). Special attention was given to face validity and the 
unidimensionality of each of the questions formulated (Diamantopoulos and Winklhofer, 
2001; Develis, 2003). The generation of three to four times questions more than the 
number intended is considered an advantage at this stage of the index development process 
as it will ensure internal consistency (Devellis, 2003) as well as minimise measurement 
error (Buckingham and Saunders, Ch.3). This resulted in an extensive list of questions for 
the Delphi consultations and the pilot testing. In addition to the questions that were 
generated based on the checklists, some others were adopted from existing assessments on 
health governance and used verbatim or were modified as identified through the literature 
review (see Annex 1. Mapping of Existing Questions from Other Assessment Tools).  
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• b. Determine the Types of Questions to Be Developed 
Applying a combination of data collection methods is a recommended practice to 
operationalise the characteristics of the five principles in a comprehensive manner as much 
as possible (WHO, 2009). This can provide evidence as well as perceptions regarding ways 
to achieve improved governance, consistent with the public sector integrity assessment tool 
of the OECD (2005) and Good Governance in Medicine, an assessment tool for the public 
pharmaceutical sector developed by WHO (2009).  
For each of the five principles, a composite index (30–38 questions) based on the main 
characteristics of each principle was developed. Each index contained questions assessing 
whether countries possessed the required processes or structures in terms of policies, laws, 
and strategies to ensure GG at the policymaking level (WHO, 2010) and whether these 
were enforced. The absence of such practices would reveal the gaps in the way in which 
MoHs or health authorities govern the policymaking process.  
Each index comprised "evidence-based” questions (EBQ) and "perception-based" 
questions (PBQ). Thus, for each principle, two lists of questions were developed. The EBQ 
demanded either a binary answer (Yes/No) or a list of sub-criteria to select answers from 
(these sub-criteria will serve as checklists of good practices). The PBQ were set in the form 
of open-ended questions.  
EBQs would be used to assess governance across time within countries, and these 
questions would be supported by documented evidence (thus the label evidence-based). 
The evidence for these questions would be collected through desk-review and an analysis 
of available information found in relevant documents, 
while the PBQs were formulated in a way so as to  yield more in-depth information, taking 
into account the specific context of a given country. The assessment is based on the 
evaluation of the role of MoHs in practising the principles of governance in the health 
policymaking process and the external factors that affect this. Specifically, these questions 
address various stakeholders’ perception, who are involved or affected by the health policy 
(Foa and Tanner, 2011). Assessments based on perception have been widely employed by 
a number of international organisations (WHO, 2009; Siddiqi et al., 2009; USAID, 2012; 
LMG, 2012). The data for these kinds of questions will be collected through a 




• c. The Process of Writing Questions 
This is considered the most difficult step in the process of index development. The 
questions should cover relevant topics without any ambiguity (Diamantopoulos and 
Winklhofer, 2001, p.272; Devellis, 2003; p.69). This is because ambiguity may cause 
people to respond differently to the same question even if they have the same opinion on a 
particular matter (Fukumaya, 2013). In addition, some people tend to apply the same 
concepts but imply different things when referring to them (Soukakou and Sylva, 2012). In 
order to minimise any possible bias due to the question design, complex, double-barrelled, 
technical, as well as uncommon and vague words were avoided (Choi et al., 2005).  
See Box 1 below for examples on the operationalisation of the concepts across the five 
principles and possible sources of data.  
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Box 1. Examples of Questions Developed Across the Five Principles 












Legal framework for 
participation to be 
involved in decision 
making  
Evidence-Based Question  
Is there a legal basis/requirement 
(law/regulation/policy) to include 
various stakeholders in the health 
policymaking process? 





Verified by KI 
interviews  
Institutional, technical 
capacity and leadership 




How do you view the role of 
MoH/health authorities/national 
programmes in encouraging stakeholder 
participation in policy formulation and 
in the development of X Policy 
specifically? Does the MoH/health 
authority/national programme have the 
institutional capacity and resources 
required to facilitate the participation 
process, in terms of leadership, 
planning, needed information, 
institutional arrangements, database of 
key stakeholders? 







Decisions related to 
priority setting and 
financial allocation 
should be made public 
Evidence-Based Question 
Are decisions related to priority setting 








and means to enhance it  
Perception-Based Question 
How can the MoH/health 
authority/national programme increase 
its transparency in the policymaking 
process? Does the MoH/health 
authority/national programme have the 










Types of accountability 
 
Evidence-Based Question 
What are the types of accountability 
mechanisms/types used by the 
MoH/health authority/national 
programme and various 
institutions/organisations involved in 
policy towards their representatives? 




by KI interviews 
 
Inform stakeholders in 
advance that they will 
be held accountable 
Perception-Based Question 
What is the best way to make various 
stakeholders accountable for their role in 
policymaking? How can it be ensured 
that they know they will be held 
accountable prior to their involvement? 
KI interviews 
81 
Box 1. (Contd.) 
Principle Characteristics Example of Questions Data Source  
Use of 
Information 
Use of information 
includes generation, 
publication, and 







commitment to linking 
evidence to policy  
 
Evidence-Based Question 
Is the MoH/health authority/national 
programme directly involved in the 
following in relation to policymaking: 
information generation, dissemination of 
health information, publication and/or 
knowledge translation into policy? 
 
Perception-Based Question 
How committed is the MoH/Health 
Authority/National Programme 
leadership to using evidence-based 
(scientific evidence) and other types of 
information in the policymaking 
process? What is the evidence for this 














access to adequate 
quality of basic health 





Mechanisms to improve 
responsiveness include 
institutional change and 
assessing public 
preferences, among 
other things  
Evidence-Based Question 
Does X Policy include an objective/goal 
that MoH/health authority/national 
program will ensure access to adequate 
quality of care services for all the 
population/patients, including 
disadvantaged/vulnerable groups 
covered under the policy? 
 
Perception-Based Question: 
How do you view the MoH/health 
authority/national programme 
institutional capacity to collect/gather 
public needs/preferences that are to be 
incorporated into policymaking process? 
What mechanisms can be employed to 













KI interviews  
 
• d. Questions Weighting 
Assigning significance to various items or principles based on their contribution to the 
quality of governance is beyond the scope of this study. As mentioned earlier, it is not an 
aim of this research to determine the prominence of the characteristics of governance 
principles. Assiging weight would require additional understanding of the various 
characteristics and the way in which they affect the quality of GG principles in real settings 
(Luiz, Pereira and Oliveira, 2012).  
For this research, questions within the composite indices have been given equal weights. 
This is considered acceptable (NCAER, paper no. 83) since the focus is on identifying gaps 
and institutional weaknesses, rather than on coming up with a number or a score. The 
results of this tool is not to produce a score that does not consider contextual factors but 
rather to provide policymakers with usable data to improve the policymaking process 
accordingly (Kettl, 2016). Thus, this research does not involve assigning weights to the 
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different principles or their components based on their contribution to the quality of health 
governance, an issue that needs to be addressed in future research.  
An important question with regard to the development of the tool is whether to assign 
scores for EBQs. This was addressed during a consultation meeting that took place for 
further evaluation of the tool (see Chapter Four, Consultation Meeting-Analysis Feedback), 
and it was decided that graphic-like summaries of the findings would be used so as to make 
the data useful for policymakers (Kettl, 2016), yet be able to track changes/progress 
overtime. 
• e. Decide on the Size of Individual Indices 
The number of questions in each index should not be short as that would compromise the 
index’ comprehensiveness, and they should not be very long either, which would make the  
collection and analysis of the data burdened tasks (Develis, 2003). Expert opinions were 
required to identify the most important questions in order to include the assessment of 
governance processes, having consulted the literature and to seek their views as to whether 
any salient ones had been omitted. As mentioned earlier, this was done using the Delphi 
method. Consensus regarding the most important concepts of governance principles to be 
covered by the tool was an essential step; as discussed earlier, conceptual problems are still 
an issue in the assessment of health governance as it is the case with other fields, such as 
political science (Soukakou and Sylva, 2012; Fukuyama, 2013).  
The initial number of questions developed to cover the five principles was 140 EBQ and 
92 PBQ. All the EBQ for the five principles were put in Section A of the tool, While all the 
PBQ for the five principles were put in Section B of the tool. This resulted in the creation 
of a long tool, which presented a practical obstacle (as will be discussed in the subsequent 
chapters). However, the aim was to minimise measurement error as much as possible by 
covering all the concepts identified (Tucker, 2012). 
 
3.4 Reflecting on Conceptualization and Operationalisation  
All the characteristics attached to each of the five principles identified from the literature 
review were included based on their importance and my personal interpretation of their 
relevance in relation to the scope of the tool. The characteristics were subsequently 
categorized into meaningful components that describe "ideal" GG practices that should be 
applied by MoHs and/or health authorities at the policymaking level. All the identified 
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concepts were operationalised into the first draft of the tool to enable their assessment in a 
practical manner.  
Therefore, the tool represents a first attempt (to the extent of my knowledge) to offer a 
detailed assessment of the five governance principles at the health policymaking level. 
Thus, a major contribution of this first phase of this research was to provide an in-depth 
understanding of the way in which  the five principles could be assessed in a practical 
manner.  
As mentioned earlier, there is a need to develop a practical tool based on academic 
standards and methods; the conceptualisation and the operationalisation were the first steps 
towards fulfilling this need.  
Due to the lack of agreement concerning the implication of these principles in practical 
terms, a multi-perspective input from governance experts (through Delphi consultations) as 
well as policymakers (through face-to-face consultation meetings) and their consensus was 
required to complement the findings of the literature review. This is important to minimise 
any bias caused by the personal interpretation of the literature.  
In conclusion, the first phase of this research included conceptualisation in the form of a 
literature review on health governance and its principles, summarising the key findings in a 
coherent and logical manner, preparation of checklists that included the main concepts and 
the development of a conceptual framework. It also involved the operationalisation of 
these main concepts of governance principles into the tool constituted by composite indices 
with both EBQ and PBQ. The outcome of this phase was the development of the first draft 
of the tool organised around five principles and two types of data generation that needs to 
be further refined, which was validated by Delphi experts and a group of policymakers; 
this has been discussed in the following chapter.  
84 
Chapter Four 
Refining the Assessment Tool Using the Delphi Method and 
Consultation With Policymakers 
This chapter includes a description of the second phase of this research. It offers an 
explanation of the way in which the tool was refined, validated, and further developed 
through Delphi method consultations with governance experts and of the appropriateness 
of this method for this research topic, the purpose behind its usage, and how it is used as a 
means to explore and generate new concepts related to governance principles. The chapter 
demonstrates how the Delphi consultations yielded consensus on the selected governance 
principles’ main characteristics and their actual implication in practical terms, thus 
enriching the tool’s content. 
The second part of the chapter concerns the consultation meeting with policymakers, its 
value, participants, outcomes, and the tool’s further refinement based on this review.  
 
4.1 Refining the Tool: Delphi Method-Consultation with "Governance 
Experts" 
Since there are conceptual gaps regarding the implications of GG principles in practical 
terms and a need for consensus as to the aspects that require to be assessed in HSG, the 
Delphi method was selected. The Delphi method, as defined in Chapter Two, presents a 
flexible consultation technique executed virtually (usually through the exchange of 
emails), used to reach a consensus between a group of experts on a complex subject whose 
field has a limited number of experts, such as governance (Okali and Pawlowski, 2004). In 
addition, combining expert opinion with evidence from the literature will ensure both face 
and content validity of the new assessment tools (Campbell et al., 2003, p.818). 
The use of this consultation method involves multiple rounds of consultations, wherein 
each round builds on the results of the previous one and enables referring with the same 
group of experts from all across the world in an inexpensive way (Keeny, Hasson and 
Mckenna, 2001). The literature recommends including different kinds of experts, such as 
academics, NGOs, as well as governmental officials, practitioners, among others (Okali 
and Pawlowski, 2004).  
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This group communication is facilitated by a "Maestro", who also controls the feedback 
(Hasson et al., 2000). Delphi consultations require prior preparation and planning of the 
steps and facilitation and communication skills, necessary for a successful process (Hasson 
et al., 2000). Each round serves as a "special type" of survey, in which a questionnaire is 
created based on the tool developed, sent (usually via email, fax, or some web medium) to 
a group of experts, and they are asked to fill in the questionnaire, responding to the list of 
questions over several rounds (Okali and Pawlowski, 2004). The returned responses are 
then analysed and the questions adjusted accordingly; subsequently, the revised list of 
questions is sent back and forth among the experts (Okali and Pawlowski, 2004). They will 
be asked to revise their original responses and respond to another set of questions based on 
the group feedback; this will be done until a satisfactory degree of consensus is reached 
regarding the items that should be included in the tool (Okali and Pawlowski, 2004).  
Though the literature suggests that the classic Delphi process comprises four rounds, two 
to three rounds are preferred to avoid overloading the experts (Hasson et al., 2000). I 
decided to conduct the Delphi consultation over three rounds based on acceptable practice 
reported by Okali and Pawlowski (2004) and others (Hsu and Sandford, 2007; Kalaian and 
Kasim, 2012).  
 
4.2 Planning the Delphi 
Planning for the Delphi consultations included brainstorming about potential challenges 
and possible ways to overcome them. The first main challenge was to identify qualified 
experts in the field of health governance. The second was to attract experts to participate in 
the Delphi consultations. There were no expectations for a minimum number of experts to 
be included. The third challenge was collecting group opinions, analysing the responses, 
and following a controlled feedback process (Hsu and Sandford, 2007) in a timely manner. 
The literature from various fields offers general guidelines as to ways to develop the 
questionnaires and conduct analyses based on the scope of the research and the responses 
received, allowing to modify the classic Delphi process (Hsu and Sandford, 2007). 
Consequently, I followed a modified Delphi method to suit the objectives of this research. 
Planning the duration of the Delphi process presented another challenge. It was necessary 
to give the experts sufficient time to review the tool in order to obtain the best possible 
results in terms of number of responders and the review’s quality (Hasson et al., 2000). 
Thus, it was crucial that the time provided for the review was not short, to prevent 
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pressurising the experts as this might result in loss of interest in the consultation, and not 
too long either as it would have resulted in delaying the research. Following Hsu and 
Sandford’s (2007) work, I gave the experts three weeks to respond, and allocated six weeks 
for each round in total, including receiving responses, analysis, adjusting the tool, 
summarising the responses, and sharing them with the experts for the consecutive round. 
The expected period for the Delphi consultation was estimated to be five months (between 
July and end of November 2015).  
The part of the planning phase was to plan for the analysis of the Delphi experts responses. 
I obtained funding from the WHO for my research and recruited a statistical expert to help 
with the analysis in order to save time.  
 
4.3 Identification and Recruitment of Delphi Experts 
The first step, one of the most critical ones for the success of the Delphi process, was to 
compile a list of "governance" experts to invite from a diversity of backgrounds. The aim 
was to generate a list that included experts who were qualified professionals with relevant 
knowledge, that is, expertise in health governance (Kalaian and Kasim, 2012), who were 
available, willing to participate (Kirigia, 1996), and committed to be involved in the Delphi 
consultations over a period of at least five months (Hasson et al., 2000).  
The list of Delphi experts comprised three strands. A total of fourteen were from my 
network (people I either worked with or met during meetings related to governance held by 
the WHO). These were health governance practitioners, senior health and development 
consultants, academicians, and ministry officials from a number of countries. Furthermore, 
ten experts were identified from readings on health governance (due to their contribution to 
HSG knowledge). Further sixteen were nominated by other governance experts from my 
network, based on their experience in the field. Therefore, initially, there were a total of 40 
experts to be contacted. When I contacted this initial list of invitees, I requested additional 
recommendations of experts who might be interested in joining this research. 
Consequently, another 26 experts, nominated by other experts, were added, and I was 
allowed to use their names as points of reference to contact further experts. 
Therefore, in total, I contacted 66 experts from diverse backgrounds from different 
countries, not limiting the group to LMICs, which thereby led to the creation of a 
heterogeneous pool of experts.  
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They were contacted via email, which was a challenge by itself. The email sent was brief, 
with information about the study and what was needed of the experts presented in bullet 
points. The email included an attachment with an information sheet for participants (see 
Annex 2); furthermore, they were asked to send their consent to participate in this research 
via email. 
In addition, these experts were asked if they would agree to reveal their names to other 
experts. The common practise is that experts do not know the identities of other experts 
throughout the process while the researcher is aware of them (Okali and Pawlowski, 2004). 
Revealing other experts’ to experts while keeping their individual responses anonymous 
constitutes quasi-anonymity and is a practise recommended in Delphi consultations as it 
can encourage more experts to join and remain engaged in the process (Okali and 
Pawlowski, 2004). In fact, all the experts who joined the Delphi agreed to reveal their 
names to others and have their names published in all future acknowledgments.  
As can be seen in Table 4 below, 30 (45.5%) experts who were contacted showed interest 
in participating in the Delphi consultation; however, when the consultations started, only 
25 (38%) responded to at least one round. The literature suggests that from 60 to as few as 
15 can be an acceptable number of Delphi experts (Hasson et al., 2000), and thus the 
number involved in the current research can be considered acceptable.  
 
Table 4: Experts Recruited Based on Personal Contact or Referred by Others 
 Who Agreed to Participate Total Number Contacted  
Prior Personal Contact 12 14 
Referred by Others 17 42 
No Previous Contact  and No 
Reference 
1 10 
Total  30 66 
 
Out of those who agreed to participate, initially, I had prior personal contact with 40% of 
them, 56.6% were referred by others, while only 3% (one person) agreed to participate 
despite no personal contact or referral by anyone. The latter dropped out after the first 
questionnaire was sent, thus reflecting other findings regarding the importance of 
"gatekeepers" (Hasson et al., 2000) in the recruitment of experts. This could have resulted 
in a biased pool of experts, those who agreed to participate; however, the sample was 
sufficiently heterogeneous (in terms of level of expertise, status, seniority, institutional 
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affiliations, and countries worked in, details provided below in the Delphi Expert Profile 
section) to overcome this bias, and all experts satisfied the criteria determined for the 
profile of experts required. 
Log sheets were maintained for all consultation rounds, indicating the time when the 
questionnaire was first sent, their feedback was received, reminders were sent, and reasons 
for withdrawal wherever applicable. 
• Delphi Expert Profile 
There were 25 active Delphi experts who participated in at least one round of Delphi 
consultations, a number considered acceptable by other researchers (Hamilton, Rubin and 
Singleton, 2012) (see Table 5 for the Delphi experts’ general profiles).  
 
Table 5: Delphi Experts’ General Profile 
Sectors They Served in • 3 from the public sector: MoH, governmental anti-corruption 
agency, and parliamentary member 
• 8 from international organisations: 4 WHO and 4 USAID 
• 8 From academia 
• 2 From local NGOs 
• 1 from international NGOs 
• 2 independent consultants 
• 1 professional organisation 
Countries of Current 
Employment 
Algeria, Australia, Bolivia, Brazil, Egypt, Jordan, KSA, Lebanon, 
Mexico, Morocco, Philippines Portugal, Sudan, Switzerland, Tunisia, 
USA 
Years of Experience in 
Health Governance 
Issues* 
• 2 ˂ 5 years 
• 6 between 5–10 years  
• 2 between 11–15 years  
• 1 with 25 years of experience;1 with 40 years of experience 
*Not all experts indicated years of experience in the field of governance 
 
The group of experts included 12 females and 13 males, which is, again, an acceptable 
gender balance. The group of experts represented various disciplines and organisations 
currently working in 16 different countries as indicated in the table above (for further 
details, also see Annex 3: List of Delphi Experts and Affiliation). The countries where the 
experts had worked in or assisted in governance issues was even more diverse.  
Experts’ experience in health governance issues was wide-ranging and included health 
financing and planning, governance of civil society organisations, design and 
implementation of health governance interventions and evaluation of their effectiveness in 
capacity-constrained and fragile environments, strengthening pharmaceutical systems in 
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LMICs, strengthening health systems and health reforms, with an emphasis on smarter 
governance, conducting procurement assessments in health, development and execution of 
integrity risk assessment focusing on transparency and accountability, policymaking at the 
national level, development and delivery of training on governance in health, teaching and 
supervision of masters dissertations related to governance in health.  
Hence, the group of experts involved in the Delphi process was heterogeneous and 
appropriate for it’s the objective of the consultation, reaching a consensus from among 
multiple perspectives on HSG issues. The literature recommends representation of this 
kind to allow multiple perspectives concerning the topic under study (Okali and 
Pawlowski, 2004; Hasson et al., 2000). The inclusion of 25 experts with diversity in terms 
of years of experience (some junior and some very senior), type of organisation, and type 
of expertise (academia, professionals) contributed to the development of the tool’s content. 
The experts had different backgrounds in terms of the countries they came from and 
worked in, coming from low-, middle-, and high-income countries. Learning about GG 
practices in high income countries was useful while the perspective as to what will be 
practical in middle- to low-income countries was extremely important and informative for 
the development of a practical tool. 
Reaching a consensus in a group this diverse was a challenge; yet, it was highly important 
and needed since it would reflect different perspectives regarding  HSG based on these 
experts’ practices. The only limitation in the group of experts was an inadequate number of 
senior-level policymakers (there were only three), whose recruitment proved to be a 
difficult task. Policymakers feedback concerning the tool was essential as they would be 
the end users of the results/recommendations of this research. Fortunately, this gap was 
addressed through a consultation meeting held with policymakers, which took place after 
the Delphi process (discussed in detail in the second part of this chapter).  
The literature suggests forming various panels of experts based on their fields of expertise 
(academics, practitioners, governmental officials, and official NGOs) (Okali and 
Pawlowski, 2004); however, in this research, it was not possible to form such panels due to 
the limited number of experts in the field of health system governance and the imbalance 
in the number of experts based on their work experience. Most of the participants work in 
international organisations and academia and a lesser number belonged to governmental 
agencies and NGOs. Instead, the experts were divided into groups, depending on the 
principles they decided to review, that is, there were five groups, one for each of the five 
principles. The following section provides a description of the Delphi process and analysis 
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of the responses received from the three rounds conducted and the outcomes and the way 
in which the tool was refined according to these consultations. A summary of the Delphi 
process has been presented in Figure 3, p: 113.  
 
4.4 Round 1 
This round commonly involves brainstorming for important/relevant factors in an "idea 
generation" activity (Okali and Pawlowski, 2004). The experts are asked open-ended 
questions in the first round in order to obtain a list of relevant aspects the tool should cover 
(Okali and Pawlowski, 2004). This round was modified for this purpose as recommended 
in other literature (Hamilton, Robin and Singleton, 2012). Instead, the individual experts 
were provided sets of questions (regarding the characteristics of each of the five principles) 
and were asked whether they considered them relevant or not. This was done, first and 
foremost, to provide a theoretical background based on the literature so as to have a solid 
conceptual starting point for the tool and also to limit the number of rounds that might be 
required for the consultations. The limitation of providing pre-existing information 
(questions) rather than starting with open-ended questions is that this could result in biased 
responses as it limits the available options that can be explored (Hasson et al., 2000; Okali 
and Pawlowski, 2004). This limitation was addressed by asking experts to suggest 
questions that could be added and had not been considered initially. 
 
4.4.1 The Purpose of Round 1 Consultation 
The purpose was to assess the tool’s comprehensiveness and the five principles’ main 
characteristics’ relevance at the level of policymaking. Additionally, identify any missing 
aspect, obtain feedback on the proposed structure of the tool, clarity, and suitability of the 
questions’ wording.  
Asking the experts to justify their responses is considered an optional yet valuable step in 
the literature for expanding the theory and is thus desirable (Okali and Pawlowski, 2004); 
therefore, justifications were requested in this Delphi consultation.  
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4.4.2 The Process of Round 1 Consultation 
The experts were asked to choose and review at least two out of the five principles selected 
for the tool; this was done to prevent overburdening them with lengthy review of all 
principles. All the principles were chosen for review but not in an equal number (see Table 
6 below).  
After the experts indicated their preferences, they were sent the assessment tool with the 
sections selected with an instruction sheet (see Annex 4: Delphi Round 1 Tool). The first 
draft of the tool was sent as a generic one, in which the policy area (e.g. drug policy, 
maternal health, cancer services, among others) was not specified. Reminder emails were 
sent to them before and after the deadline. Sending reminders to experts is recommended 
in literature to increase the response rate (Hasson et al., 2000). While the experts were 
provided three weeks to send their responses, some were delayed, as anticipated. All 
responses of experts who sent their feedback were included in the analysis.  
 
4.4.3 Feedback  
Out of those who agreed to be a part of the Delphi consultation, 73% sent their comments 
in Round 1. People who did not send their feedback and did not provide a reason for doing 
so were considered as "dropouts", while those who did not send their feedback but explain 
the reason behind it were considered to have "withdrawn".  
A total of five experts withdrew from Round 1 consultation: two due to medical problems, 
two were busy travelling, and one had some personal problems. furthermore, three experts 
dropped out without any explanation since they never responded to the reminder emails. 
Table 6 summarizes the number of experts who reviewed the various principles across the 
three rounds of consultations and the total number involved in each round.  
Table 6: Number of Reviewers per Principle across Three Rounds of Consultations 
Section Round 1 
Number of Experts 
Round 2 
Number of Experts 
Round 3 
Number of Experts 
Participation 13 14 10 
Transparency 12 10 8 
Accountability 10 10 9 
Information 10 8 7 
Responsiveness 9 11 7 
General Comments  2 1 --- 
Total Number of 
Experts 
22 21 15 
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Okali and Pawlowski (2004) suggested including 8 to 18 experts per panel, which means 
that there was an acceptable number of experts in all rounds, except for Round 3, as a 
substantial number of withdrawals/dropouts took place. 
Over the three rounds of consultations, 25 experts were involved. In total, 18 experts 
reviewed two sections, three reviewed three, and four were asked to review the whole tool 
(five sections).  
Two experts offered general comments regarding the principles they reviewed and not 
individual questions. Nearly all the others answered the question whether individual 
questions were relevant or not relevant; some suggested specific changes to the questions, 
and few also added justifications for their choices. In addition to the specific comments, 
several general comments were provided on the tool as a whole.  
 
4.4.4 Analysis and Outcomes 
The analysis of the responses received in round 1 included only a simple counting of the 
questions marked as relevant as against not relevant within each principle/section. Based 
on these, the percentage of agreement to retain and remove questions across the five 
principles were calculated by me.  
• Questions to Be Removed  
Any question that was labelled as not relevant was considered as a suggestion for removal. 
It was decided that questions that at least two experts had labelled as not relevant would be 
removed. The agreement to remove a question was calculated as the percentage of experts 
who answered "not relevant" against the total number of experts who reviewed the 
principle. This decision was made to shorten the list of questions as much as possible.  
The percentages of agreement to remove a question across the five principles ranged from 
15.4% to 44.4% (average 24.3%). In most cases, the questions that were removed were 
duplicates either within the same principle, especially PBQ or because they appeared under 
other principles. A few were suggested for removal due to practical issues such as being 





Table 7: Questions Suggested to Be Removed Due to the Difficulty in Assessing Them 
Principle Questions Suggested for Removal Due to Difficulty in Assessment 
Participation 
Is it specified in the mandate of the committee the level of participation? 
Consultation, partnership, delegated power, and control 
Is there a mechanism for consensus building between various stakeholders?  
Transparency Are there written criteria for decision-making in relation to policy 
formulation? 
Accountability Are justifications included during evaluation/monitoring?  
Use of Information How has evidence-based research been utilised in policy formulation? 
Instrumental, conceptual, symbolic use, not used 
 
• Questions to Be Retained 
Questions were retained if all the experts or all except one labelled these questions as 
relevant. The agreement to retain questions across the five principles ranged from 89% to 
100%. This signifies means that any individual question retained received more than 70% 
agreement regarding its importance, as recommended by Okali and Pawlowski (2004).  
• Questions to Be Added  
It was also decided that new questions will be added for assessment during Round 2 based 
on experts’ individual requests. The concepts that were suggested for adding to the tool 
across the five principles and were thus added to the final draft of the tool have been 
provided in Table 8 below.  
Table 8: New Concepts Suggested for Addition per Principle: Round One  
Principle Concepts Suggested for Addition 
Participation • Gender balance between stakeholders participating in formulation  
• Presence of dedicated resources to enable/facilitate participation  
• Presence of a participatory body to oversee policy implementation 
• Presence of mechanisms to enable vulnerable groups’ participation  
Accountability • Requirement to sign a contract/memorandum of understanding (MOU) with 
stakeholders before engaging them in the formulation process  
• Stakeholders should be informed before their engagement that they will be 
held accountable  
• The public should hold various stakeholders accountable for their role in 
policymaking  
Transparency • Decisions related to priority setting should be made public 
• Decisions related to resource allocation should be made public  
• Conflict of interest (COI) declaration should be made by all stakeholders 
• Information should be released in a "predictable manner"  
Use of 
Information 
• MoH should make the data generated at service delivery level accessible to 
researchers  
• MoH should have a mechanism in place to check the sources of funding for 
research used in policy  
• Information about how national evidence is generated and MoH adapts 
research findings to local context should be disseminated 
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Responsiveness • Need assessment targeting the public should be undertaken as a part of policy 
formulation 
• Health policy should be assessed to ensure that it meets the population’s needs  
 
The justifications offered the Delphi experts for the concepts added across the five 
principles were as follows. 
• Concepts Added to Participation 
Gender balance: It is necessary to highlight the importance of women’s participation in 
the policymaking process, thereby ensuring fair representation. In some countries, females 
are highly discriminated against and their voices are not heard, while in others, this is not 
the case. Therefore, identifying whether this is the case with regard to policy formulation 
in a certain country reflects on stakeholder participation and representation, which will 
affect policymakers’ recommendations.  
Presence of dedicated resources: Resources need to be available in order to facilitate and 
pay for the expenses of meetings (venues, coffee breaks, and other meals) as well as 
administrative work or material (print outs, among other things) related to meetings (Smith 
and Katikireddi, 2013;  Matthews, Pulver and Ring, 2008). Furthermore, it is 
recommended that incentives be offered for participation in the form of a fee or honoraria 
or at least provide reimbursement for transportation and accommodation, as ways to 
encourage participation and commitment (Emerson, Nabatchi and Bologh, 2011). This is 
because lack of participation may have been caused due to the absence of dedicated 
resources, and hence, these should be provided to cover the relevant costs.  
Participatory body for implementation: Participation should continue throughout the 
policymaking cycle to ensure ownership, which can thus enhance the possibility of success 
in policy implementation (Emerson et al., 2011). Stakeholders’ oversight in policy 
implementation is crucial to the process. 
Enabling participation of vulnerable populations: There should be mechanisms in place 
to offer vulnerable groups an opportunity to participate in decision making related to their 
health or at least be consulted and heard. Accordingly, the MoH/Health authorities should 
make some kind of investment to help enable the participation of the most vulnerable 




• Concepts Added to Accountability 
Informing stakeholders that they will be held accountable: The various stakeholders 
should be informed before being engaged in the policy formulation and implementation 
process about their roles and responsibilities.  
Signature of Memorandum of Understanding (MOU)/contract: This should be done to 
ensure the accountability of all stakeholders, and this can be done by ascertaining that all 
stakeholders are informed about their duties, roles, and responsibilities in a written form.  
Public role in holding stakeholders accountable: There is a need to establish 
mechanisms for citizen oversight in policymaking (Brinkerhoff et al., 2008) through health 
boards or other means to allow the public to demand explanations regarding certain health 
issues or decisions.  
• Concepts Added to Transparency 
Decisions related to priority settings and resource allocation should be public: 
Accessibility to such decisions is a sign of transparency (Otenyo et al., 2004; Relly and 
Sabharwal, 2009) and necessary to ensure proper accountability and increase public’s trust 
in government decisions.  
Information released in a "predictable manner": Predictability is one factor that must 
be included in transparency. It signifies that relevant stakeholders and the public can have 
definite expectations as to when they will receive information. Accordingly, there should 
be published timelines, which should include what to expect in the relevant information 
and when to expect it.  
Conflict of interest declaration: Participants should declare their affiliation and any 
relationship and/or remuneration that might influence their participation and contribution 
to the policy development and implementation, another sign of transparency (WHO, 2009). 
This declaration does not imply that they do not have the right to participate and offer their 
feedback. In reality, most stakeholders will have a conflict of interest; it is an inherent 
issue as actors and experts in the health system. If only neutral parties are consulted, then 
stakeholders’ real positions would not be captured. It is only a matter of declaring these 
conflicts to everyone involved to be transparent about it.  
• Concepts Added to Use of Information 
Making raw data accessible to researchers: A part of governance entails sharing 
information required to inform policies and conduct relevant research. Data generated at 
the health facilities should be easily accessible by researchers and made available to them. 
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The reason behind this proposed addition could be the fact that the majority of Delphi 
experts from academia selected this principle and thus the addition of this question 
appeared reasonable to all.  
Checking the source of funding of research: It is important for MoH/health authority to 
have a mechanism in place to ascertain whether the research conducted for policymaking is 
financed by a private or any other entity that has a conflict of interest in relation to the 
policy in question.  
National evidence generation and adaptation: The way in which evidence is encouraged 
and generated at the national level and the factors that affect its generation are important 
pieces of information. Moreover, the ways in which they can be adapted to the context of 
the policy in question specifically and to the country in general are issues that need to be 
taken into consideration. 
• Concepts Added to Responsiveness 
Needs assessment targeting the public as a part of policy formulation: The assessment 
of the health system’s responsiveness should be based on consumers/users’ feedback as 
they represent the best source of information. This implies that it is important for 
policymakers to understand the public’s perception as well as preferences with regard to 
the health system and allow them to express their needs (Darby et al., 2000; Siddiqi et al., 
2009). This assessment is suggesting the use of surveys, public forums, telephone hotline, 
or any other appropriate means.  
Health policy should be assessed to ensure that it meets population needs: It is 
important to be able to assess the various elements of responsiveness as a part of the 
specific policy under evaluation. Determining whether the policy in question satisfies 
people’s expectations comprises an issue of governance and thus should be included in the 
evaluation phase.  
It is important to highlight that Most of the concepts suggested (see Table 8) for addition 
were not found in the literature reviewed. They were suggested based on their significance 
in practice; furthermore, the Delphi experts were asked to approve their addition to the tool 
in subsequent rounds.  
The specific comments and suggestions regarding the retention of individual questions 
guided the modification of the questions, which included rephrasing (as some questions 
were vague and required further elaboration), editing and rewording (to enhance clarity), as 
well as rearrangement. Some questions were merged with others as they covered the same 
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concepts. The general comments received on the tool as a whole (whether addressed or 
not) have been summarised in Table 9 below.  
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Table 9: General Comments Received by Delphi Experts during Round One 
General Comments Addressed and How 
• Specify a policy type as an example to make the review easier: National Health Strategy was 
chosen as an example  
• Relate questions to different phases of policy process: Questions were in relation to formulation 
phase 
• Define five principles: Detailed definitions were added  
• Define policy and policymaking: Definitions were added  
• Tool is excessively long: One of the objectives of the Delphi consultation was to make it shorter  
• Some questions are redundant and repetitive: Duplications were removed 
• Some questions can be merged: This was done to questions that covered same concepts 
• Some questions require filter question with sub-questions: This was done for many EBQs 
• Sequence of questions needs to be revised: Revisions were made to reflect a more logical sequence 
• Tool requires pre-testing: A pilot was planned  
• Need a sampling strategy of KIs to include different categories and data collection protocol: These 
were developed as a part of the manual  
• Tool does not reflect the broader country context: Information regarding the country’s context and 
health system structure were included in the report  
General Comments that Were Not Addressed and Reasons for It 
• Two reviewers suggested removing responsiveness since there was a great amount of overlapping 
with other sections and this would form a conceptually weak: I believed in the importance of this 
principle for its inclusion and testing (further details provided in the section below). 
• Data collection through desk-review alone would be difficult: The decision regarding the best data 
collection method was postponed till after the finalisation of the tool’s content. 
• Need to provide incentives for KIs: Uncertain whether it is ethical to provide financial incentives to 
KIs as it is believed that their incentive is improving the policy process. 
• Classify questions into categories such as legal framework, operational management, and others: It 
was deemed inappropriate to group questions further as they were already grouped in accordance 
to the five principles. 
• Use Likert scale for EBQs: One of objectives of the tool is to produce lists of good practices to 
follow, and the use of Likert scale would not enable this approach. 
• The focus is on policy formulation only, but other aspects require to be addressed as well: The tool 
is already an elaborate one since it explores considerable detail and thus cannot cover other phases 
of the policy cycle.  
• The assessment of reliability and validity is difficult with such tools: Validity testing was 
undertaken as a part of Delphi process in terms of content. Testing reliability was recognised as an 
issue and will be discussed later. 
• Assign a score that places each country on a continuum of weak or good governance: This step was 
planned but the final decision was left to policymakers for a later date, and they voted against this 
alternative. 
 
With regard to the section on responsiveness, two experts out of the nine who reviewed it 
during Round 1 suggested that it should be dropped from the tool since it is conceptually 
weak as compared to the other principles. This could be due to the fact that was not 
adequately developed at the conceptual level in the literature: it defines responsiveness at 
the service delivery level only (as discussed in Chapter Three). Responsiveness is defined 
by several scholars/institutions as being responsive at the policy level, whereby 
"institutions and processes should try to serve all stakeholders to ensure that the policies 
and programs are responsive to the health and non-health needs of its users" (Siddiqi et al., 
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2009, p.18). Governments/MoHs are obliged to listen to the needs of their citizens, act on 
their concerns, and respond to their expectations in policy development (Darby et al., 2000; 
Ura and Ellis, 2008). Additionally, there is a lack of literature to support what 
responsiveness really means in an operationalised way. These reasons contributes to its 
inadequacy. However, due to this deficiency, I decided to retain it in the tool in order to 
allow an opportunity for its conceptual development with the help of governance experts. 
This step is considered suitable as it is consistent with the objective of this research and the 
tool, whose aim is to increase the understanding of GG at the level of policymaking by 
uncovering the significance of its principles in depth. The experts were informed that it 
will be retained for these reasons, and none of the eleven experts who reviewed it in Round 
2 objected to this decision. Thus, despite some reservations, the majority saw it as an 
important principle and the literature offers a considerable amount of evidence to support 
this view (Darby et al, 2000, Gostin et al., 2003; Siddiqi et al., 2009). Therefore, it was 
decided that it will be retained in the tool. Moreover, the research process would facilitate 
the identification of its characteristics for further conceptual development. Responsiveness’ 
conceptual development in the tool has been discussed in the section on Round 3.  
 
4.5 Round 2 
4.5.1 The Purpose of Round 2 Consultation 
The purpose of this round was to reach a consensus regarding the questions to retain, add, 
and remove as well as shorten the list of questions in order to have a practical tool. Round 
2 consultations offered the Delphi experts an opportunity to revise and validate their initial 
responses to the individual questions, confirm or modify them, based on the collective 
responses of other experts (Kalaian and Kasim, 2012). As recommended in the literature, 
the inclusion of an aggregated summary of experts’ feedback received is the most common 
practice in such consultations (Keeney Hassoun, and McKenna, 2001; Holey et al., 2007; 
Hsu and Sandford, 2007). As stated earlier, this allowed the experts a chance to revise the 
implemented changes based on the responses from Round 1. Thus, the modified tool for 
Round 2 consultation included three subsections pertaining to each of the five principles.  
• Questions to be retained 
• Questions to be added 
• Questions to be removed finally from tool  
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4.5.2 The Process of Round 2 Consultation 
Delays in receiving feedback from Round 1 led to the postponement of Round 2, which 
resulted in reduced time for sending feedback (18 days instead of 21). All the 22 experts 
who sent comments on Round 1 were invited to participate in Round 2.  
Furthermore, three experts (who were contacted at the start of the Delphi process and 
exhibited an interest in participating but dropped out) asked to join Round 2. They were 
considered "new comers" since they did not need to participate in Round 1 (Hamilton, 
Rubin and Singleton, 2012). Consequently, a total of 25 experts were consulted for Round 
2.  
A three-page introduction was added to the tool in a bullet-point format along with a 
summary clarifying a number of issues (as illustrated in Table 9). The instructions 
provided to the experts were specific and simple to follow so as to make the review process 
as convenient as possible but at the same time systematic as well.  
For this round of consultation, the experts were sent the principles/sections they had 
previously reviewed (during Round 1), and they were informed that each principle 
currently contained three subsections/parts (as mentioned above). Furthermore, they were 
specifically asked to do the following: 
• For retaining questions: They needed to rate the importance of the questions on a 
Likert scale (1: not important, 2: little significance, 3: average importance, 4: 
important, 5: very important) similar to what was previously used in Delphi (Australian 
Institute of Health and Welfare (AIHW), 2009). 
• For adding questions: Consensus was required for this. If it was agreed that it was to 
be added, the importance of each question was required to be rated with a Likert scale 
(as done above).  
• For questions to be removed: Decisions needed to be made regarding whether certain 
questions should be removed and justifications were required in cases not agreeing to 
remove.  
• Experts were also asked to add general comments regarding the second draft of the tool 
in comparison to the first draft.  
All of the experts’ responses gained over the three rounds were entered in Excel sheets and 
sent to the statistician for analysis after rounds 2 and 3. The tool was not sent to him, only 
the coded numbers for the questions with the responses, thus making the process blinded. 
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The spreadsheets facilitated the systematic monitoring of questions that different experts 
rated differently at different points in time (mainly between rounds 2 and 3). 
 
4.5.3 Feedback 
Out of the 25 experts who received draft 2 of the tool, 21 sent their feedback and 
comments. In this group, three dropped out without any excuses and one withdrew due to 
prior engagements (see Table 6 for the number of reviewers per principle in Round 2). A 
few provided justification for their suggestions to add or remove items similar to Round 1. 
A two-week delay was experienced in receiving the responses compared to the one-week 
delay in Round 1.  
General comments concerning the tool included concerns regarding the length of the tool, 
processes followed to conduct the tool at the national level, difficulties involved in some 
questions through a desk review, suggestions to include a general section of the tool to 
offer an overview of the country’s context, and overlap between principles and some 
repeated questions. Furthermore, a total of ten experts commented that the tool was 
improved in terms of the questions’ coherence, wording, clarity, and the robustness of the 
tool in general.  
 
4.5.4 Analysis and Outcomes 
Earlier work on Delphi consultation recommend the production of descriptive statistics 
based on an analysis of questions’ ratings by experts in order to gain statistical summaries 
for each (Hassoun et al., 2000; Holey et al., 2007). These include mean, median, and 
standard deviation (Hassoun and Keeny, 2000), percentage response rates, as well as 
agreement percentages (Holey et al., 2007) and the coefficient of variance (CV) (Kalaian 
and Kasim, 2012), which were produced for Round 2 analysis. The application of simple 
statistics offers the advantage of sharing aggregated summaries of the feedback along with 
justifications for decisions made that were presented to the Delphi experts in a user-
friendly manner. This was crucial to the success of the method practised or applied from a 




For removal of questions: Agreement concerning the removal and change in agreement 
on removal of questions between rounds 1 and 2 was calculated as percentages (as 
discussed in the analysis of Round 1). It was found that agreement on the removal of 
suggested questions in this round ranged from 54.6% to 100%, with an average of 81.2%. 
Hence, the majority of experts agreed on removing the suggested questions. This is an 
indicator of a consensus among other experts, which is essential for the success of Delphi 
consultations (Hasson et al., 2000). This also represents a large increase in agreement from 
Round 1, in which the average on removal was only 24.3%. This demonstrates an 
advantage of Delphi that is reflected in the group dynamics that take place, wherein experts 
tend to change their opinion in line with others’ views (Hassoun et al., 2000) to reach the 
required consensus. Certainly, the aim is not to reach a consensus for the sake of it, rather, 
to gain experts’ contributions towards the identification of items not relevant or those that 
are duplicate and thus redundant. Questions were removed if they received agreement 
exceeding 70% for removal; as Okali and Pawlowski (2004) suggested, this presents an 
acceptable level of agreement.  
For retention of questions: The median, standard deviation, and CV were computed for 
each question (Hasson et al., 2000). Furthermore, the average rating (the sum of the ratings 
divided by the number of questions) based on the rating of importance as made by the 
experts was calculated for all questions within a subsection for each of the five principles 
(Kalaian and Kasim, 2012). Moreover, within each subsection, questions were ranked 
according to value of the CV, with 1 being the greatest (indicating the highest variability 
among experts in rating items). All of these were calculated to determine if consensus was 
reached among experts by identifying questions that received the highest rating in 
importance, lowest rating in comparison to the mean/average ratings, and variations in 
ratings among experts with the CV.  
Questions that were retained received an average rating equal to or higher than the average 
rating of that given subsection. This cut-off point was determined by the statistical expert 
and myself. Furthermore, questions that received the highest CV (high variability among 
experts in terms of importance) were removed. Moreover, the questions that received 70% 
or more in agreement were retained in the tool.  
For addition of questions: The percentage of agreement on adding new questions was 
calculated for each question within each subsection, which ranged between 54.6% and 
100.0%, with an average of 75.3%. This indicates that the majority of experts approved the 
addition of the individual questions. Only questions that received an average rating equal 
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or above the average rating of the corresponding subsection were added. Thus, questions 
with the lowest average rating were not added. In addition, questions with the highest CV 
were not added to the tool as well as this indicates variation in rating of importance by 
experts (disagreement on importance). 
The experts suggested 44 questions (23 evidence-based and 21 perception-based) in Round 
1 for addition as important aspects that required to be covered. Based on the analysis 
discussed above, a total of 30 questions received agreement for addition (see Table 10 for 
the number of questions before and after Round 2). This implies that experts agreed to take 
on 68% of the suggestions. This addition of new questions represents new information 
gained from the Delphi consultation (Kalaian and Kasim, 2012), which contributed to the 
broadening of knowledge concerning the topic under study (Hasson et al., 2000). Thus, 
Delphi consultations were not only employed to reach consensus on concepts identified 
from the literature but also to generate knowledge by allowing experts to express opinions 
and offering them a chance to conduct mutual reflections and gain feedback. This 
contributed, to some extent, to the development of a pragmatically usable and policy-
relevant tool, which is also substantively robust in relation to the literature Overall, the 
experts agreed to remove 35 out of 44 questions (i.e. 79.5%) that had been suggested for 
removal during Round 1. This implies that out of all those suggested for removal during 
Round 1, only 9 (four EBQ and five PBQ) were retained for Round 3 as they did not 
receive consensus of 70% or more among experts for removal (see Table 10).  
 
Table 10: Number of Questions to be Retained, Added, or Removed before and after Round 2 









Questions to be 
Retained 
52 45 44 32 
Questions to be 
Added 
23 21 15 15 
Questions to be 
Removed 
23 21 19 16 
 
The Delphi consultations resulted in a decrease in the number of questions from 89 to 63 
for EBQ and from 69 to 52 for PBQ. As mentioned earlier, the significance of reducing the 
number of questions within the tool is to render it practical and applicable, as highlighted 
by the Delphi experts.  
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4.6 Round 3 
During this round, consensus between experts was expected on the final list of questions to 
be retained, and if consensus cannot be reached, adjusted lists of questions would be resent 
for further consultation until the point a consensus or plateau among the different experts is 
attained (Okali and Pawlowski, 2004). 
 
4.6.1 The Purpose of Round 3 Consultation 
To reach a consensus among experts on the final draft of the tool to be pilot-tested. 
 
4.6.2 The Process of Round 3 Consultation 
Delays in receiving the feedback from the experts in Round 2 resulted in delays in the 
analysis and the adjustment of the tool for Round 3. Consequently, the experts were 
provided less than three weeks (19 days) to send their feedback. The tool was sent to 20 of 
those who had sent their comments on Round 2 (one asked to withdraw after Round 2). 
The tool itself included a five-page summary concerning the way in which this draft was 
adjusted, general clarifications, statistical analysis conducted for Round 2 responses, the 
purpose of Round 3, and what was requested from the experts.  
They were also informed regarding a few questions that were retained in the tool despite 
receiving a lower average rating than the average rating of the relevant subsection as these 
were considered "fundamental" inquiries based on the literature review. I decided to retain 
these questions for one more round of consultation and informed the Delphi experts 
regarding this decision in order to be transparent and allow room for further discussion (see 
Table 11 below for these questions). 
Table 11: Questions Retained Despite Their Lower Average Rating  
Principles Questions Retained Despite Low Rating 
Rating 
Received/Question 
against Average Rating 
of Importance/Section 
Participation 
Is there a written scope/mandate for stakeholders’ 
involvement in the formulation of health policy?  
4.31 vs. 4.43 
 
Are other mechanisms used by MOH/health authority to 
encourage participation by different stakeholders?  
4.38 vs. 4.43 
Accountability 
What are the types of sanctions applied/might be applied to 
bodies responsible for implementation of various sections 
policy X in case of violation/not adhering to set standards?  




Does the document relating to policy X include the 
following: how policy was formulated, objectives, purpose 
and goals, evidence used, how decisions were 
made/justifications, the body responsible for policy, clear 
distribution of responsibility for implementation, timeframe 
for implementation, indicators and targets and plans of 
M&E, funding requirements? 
4.44 vs. 4.46 
 
Did the participants declare any conflict of interest by 





Does MoH/health authorities have a mechanism in place to 
check sources of funding for research to be used in policy? 
4.2 vs. 4.42 
Were other types of information (other than research) 
utilised in the policy formulation of policy X? 
4.33 vs. 4.42 
 
 
As can be seen from the table, the lower average rating received for each individual 
question is slightly lower than the average rating of importance for the whole subsection 
(average rating of the section was set as a cut-off to remove questions as discussed in 
Round 2). All questions retained despite the lower average rating received an average 
rating above 4 (4 is important) on the scale of importance from 1 to 5 (5 is very important).  
The justifications for retaining the questions presented in Table 11 based on literature the 
has been given below. 
• Participation 
With regard to the written mandate/scope: A written mandate that includes SOPs, by-
laws, decision rules, conflict resolution mechanisms is necessary to ensure clarity 
regarding roles and responsibilities (Cornwall et al., 2001). There is a need for shared 
commitment, motivation, set of values, and goals, determined from the beginning 
(Emerson et al., 2011). In order for the mechanisms to encourage participation, the 
government is responsible for creating and facilitating mechanisms, spaces, and places to 
promote participation of interested citizen (Papadopoulos and Warin, 2007). Engaging the 
public requires government planning and resources (Bishop et al., 2009). Different 
methods/mechanism/strategies can be utilised to encourage citizens’ participation (Charles 
and de Maio, 1993; Mitton et al., 2009; Oxman et al., 2009). 
• Accountability 
With regard to the types of sanctions, for meaningful accountability, all the following 
components are required: setting standards, investigation and answerability, allowing 
justifications, including sanctions, as well as including enforcement mechanisms 
(Brinkerhoff, 2004; Murthy, 2008). Policymakers should be aware of all the types of 
sanction they can enforce based on their authority under law (Murthy, 2008).  
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For methods to foster/enable accountability: Several mechanisms are suggested, which 
should be used to enable and facilitate their enforcement (Tuohy, 2003; Ebrahim, 2003; 
Taryn, 2008; Brinkerhoff and Bosart, 2008;). 
• Transparency 
For priority decisions to be made public: The availability of such decisions is a sign of 
transparency (Otenyo et al., 2004; Relly and Sabharwal, 2009). With respect to the 
components of the strategy document, the content of the information forms another 
important criteria for transparency; the policy document essentially reflects transparency in 
the formulation and implementation plans (Otenyo and Lind, 2004; Taryn, 2008; NAO, 
2012). In relation to conflict of interest (COI), participants declaring their affiliation and 
any relationship and/or remuneration that might influence their participation and 
contribution to the policy development and implementation also constitutes a sign of 
transparency; however, this declaration does not imply that they do not possess the right to 
offer their feedback (WHO, 2009).  
• Use of Information 
Regarding checking the source of funding: It is important for the MoH/Health authority 
to have a mechanism in place to ascertain whether the research used is financed by a 
private entity or any other with a conflict of interest in relation to the policy in question 
(this was the rationale given by a Delphi Expert). For using other types of information, 
expert opinion, financial information, governing laws, political direction, and others can be 
used in policy formulation in addition to scientific evidence (Oxman et al., 2009). They 
can be utilised on a regular basis and in emergencies at all levels of the policymaking 
process, being made available to all interested stakeholders (WHO, 2007a, Ch.3). 
In conclusion, I believe that these questions required to be retained as they are important 
aspects of HSG and their application is feasible in real settings. Hence, they were proposed 
for further consideration during Round 3 by the governance experts.  
In addition, during Round 3, next to each question, the average rating of importance 
calculated during Round 2 was inserted. The statistical information was shared with the 
experts in Round 3, first, for transparency concerning the analysis and the decisions taken, 
and second, to highlight the questions that gained collective agreement (Hasson et al., 
2000); this was done so that they could compare their opinions with those of the rest of the 
group (Okali and Pawlowski, 2004).  
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Experts were asked to do following for this round; For each of the EBQ Section A and 
PBQ Section B: 
To review the questions and the average rating of importance and rate the importance again 
(as in Round 2) with a Likert scale. They were asked to do so to assess the consistency 
between rounds as well as evaluate the reflective re-rating based on the feedback of the 
group of experts.  
To rank the importance of each of the questions (Hsu and Sandford, 2007; Okali and 
Pawlowski, 2004) in relation to others within the same section, 1 being is the most 
important within a given set of questions, 2 following in importance, and so on, with all 
numbers being utilised once. The reason they were asked to rank as well as rate was to 
have two ways of assessing questions’ importance, and most importantly, ascertain 
whether there was a sufficiently high degree of consensus on the final list of questions in 
order to be able to terminate the Delphi consultation.  




Out of the 20 experts who were sent the third draft of the tool, only 15 responded: three 
dropped out with no excuse and two chose to withdraw (one for medical reasons and the 
other due to prior engagements) (see Table 6 for the number of reviewers per principle). 
The final response was received 17 days after the set deadline.  
Even the general comments provided during this round were fewer in number compared to 
the other two, with only eight people offering general comments. Almost all who sent 
responses in Round 3 did not send any particularly critical comments regarding the tool; 
rather, they basically confirmed their Round 2 responses.  
It was evident from the responses received in Round 3 that there were incomplete data, 
experts lost interest in reviewing the tool, or they were simply overwhelmed or 
preoccupied. There was a clear decrease in comments and justification as the rounds 
progressed; the maximum number of comments were received in Round 1, while the least 
were received in Round 3. According to the literature, this is termed as "sample fatigue" 
(Hasson et al., 2000), which was expected at this stage of the consultations and so was the 
number of experts who dropped out from rounds 2 to 3.  
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The general comments received during this stage were as follows: "Tool is shaping out to 
be very comprehensive and yet easy to follow." "Tool improved greatly since first round, 
but it continues to be long." "Overall tool has kept and refined relevant questions, and with 
pilot testing it will become clearer." "Some questions still need to be merged and made 
shorter." "After the Round 3 consultation tool is now ready and is efficient." "Tool now is 
more succinct and has a better flow." "Tool is becoming more and more precise.".  
All the responses of experts’ rating for rounds 2 and 3 as well as the ranking for Round 3 
were entered onto the same Excel sheets to facilitate the comparison of responses and 
analysis. The Excel sheet was sent to the statistical expert for analysis, and he was blinded, 
similar to the second round.  
 
4.6.4 Analysis and Outcomes 
The analysis for the rating was conducted as follows: 
1. For each question, the average rating for rounds 2 and 3 by the experts who 
participated in both (Wilcoxon signed rank test) was calculated. The Wilcoxon test 
is a nonparametric statistical method recommended in the literature for use in the 
Delphi process for a sample size of experts in different panels lesser than 30 
(Kalaian and Kasim, 2012). 
2. The percentage of experts who gave a rating of 5 in Round 2 and in Round 3 again 
(McNemar’s test) was calculated. The rationale for deploying the McNemar’s test 
is the same as that for the Wilcoxon test: to ascertain any change in opinion 
between rounds 2 and 3 (Kalaian and Kasim, 2012). The Wilcoxon and McNemar 
test results revealed no change in experts’ opinion between rounds 2 and 3, thus 
indicating stability, which refers to "consistency of answers between successive 
rounds of study" (Holey et al., 2007, p.60). The results demonstrated that while for 
the majority of the questions the average rating decreased, none of these decreases 
were statistically significant. Similarly, for the majority of questions, the 
percentage of 5 as the rating decreased; but, again, none were statistically 
significant.  
3. The kappa statistic, which was also used to measure the level of agreement between 
rounds 2 and 3 ratings, was calculated. The higher the kappa value, the better the 
agreement. In general, a kappa exceeding 0.25 is considered to signify weak to fair 
agreement, one below this figure implies no agreement, while a kappa value of 
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lower than zero signifies a complete change in opinion (Hsu and Sandford, 2007). 
In the sample, kappa varied from negative to positive. Some of the experts changed 
their opinions, whereby instead of giving 5 (most important) as they did in Round 
2, they gave a rating of 4 (important) in Round 3. Although the literature 
recommends using Kappa to take decisions on agreement during Delphi (Okali and 
Pawlowski, 2004; Holey et al., 2007), we (statistical expert and me) decided not to 
include the results of kappa in the final analysis for the reason mentioned above. 
Hence, the final decisions were based on Wilcoxon and McNemar results instead. 
 
For the ranking, the following was undertaken: 
Computing the average and median rank for each question (within each subsection), 
similar to the process performed for the rating and following the same rationale and 
recommendations in the literature; 
Ranking questions based on average and median rank (within each subsection). 
Questions that were ranked in the lowest 20% were removed, as suggested by Okali and 
Pawlowski (2004), and thus, 10 to 12 EBQ and PBQ were retained for each principle. Only 
10 experts out of the 15 performed the rating and ranking for all the sections they were 
asked to review. However, 14 did undertake ranking, and the results demonstrated 
agreement with the rating conducted in Round 3. This provided a clear indication of the 
questions that received the lowest ranking and  thus were dropped from the tool. Table 12 
below presents the total number of questions before and after the Round 3 consultation. It 
also presents the decrease in the number of questions across the five principles of the tool 
following each of the three rounds of consultations. 
 
Table 12: Number of Questions across the Five Principles and the Sections of the Tool after 














EBQ PBQ EBQ PBQ EBQ PBQ EBQ PBQ 
Participation 23 15 20 17 15 11 12 9 
Transparency 19 11 14 12 10 10 10 9 
Accountability 14 16 13 13 11 10 12 9 
Information 18 13 12 12 13 10 12 9 
Responsivenes
s 
15 14 16 12 14 11 12 9 
Total 89 69 75 66 63 52 58 45 
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4.7 Effect of the Delphi Process on the Tool 
The effect of the Delphi consultations on the tool was mainly on the content, coherence, 
and the structure. The general comments have been summarised in Table 9. The specific 
comments primarily concerned clarity and practicality in addition to the inclusion of new 
concepts. The three rounds of consultations with at least 15 governance experts (Round 3) 
resulted in the following: concepts that were retained are all based on Table 3 (from 
chapter three), extracted from the literature review; almost all the concepts identified from 
the literature were included in the tool whether as EBQs or PBQs . The questions that were 
removed were either duplicates or concepts difficult to assess (see Table 7). Concepts that 
were added in the final tool have been summarised in Table 8.  
See Table 13 below for examples of how questions evolved before and after the three 
rounds of Delphi consultations to visualise the significance of the change in refining the 
tool’s content.  
As for responsiveness, the final draft of the tool after the three rounds of Delphi 
consultations suggests that any health policy should comprise the domains of 
responsiveness as defined by the WHO (discussed in Chapter Three) in the form of 
goals/objectives, and these are as follows: 
• Ensuring access to adequate quality of services for all; 
• Respect for confidentiality and dignity of the beneficiaries; 
• Health providers/health institutions should respect the autonomy to participate in 
health related decisions, freedom of choice of care provider, and provide all 
information related to medical conditions in an understandable manner; 
• Health/public health services should be provided within a reasonable timeframe; 
• Needs assessment targeting the public should constitute  an integral part of the 
policy formulation process, whereby policies should be formulated based on the 
people’s to ensure that their rights and needs will be addressed in their 
implementation; 
• The monitoring and evaluation of a given policy should contain a component to 
assess whether the policy fulfils the population’s needs. 
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Table 13: Examples of Questions before and after the Delphi Process across the Five 
Principles  
 Before Delphi After Delphi 
Participation 
Are the following stakeholders 
represented in the policy formulation 
that is concerned with … ? 
• State actors (government): Specify: 
Health service providers 
(professionals and organisations): 
Specify: 
• Beneficiaries and/or public: 
Specify: 
• Civil society: Specify: 
• Media 
• Others: Specify: 
Were the following stakeholders represented in 
the formulation that was concerned with the 
national health strategy? (select all answers that 
apply by adding a √) 
• State actors (government, other than MoHs, 
national, local): Specify: 
• Health service providers (professional 
association/unions/orders and health service 
organisations/hospital boards (public or 
private)): Specify: 
• Parliamentary members 
• Beneficiaries (patient associations) and/or 
public: Specify: 
• Civil society: Specify: 
• Development partners/international 
organisations: Specify: 
• Funders/financiers: Specify 
• Academic institutions/researchers: Specify: 
• Private sector (medical, pharmaceutical 
industry, insurance companies): Specify: 
• Most vulnerable or key affected populations: 
Specify: 
• Media 
• Others: Specify:  
Accountability 
Is there a formal mechanism to hold 
the participants/stakeholders in the 
policy formulation related to … 
accountable? 
Y/N 
Is there a formal mechanism(s) to hold 
stakeholders (public officials and non-state 
actors) in the policy formulation related to the 
national health strategy accountable (for decision 
and policies formed): Y/N 
• To their institutions/organisations 
• To the Public 
Transparency 
Is the MoH transparent in the 
policymaking process? How? 
 
Was the policy formulation process of the 
national health strategy perceived as transparent 
by stakeholders? By the public? What made it 
transparent? What could have been done to make 
it more transparent? 
Information 
Was enough evidence used in the 
formulation of the policy?  
What type of evidence was used? 
What type of evidence was used in the 
formulation of the national health strategy? Do 
you consider the evidence used 
pertinent/adequate? Why? What additional 
evidence would have been necessary? 
Responsiveness  
Does the policy document relating to ... 
mention that it will not impose any 
discrimination?  
Y/N 
Does the national health strategy document 
provide for/ensure that it will be inclusive of all 
the population/patients? 
If yes, does it identify specific 
disadvantaged/vulnerable groups to be included?  
Specify: 
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4.8 Validity Testing as Part of the Delphi Process 
The Delphi method ensured content as well as construct validation of the tool developed 
(Okali and Pawlowski, 2004). Content validation was achieved by gaining consensus on 
the characteristics of governance principles identified based on theoretical definitions 
covered within the tool (Trochim, 2006). The experts were asked to double check whether 
the questions in the tool captured all aspects of the principles to be assessed. The 
involvement of knowledgeable and interested experts in the Delphi process maximised the 
content validity of the tool (Hassoun et al., 2000).  
With regard to construct validity, it was achieved by asking experts to validate the 
researcher’s categorisation of the main aspects derived from the literature for assessment 
under each of the five principles. In addition, it was achieved by asking the experts to 
validate their own responses, which contributed to consistency of understanding of the 
governance principles (Okali and Pawlowski, 2004). Furthermore, construct validity was 
achieved by experts’ contribution to the generation of new concepts (that were not found in 
the literature review) to be included in the tool and the reprioritization of questions to be 
retained. 
Face validity was determined by considering the list of questions as a whole and 
determining whether they made sense and what they should assess in terms of governance 
principles and their role in the health policymaking process (Trochim, 2006). Finally, 
concurrent validity was also increased with the three successive and successful rounds of 
consultations (Hassoun et al., 2000).  
 
4.9 Commitment, Attrition, and Key Factors in the Success of the Delphi 
Consultation 
Experts’ commitment to be involved in Delphi consultations was a key factor in its success 
(Hasson et al., 2000). The commitment is related to their interest in the subject under study 
(Hasson et al., 2000), and all the experts who were involved in the Delphi process 





• 14 experts (out of 25) were involved in the three rounds of consultations (56%)  
• 5 were involved in two rounds (20%)  
• 6 were involved in only one (24%).  
The majority of the experts sent their comments on time, despite delays caused by a few.  
Attrition refers to experts’ dropouts/withdrawal from the Delphi consultation (Okali and 
Pawlowski, 2004) (see Table 14 for attrition rate across the three rounds of consultations). 
 
Table 14: Attrition Rate Through the Three Rounds of Consultations  
Delphi Rounds Total Number of 
Experts Consulted 
Total Number of 
Responders (%) 
Attrition Rate 
Round One 30 22 (73%) 27% 
Round Two 25* 21 (84%) 16% 
Round Three 20** 15 (75%) 25% 
*3 newcomers, ** one expert asked to withdraw from Round 3 
 
The Delphi consultation has the potential to generate low response rates due to the fact that 
multiple rounds of consultations are needed (Hsu and Sandford, 2007). A total of 60% of 
experts at the end of consultations presents an extremely good figure, given the extensive 
review required in each round; further, it also signifies a high level of commitment.  
Other key factors that contributed to the success of Delphi process in this research, 
consistent with what is mentioned in the literature includes the following: 
1. Selection of appropriate experts (Hsu and Sandford, 2007); 
2. It is important to be referred by someone (gatekeeper) in the process of recruiting 
experts (Hasson et al., 2000); 
3. Administrative skills (Okali and Pawlowski, 2004), using a coding system for 
responses of experts and across the three rounds, following up with experts, 
managing and analysing responses (with the help of statistical experts);  
4. Maintaining a diary that included all details related to Delphi, from planning to 
implementation of the three rounds for proper planning, management, and 
reflection. 
5. Use of emails as a method of communication and Skype calls when there was a 
need to facilitate the Delphi consultation (Hsu and Sandford, 2007).  
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4.10 Reflecting on the Delphi 
In general, the comments of Delphi experts led to improvement in the way the questions 
were framed, the merging of several questions, and addition of filter questions and sub-
questions. In addition, new questions were added and others were removed.  
Most of the comments were reflected in draft 2 and draft 3 of the tool. Comments that were 
not addressed were highlighted, and explanations were provided as to why they were not 
addressed. I assumed a neutral position  to the degree possible to the experts’ comments to 
reduce the possible bias from my own interpretations to the application and practise of 
HSG.  
The generation of descriptive statistics for this research enabled gaining an oversight of the 
data and the patterns of the overall responses. This further aided in minimizing any 
tendency to privilege responses possibly indicative of the  main researcher’s (myself) 
preferences by contributing to a reduction in the subjectivity involved in making decisions 
regarding the retention or removal of questions (Holey et al., 2007). 
Every single comment was extremely important to highlight the strengths and weaknesses 
of the tool and gaps that needed to be addressed. The experts offered guidance to anticipate 
problems/concerns that could have emerged in conducting the tool. Therefore, I was able 
to provide a practical approach regarding overcoming these concerns during the pilot 
testing and in the manual, which was developed to help future assessors apply and conduct 
the tool. Most of the criticisms given on the tool were expected as the experts were 
highlighting the limitations of the tool, and some were useful in enhancing the tool’s 
design and minimising these limitations. Reflecting and addressing the comments proved 
to be a learning experience that was enriching. 
The experts in the Delphi constituted a heterogeneous group of individuals working in 
international development organizations, academia, public sector, and civil society, with 
experience, from high to LMICs. This resulted in the inclusion of different perspectives 
concerning HSG, the way in which it is practiced, how it ideally should be, and how they 
would like to see it implemented. Reaching a consensus in such a heterogeneous group on 
a complex subject was considered a positive indicator for producing a robust and a useful 
tool, waiting to be applied to test its practicality (see next chapter of pilot).  
See Figure 3 for summary of the three rounds of Delphi.  
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Figure 3: Summary of the Three Rounds of the Delphi Process 
* Relevant/Not Relevant 
** 3 New Comers 
 
The following section will describe the consultation meeting with high-level policymakers 
and their contribution in further refining the tool.  
 
4.11 Refinement Review: Consultation Meeting with Policymakers 
This section covers the consultation meeting that took place with policymakers after the 
Delphi consultation. It discusses the benefit of having the policymakers’ feedback 
regarding the tool in terms of its practicality, applicability, as well as usefulness for 
practice. It was important to obtain the policymakers’ feedback on the tool (before it was 
finalised) as they will be its end users. Furthermore, it was essential for the tool’s 
development in order to determine its value in facilitating the improvement of their 
governance practices at the policymaking level.  
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Conducting the Delphi consultations with experts over several rounds followed by a face-
to-face panel meeting for further discussion is recommended for newly developed 
assessment tools, and this is termed as the RAND method, a systematic method to assure 
the tool’s quality (Campbell et al., 2003). Moreover, it was deemed beneficial to combine 
the perspective of governance experts as well as policymakers to have "an agreed upon" 
tool for use. In the original research design, the consultation meeting was planned after the 
pilot testing as a final mode to obtain feedback on the tool. This was modified due to the 
time constraints of the funds received from the WHO to cover the cost of the consultation 
meeting.  
• Funding the Consultation Meeting 
I applied for funding to the WHO in consultation with the leading expert at WHO, Dr. 
Sameen Siddiqi (who developed a tool to assess governance and on which this work was 
founded; he is a Delphi expert as well), to cover the consultation meeting, and it was 
approved due to the importance of the topic for the WHO EMRO office. They were 
focusing on finding practical ways to assess and improve HSG at the country level. The 
one-day consultation meeting took place in December 2015 in Lebanon, right before the 
pilot test as the funding was earmarked for spending during 2015.  
 
4.11.1 Selection of Participants 
The plan was to invite high-level policymakers since they will be the end-users of a tool of 
this kind. Since funding was obtained from the WHO EMRO office, it was considered 
appropriate to invite policymakers from the region. In addition, I was planning to invite 
some of the Delphi experts, if the available funding was sufficient. The contact with Dr. 
Siddiqi facilitated compiling a list of high-level policymakers from the region, who were 
known to have an interest in improving HSG and may have been looking to conducting 
similar assessments in their countries. The suggested invitees were from Iraq, Iran, Jordan, 
Egypt, Palestine, Lebanon, Pakistan, and Morocco (not an EMRO country).  
All participants were invited by email to the meeting, and all accepted the invitation except 
one. It was important to have a gatekeeper (Dr. Siddiqi) to recruit the policymakers to 
attend such a meeting, for the same as with Delphi experts, as it makes 
experts/policymakers more responsive towards participation. Two Delphi experts from 
Lebanon were also invited (since their participation did not impose any additional cost). 
The meeting was moderated by an academician who was also interested in HSG, and a 
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note keeper attended the meeting as well. My academic supervisor and a WHO Geneva 
staff who works on governance joined the meeting via Skype (see Annex 5 for the list of 
participants). So, there were in total seven policymakers from seven countries. Among the 
policymakers, there were two former ministers of health, and one of them is currently a 
parliamentary member, one an acting minister, and two were general directors, in addition 
to Dr. Siddiqi and another WHO former expert on governance. The participation of senior 
policymakers with diversity in terms of the contexts they belonged to, institutional roles 
(some were in political roles while others were in policymaking roles), type of experience, 
and interest in health governance, made the review process a valuable one. They 
considered the tool from the perspective of the need to have a practical tool that might 
favourably impact the policy process. 
 
4.11.2 Objectives and Outcomes of the Meeting 
The objectives of meeting were as follows:  
• Review the content and the design of the tool; 
• Discuss the operational aspects of implementing/conducting the tool in different 
countries; 
• Discuss the most appropriate way for data presentation of the tool’s findings. This 
was the most important aspect of the meeting as it was essential to obtain 
policymakers’ feedback concerning their preferred way of receiving the results in a 
meaningful way, so that they can act upon them, given the tight schedule to review 
detailed assessment reports. 
 
These objectives were set with the following aims: 
• Finalise the tool to be ready for pilot testing; 
• Provide feedback on the presentation of the results. 
To facilitate the review process, the tool was sent by email to participants two weeks prior 





The feedback received during the meeting was categorised into the following:  
• Methodology and process for conducting the tool; 
• Content and structure; 
• Analysis and presentation of the results. 
 
As an outcome of the meeting, the following changes were made: 
• Methodology 
1. Desk review and KI interviews: The policymakers advised that the methodology of 
collecting the data for the EBQs should be changed to interviews with KIs supported 
by a desk review, as, in their view, only the latter would be insufficient. It might be 
difficult to find documentation for the work of MoHs/health authority in LMICs. 
Thus, depending only on document reviews for data collection data would pose the 
risk of having incomplete information, which may not reflect reality (OECD, 2005). 
Hence, I decided to conduct a desk review first, followed by interviews with KIs, and 
during the latter, the KIs would be asked whether they could provide any kind of 
documents to support their responses. Furthermore, it should also be noted that this 
concern regarding the applicability of data collection through the desk review only 
was raised earlier as well  by some of the Delphi experts; but, it was not addressed at 
that point. 
2. Data collection  for the PBQs was retained as it was, which implies that both sections 
(A and B) of the tool would involve face-to-face interviews. Thus, the tool should be 
conducted as a series of steps, including the desk review of all relevant documents, 
followed by two sets of interviews (one to cover the  EBQs, Section A, and the other 
to cover the  PBQs, Section B). The decision to include two sets of interviews with 
KIs was based on the length of the tool and the time required to conduct it, which 
was also done by Baez-Camargo and Jacobs (2011). It was decided to retain the long 
list of questions for the pilot testing due to the significance of the components to be 
assessed.  
3. KIs: These should be selected because they have been involved in the policymaking 
process. They could be the policy formulation technical team within the MoH, 
policymakers, and/or the other stakeholders, including the private sector. Their 
number will depend on the policy type (whether it is broad or specific, number of 
stakeholders that will be affected, among other things), its complexity, the 
characteristics of the policy, and how many groups or organisations were involved in 
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the formulation process. However, the policymakers suggested KIs between 8 to 25 
would be reasonable. Therefore, my target KIs for the pilot was within this range.  
4. Endorsement and who should conduct the tool: Since the tool is intended to be used 
by policymakers to cover a "sensitive and complex” issue, it was important to decide 
who should be entrusted with conducting the tool at the country level to ensure the 
implementation of the recommendations that will result from doing so. The 
policymakers agreed that the tool should be endorsed by the MoH and should be 
conducted under the supervision of senior staff to ensure ownership, and 
consequently, better implementation of the recommendations generated from its 
application. It could be conducted by a team from within the MoH, the team could be 
junior staff, but they should be working under the supervision and the guidance of 
senior staff. Alternatively, the MoH could nominate an external expert (from 
academia, for example) to conduct the tool; but, again, it should be conducted in 
collaboration with senior staff at the ministry to ensure ownership and commitment 
to implement the recommendations. It will be pointless to conduct the tool by 
academia or any other independent researcher without an endorsement by MoH, in 
which case, it would not serve its purpose, which is improving practices and not only 
assessing it. I agreed with this recommendation in light of the problems that might 
arise from this approach. For example, the review could be politically inflicted, 
especially in hierarchical systems, where KIs might be concerned with providing the 
"right” answer, or when KIs might try to defend their practices or conceal relevant 
information for different reasons. This is another reason due to which it is important 
to conduct a desk review of available documents before conducting the interviews as 
well as asking KIs to provide evidence when available, which can be documented in 
the final report of the assessment. In addition, the triangulation of the responses of 
different KIs is recommended in the analysis of the results. The endorsement of a 
senior official or a political will to improve the governance practices would be 
helpful in implementing the recommendations of the assessment in practice.   
Donor organisations could also conduct the assessment tool as a prerequisite for 
funding as GG in policy process is attractive to donors (Pyone  et al., 2017). If they 
do so, they should emphasise the significance of providing evidence of GG practices 
by KIs to support their responses as well as to hold policymakers accountable for 
their claims for having such processes in place.  
5.  It was also recommended that an orientation meeting be conducted with the MoH 
before the assessment to help locate the required documents for the desk review and 
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to identify other stakeholders who could be contacted as potential KIs. Finally, it was 
agreed that the tool would be implemented retrospectively and applied to newly 
developed policies (within a year).  
•  Content and Structure 
In general, the feedback on the content pertained to wording, ambiguity, and sequence. It 
was suggested that the list of PBQs be shortened, in particular, because some overlapped 
with the EBQs. One recommendation regarding the content was to place the accountability 
questions before the transparency ones to allow improved consistency and flow. One 
question concerning the rule of law was added to the accountability section. The majority 
of the policymakers agreed that it was important to retain the responsiveness section due to 
its importance as it highlights the components that require to be included in any health 
policy, if it is to be responsive to the needs of the population. Assessing the responsiveness 
section might generate useful recommendations reflecting on the importance of having 
patient-centred policies as a part of being responsive. They agreed upon domains of 
responsiveness for assessment as part of the goals of any health policy (discussed in 
Chapter Three) and welcomed the additions that the Delphi experts had added (as 
discussed in chapter four). In addition, the policymakers suggested to add to 
responsiveness characteristics; that policies should include an explicit package of benefits 
that will be provided as it is the right of the public/patients to know their rights and 
responsibilities, which should be clearly stated in any health policy (when applicable). This 
will reflect on the health system’s responsiveness.  
Also, they suggested adding information about the way in which the referral will take place 
from one level of the healthcare system to the others, so the public is aware of what they 
will be eligible for and what to expect in terms of referring their medical cases from one 
level to another and how this referral will take place within the stated time frame for this 
referral. These should be clearly stated, which would again form a sign of the health 
system’s responsiveness.  
It was also recommended that the questions concerning the inclusion of an official 
complaints mechanism be moved from the accountability section to the responsiveness 
section as being responsive to the needs of people entails having such a mechanism in 
place to enable public to report any violation or raise concerns regarding the services 
provided to them. In order to encourage people to employ such mechanisms, it is crucial to 
ensure follow up on the complaints reported. Moreover, the investigation on complaints 
should be conducted in a timely manner, and the results should be published (actions and 
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justifications). Also, they suggested moving the question about having a communication 
strategy in place to inform the public regarding national policies from the transparency 
section as communication is a component of responsiveness (Darby et al., 2000). A 
communication strategy is essential to ensure that information is freely available and 
directly accessible to the public. It should also be the case that sufficient information is 
provided in an easily understandable form and with a suitable channel of communication. I 
agreed with the proposed additions and shifting of questions to the responsiveness section.  
The policymakers also suggested extending the answer options of the EBQ to include 
"Yes", "No”, "In process", "Don’t know", and "Not applicable”. I agreed with this 
suggestion as well as some processes might be in progress or not finalised yet, and some 
KIs may not be aware about certain process, and some questions might not be applicable in 
some contexts, making this a logical suggestion. 
Before the consultation meeting, the number of EBQs and PBQs was 58 and 45 
respectively, which was reduced to 52 and 36. The decrease in the number of questions 
was less as a result of the consultation meeting in comparison to the individual rounds of 
the Delphi process. Again, this demonstrates that policymakers did not suggest 
considerable changes in the content; their main contribution was to adjust the methodology 
for conducting the tool and its structure. This made it a more practical, user-friendly, and 
therefore effective tool in terms of highlighting key aspects of GG of policymaking 
process. 
• Presentation of Results 
It was decided that scoring would not be used. All the participants agreed that scoring 
would be difficult as it would be used to compare and rank countries, which would not be 
appropriate as different countries have different health systems, political systems, and face 
different instabilities, all of which affect the governance of the health system and the 
policymaking process. Furthermore, scoring questions would require giving different 
weighing to different questions, and this was not possible at this point of the tool’s 
development. In conclusion, it was agreed that scores would not be used to report the 
findings of the tool.  
Instead, it was agreed that various formats would be employed to present the findings in a 
useful way for policymakers and the MoH/health authorities. This is consistent with Kettl’s 
(2016) recommendation, making "data speak in a language that policymakers can hear" by 
using graphics and summaries (Kettl, 2016, p.578). Thus, it was decided that the final 
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presentation of the findings will be in the form of a strengths, weaknesses, opportunities, 
and threats (SWOT) analysis, traffic lights symbol summary, and a list of 
recommendations covering the five principles to enhance their practise at the policymaking 
level. The traffic lights summary was utilised by the WHO to present summary findings of 
the pharmaceutical sector’s profile to policymakers (WHO, 2014) in a simple and 
attractive format. Red was used for processes, practices, structures, documents, and 
policies that did not exist, while green was used to indicate that they exist and function 
well and effectively. Lastly, yellow suggested that work was in progress or ongoing.  
It was suggested that a manual be included to enable the tool’s application for future users. 
Finally, it was decided that the tool would be called a guidance tool and not an assessment 
tool since the end-users of the tool will be policymakers, and they will be cognisant of the 
concepts covered and their importance in contributing to GG in policymaking. 
Furthermore, the tool might initiate wider reflections by policymakers and stakeholders 
regarding the recommendations produced by using the tool. The expected outcome of 
conducting the tool is to focus on improvement based on the results rather than judging or 
rankings of countries. The nature of this guidance nature was implied in the importance of 
assessing HSG, as discussed in Chapter One, and in the scope and the purpose of the tool, 
mentioned in Chapter Two.  
• General Feedback 
All the participants in the consultation meeting emphasised the importance of HSG in 
general and at the policymaking level in particular. It was agreed that there is a global gap 
in knowledge as well as a lack of tools to assess the situation in different countries and that 
the time was opportune to expand by building on previous work. Some participants praised 
this research as a step towards closing some of the existing gaps. They emphasised that 
tools (like the one presented during the meeting) should not be an end in themselves and 
that guidance should be provided to countries regarding ways to improve the quality of 
governance, taking into account the political context, specificity of each country, and other 
factors. The adjusted tool was sent to three policymakers after the meeting (among the 
ones who attended), and they were asked to provide final feedback regarding the 
adjustments made. All three who were sent the adjusted draft of the tool apologised for not 
having time to review the tool again and said they trusted the changes made. This indicates 
the reason due to which it is better to consult high-level policymakers through face-to-face 
meetings.  
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4.12 Reflection on the Consultation Meeting 
The process that was followed during the consultation meeting to review the tool to meet 
the objectives of the meeting was essential for its success, given the short span of time that 
was given to discuss various essential issues. Another critical factor that contributed to the 
success of the consultation meeting was the selection, quality, and interest of the 
policymakers who participated. Face-to-face discussions carry the advantage of creating 
room to discuss more issues, not being limited to focussing on questions asked to the 
participants for feedback. This was unlike the Delphi consultations, in which the experts 
responded to the specific questions they were asked regarding the tool. The policymakers’ 
advice regarding the methodology (with regard to conducting interviews with KIs 
combined with desk reviews) was extremely helpful as they offered practical and logical 
advice based on their experience in the context of their countries (all LMICs) and was 
consistent with some of the concerns raised during the Delphi consultation about having a 
desk review as the only source to collect data for the EBQ. In addition, the meeting led to 
gaining feedback regarding ways to present the findings of the tool in a useful way to busy 
policymakers. In conclusion, their contributions were helpful in refining the tool further 
before the pilot test.  
In sum, to the extent of my knowledge, the proposed tool is the first health governance 
assessment/guidance tool to be developed and validated by the Delphi process. This 
process was particularly appropriate because health governance remains a vague concept 
that requires operationalisation of theories as well as experts consensus regarding what 
constitutes good governance practices. Hasson et al. (2000, p.1013) stated that "several 
people are less likely to arrive at a wrong decision than a single individual". This research 
and the tool involved starting a highly useful dialogue amongst experts in the field that 
enriched their understanding regarding HSG. The consultation review by a group of high-
level policymakers from different countries, who reviewed the tool from the perspective of 
the end-user, offering an extremely insightful direction regarding aspects that might be 
applicable and those that might not be in real life settings. Furthermore, they offered advise 
concerning on ways to conduct the tool to generate useful information and present the 
findings to attract policymakers’ attention. The purpose of the consultation meeting was to 
offer feedback regarding the usefulness, practicality, and feasibility of the tool, while the 
Delphi process’s purpose was to further develop the conceptual content of the initial tool, 
in order to test its validity. Both of these steps were essential before it was pilot tested. 
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Combining the perspectives of policymakers with those of the Delphi/governance experts 
resulted in taking a step further with regard to our understanding of HSG.  
The tool was build on a rigorously robust academic basis and received consensus on the 
content by some experts in the field in addition to some policymakers from LMICs. It is 
hoped that the tool will receive further and broader consensus regarding its practicality and 
usefulness to generate relevant information.  
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Chapter Five 
Pilot Testing and the End-Product 
This chapter covers the final phase of this research. It begins with a description of the 
process followed for the tool’s pilot testing in a real setting, which should be replicated 
whenever the tool is used in other settings. The chapter also includes the method followed 
for the analysis, a presentation of the results obtained, recommendations emerged, and the 
way in which the pilot led to the further refinement of the tool. The chapter concludes with 
a description of the end-product: the tool and its manual.  
 
5.1 Pilot Testing 
After adjusting the tool based on the feedback received from the policymakers and the 
other experts during the consultation meeting, it was deemed ready for field testing. Pilot 
testing constituted an important step in the development of this new guidance tool (as 
labelled by the policymakers). The pilot testing of the final draft of the tool was planned to 
assess its feasibility in practice in terms of consistency, ease and speed of data collection, 
among other factors (Campbell et al., 2003). Other factors such as acceptability of the 
questions was also considered in the piloting phase (Campbell et al., 2003, p.818). 
 
5.1.1 Pilot Testing Process 
• Setting 
The pilot testing was conducted in Lebanon for practical reasons (since I reside and work 
there). In addition, Lebanon is classified as a middle-income developing country, and as 
mentioned earlier, the tool was developed to be used specifically in LMICs, where it is 
believed it would be most useful due to the lack of governance in these countries (as 
discussed in Chapter Two). With regard to this, it has been asserted that in Lebanon, 
among the top five most problematic factors for development in general (with implications 
for the health sector) are corruption, inefficient government bureaucracy, and policy 
instability (World Economic Forum, 2016). Thus, improving GG in all sectors and at all 
levels should facilitate the achievement of the developmental goals (Pyone et al., 2017). 
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• Policy Type 
The tool is generic in nature as it was designed to be sufficiently flexible to analyse the 
governance processes of the policymaking of any kind of health policy. The experts and 
the policymakers agreed that the policy process to be evaluated should be related to a 
recently formulated and implemented national policy/strategy in a country within the 
previous year. The mental health strategy for Lebanon (2015–2020) was selected as it was 
developed nine months before the pilot phase. It also seemed an appropriate option for the 
pilot as it forms a specific type of health policy and is not too broad, with a limited number 
of stakeholders. However, the tool can be employed with other broader types of policy 
such as human resources policy or the strategy on non-communicable diseases (NCD). 
• Study Design 
The pilot testing included two parts: desk-review and KI interviews based on the tool. The 
data collection started with a general desk review to compile background material and data 
collection from various documents in order to gain a clear understanding of the strategy 
developed and the mental health issues, in specific, in Lebanon as well as to acquire a 
general perception of the health system to comprehend the context. The second part of the 
pilot included face-to-face interviews with KIs using the developed tool. 
• Study Procedures 
1. Desk Review of Documents 
The following documents were reviewed:  
• Mental health strategy (2015–2020) in both languages, English and Arabic; 
• Relevant laws and policies related to mental health in Lebanon; 
• Health statistics concerning mental health; 
• Media reports; 
• Newsletters and patient leaflets developed and published by the mental health 
programme; 
• Scientific publications regarding mental health in Lebanon; 
• Relevant laws and regulations pertaining to drafting national policies in general and 
publishing them. 
• The ministry of health’s official website was reviewed extensively as well.  
During the review of the documents, I was looking for the authors (to reflect on the 
credibility and the reliability of the source), the organisation responsible for issuing the 
document, whether the MoH or another agency (to consider whether it is an official 
document, academic research, and so on), date of issue (to consider whether it was up to 
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date), whether the document was published or unpublished (to assess its availability), and 
whether it can be found in one place, such as a website, department, and so on (to assess if 
it is accessible or not). I also looked for references, considered ease of access, and 
considered the language of the available documents. I was mainly searching for answers to 
the questions in the tool, and I did that by going back and forth to different sections within 
the tool. I identified all the documents initially reviewed by searching for published 
documents as well as the MoH websites for additional ones. The initial document review 
process took around three weeks. The document review process was important before 
conducting the KI interviews as it can offer insights regarding issues related to the policy 
under study and the relevant stakeholders. This will be of value for assessors who use the 
tool and review a policy domain that they are familiar with as well as for assessors 
unfamiliar with the policy or the national context. The primary challenge with the 
document review was  ensuring that all relevant documents are identified, to avoid missing 
out any important ones; the mental health team were asked for guidance during the 
orientation meeting (see below); the KIs were also consulted during the interviews for 
relevant documents to compile the maximum number of useful sources. The only way to 
ensure that the results extracted from the documents are reliable was to compare them with 
the responses of KIs. In case of contradictory findings, further investigation would have 
been required, either with the national team, the KIs themselves, or interviews would be 
needed with more KIs. During the pilot, I did not come across any contradictory 
information between the document review and the responses generated by the interviews 
with the KIs.  
2. Orientation Meeting with the National Team 
A preparatory meeting was conducted with the mental health program team to inform them 
about the pilot, the purpose of the tool, how the pilot would be conducted, and to ask for 
their help to conduct a mapping of all stakeholders, who were involved in the formulation 
process of the strategy. The mental health team provided a list of names of relevant 
stakeholders along with their contact details. To avoid the risk of leaving relevant 
stakeholders out of the list (whether intentionally, due to the concern that they will not 
offer positive feedback, or unintentionally), the list of the relevant stakeholders was 
verified with the KIs, who accepted to be interviewed, and from the document review that 
was initially undertaken.  
Thus, purposeful sampling was employed to ensure the selection of "information rich" KIs 
using what is termed as snowball or chain sampling (Patton, 1990). The KIs identified 
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were deemed knowledgeable about the policy formulation of the mental health strategy of 
Lebanon and were directly involved. These KIs included official staff from the mental 
health programme as well as representatives of various organisations. During the 
consultation meeting for constructing the tool, it was advised that only those stakeholders 
be included who were involved in the process of developing the policy as those excluded 
from the formulation process (whether intentionally or unintentionally) would not 
contribute a useful perspective. This implies that KIs who were not involved would not be 
able to identify the process’s strengths and weaknesses.  
3. Approaching Potential KIs 
The list that was provided by the national team and included eight categories of 
stakeholders, who were involved, and these have been summarised in Table 15 below. The 
list included 23 names (some from the same organisation); so, I contacted a total of 20 
potential KIs (I contacted one from each organisation, except for the mental health 
programme team), and all were contacted by email with an invitation to participate in the 
pilot. The KIs were informed that the national mental health programme was informed 
about the assessment and their names were suggested by the programme. This was done 
with the view that policymakers at the consultation meeting were aware of the significance 
of the political "buy-in" and "ownership", which was believed to increase the number of 
KIs willing to be interviewed. It was further believed that if the senior leadership’s interest 
in enhancing the governance of the health policymaking process is publicised, more KIs 
will be encouraged to participate.  
Out of the 20 KIs contacted, 11 responded positively to the invitation,  a response rate of 
55%, and all those who agreed participated in the pilot. The original plan was to have a 
sample size of 10 to 15 KIs for interviewing.  
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Number Contacted Number that Agreed 
to be Interviewed 
UN Agencies 2 2 2 
Local NGOs 2 2 1 
International NGOs 3 3 1 
Universities 5 3 2 
Professional 
Associations 
3 2 1 
Mental Health Units 
and Hospitals 
2 2 1 
Governmental 
Agencies Other than 
MoH 
2 2 0 
Mental Health 
Program Team-MoH 
1 4 3 
Total  20 11 
 
The email included a brief about the research and the tool, what the pilot would include, 
and what was required from KIs (see Annex 8, Manual Annex for information sheet sent to 
KIs). The consent form was attached to be signed and returned by email by those who 
agreed to participate. Those who did so were asked to set an interview time at a place that 
suited them. Furthermore, in the email, the potential KIs were informed that two interviews 
would be conducted with them. The first would be conducted to collect data related to 
EBQ using a structured questionnaire, in which they would be asked to provide evidence 
and documents to validate their responses whenever possible. The second interview would 
be conducted to collect data for PBQ, also via face-to-face semi-structured interviews as 
this would allow the generation of in-depth information regarding the process followed in 
of mental health strategy development.  
The KIs were informed that each interview might require around 50 minutes, and they 
were given the option to have one interview to cover both sets of questions. May (1991) 
reported that the length of the interviews varies depending on the topic, researcher, and 
participant, and usually, interviews with professionals can last for up to 60 minutes. 
However, longer interviews can be conducted on more than one occasion (Gill, Steward, 
Treasure and Chadwick, 2008), while others suggest that interviews that last from 50 to 90 
minutes are acceptable (Choi and Oak, 2005).  
The reasons for including two interviews for each KI were as follows; first, the time 
needed to conduct the two sections (A and B) of the tool; the second reason was to allow 
assessors more time to read and analyse the documents provided during the first interview. 
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The time lapse suggested between the two interviews was set to be one to two weeks at the 
most. The intervening time between the two interviews actually offered both the assessor 
and KIs opportunities to reflect and contribute to the learning from the tool. This was 
highlighted by some of the participants at the end of the interviews (as discussed below 
under the KIs feedback section). Baez-Camargo and Jacobs (2011) also suggested using 
two rounds of interviews for the assessment they developed on health governance in low 
income countries.  
4. Interviews Conducted with KIs 
As mentioned above, 11 KIs were interviewed (see Table 15). The only category that was 
not included in the pilot sample was other governmental agencies (such as the Ministry of 
Social Affairs and the Ministry of Justice) since all potential KIs contacted did not respond 
to the invitation email. This may be because it is difficult to recruit this category by email 
or they do not have the time, are not interested in the topic, or are simply unaware of the 
topic and its significance.  
Out of the 11 KIs, 
• three (27.3%) decided to have the two sets of interviews in one session; 
• five (45.4) opted for two different times for the interviews; 
• three (27.3%) refused to do the second interview (one said they had nothing else to 
offer and the other cited a tight schedule as the reason).  
Hence, 11 KIs answered the EBQ, while only eight answered the PBQ. All of the KIs were 
engaged in the interviews for more than 45minutes. This could be due to their interest in 
the topic (as it is reflected in their responses when asked about their feedback on the tool, 
discussed below). In total, 16 interviews were conducted to cover the two sets of questions 
between the beginning of March and end of April 2016. The KIs were asked to sign an 
informed consent sheet before starting the interviews in cases in which this was not done 
by email (see Manual Annex 8 Consent form). They were assured of the confidentiality 
and anonymity of their answers. All questions were asked in relation to the aforementioned 
mental health strategy that had been recently developed. For each KI, a questionnaire was 
coded and their answers and notes were recorded during interviews. They were asked for 
permission to tape record the interviews even with the EBQ and were given a chance to 
elaborate their answers and explain the policy formulation process in detail.  
Thematic saturation, that is, having no further useful information from KIs (Guest, Bunce 
and Johnson, 2006), was reached with KI number 7; however, I continued the recruitment 
131 
process as the target was to include all categories of the stakeholders in the pilot to ensure 
the collection of as much perspective as possible, and this could be reached by including a 
diverse set of KIs (see Table 15 of KIs who were interviewed).  
 
5.1.2 Analysis of the Pilot Findings  
After each interview, the responses were entered into Microsoft Office Excel for the EBQ, 
while transcriptions were prepared for the PBQs, with notes recorded on a separate sheet. 
In addition, observations and comments regarding the tool itself and the various questions 
were recorded for the final adjustment of the tool.  
The data were entered onto an Excel sheet and analysed, and I generated the descriptive 
statistics (which merely entailed a simple counting of the responses Yes, No, Don’t Know, 
In Process, Not Applicable) as the sample size was small (11). Thematic content analysis 
was also conducted after the transcription of the interviews. This included generation of the 
initial ideas from the interviews, identification of common themes and concepts from the 
responses of KIs, followed by their categorisation, coding, and analysis (Braun et al., 
2006). This was mainly done to see common themes that emerged from the interviews, 
mainly pertaining to challenges and factors that facilitated or obstructed the policymaking 
process. (see Annex 6 Summary of Results: A. Summary of Evidence-based Question 
Analysis and B. Summary of Perception Based Questions Analysis). 
 
5.1.3 Results  
This section presents the findings of the pilot based on the data collected and analysed 
from both the desk review and the KI interviews. The pilot allowed the identification of the 
strengths and the gaps in the mental health strategy formulation process from a governance 
perspective. (see Annex 6 Section C for Summary of findings per principle and according 
to identified characteristics).  
From the findings, it can be observed that the tool could assess the extent to which the 
development of the Mental Health Strategy fulfilled GG principles.  
The gaps that were identified across the five principles were the absence of a formal 
national committee or working group formed officially for the development of the strategy, 
no adherence to a structured process, lack of a written mandate specifying roles and 
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responsibilities, absence of a follow up with stakeholders regarding implementation plans, 
and monitoring and evaluation (M&E), absence of published minutes of meetings; 
furthermore, implementation plans and progress reports were not shared with all 
stakeholders, no clear implementation plans and roles and responsibilities were defined and 
beneficiaries, and parliamentary members and the media were not involved in the 
formulation process. Moreover, stakeholders involved in the policy formulation process 
did not sign a Memorandum of Understanding (MoU) before being engaged in the 
policymaking process, the MoH does not use formal mechanisms to hold public officials 
and other stakeholders accountable for their role in the policy formulation, independent 
audits are not conducted to ensure implementation within a set timeline to assess whether 
targets are reached, whistle blowing mechanisms and watchdog organisations are not 
encouraged, no sanctions are set in case of violations/failing to  adhere to the set standards, 
and relevant law are not enforced. There is no regulation to allow public access to 
government information, resource allocations related to the strategy are not made public, 
there is no action/operational plan published, and no COIs were signed by the stakeholders 
who were involved in the policy formulation. The MoH does not validate the data sources 
nor check the source of funding of research, there is no specialised unit for research 
analysis for policymaking, financial information was not utilised for the strategy 
development, public opinion concerning the strategy was not sought, and progress reports 
regarding the strategy implementation are not disseminated to the public. The strategy does 
not specify an explicit benefit package for the patients, nor the way in which the referral 
will take place from one level of care to other, no timeframe is set to provide the services 
needed, and no needs assessment was conducted as part of the formulation process. 
Based on the summaries of the results and the analysis, in order to prepare a useful brief of 
findings for policymakers (as they are usually not interested in reading detailed reports), 
the traffic lights symbol summary for each of the five principles (for implications see 
below), general SWOT analysis, and a list of recommendations were prepared and have 
been presented below. 
 
Implication of Traffic Light Results  
 
Colour Code Meaning 
 Does not exist/not practised 
 Either in progress or exists, but not practised or 
exists, but stakeholders are not aware of it 
 Exists 
NB: The policymakers should work on turning the yellow and red into green as well as maintaining 
the green  
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Legal basis/requirement (law/regulation/policy) to include various stakeholders in the health 
policymaking process 
 
A commitment to ensure some degree of stakeholder participation in formulation and implementation  
A body or mechanism(s) employed to involve stakeholders in the development of the mental health 
policy, working group  
 
Formally formulated  
A written scope/mandate for stakeholder involvement in the formulation of the mental health policy 
exists 
 
Roles and the responsibilities of participants for various stakeholders are specified  
Qualifications of the participants for various stakeholders are specified  
Timetable to perform the work   
The various stakeholders represented in the formulation of mental health policy included the 
following:  
 
State actors (government, other than the MoH, national, local)  
Health service providers   
Parliamentary members   
Beneficiaries (patient associations) and/or Public  
Civil society  
International organisations  
Funders/financiers  
Academic institutions/researchers  
Private sector (medical, pharmaceutical industry, insurance companies)  
Most vulnerable or key affected populations  
Media  
Participants involved in the formulation of mental health policy were as follows:   
Appointed  
Elected   
Representing their organisations  
Gender balance/consideration (male versus female) among the stakeholders participating was 
considered 
 
Dedicated resources made available to enable participation included the following:   
Cost of meetings (venue, coffee breaks, and printouts)   
Incentives for participants (fee or honoraria)  
Transportation (direct payment or reimbursement)  
Documentation (minutes of meetings) exists  
Minutes published/made available to the public  
Final decisions were taken by participants:  
Consensus  
Various stakeholders to be involved in the implementation of the mental health policy included:  
State actors (government)  
Health service providers   
Beneficiaries (patient associations) and/or Public  
Civil society  
Development partners  
Academic institutions/researchers  




Local authorities/community-based organisations  
Roles and responsibilities of the various stakeholders in the implementation process specified  
Participatory body to oversee the implementation of the mental health policy  
Strategies used by the MOH/Health authority to encourage participation by different stakeholders in 
policymaking in mental health 
 
Opinion polls/surveys  
Focus groups  
Online platforms  
Voting  
Hotline  




MoH/health authority requires signature of contracts/MoU with various stakeholders before 
engaging them in:  
 
Policy formulation  
Policy implementation  
Formal mechanism(s) followed by MoH/health authorities to hold public officials and non-state 
stakeholders involved in the policy formulation accountable  
 
Stakeholders are held accountable as:  
Institutions/organisations represented   
Individuals are represented  





MoH/health authority holds its staff accountable for implementing the mental health policy by 
conducting: 
 
Evaluation of the performance of the individual staff on an annual basis  
Administrative/performance audit of the relevant department(s) on an annual basis  
Contracts’ oversight  
Various stakeholders are aware of this process/results made public   
Formal mechanism(s) to hold implementing bodies accountable in line with set timelines and targets 
exist 
 
Internal within the health sector  
External by independent bodies  
External by the public  
Various stakeholders who are aware of this process/results made public   
Components of accountability mechanism(s) used by MoH/health authority at all levels are in place 
and include:  
 
Set standards   
Investigation and answerability/justifications   
Sanctions  
Enforcement  
Rewards for performance   
Appeals  
Tools used by MoH/health authority to foster accountability include:   
Information system that generates key performance indicators  
Dissemination of information  
Participation of public/civil organisations  
Whistle blowing mechanisms  
Watchdog organisations collaboration and protection   
Performance incentives for good performance*  
Enforcement of rules and regulations**  
Appeal mechanisms  
Monitoring and evaluation (M&E) of mental health policy exists and includes:  
Compliance with mental health policy by professionals/private sector  
Policy outcomes in terms of health improvement, efficacy, equity, and quality  
Various stakeholders who are aware of this process/results made public   
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M&E process is formal  
M&E conducted independently***  
Types of sanctions applied/might be applied to implementing bodies in case of violation/not 
adhering to standards set/ failure to implement  
 
Legal sanctions  
Regulatory/administrative sanctions  
Using media: Name and shame  
Softer sanctions  
Laws in place related to the mental health policy  
Enforced  





 Transparency  
A law/mechanism that allows the general public access to government information and documents  
A law/government policy in place to promote electronic government services to improve public access 
to government information and services* 
 
Official website for the MoH/health authority  
User-friendly  
Updated on regular basis  
Access to the website open to all   
Decisions related to priority setting in relation to the mental health policy made public  
Decisions related to resource allocation regarding the mental health policy made public  
Official, up-to-date (within last five years), and detailed policy document regarding mental health 
policy 
 
Publicly available  
Easily accessible   
Available on the MoH/health authority website  
Available in the official/national language of the country  
Document related to mental health policy includes the following information:  
Background on how the policy was formulated (based on international guidelines, best practices, 
among other things) 
 
Objectives, purpose, and goals based on priority problems  
Evidence used to inform policy formulation  
Mechanisms to engage stakeholder participation   
Stakeholders (names and affiliation) who participated/consulted in policy formulation  
How decisions were made/justifications for decisions   
Other factors that influenced the policy formulation  
Body responsible for releasing or approving the policy  
Clear distribution of responsibility for implementation   
Contracting requirements for implementation if required  
Time frame for implementation  
Measurable indicators and targets**  
Plans for monitoring and evaluation  
Funding requirements/allocation  
Intended audience of the document  
Official publication(s) related to implementation of mental health policy available, such as:   
Five-year strategic plan/operational plan  
Programme/project documents  
Relevant MoH/health authority decisions  
Progress reports***  
Financial reports including how funds were generated/secured for implementation/source of funding  
Policy evaluation****  
Scientific publications  
Contracts made for implementation   
Details about recruitment made for implementing  
1. MoH/health authorities release information related to formulated and implemented policies in a 
periodic/regular manner***** 
 
Participants declared any conflict of interest by signing an official form  
In the policy formulation  
In the policy implementation    
A policy on conflict of interest management exists  
MoH/health authority is using or has used in the past 12 months, to inform/disseminate to stakeholders  
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(including the public) about mental health policy: 
Use of mass media  
Wide scale advertisement  
Bulletins/newsletters   
Targeted personal invitations  
Contact by email, telephone, mail  
Website  
Social media  
Smart phones applications  
*Government policy in place to promote electronic government services to improve public’s access to 
government information and services: It is a government policy to simplify procedures and improve access to 
services using electronic services, but stakeholders are not aware of this policy  
**The strategy includes targets but not indicators  
***Progress reports are not published and are shared with some and not all stakeholders  
****Policy evaluations are not developed yet as it is still too early to do so 
*****Stakeholders believe that the national programme is not publishing relevant information in a regular 





*Knowledge translation to policy is not used yet, but there are plans to use it 
**Progress reports are not disseminated to all stakeholders 
 
Information  
MoH/health authority directly involved in the following in relation to policymaking:   
Information generation  
Dissemination of health information  
Publication  
Knowledge translation to policy*  
MoH using:   
Data collection tools, specify: examples: vital registries, surveys (population, facilities, etc), health 
statistics 
 
Data management technologies, specify:  
Validation of data sources  
MoH/health authority has a form of partnership/collaboration with research centres   
MoH/health authority allocates funds in its yearly budget for research related to policy  
MoH/health authorities make raw data generated at health facilities/health service delivery level 
accessible to researchers 
 
A specialised unit/staff in the MoH/health authority to deal with research analysis for policymaking 
exists 
 
MoH/health authorities have a mechanism in place to check sources of funding of research to be 
used in policy 
 
Mental health policy was informed by scientific evidence  
The scientific evidence used in policy formulation of the mental health policy is as follows:  
Reliable and of good quality source/peer-reviewed studies  
Up to date (published in the last 5 years)  
Comprehensive  
Locally appropriate  
Easily accessible  
Global  
National  
Other types of information utilised in the policy formulation of mental health policy  
Financial information  
Governing laws  
Political direction and commitment  
Public opinion  
MoH/health authority produces periodic progress reports/M&E reports on mental health policy   
Progress reports are disseminated to the public  
Progress reports are disseminated only to stakeholders**  
The following are used to disseminate:  
Printed material; flyers  
Website  
Emails   
Objectives of progress reports  
Increase awareness  
Judge the situation/identify problems   
Provide evidence  





*The strategy mentions the rights but not the responsibilities of the patients/users. 
**There are plans to assess whether the policy is meeting the needs of the population; this emerged as a 
result of this assessment 
.Responsiveness  
Mental health policy provides for/ensures that it will give access to quality services for all the 
population/patients including disadvantaged/vulnerable groups to be covered by the policy. 
 
Mental health policy provides for/ensures that the health services will respect the confidentiality and 
dignity of the population/patients. 
 
Mental health policy refers to the rights as well as the responsibilities of the patients/user clearly.*  
Mental health policy refers to the explicit benefit package to be provided to the patients at the different 
levels of care. 
 
Mental health policy provides for/ensures that health services will be provided to patients within 
reasonable timeframe. 
 
Mental Health Policy refers to how the referral of patients will take place from one level of care to the 
other..  
 
Needs assessment was conducted as part of the mental health policy formulation process  
Monitoring and evaluation plans of the mental health policy include a component to assess whether the 
policy is meeting the population’s needs through conducting patient satisfaction surveys/exit surveys. 
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The SWOT analysis below was used to highlight the strengths, weaknesses, opportunities, 
and threats. It should be noted that the opportunities and threats emerged mainly from the 
PBQ, and they represent contextual factors that affected the mental health strategy 
development process and might affect the implementation of the strategy. These factors 
were the political will, financial factors, donors’ interest, cultural issues, and window of 
opportunity to work on mental health strategy. The strengths and the weaknesses, 
conversely, mainly emerged from the EBQ based on the checklists of "good practices".  
 
Box 2: SWOT Analysis of the Findings of the Pilot 
Strengths 
• There is a new national programme with a 
motivated team  
• Commitment of the MoH/national 
programme to coordinate with all and 
involve all  
• Leadership of the MoH and the national 
programme were key to success  
• Mental Health is now a priority for the 
MoH 
• Mental health national strategy in place and 
serves like a guiding roadmap 
• National programme started to sign MoUs 
with stakeholders (but not all)  
 
Weaknesses 
• No formal national committee or working 
group was formed for the development of 
the national strategy 
• No structured process was followed; 
nothing was documented  
• No written mandate that specifies roles and 
responsibilities  
• No follow up was conducted with 
stakeholders regarding implementation 
plans and M&E 
• Minutes of meetings, implementation plans, 
and progress reports are not shared with all 
stakeholders  
• No clear implementation plans, and roles 
and responsibilities are not defined  
• Beneficiaries, parliamentary members, and 
media were not involved  
• Public is not informed  
• Need to set various components of 
accountability: setting standards, having 
sanctions, enforcement, among other things 
Opportunities 
• Availability of funding by donors  
• All stakeholders are motivated to be 
involved  
• Political commitment positively influenced 
the strategy to include all people not just 
Lebanese and vulnerable groups; plans to 
encourage the establishment of patient 
support groups 
• Technical support provided by international 
agencies as well as international and local 
experts 
Challenges 
• Sustainability once the funds are over  
• Strategic planning of next steps and 
resource mobilisation  
• Accountability is a cultural issue that is 
related to what is right and wrong and 
remains a vague concept 
• Need to pass the amendments on the current 
law and enforcement  
• Receiving funding from the government 
• Governance requires institutional capacity, 




The EBQ within the tool enabled identifying good practices and governance gaps in the 
policy formulation process based on supporting evidence that was documented and 
validated through interviews with KIs, and these were translated into strengths and 
weaknesses through the SWOT analysis. The PBQ allowed the KIs to elaborate on the 
policy formulation process they were involved in and the external factors that affected it. 
Thus, these questions elicited in-depth information that was translated into opportunities 
and threats based on the claims and the perceptions of KIs. Based on the findings and the 
SWOT analysis, the recommendations below were generated. 
 
Box 3: Recommendations to Policymakers for the Future Policy Formulation Process Based 
on the Results Generated by the Pilot of the Tool 
• National committees/working groups responsible for policy formulation should be 
officially/formally formulated by a ministerial decree or by a similar mechanism.  
• Mandate for work including TORs, roles and responsibilities, and timeframe need to be set 
and documented.  
• The inclusion of public (patients and beneficiaries) as well as parliamentary members, if 
possible, is recommended 
• Involve media in the policy formulation process to sensitise them from early on regarding 
issues related to the concern policy; training the media on tackling health issues is 
recommended.  
• It is extremely important to document minutes of meetings and share them with all 
stakeholders.  
• Allow people to join the meetings via skype or webinar  
• Need to form a participatory body to oversee the implementation of the strategy (it could be 
the same as the national committee formed to develop the strategy); ensuring participation 
throughout the policymaking cycle is crucial for good governance. 
• Operational plans/implementation plans should be published and shared with all. 
• The public need to be informed regarding draft policies/strategies and should be given the 
chance to forward feedback and comments. This is consistent with a decree that was issued 
by the Lebanese council of ministers in 2012, asking all ministries to post draft policies and 
strategies on their websites for at least two weeks for the public (including scientific 
entities, academia, media, and the lay people) to comment on.  
• All participants should sign MoUs and conflict of interest declaration before being engaged 
in the policy formulation.  
• MoH/national programme should set formal accountability mechanisms to hold various 
stakeholders accountable during formulation as well the implementation phase. 
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• MoH/national programme should work on setting standards, sanctions, as well as 
incentives. 
• MoH/national programme should set in place a complaints system and publish results of 
complaints investigations.  
• MoH/national programme should disseminate progress reports as well as M&E reports and 
other relevant documents to all stakeholders and publish these on their websites.  
• MoH/national programme should develop and publish financial reports on the sources of 
funding, how funds were allocated, and spent. Financial information should be taken into 
account when formulating a policy. 
• Needs assessment targeting the public should be conducted before the formulation of health 
policies as well as after implementation to assess responsiveness of the policy to public 
needs as well as to the services provided as a part of the policy. 
• There is a need to have a specialised unit/staff for research analysis for policy making 
• A benefit package should be clearly stated within a policy/strategy with a timeframe to 
provide services as well as setting a referral system so the patients/service users know what 
to expect. 
 
The results and the recommendations of the pilot were presented to the policymakers and 
were shared with the national team for their reflection, feedback, and to set their priorities 
to work on based on these recommendations. The mental health team implemented some of 
the recommendations while they were developing a new national strategy related to 
substance abuse.  
The pilot was able to demonstrate the positive qualities and advantages of using the tool 
based on specific aspects in terms of covering multi-dimensions of governance in a 
detailed and focused/specific manner, findings to be supported by evidence, and enabling 
the development of practical recommendations based on the gaps identified that can be 
acted on in future. In addition, the tool can have wider implications for learning in relation 
to the development of other policies in the future. Finally, to prove that the tool is reliable, 




5.1.4 Feedback from the KIs and Others on the Tool 
The KIs were also asked during the interviews of their opinion about the tool regarding the 
questions and its structure. Their comments were mainly about the structure and the 
usefulness of tool and to a lesser extent the content. The table below summarises the 
positive comments as well as criticism, and as can be  seen, some were attended to, while 
other matters could not be addressed.  
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Table 17: Summary of the Feedback Received on the Tool by KIs 
Positive Feedback Critiques 
• It serves as a guide 
• It has highlighted certain things that can be 
done differently the next time 
• It is an educational tool/checklist and is useful 
• It is a new topic to be tackled 
• The process it is suggesting is interesting 
• It gave a chance for reflective thinking on how 
the process went and identified gaps 
• It engages the responder on his/her citizenship 
and acts as a reminder for commitments 
• Inclusion of public in health policies is an 
important aspect that was missed and this tool 
will push policymakers to tackle this  
• It helps to think outside the box to include all 
stakeholders including other sectors and other 
ministries 
• It is educating stakeholders about governance 
• It is a comprehensive/exhaustive list, detailed, 
well designed, specific questions, explicit, 
well written 
• The tool is enjoyable and interesting 
• It was a good idea to have two interviews with 
a time interval to allow  reflection  
Critiques that were taken care of 
• Some wording need to be improved 
• Questions need to be clearer and simpler 
• Some terms require definitions and others 
need to be explained 
• Section one of the questionnaire could be 
shorter as there is some redundancy 
 
Critiques not tackled 
• Highlighted things are not applicable but 
important 
• Section one is long and was recommend 
to comprise two versions: a long one for 
direct stakeholders (policymakers) and a 
shorter one for others 




As for the feedback that was received concerning the length of the tool, I am quoting here 
different KIs: 
• "It needs time to think about the answers, but it is challenging and enjoyable." 
• "Although long yet it is an important tool and worth the time." 
• "I enjoyed it and did not notice the time and it is worth it." 
One of the main concerns about the tool was its length, as discussed previously in Chapter 
Four; the Delphi experts emphasised the importance of getting the number of questions 
down to a much tighter and coherent structure of questions by concentrating on the most 
salient aspects of the principles of GG.  
• Feedback by Others 
The result of the pilot on the mental health strategy development process was shared with 
the relevant national team and policymakers. One high official said after seeing the results 
and the recommendations: "the tool depicts reality of how things were done. 
Recommendations are very useful and we have already started using them for other 
strategies. This exercise has been very useful for us".  
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Other feedback was received from one of the policymakers from another country who 
participated in the consultation meeting when the final version of the manual and the tool 
were shared with him: "The tool looks more sensible and applicable. In fact, since being in 
the loop with this research, I have developed an interest in making this practical and have 
advocated using the tool in our context. We are happy to tailor and pilot the tool on the 
national action plan for the prevention and control of NCDs that we are developing in our 
country". 
In addition, the results of the pilot were presented as a poster at the Houston Global Health 
Collaborative GLOCAL conference that took place on 9–10 March 2018 in USA, under 
the title "Evaluation of a National Health Policymaking Formulation Process from a 
Governance Perspective". It was submitted under the category of evaluation of program, 
innovation and sustainability. The participants praised the data presentation as traffic lights 
as a smart way to attract the attention of policymakers on the findings. One participants 
from a developing country who works at the ministry of health showed interest to get the 
tool to conduct in her country, and she sent an official request after the conference (see 
Figure 4 for the poster presented).  
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Figure 4: Poster Presentation of the Pilot Result at GLOCAL 2018 
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5.1.5 Outcome of the Pilot  
Based on the results of the pilot testing phase and the feedback received, the tool was 
adjusted accordingly. The changes made to the tool after the pilot included adjustment of 
some wordings of the questions, such that some terminologies were replaced for better 
understanding. The changes also included removing duplicate questions within the same 
principle and between principles as there was some kind of overlap (this is due to the 
interrelationship between the principles, as discussed in chapter three) and repetition, 
mainly reflected between questions and sub-questions and between EBQ and PBQ. As a 
result, the sub-questions of the EBQ were reduced and a few questions in the PBQ section 
were removed.  
The accountability section was revised and adjusted to reflect coherence and applicability. 
The revision of this section included clarifications of questions, adjusting sequence of 
questions, and removal of duplications. One question was split into two as it created 
confusion when asked as a main question and a sub-question. 
The responsiveness section received positive feedback from the KIs as it is highlighting 
important aspects that are usually overseen by policymakers but were important to ask the 
KIs about and explaining what responsiveness to the needs means in practical terms.  
The number of questions before the pilot were 52 and 36 for EBQ and PBQ, respectively 
and afterwards these became 53 and 30, which made the tool more practical.  
It was clear from the pilot that the unit of analysis could be MoH/health authorities or even 
the national programme and thus this option was added. This reflects that the tool might 
need some adjustments depending on the policy type and the context/country being used 
in. This can be done without affecting the content and the validity of the tool.  
 
5.2 The End Product of the Research 
Table 18 presents sample questions from the section on participation before and after all of 
the refinement process, illustrating what questions were kept, added (justifications in 
chapter four) or deleted (justifications at the end of Table 18). All the changes that were 
introduced to the tool were explained and justified in chapters three, four and five.  
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Table 18: Sample Questions Edited, Added, and Deleted from the Evidence-Based Section on 
Participation to Compare the First Draft of the Tool with the Final Tool after the Delphi 
First Draft: Participation Final Tool: HP-GGT: Participation 
Is there a legal obligation (law) to include various 
stakeholders in the health policymaking process? 
• In policy formulation: Y/N 
• In policy implementation: Y/N 
• Not specified 
Is there a legal basis/requirement 
(law/regulation/policy) to include various 
stakeholders in the health policymaking process?  
(Assessor: Read the response options and circle the 
answer given by the key informant) 
Y, N, P, DK, NA 
If Yes, please specify what is it? 
and in what phase of the policymaking process is it 
specified to consult with stakeholders   
If No, is there still a commitment from the 
MoH/health authority/National Programme to ensure 
some degree of stakeholder participation in the 
formulation and implementation of national health 
policies? 
Is there a mechanism(s) used to involve participants 
in the policymaking process that is concerned 
with…? such as: 
• National committee 
• Advisory board 
• Working groups 
• Other, please specify 
 
Was there a body or mechanism(s) that was used to 
involve stakeholders in the policymaking process 
that was concerned with the development of the X 
Policy?  
Y, N, P, DK, NA 
If Yes, what body or mechanism (s) was used to 
involve stakeholders in the policymaking process 
that was concerned with the X Policy?  
(Assessor: Read each response option, allow key 
informant to reply, and check by adding (√) all 
options that key informants identify) 
A national committee 
An advisory Board 
Working group (s) 
Other, please specify: 
Is the mechanism(s) for participation (indicated 
above) provided for by: 
• Law 
• Ministerial decree 
• Administrative decision 
• Other, please specify 
Is the participation process in policy formulation: 
• Formal  
• Informal 
How was this body /mechanism (mentioned above) 
formulated?   
Formally (in written format), please specify how and 
by whom 
Informally, please specify how 
If it was formally formulated 
- Was there a written scope/mandate for 
stakeholders’ involvement in the formulation of the 
X Policy? 
Y, N, P, DK, NA 
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- Is there written scope/mandate for the various 
stakeholders involved in policy formulation?  -Y/N 
If it exists, what is the mandate? 
What is the scope/mandate for the stakeholders?  
 
Were the roles and the responsibilities of the 
participants for the various stakeholders specified? 
Y, N, P, DK, NA 
 
Were the qualifications of the participants for the 
various stakeholders specified? 
Y, N, P, DK, NA 
 
Was there a timetable for the work to be carried out? 
Y, N, P, DK, NA 
- Are the following stakeholders represented in the 
policy formulation that is concerned with….? 
- State actors (government), please specify. 
- Health service providers (professionals & 
Organisations), please specify. 
- Beneficiaries &/or public, please specify. 
- Civil society, please specify. 
- Media 
- Others, please specify 
-  Were the following stakeholders represented in the 
FORMULATION that was concerned with X 
Policy? 
State actors (Government, other than the MoH, 
national, local), please specify. 
Health service providers (professional 
association/unions/orders &health   service 
organisations/hospital boards), please specify: 
Parliamentary members  
Beneficiaries (patients associations) &/or public, 
please specify. 
Civil society, please specify. 
Development partners/international organisations, 
please specify. 
Funders/donors, please specify 
Academic institutions/researchers, please specify. 
Private sector (medical, pharmaceutical industry, 
insurance companies), please specify. 
Most vulnerable or key affected populations, please 
specify. 
Media 
Others, please specify. 
Were representatives from local/regions within X 
Country represented? 
How? 
 For each category of stakeholders identified above, 
how were the participants involved in the 
formulation of X Policy selected?  
Appointed, nominated , were there set criteria for the 
selection? 
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Was their participation: 
Voluntary  
Mandatory  
Is it specified in the mandate the level of 
participation?  
Consultation/Partnership 
Delegated power and control 
-Not specified 
Deleted 
Justifications for the deletion:  
As it is difficult to specify such data in the mandate 
but the answer can be reflected from practice 
Is there a balance in the mix of stakeholders’ 




Justifications for the deletion:  
The answer can be extrapolated once we know who 
were the stakeholders involved 
 Added 
Is there a gender balance /consideration (male vs. 
female) among the stakeholders participating in the 
formulation of the X Policy?  
Y, N, P, DK, NA  
 Added 
Is there a participatory body to oversee the 
implementation of the X Policy? 
Y, N, P, DK, NA  
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From the table above, it can be seen that the final tool in comparison to the first draft has 
improved tremendously in terms of wordings, answer options, sub-questions have been 
expanded, and instructions for assessors have been added. All of these changes reflect the 
advantages of all the stages performed within this research towards the aim of producing a 
robust, useful, and practical tool to assess health policy governance (see also annex 4 for 
the first draft of tool before Delphi and annex 7 for the final tool to see how it improved in 
terms length, content and structure).  
Based on the pilot and how things function  in real life, it offered a considerable of insight 
that was included in the manual, developed after the pilot for use by future assessors. It 
includes justifications for all questions in the tool whether based on literature or additions 
suggested by the Delphi experts (see attached final tool and manual in annexes 7 and 8). 
The box below presents the outline of the manual. 
 
Box 4: Outline of the Manual 
Chapter I: Introduction to Health Policymaking-Governance Guidance Tool (HP-GGT) 
• Background 
• Rationale for Development of HP-GGT 
Process of Development of HP-GGT 
Chapter II: Overview of HP-GGT 
• Overall Objectives of HP-GGT 
• Scope of HP-GGT 
• Structure of HP-GGT 
-Chapter III: Methodology of Conducting HP-GGT 
• Users of HP-GGT 
• Steps to Conduct HP-GGT 
• Data collection: Desk Review and KI Interviews 
• List of Suggested Documents to Be Reviewed 
•  List of Potential KIs to Be Interviewed and Sampling Strategy 
• General Tips for Interviews 
• Displaying Results, Analysis of Findings, and Recommendations  
•  Final Assessment Report 
Chapter IV: HP-GGT: Questions and Explanations for Questions 
• Section A of HP-GGT: Evidence-Based Questions: For 5 principles with Explanations for Each Question 
• Section B of HP-GGT: Perception-Based Questions: For 5 Principles with Explanations for Each 
Question 
Chapter V: Limitations  
Glossary  
Annexes 
Annex 1:  
A. Letter Addressed to KIs 
B. Information Sheet  
C. Informed Consent 
Annex 2: Sample Excel Sheet for Data Entry  
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5.3 Reliability Testing 
For the purpose of this pilot, the reliability testing was planned using test-retest reliability 
or inter-rater reliability, in which the tool was supposed to be conducted by two different 
people (myself and an independent person with a masters degree in public health who was 
recruited for this purpose) and the results compared (Devellis, 2003) and correlated 
accordingly (Chung, Pillsbury, Walters, Hayward and Arbor, 1998) to determine the extent 
to which the two independent raters agreed on their interpretation of results (test 
agreement) (Devellis, 2003). The independent assessor was supposed to re-conduct two to 
three interviews with the same KIs and those were to be randomly selected to test the 
reliability of the tool.  
Unfortunately, all the four KIs who were approached for the interview for re-conducting by 
another assessor refused to do so due to the time it took the first time (although they were 
informed in the initial information sheet sent that they might be selected a second time, 
with a less than 20% chance of being re-interviewed) and insisted on the fact that their 
answers will not change. So, the reliability was dropped due to the difficulty involved in 
conducting it as planned in a real life setting.  
The consistency of the data generated by the tool should be studied in the future after 
applying the tool in different settings/countries with different types of policies.  
 
5.4 Reflection on the Pilot 
In general, the pilot went well and as planned, except it took more time than was planned. 
The specific contribution of the pilot, as discussed above, was mainly to test the KIs 
interest and willingness to participate in such research, acceptability of the questions, 
wordings used, and the length of the tool, removal of duplicate questions, feasibility of 
collecting and reviewing the relevant documents, amount and the usefulness of the 
information that can be generated by the tool, how this information can be analysed, and 
how the results can be presented in a logical manner. In addition, the pilot was helpful for 
developing instructions and tips to be added to the manual for future users based on 
observations from the field, and to finalise the tool. The acceptability, feasibility of 
conducting the tool ,and the usefulness of the results generated was demonstrated in the 
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context of a LMIC. This is valuable as the tool is intended to be used in such countries (as 
discussed in Chapter Two) for better understanding of health governance issues and its 
improvements.  
The overall contribution of the pilot was mainly to demonstrate if the research reached its 
main aim, developing a SMART tool (as discussed in Chapter Two), which is practical yet 
robust and can contribute to policymakers’ reflexivity to improve their policy governance 
practices (that are related to identified key good practices, important for high-quality 
governance), and this was effectively demonstrated.  
With the end of the pilot testing, which was followed by finalising the tool and the manual, 
this research was concluded. This does not imply that this is the final step for the tool. It is 
a dynamic/live tool as it will continue to be adjusted, and it will undergo further revisions 
if needed after being used "in the field" in other countries (hopefully) with different types 
of health policies in different contexts. One of the advantages of this tool is that it is a 
generic tool that can be used to assess the formulation process of any type of policies (as 
discussed in Chapter Two).Furthermore, the tool is not an end by itself, but rather the 
beginning of a process to improve health governance understanding, importance, and 
application in practice. Yet, the recommendations and their applicability need to be 
realistic (Fryatt et al., 2017). In addition, this tool, if applied in various countries, will help 
in generating and documenting what different countries are doing to improve their HSG at 
the policymaking level, which is recommended for "collective action across countries" to 
improve governance (Fryatt et al., 2017). However, further research is required to explore 
the "good practices" that are suitable for different settings. In conclusion, the last phase of 
the research included pilot testing of the tool. The pilot was important to test the practical 
aspects of the tool and demonstrate its advantages and show how the KIs and the national 
policymakers perceived the tool and its findings. Certainly, the pilot’s contribution to the 
tool’s development was limited to adding the final touches on the tool after testing its 
practicality, while the Delphi and the consultation meeting were essential for the 




In this final chapter, I offer a brief overview regarding the importance of HSG , the gaps in 
Knowledge, and the lack of a practical tool to justify the focus of this research. I present a 
brief summary of the contribution of each of the three phases (the academic literature 
review, Delphi consultations, and policymakers’ input and the pilot). Subsequently, the 
significance of this research as a whole with regard to its contribution to existing 
knowledge and possible contribution of health governance to policy practice is covered as 
well.  
I present the key limitations of the tool stemming from practical and conceptual  origins. I 
conclude the chapter with suggestions for future research that should be conducted to 
complement this work and other existing work with the aim to gain a better understanding 
of HSG and determine the best ways to improve its quality in practice at the policymaking 
level.  
• Importance of Assessing HSG and Gaps 
A World Health Report in 2000 emphasised the importance of governance in the health 
sector. Soon after, governance became one of the core building blocks of any health system 
(WHO, 2007) due to an emerging consensus among international health agencies that 
identified its salience in promoting improved health outcomes, especially in LMICs 
(Siddiqi et al., 2009), which is yet to be confirmed by empirical evidence to explain and 
verify the actual relationship between HSG and the performance of the health system and 
health outcomes.  
It was claimed that GG might ultimately lead to improved health outcomes (Barbaza and 
Tello, 2014), contribute to discouraging corruption in the health system (WHO, 2007), 
increase efficiency of the health sector (Brinkerhoff and Bossert, 2008), might raise the 
performance, as well as might improve the population’s health status (Lewis and 
Pettersson, 2009), and further enable Universal Health Coverage (Hamra and Bigdeli, 
2016). All of the above have contributed to the interest in expanding the knowledge on 
health governance and determine the best ways to practice it in the past two decades. Thus, 
policymakers are interested in improving governance at all levels of the health system as a 
part of their role to steer the sector (Siddiqi and Jabbour, 2012). Donors as well as 
international organisations’ are also interested in enhancing health governance practices as 
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a pre-requisite/condition for funds for the health sector (Lopez et a.l, 2011). This 
importance and interest resulted in the need to make health governance "actionable" for 
policymakers (Barbaza and Tello, 2014). This entailed assessing HSG in a normative way 
to diagnose the way in which it is practiced and can be improved, essential for the concrete 
implementation of governance practices.  
Despite the agreement concerning the importance of governance within the health system, 
there is disagreement with regard to its role and best ways to define the implication of 
governance and to operationalise its meaning in practice (Barbaza and Tello, 2014). In 
addition, there are a number of widely common principles for GG suggested by different 
organisations but in different combinations, based on different organisational priorities 
(WHO, 2000, USAID, 2008, Siddiqqi et al., 2009, Lopez et al.,2011). These resulted in 
challenges in its assessment in a substantial and beneficial manner. Consequently, 
international organisations and researchers are interested in developing useful assessment 
tools to aid policymakers in enhancing governance, filling gaps in knowledge, and 
initiating change in practice (Alliance HPSR, 2008). Most of the work conducted so far has 
been undertaken by international organisations (Barbaza and Tello, 2014), and to a lesser 
extent, academic institutions (Lopez et al., 2011; Baez-Camargo and Jacobs, 2011). The 
assessment tools that were developed had limited application in practice due to several 
factors (as discussed in Chapter One). Hence, there is a necessity to produce a policy tool 
based on academic research, which is also practical and useful, in order to enable a better 
understanding of GG in practice.  
This present work involved following an evidence-based approach to address some of the 
gaps in knowledge and practice and to assist policymakers by benchmarking good 
practices in diverse contexts, as discussed in Chapter Two. The tool developed for this 
research was designed to address this challenge by developing concrete applications of 
selected principles to improve upon the abstract approach previously followed by others.  
HP-GGT is built on current and previous work conducted by others as it constitutes a good 
strategy to advance governance research; we need to focus on areas on which there is 
consensus and which others did not explore (Robichau, 2011).  
• Defined Scope of HP-GGT 
Drawing from the ten principles derived from Siddiqi et al.’s (2009) work, with its aim 
directly related to HSG, five were selected for inclusion in the proposed tool, namely, 
participation, transparency, accountability, use of information, and responsiveness. The 
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reason behind the selection of these five principles is their importance to health 
governance, as discussed in Chapter Two.  
The level of analysis is policymaking formulation level. This renders HP-GGT one of the 
few tools that focusses exclusively on the governance of health policy development level 
as most tools reported in literature focus on either both formulation and implementation or 
on implementation alone (Gilson and Raphaely, 2008; Siddiqi et al., 2009). Changing 
governance processes through the application of GG at the formulation level might 
improve policy design (MacGregor, Singleton and Trautmann, 2014). The unit of analysis 
is MoH/Health authority since it is the steering entity responsible for setting national 
policies, regulations, and plans. It is important that MoH/health authorities assume a 
leading role in conducting the assessment to allow a sense of ownership and utilise results 
to better inform policy formulation processes and improved governance of the system. 
Defining the scope of the tool was performed as a part of the initial proposal and was not 
subjected to the Delphi consultations.  
Few tools on HSG offer a combination of data collection approaches. The HP-GGT 
combines both evidence-based and perception-based questions. EBQ provides a snapshot 
of the situation at a given time and can be utilised to track changes, while PBQ add in-
depth understanding of the processes, explains the changes, and reflects on the content.  
• Contribution of Each of the Research Phases to the Tool’s Development  
The research was executed as a step-wise process through three phases. 
Phase I conceptual and framework development: This involved building a strong 
conceptual foundation for the tool based on the available literature from which the first 
draft was created. This was achieved through the conceptualisation of the five principles in 
terms of identifying their key characteristics/aspects/concepts. Armed with the knowledge 
from other works regarding these principles, the basic form of the tool was formulated. 
Phase II content and methodology refinement of the tool: This focused on refining the 
tool’s content by seeking informed expert opinion through a modified Delphi process. 
Governance experts contributed to agreeing on the core concepts that should be attributed 
to the five principles selected for assessment through the tool’s application. They also 
contributed to making the concepts more relevant to health governance policy. In addition, 
they also proposed new concepts to complement the assessment of the principles, thus 
ensuring the tool’s construct validity. 
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The Delphi process was followed by consultation with high-level policymakers, who were 
mainly engaged to assess the tool’s practicability in the context of health, while they also 
offered further suggestions for its modification, as presented in Chapter Four.  
Phase III applicability and testing of the tool: The pilot testing of the tool took place in a 
middle-income country, Lebanon. The formulation process of the newly developed 
National Mental Health Strategy was assessed to demonstrate the tool’s practicality with 
regard to data collection, usefulness of the data generated to offer recommendations for 
future policy improvements, as demonstrated in Chapter Five.  
• Contributions of the Research 
The contribution of this research can be considered at two levels. At the level of 
knowledge, it has contributed to an enhanced  understanding of governance and its 
principles in relation to health policymaking. The application of the Delphi method 
contributed to bridging the gap in academic research concerning health governance for its 
practical application at the policymaking level. This implies that collaboration in the 
identification of the main concepts in the literature with groups of experts, some of whom 
came from an academic background while others had practical experience in the field of 
HSG, constituted a novel input of this research endeavour. Thus, at the level of policy 
application, the proposed HP-GGT that contains a list of good practices can be 
implemented to enhance and improve the governance of the policymaking process. A 
practical advantage of the tool is that it covers multi-dimensional aspects that once 
assessed will be available for policymakers to reflect on its concrete recommendations for 
enhancing the quality of the policymaking governance process in their jurisdiction. 
At the level of knowledge, this research resulted in bringing abstract concepts into policy 
application through conceptualisation and operationalisation. Most organisations define 
health governance by its principles. The same approach was followed. However, an in-
depth exploration of the characteristics of the five of principles based on the summarised 
evidence obtained from the literature (not reported under health governance before) 
fulfilled the demand for the concrete application of the governance principles (as observed 
in the existing literature). These summaries constituted non-exhaustive lists of these 
characteristics that received consensus through the consultative and iterative discussions 
with knowledgeable experts. These experts identified these characteristics as the most 
important ones to assess and further facilitated the development of new insights by 
underpinning concepts not covered in the conceptualisation phase. These characteristics 
are employed in the tool to sensitise policymakers regarding their contribution to GG and 
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offer examples of good practices documented in the literature and validated by the Delphi 
experts.  
HP-GGT is the first health governance tool developed through Delphi consultations, and 
it's added value is due to a lack of consensus regarding the best way to assess it due to a 
lack of standardised tools. Thus, the knowledge contribution was made through 
elaboration, specification, and the analysis of the concepts/components in relation to their 
principles (see Annex 9, a sample of how participation was proposed to be assessed by 
Siddiqi et al. (2009) vs. how HP-GGT is assessing it). 
At the level of policy practice, the assessment focuses on the policymaking process and 
principles of governance that fall under it. It is designed to be applied to any policy type; 
the findings would subsequently inform enhancements to the policymaking process in 
general. The tool raises important questions for policymakers to reflect on and then 
consider them in developing health policies. The tool proposes interventions that can be 
utilised to enhance the gaps in governance identified. Thereafter, it is up to the 
policymakers to decide what is important to deal with and when, based on the 
recommendations generated by the tool and the context they operate in.  
The end-product of this research is the tool and its manual. It can be employed as an 
assessment tool to evaluate a policymaking process followed retrospectively; thus, it 
provides an opportunity to analyse governance processes in health policy formulation. It 
can assess the strengths and weaknesses of the process of the policy formulation and offer 
recommendations accordingly. The tool and the manual can be employed like a 
guide/model to apply GG when developing national policies/strategies. Consequently, the 
tool is considered a guidance tool that can add value to the health policymaking processes 
and research on health policy. As the principles of governance were translated into 
mechanisms and specific activities, the applications of these GG principles will facilitate 
strengthening the institutional capacity of MoH/health authorities and their stewardship 
role as well as improving the policymaking process.  
This tool represents the first step towards benchmarking good practises in health 
governance at the policymaking level. It serves as an entry point for change through mere 
consultation with KIs (stakeholders who were involved in the policymaking and are 
knowledgeable about the health sector) on the right questions. This was reflected in the 
feedback provided by KIs during the pilot. HP-GGT helps in providing insights and 
extending the consideration of potential solutions (Singleton et al., 2014). In addition, the 
tool emphasises the importance of documenting the policymaking process.  
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• Process of Reflection  
A critical examination of the approach followed to develop the HP-GGT would reveal that 
it constituted as approach of reflection.  
Delphi experts reflected on the content derived from the literature, contributed to it, and 
validated it through an extensive consensus process.  
High-level policymakers considered the data collection methodology of the tool and the 
optimum ways to present the findings. The pilot allowed another round of reflection by the 
KIs, and this facilitated in the final refinement of the wording, removal of duplicates, and 
assessment of the tool’s practicality. The final reflection took place when the findings were 
presented and the recommendations of conducting the tool were presented to the national 
policymakers, who found them useful, realistic, and comprehensive. The presentation of 
the findings was helpful to policymakers for visualising the strengths (green), weaknesses 
(red), and the processes that their application required acceleration (yellow).  
The four elements together (literature search, Delphi consultation, policymakers’ input, 
and the pilot) contributed to in-depth knowledge concerning the key pillars of the five GG 
principles and towards generating a simple yet practical tool that might positively influence 
the governance of health policy. The research resulted in a valid, rigorous, evidence-based 
tool that can produce useful information. Thus, it can be utilised by national policymakers 
and international organisations interested in working on HSG at the national level.  
• Limitations 
The HP-GGT does not represent a perfect tool; like any other instrument of its kind, it has 
some limitations that can be classified into practical and conceptual ones.  
Practical limitations include the need to conduct a series of interviews and extensive 
review of available secondary information. The findings of the assessment will depend 
greatly on the existence of relevant documents to be reviewed, given that the culture of 
documentation in some LMICs countries might be poor. Furthermore, identifying relevant 
KIs for interviews is critical and a key element in the success of the assessment; this is 
because the results obtained will depend on the number of KIs who will agree to be 
interviewed, their level of knowledge concerning the policy process under evaluation, and 
their openness in responding to the questions. It is crucial to engage a relevant mix of KIs 
in order to gain a multi-perspective reflection regarding the policy development process 
from a governance perspective. A proper mapping of the stakeholders is an absolute 
necessity before initiating the assessment as it was done in the pilot (Chapter Five).  
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Another practical limitation of the tool is that the tool is rather long, requiring a minimum 
of two hours to complete both sections (around one hour for each). This might result in a 
low rate of acceptance by KIs given their tight schedules; this is the reason due to which it 
was suggested that two separate interviews be conducted, if found acceptable by the KIs. 
Moreover, translating the tool into other languages for application in other contexts might 
be a problem due to the possible cultural differences, which can lead to some inaccuracies.  
The conceptual limitations include a narrow scope in terms of the level of analysis and the 
principles covered. The level of analysis only concerns the formulation and not the 
implementation phase or any other phase of the policymaking cycle. A wider scope in this 
regard would have been preferable, in particular, because quite commonly, these phases 
overlap, and hence, the tools’ findings would have been more comprehensive. As evident, 
the tool involved only five principles of GG out of the ten identified in the literature, which 
limited its comprehensiveness again. However, considering the fact that it has been 
criticised by some for being too lengthy, this limitation could be insurmountable at this 
stage. That is, for the tool to be practical and realistic it would seem that, if anything, it 
should be shorter if possible rather than longer.  
The conceptualisation of the responsiveness principle was probably the weakest as it was 
indicated by two Delphi experts; yet, no consensus was reached on eliminating it from the 
tool. This weakness could be due to the fact that it was tackled in the literature only as 
clinical responsiveness at the service delivery level (Chapter Three). It was also the least 
chosen principle for review during the Delphi process; it was reviewed by eleven experts, 
while the most reviewed principle was participation, reviewed by fourteen (as discussed in 
Chapter Four). Moreover, responsiveness is classified in literature as an outcome of 
governance, while the other selected principles were processes (Baez-Camargo and Jacobs, 
2011; Barbaza and Tello, 2014). Considering this conceptual weakness of responsiveness, 
it was logical to retain it in the tool to conceptually develop it further with the help of 
governance experts. Additionally, introducing the principle to policymakers to highlight its 
significance and offer a better understanding of responsiveness and its potential role at the 
policymaking level was helpful, starting from the policy formulation phase. Concepts of 
responsiveness reflected in the questions were praised by the KIs during the pilot.  
Another conceptual limitation of the tool is that it does not explore the relationship 
between the principles as it does not suggest the most important ones, ones that are the 
result of others, precursor to others, and these issues remain unresolved. The reliability 
testing was not conducted due to practical concerns as discussed in Chapter Five.  
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A general limitation associated with improving governance is that it is a complicated and 
ongoing continuous process that would require institutional changes at several levels, and 
there is no universal solution for all governance problems (Grindle, 2016); furthermore, the 
required change cannot happen simultaneously (Grindle, 2004). Improvement in the 
quality of governance involves modifications in long-standing practices, strategies, 
interests, cultural habits, and social norms (Grindle, 2004; 2008). Thus, the process of 
change should be gradual. Improving all the practices that are listed within the tool at the 
same time is not possible due to the efforts required to do so and the negative aspects that 
might emerge when GG principles are applied, mainly due to the need to invest in human 
and financial resources and the lengthy process associated with such modifications and 
changes (as discussed in Chapter Three). Aiming for "good enough" governance will be a 
more realistic goal that would require further realistic investment for the improvements 
required in HSG (Grindle, 2004; Fryatt et al., 2017).  
• Future Research 
Future research should be focused on the other principles of GG within the health context 
(ethics, equity, efficiency, effectiveness, rule of law, and strategic vision). Moreover, the 
other phases of the policymaking cycle require to be investigated, possibly using the 
proposed tool with some modifications. Further, the subsequent research that expands on 
this one would further require  assigning different weights to different characteristics as it 
will be useful to advise policymakers on installing fundamental/core components as 
against desirable processes/mechanisms, which will further improve the quality of 
governance at the policymaking level.  
HP-GGT should be tested in other countries with different kinds of policy to ascertain 
whether it is flexible for application in other contexts and with other health 
policies/strategies.  
There is a necessity for in-depth research to explore the relationships among the 
governance principles identified and their interaction in the policymaking cycle as 
suggested by the framework developed and discussed in Chapter Three. Identifying the 
nature of the relationships between the various principles can assist policymakers and 
others to perform better and more realistic planning of interventions to improve health 
governance as this would help them focus efforts on the principle(s) that will positively 
affect the others if enhanced.  
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Finally, further in-depth research is required to explain the association and to verify or 
falsify the causation claim between applying GG within the health system and improving 
its performance and eventually improving health outcomes and indicators.  
In conclusion, the assessment of health governance at the policymaking level does not 
comprise an end in itself; rather, it forms the beginning of a complex and continuous 
improvement process that would require gradual institutional changes at several levels 
(Grindle, 2016). Siddiqi et al. (2009, p.24), stated that the "Road to GG in health is long 
and uneven", and I would like to believe that the tool created through this work presents a 
positive step along this road, one that provides the opportunity to act as a medium for 
initiating a concrete dialogue with policymakers who wish to enhance their governance 
practices at the policymaking level. 
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Annex 1. Mapping of Existing Questions on the Five Governance 
Principles in Various frameworks/Assessments 
Framework 
Assessments 











































































































- - Are the private sector, civil society, 
line departments and other 
stakeholders consulted in decision 
making? 
- - How are decisions related to health 
finalized: cabinet, parliament, head of 
government or state?  
- - How are the inputs solicited from 
stakeholders for health policy?  
- - How does government reconcile the 
different objectives of various 
stakeholders in health decision-
making? 
- - Are other state ministries involved in 
by the MOH in policies and programs 
to tackle health determinants? 
- - What is the level of decentralization 
in decision-making? 
- - What is the extent of community 




-  Extent to which communities (either 
directly or through elected leaders) are 
involved in the health needs 
assessment, national health policy 
development, and planning of health 
development 
-  Extent to which communities (either 
directly or through elected leaders) are 
involved in management of health 
services and other health enhancing 
services  
- Extent to which communities (either 
directly or through elected leaders) are 
involved in monitoring and evaluation 
in the achievement of health 
development objectives and targets 
spelt out in national health strategic 
plan.  
-Existence of vibrant intersectoral 
committees for tracing progress on 
socioeconomic determinants of health 
- Extent to which the legislative and 
policy environment forges partnerships 
with the faith-based organizations and 
private for profit sector in health 
financing, health systems input creation 
and health services provision to 
facilitate implementation of national 
health policy & strategic plan  
 
All qualitative in nature 
Data collected through 






















parliamentarians and civic 









-In-depth interview with 
prime-minister/president 
office 
-Review of health-related 
legislations and interviews 
of leaders of faith-based 
and private for profit 













































































-To what extent was the formulation 
process for the vision for health and 
health system strengthening strategy 
inclusive of main stakeholders for 
national consensus and ownership? 
-Are common values shared across the 
health sector and is an ethical base for 
health improvement established?  
- Are health-system wide 
accountability and transparency 
ensured? 
- Are there strategies in place to engage 
and involve patients and citizens in 
shared decision-making and priority 
setting? 
- Are the roles and responsibilities of 
the public, private and voluntary 
sectors and of civil society specified in 
implementing the health strategy? 
- Is there a strategy in place to 
collaborate and build coalitions across 
all sectors in government, and with 
actors outside government, to attain 
health system goals?  
 
 
-The public and concerned stakeholders 
have the capacity and opportunity to 
advocate for health issues important to 
them and to participate effectively with 
public officials in the establishment of 
policies, plans, and budgets for health 
services 
-Willingness of the public and 
concerned stakeholders to participate in 
governance and advocate for health 
issues 
 
-Comparative case studies 
of countries across the 























-Interviews with wide 














































- - What is the role of press/media? 
- - What is the role of elected bodies 
(legislature)? 
- - What is the role of judicial system? 
- - Are mechanisms for overseeing 
adherence to financial, administrative 
rules in place? 
- - What evidence is present about the 




-Existence of transparent results-
oriented reporting and assessment 
frameworks to assess progress against 
national health strategic plan target 
indicators 
- Extent to which diagnostic reviews of 
national arrangements and procedures 
for public financial management, 
accounting, auditing, procurement, 
results frameworks and monitoring 
All qualitative in nature 
Data collected through 










-Review reports of the 
public expenditure and 
financial accountability 
(PEFA) initiative, if does 
not exist, conduct the 














































































Make use of legal, 
regulatory and 
policy instruments 






























provide reliable assessments of 
performance, transparency and 
accountability of country systems 
- Extent to which evidence from 
diagnostic reviews is used in the design 
of reforms to ensure that national 
systems, institutions and procedures for 
managing all health resources are 
effective, accountable and transparent 
- Extent to which reliable and timely 
budget 
execution and audit reports are 
transparently reviewed by relevant 
parliamentary committees and 




-Does the ministry of health ensure that 
legislation and regulations are fairly 
enforced? 
- Is the right mix of powers, incentives, 
guidelines best practices and sanctions 
used to steer stakeholders in the chosen 
direction?  
- Are the health system incentives 
aligned to make sure that they support 
the attainment of policy goals? 
 
-Civil society organizations (including 
professional, NGOs, media, etc) 
oversee health providers and provider 
organizations in the way they deliver 
and finance health services (acting as 
watchdogs) 
-The public or concerned stakeholders 
(e.g., community members) have 
regular opportunities to 
meet with health care providers about 
service efficiency or quality (existence 
of client-provider committees or 
similar mechanisms) 
-There are procedures and institutions 
that clients, civil society, and other 
concerned stakeholders can use to fight 
bias and inequity in accessing health 
services (existence of organizations for 
patients rights, independent judiciary 
body & law enforcement) 
 
-Health sector regulations are known 
and enforced in both public and private 
training institutions and health facilities 
(Do government regulatory agencies 
have the necessary resources (human, 
technical, financial) to enforce existing 
legislations and regulation? What 
attempts has the government made to 
support compliance with regulations? 



















-Interviews with KIs 
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been effective? 
-Procedures exist for reporting, 
investigating, and adjudicating 
misallocation or misuse of resources: 
(What are the policies in place for 
dealing with mismanagement? What 
opportunities exist for concerned 
citizens or health workers to report 
resource allocation problems, 
malpractice, counterfeit drugs? Is an 
impartial ombudsman available for 
investigating them? What laws exist to 





































-Is information about financial 
administrative procedures readily 
available? 
- How transparent is the process of 
resource allocation? 
- Are there monitoring mechanisms in 
place to ensure transparency of 
decisions? 
- Who is involved in monitoring of 
health services? 
- How are the district managers 
appointed/transferred? 
- How soon is information from 
financial audit available after the funds 
are distributed? 
 
-The national government is 
transparent with regard to health sector 
goals, planning, budgeting, 
expenditures, and data. It regularly 
communicates with stakeholders in the 
health sector 
All qualitative in nature 
Data collected through 


















































-What information is available about 
the health system and health in the 
country and how accessible is it? 
- What is the reliability of information 
available for development of policies? 
- What evidence is there for the use of 
information in decision-making 
process? 
- How is the relevant information about 
health generated? 
- How is implementation of health 
policies monitored? 
 
-Existence of a national health research 
system & policy/strategic plans that are 
being implemented as evidenced in 
research outputs and their use in health 
policy, planning and decision-making 
-Existence of a functional Health 
knowledge management systems 
(HKMS) that does 
acquisition, creation (probably through 
research and practice), diffusion, 
application and evaluation/ 
All qualitative in nature 
Data collected through 











Review existing Health 
Research Systems 
Analysis (HRSA) reports; 
and where non- existent 
conduct an assessment of 




























































































































improvement of knowledge 
-Health management information 
systems: Extent to which a country has 
legal and policy 
frameworks supported by sufficient 
human resources, financing and 
infrastructure; core health indicators 
identified covering determinants of 
health, health system inputs, outputs 
and outcomes; key data available from 
six main sources and standards for their 
use - for census, vital events 
monitoring, health facilities statistics, 
public health surveillance, population-
based surveys and resource tracking; 
optimal processes for collecting, 
sharing and storing data, data flows and 
feedback loops; dissemination of 
information and effective use of data 
for policy and advocacy, planning and 
priority setting, resource 
allocation, and implementation and 
action 
- Existence of a comprehensive 
national policy and a legal and strategic 
framework to guide and nurture the 
growth of Information, communication, 
& technology (ICT), while at the same 
time protecting the welfare of its 
citizens 
-Extent to which the necessary 
investment in ICT 
Infrastructure, including fixed phone 
lines installation, equipment (e.g. 
computers, servers, networks) and 
Internet connectivity in the entire 
health system, i.e. from the Ministry of 
Health headquarters down to the level 
of community-based public health 
programmes 
 
-Does the health ministry ensure that 
strategy-based information, research 
evidence and other important data is 
generated, analyzed and used for 
decision-making by policymakers, 
clinicians, other health system actors 
and the public?  
- Are research evidence and strategy-
based performance information 
(including health system performance 
assessment) built into ministry policy 
development and decision-making 
processes?  
 
-Public and private sector providers 
report information to the government 
(Issues to examine are: type of data 
reported, timeliness of reports, quality, 
and ease of use by policymakers, and if 
reports; and where they do 
not exist undertake an 
assessment of HKMS 













-Review existing NHIS 
reports; and where non-
existent conduct an 
assessment using Health 














used in policy, planning and 
monitoring) 
-Service providers use evidence to 
influence/lobby government officials 
for policy, program changes 
 
-Government officials rely on research 
and evaluation studies and existing HIS 
when they formulate laws, policies, 
strategic and operational plans, 
regulations, procedures, resource 
allocation decisions and standards for 



























































of system design 






-Are health subsidies targeted? What is 
the targeting mechanism? 
- Is needs assessment conducted as part 
of the policy process? 
- Does the health policy address the 
health needs/burden of the local 
population? 
- Is the quality of health services and 
user satisfaction valued high by the 
MOH? 
- How does the health system respond 
to regional/local priority health 
problems? 
- How responsive are the health 
services to the medical and non-
medical expectations of the population?  
 
 
-Extent to which health systems 
exercise respect for persons (dignity, 
autonomy in choice of interventions 
and confidentiality) and are client 
oriented (prompt, adequate basic 
amenities, access to social support 
networks, choice of provider)  
 
-Is the health system able to adapt its 
strategy and policies to take into 
account of changing priorities and 
health needs?  
 
 
-What mechanisms are in place to 
ensure the participation of key 
stakeholders in the health policy 
agenda? Which groups are represented 
during these discussions? 
-Mechanisms and strategies used by the 
government to engage all health 
stakeholders in policy and planning 
include workshops to discuss policies 
and develop strategic plans, and 
widespread distribution of policies and 
plans to all major health entities 
 
All qualitative in nature 
Data collected through 















Exit client surveys among 
samples of different levels 
of health facilities, 
regional and district 







documents, and interviews  
-Results will be reported as 














-Existence of an up-to-date national 
health strategy linked to national needs 
and priorities  
-Existence and year of last update of a 
published national medicines policy  
- Existence of policies on medicines 
procurement that specify the most cost-
effective medicines in the right 
quantities; open, competitive bidding of 
suppliers of quality products  
-Tuberculosis—existence of a national 
strategic plan for tuberculosis that 
reflects the six principal components of 
the Stop-TB strategy as outlined in the 
Global Plan to Stop TB 2006–2015  
-Malaria—existence of a national 
malaria strategy or policy that includes 
drug efficacy monitoring, vector 
control and insecticide resistance 
monitoring  
-HIV/AIDS—completion of the 
UNGASS National Composite Policy 
Index questionnaire for HIV/AIDS  
-Maternal health—existence of a 
comprehensive reproductive health 
policy consistent with the ICPD action 
plan  
-Child health—existence of an updated 
comprehensive, multiyear plan for 
childhood immunization  
-Existence of key health sector 
documents that are disseminated 
regularly (such as budget documents, 
annual performance reviews and health 
indicators)  
Existence of mechanisms, such as 
surveys, for obtaining opportune client 
input on appropriate, timely and 
effective access to health services  
-Rules-based indicators; 
whether a country has an 
appropriate policies, 
strategies, and codified 
approaches for health 
system governance 
 
-Data sources: Review of 
national health policies in 
respective domains (such 
as essential medicines and 
pharmaceutical, TB, 
malaria, HIV/AIDS, 






Annex 2. Information Sheet—Delphi Experts Governance Assessment 
Tool for Health Policymaking 
 
********************************* 
How can national and international policymakers evidence and benchmark the 
quality of health policy governance in diverse developing country contexts? 
 
Your expertise is sought to contribute directly to research which is developing a 
 Health Policymaking Governance Assessment Tool, HP-GAT. 
 
HP-GAT is intended to offer national and international stakeholders a robust, 
rigorous and practical assessment of the characteristics and quality of governance in 
health policy. 
****************************** 
According to WHO, Governance in health is an essential element for achievement of the 
health millennium development goals since Governance is considered one of the core 
components of any health systems. Assessing and understanding governance at all levels of 
the health system is crucial in order to understand how to improve its performance. 
Previously several assessment tools of health system governance have been proposed, but 
for a range of reasons, they are not widely used. Thus, there is a need to develop practical 
tools that are based on academic basis.  
****************************** 
 
Purpose of the Research 
 
This research is focused on methodological work to develop a SMART governance 
assessment tool. That is, the aim is to develop an assessment tool which is capable of 
analysing health governance in developing countries in a Specific, Measurable, 
Achievable, Realistic and Timely manner. The HP-GAT should be a valid, reliable and 
practical assessment tool to examine whether key governance principles are practiced at 
the policymaking level. The key principles, as identified from existing research, are: 
participation, transparency, accountability, use of information and responsiveness.  
The selected governance principles will be assessed in relation to the health policymaking 
process, focusing on formulation and implementation. The HP-GAT is designed to be 
applied to the assessment of Ministries of Health/Health Authorities, that is, to the 
governance of health policymaking at national level. It can be used as an entry point by 
policymakers and/or international organizations to assist Ministries of Health 
(MOHs)/Health Authorities to better govern their health systems as the tool can be used as 








Outline of the Project 
1. Develop initial assessment tool, using existing research to identify key governance 
principles based on literature review and previous work on health governance, and 
processes of assessment tools development.  
2. Improve the organisation, principles, questions and practicality of the initial 
assessment tool in an iterative Delphi-method consultation with experts.  
3. Pilot test the developed assessment tool among policymakers in 1 to 2 developing 
countries.  
4. Finalise the assessment tool in light of pilot testing. 
Description of the Assessment Tool 
The assessment tool is a structured questionnaire, divided into five sections (Sections 1-5). 
Each section is concerned with one of the key governance principles: participation, 
transparency, accountability, use of information and responsiveness. Each principle is 
assessed separately in relation to how it is applied in policymaking process mainly at 
formulation and implementation.  
For each principle, the assessment tool has two sets of question (A&B). The first set is 
evidence-based questions that evaluates the existence of certain structures, procedures, 
guidelines, legislation that indicate the application of the governance principle. Answering 
these questions could be done by desk-based research. Answers in this part of the 
assessment questionnaire might be given scores or follow a “Traffic Light System” that 
can be used to evaluate progress or changes over time.  
The second set of questions is perception based that evaluates the perceptions of key 
informants/stakeholders about practices of good governance. This would be done via semi-
structured interviews. The assessment tool is designed to be flexible enough to analyse 
processes of policymaking of any type of health policy (example: primary health care or 
pharmaceutical policies and others), and to be adapted to country context. 
 
Description of the Process of Participation in this Study-Delphi Phase:  
We are currently in the process of evaluating the developed tool with "Governance 
Experts" within and beyond the health sector (like you) to seek your informed expert 
opinion on the rigor, content, relevance and conceptual organization of the tool as well as 
its feasibility and practicality in order to maximize its content validity. We are seeking 
your opinion (in addition to other experts) using Delphi Method consultation (which is a 
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flexible group method that does not require panel of experts to meet face-to-face instead 
through virtual meetings).  
Being a Delphi expert means that you will be consulted via email by receiving 3 
successive requests (4 if needed) for feedback on the tool and answer few questions about 
the suggested tool. You will receive one questionnaire every 6 weeks and you will be 
given 2-3 weeks to send your feedback at each round of consultation. The expected 
period of the Delphi consultation to take place between July and October 2015. A 
detailed schedule will be provided to you once you approve to participate.  
Quasi-anonymity will be followed as experts’ names participating in the Delphi will be 
revealed to other experts (unless you wish otherwise) while their responses will be 
anonymous to each other as responses will be coded. Raw data will be available only to the 
PI and all related documents of the study will be stored under lock for at least 3 years.  
 
   Summary of the Delphi Consultation to be followed: 
Round 1:  
- To assess comprehensiveness, relevance, report on any missing aspect as well as to receive 
feedback on wording of questions and suggested structure of the tool. 
- First draft of the tool to be sent to experts constitutes a long “laundry list” of concepts 
identified in literature related to selected governance principles. 
- Experts are asked to provide reasoning or brief justification for adding or deleting questions 
from the tool.  
Round 2: 
- To narrow down the original list to most important aspects to be assessed. 
- Revised draft of the tool based on Round 1 consultation will be sent to experts to 1) revise 
and validate the revisions implemented from Round 1 responses and 2) select and rank 
items to be kept in the tool. 
- Items selected by more than 50% of the experts will be retained.  
Round 3: 
- To get a final feedback on the tool. 
- Revised tool based on Round 2 will be sent for final feedback on 1) items retained, 2) 
practicality and 3) feasibility of the tool.  
- Overall the aim is to generate consensus between experts on final tool to be pilot tested. 
Another round will be suggested in case of major disagreement on the questions and 
rankings.  
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Once the assessment is finalized, it is planned to pilot test it in one to two developing 
countries (EMRO Region). It is hoped that the final product will be used by WHO, 
MOHs/Health Authorities or other international stakeholders. 
 
Ethical Approval 
This research received ethical approval from the Research Ethics Approval Committee for 
Health at Bath University as this research is part of the professional doctorate degree the 
principle investigator is doing.  
 
Benefits to participants will be related to gaining more knowledge about governance issues 
at the health policy making level. Thus, transforming theoretical knowledge into practical 
one. Your contribution to the development of the final tool will be acknowledged. No risks 
of any kind will be inflicted on the participants.  
 
 
For More Information you can kindly contact: 
 
-Principle Investigator: Rasha Hamra, PharmD, MPH, Dr. Health Candidate at Bath 
University-UK 
Director of Health Education & Public Relations Department-Lebanese Ministry of Health 
   Member of Technical Committee on Good Governance in Medicine-WHO  





Annex 3. List of Delphi Experts & Affiliation 
 
Expert Name Position/Title Rounds 
Involved In  
Dr. Ahmad 
Abuzaid 
Head of Prevention Department 
 Anti-corruption commission-Jordan 
1 
Mrs. Alia Al-Dalli International Director MENA, SOS Kinderdorf 
International-Morocco 
Former Director of the UNDP Regional Centre in Cairo 
(RCC) 
1  
Dr. Alissar Rady Senior National Professional Officer 
WHO office – Lebanon 
All 
Dr. Alla Shukralla Chairperson of Association for Health and Environmental 
Development 
Head of training and research unit at the Development 
Support Centre 





Professor of epidemiology and public health 
Jordan University of Science and Technology- Jordan 
All  
Mrs. Ma. Caroline 
Belisario 
 
Consultant of the Health Policy Development Program - 
UP-Econ Foundation-USAID Project Procurement Expert 
and Executive Director of Diaspora for Good Governance-
Philippines 
All 
Dr. Chokri Arfa Professor of Health Economics & General Director 
INTES/University of Carthage-Tunis 
1&2 
Dr. David Peters Chair, Department of International Health-John Hopkins 
University 
1 
Ms. Didar Ouladi National Coordinator (Head) of Public Health Department 
Nur University-Bolivia 
Member of Global technical Team on GGM-WHO 
All 
Dr. Fadi Jardali Associate Professor-Faculty of Health Sciences 
Director-Knowledge to Policy (K2P) Center 
Co-Director-Center for Systematic Reviews in Health 
Policy & System Research (SPARK) 




Initiator of global program on Good Governance for 





Principal Technical Advisor 
Systems for Improved Access to Pharmaceuticals and 
Services (SIAPS) Program 
Center for Pharmaceutical Management 
Management Sciences for Health-USA 
All 
Dr. James Rice Global Lead Governance 





University of Newcastle-Australia 




Independent consultant (2013 to present); formerly CSO 
Governance Officer for the USAID Leadership, 





Management Sciences for Health (2011-2013)- Brazil 
Prof Lamri Larbi Professor Economics University of Algiers 
Expert-Consultant in Health Economics-Algeria 
All  
Mrs. Lourdes De 
la Peza 
Principal Technical Advisor, Leadership Management and 
Governance Project (LMG) Management Sciences for 
Health (MSH)-Mexico 
All 
Prof Lubna Al 
Ansary 






Senior Technical Advisor 
Leadership, Management, and Governance (LMG) Project 
Health Programs Group 




Department of Health Systems Governance & Finance-
WHO-Geneva 
2&3 
Dr. Nabil Kronfol Professor of Health Policy and Management (retired) 
Founder and President, Lebanese Health Care Management 
Association 
National Independent expert –Lebanon 
All 
Dr. Nagla El 
Tigani El Fadil 
Director of Information and Planning 
Sudan Medical Specialization Board, Khartoum-Sudan 
All 
Dr. Paulo Ferrinho Director, Full Professor  
Institute of Hygiene and Tropical Medicine 




Director, Department of Health System Development 
WHO-EMRO office-Egypt 
1&2 
Dr. Walid Ammar General Director of Lebanese Ministry of Public Health  






Annex 4. Tool Delphi Round 1: Health Policymaking Governance 
Assessment Tool HP-GAT 
 
ROUND ONE: Instruction Sheet for Delphi Experts 
 
This is the first draft of the tool and it constitutes a long “laundry list” of concepts 
identified in literature related to selected governance principles 
 
ROUND ONE: The purpose of this round is to:  
- Assess tool comprehensiveness and relevance 
- Report on any missing aspect and feedback on the suggested structure of the tool 
- Report on the clarity and appropriateness of questions wording 
 
Please REMEMBER: 
- The HP-GAT is a generic list of questions, and the tool is designed to be flexible enough 
to analyse processes of policymaking of any type of health policy (example: primary health 
care or pharmaceutical policies and others), and to be adapted to country context.  
Thus when the tool to be used in real setting, the type of policy need to be identified.  
For this exercise the type of policy is left blank…,  
i.e. Is there a mechanism(s) used to involve participants in policymaking process that is 
concerned with…..? 
- Unit of Analysis is Ministry of Health (MoH)/Health Authorities  
 
WHAT YOU ARE ASKED TO DO:  
- There are FIVE (5) sections of this very first draft of the HP-GAT. You are asked to 
comment on the questions, content and comprehensiveness of this draft. 
- You are asked to select TWO (2) sections on which to comment. Please indicate your 
reason for selecting these two (e.g. they are the most important for health policy 
governance, or they are most close to your professional expertise). Feel free to comment on 
more than two sections if you wish to.  
- You are asked to read carefully the 2 sets of questions (A. Evidence Based Questions & B. 
Perception Based Questions) within each of these sections  





1. Is the question (and its possible answers for evidence based questions) relevant to the 
policymaking process? 
a.  If it is Relevant you just need to add R, if it is Not Relevant add NR. 
       If you indicate that a question is not relevant, then you are suggesting it 
should be removed from the tool. 
b. Please provide brief justification for your answers for the relevance of the questions. 
2. Does the question need editing? If it does, kindly suggest an alternative where possible. 
3. At the end of each set of questions, please suggest any important items that currently not 
covered by the assessment tool that need to be added, with a brief explanation of their 
importance.  
4. Also, at the end of each set of questions, please comment on the structure of the tool, and 
the order of the questions. 
5. In the general comment section, Please give your overall overview of the assessment 
tool/sections reviewed and anything you would like to add or suggest. 
 










SECTION ONE: PARTICIPATION at policymaking level 
A. Evidence Based Questions 
Answers for these questions will be collected 
through desk review of relevant documents 
Relevant/Not 
Relevant 




1.A.1 Is there a Legal obligation (Law) to 
include various stakeholders in health 
policymaking process? 
- In Policy Formulation         Y/N 
- In Policy Implementation      Y/N 





1.A.2 Is there a mechanism(s) used to involve 
participants in policymaking process that is 
concerned with…..? like 
- National committee 
- Advisory Board 
- Working Groups 
- Other, Specify: 
    
1.A.3 Is the mechanism(s) for participation 
(indicated above) provided for by: 
- Law 
- Ministerial Decree 
- Administrative Decision 
- Other, Specify: 
   
1.A.4 Is the participation process in policy 
formulation: 
- Formal  
- Informal 
   
1.A.5 Are the following stakeholders 
represented in the policy formulation that is 
concerned with….? 
- State Actors (government): Specify: 
- Health Service providers (Professionals & 
Organizations): Specify: 
- Beneficiaries &/or Public: Specify: 
- Civil Society: Specify: 
- Media 
- Others: Specify: 
   
1.A.6 Is there a written scope/mandate for the 
various stakeholders involved in policy 
formulation?  -Y/N 








-Delegated Power & Control 
- Not specified 
   
1.A.8 If there in place any other mechanisms 
used by MoH to encourage participation? (can 
choose more than one answer) 
- Opinion Pools 
- Need/Impact assessments 
- Surveys 
- Focus groups 
- Public Hearings 
- Online platforms 




- Citizens juries 
- Roundtables 
- Voting 
- Inter-governmental conferences  
 - Policy dialogues 
- Others, specify:  
1.A.9 Is there written criteria for duties, 
responsibilities & obligations of various 
participants at policy formulation level? Y/N 
   
1.A.10 Is there a balance in mix of stakeholders’ 
participation in policy formulation? Public vs. 
Private Y/N 
   
1.A.11 How the participants were selected? 





- Mandatory  
- Others: 
    
1.A.12 Is the MoH providing financial support 
for participants? 
- No financial support 
- Reimbursement 
- Fee or Honoraria 
   
1.A.13 Is there documentation of participants’ 
contribution to policymaking? Y/N 
   
1.A.14 Is there documentation on how decisions 
were made? Y/N 
   
1.A.15 For each of stakeholders: specify if:  
- Representing themselves 
- On behalf of organizations/others 
   




- Other procedures 
- Not specified 
   
1.A.17 Is there a mechanism for consensus 
building between various stakeholders? Y/N 
   
1.A.18 Are the various stakeholders consulted 
on regular basis? Y/N 
   
1.A.19 Is MoH following any of the following 
methods to inform stakeholders about policy 
development & implementation? 
(can choose more than one answer) 
- Use of mass media 
- Wide Advertisement 
- Targeted, Personal Invitations 
- Contact by email, Telephone, Mail 
- Website 
- Others, specify: 
   
1.A.20 Who is responsible for the direct 
Implementation of the policy? 
 (can choose more than one answer) 
- MoH  
- Other Governmental Agency: Specify: 
- Private Sector: Specify: 
- Civil society & NGOs 




- Others: Specify: 
1.A.21 Are the following stakeholders involved 
in the implementation of the policy? 
- State Actors (government): Specify: 
- Health Service providers (Professionals & 
Organizations): Specify: 
- Beneficiaries &/or Public: Specify: 
- Others: Specify:  
    
1.A.22 Are the roles and responsibilities of the 
various stakeholders in the implementation 
process specified in the formulation policy 
document?  
Veillard, 2011 Y/N 
   
1.A.23 If there in place any other mechanisms 
used by MoH to encourage participation (co-
production) in implementing the national policy 
of….. ?  
(can choose more than one answer) 
- Regular meetings 
- Workshops 
- Orientation Sessions 
- Others: Specify: 
   
OVERALL COMMENTS on Evidence Based Questions for PARTICIPATION:  
 
B. Perception Based Questions 
These questions will be asked to key informants 




Justifications Need Editing 
Kindly Suggest 
Alternative 
1.B.1 Are all relevant stakeholders being 
consulted in the policy formulation of…..? 
Why? 
   
1.B.2 Is the MoH giving enough roles for 
various stakeholders in the implementation 
phase? How? 
   
1.B.3 What is the role of various 
participants/stakeholders in the policy 
formulation? Is it a consultative role? Is 
negotiation taking place? Or is there a power 
control by certain participants? By whom?  
   
1.B.4 What are the strengths and weakness of 
the participation process? Can you give 
examples where participation made an impact-
for better or worse? 
   
1.B.5 What are the barriers and facilitators of the 
participation process?  
   
1.B.6 Do you consider the participation process 
effective in terms of having informed 
participants, ensuring response to different 
stakeholders & achieving policy decisions? And 
why? 
   
1.B.7 Do you consider the participation of 
various stakeholders in implementing the policy 
effective in reaching policy goals? And why? 
   
1.B.8 How you evaluate the process of selection 
of the participants? 
   
1.B.9 Does the MoH have the needed resources 
to facilitate the participation process? In terms 




of leadership? Planning? Needed information? 
Institutional arrangements? Etc, Explain 
1.B.10 What is the influence of powerful 
stakeholders in the decision making process? 
Who are these?  
   
1.B.11 What is the influence of powerful 
stakeholders in the implementation process? 
What about conflict of interest of various 
stakeholders? 
   
1.B.12 Is there any lobbying taking place by any 
stakeholders? How? 
   
1.B.13 How you see the role of MoH in 
encouraging participation?  
   
1.B.14 Tell me more about the roles of different 
stakeholders in decision making? Do they have 
different roles in agenda setting, formulation, 
implementation & monitoring? & How? 
   
1.B.15 To what extent communities are involved 
in the implementation process? Kirigi et al., 
2011* 
   





SECTION 2. TRANSPARENCY at the Policymaking Level 
A. Evidence Based Questions 
Answers for these questions will be 





Justifications Need Editing 
Kindy Suggest 
Alternatives 
2.A.1 Is there up-to-date, detailed policy 
document regarding…..? Y/N 
   
2.A.2 Does the policy document include the 
following information: 
(can choose more than one answer)  
- Background on how the policy was formulated 
- Evidence used in policy formulation 
- Stakeholders who participated in policy 
formulation 
- Other factors that influenced the policy 
formulation: Specify: 
- Responsible body for releasing the policy 
    
2.A.3 Is there official publications related to 
policy implementation of ….available? Such as: 
- Public service report 
- Relevant MoH decisions 
- Progress reports 
- Financial reports 
- Others: Specify 
   
2.A.4 Does the policy implementation 
document(s) include the following information: 
(can choose more than one answer) 
- Action Plan for Implementation 
- Timeline for implementation  
- Progress on Implementation 
- Outcomes on Implementation 
- Others: Specify 
   
2.A.5 Are the following documents publicly 
available/easily accessible to relevant 
stakeholders? 
-Policy Document                  Y/N 
-Implementation Document           Y/N 
   
2.A.6 Are the document (s) intended for the 
following audience: 
(can choose more than one answer) 
- Public 
- Different policy actors 
- Media 
- Others: Specify: 
   
2.A.7 Is there a law in place about “access to 
information? Y/N 
   
2.A.8 Is there a law in place to encourage "cyber 
transparency"/ E-Governance? Y/N 
   
2.A.9 Is there an official website for the MoH? 
Y/N 
   
 2.A.10 Are the policy documents published on 
the MoH website? Y/N 
   
2.A.11 Is there any report in media in the past 12 
months about the policy formulation &/or 
implementation? Y/N 
   
2.A.12 Is there in place any communication 
strategy for the public/professionals and others 
to comment on the policy document and 
implementation process and receive feedback? 
Y/N  , Specify: 
   
2.A.13 Are there written criteria for decision-
making in relation to policy formulation? Y/N 
   
2.A.14 Is the documentation of participants’ 
contribution to policymaking published? Y/N 




2.A.15 Are the documents on how decisions 
were made published? Y/N 
 
   
2.A.16 Are the names of the participants in the 
policy formulation published? Y/N 
   
2.A.17 Are the names of the implementing 
bodies published? Y/N 
   
2.A.18 Are the roles and responsibilities of the 
various stakeholders in the implementation 
process published? Y/N 
   
2.A.19 Did participants in the policy 
formulation/implementation declared any 
conflict of interest by signing an official form? 
Y/N 
   
OVERALL COMMENTS on Evidence Based Questions for TRANSPARENCY:  
 
B. Perception Based Questions 
These questions will be asked to key informants 








2.B.1 What makes the policy formulation 
process transparent? How transparency can be 
best achieved? 
   
2.B.2 Was the policy formulation process 
transparent? Between participants? to the 
public? Why? 
   
2.B.3 Is the policy implementation process 
transparent? Why? 
   
2.B.4 Is the information in the policy 
document(s) enough in terms of completeness 
and usefulness? Can you elaborate?  
   
2.B.5 What is the importance of being 
transparent at the policy formulation and 
implementation level? 
   
2.B.6 Is the MoH transparent in the 
policymaking process? How? 
   
2.B.7 How can the MoH increase its 
transparency in the policymaking process? 
   
2.B.8 What are the formal mechanisms that 
should be in place to monitor transparency? 
   
2.B.9 Is the participation of various stakeholders 
in the formulation process makes it more 
transparent? How? 
Or, Is the transparency in the formulation 
process is encouraging the participation of the 
various stakeholders? How? 
   
2.B.10 What are the formal mechanisms that 
should be in place to monitor transparency at the 
implementation? 
   
2.B.11 Are the roles and responsibilities of the 
various stakeholders in implementing the policy 
transparent? Can you give examples?  
   




SECTION THREE. ACCOUNTABILITY at policymaking Level 
A. Evidence Based Questions 
Answers for these questions will be collected 
through desk review of relevant documents 
Relevant 
/Not Relevant 
Justifications Need Editing  
Kindly Suggest 
Alternative 
3.A.1 Is there a formal mechanism to hold the 
participants/stakeholders in the policy 
formulation related to….accountable? Y/N 
   
3.A.2 Is there a formal mechanism to hold 
implementing bodies responsible for 
implementation of ….accountable? Y/N 
   
3.A.3 Who is held accountable from the 
participants/stakeholders? 
Can choose more than one answer:  
- Governmental Staff  
- Professionals 
NGO Representatives 
- All  
- Others: Specify 
   
3.A.4 What is the type of the accountability 
mechanism used? 







    
3.A.5 Does the Accountability Mechanism 
include the following components? Can choose 
more than one answer:  
- Set Standards  
- Investigation & Answerability  
- Sanctions 
- Enforcement 
- Rewards for Performance  
   
3.A.6 Who is the authority responsible for 
holding the stakeholders accountable? Can 
choose more than one answer:  
- Internal within the health sector, 
Specify: 
- External by independent bodies, 
Specify 
- External by public: Specify: 
- Self-responsibility 
   
3.A.7 Is there an evaluation/monitoring of: 
- Policy Formulation 
- Policy Implementation  
- None 
   
3.A.8 Is the evaluation/monitoring process 
formal? Y/N 
   -   Evaluation done by whom: 
   
3.A.9 Are justifications allowed during the 
evaluation/monitoring? Y/N 
      
3.A.10 Is the evaluation/monitoring results 
disseminated? Y/N 
      
3.A.11 What are the types of sanctions applied 
to participants/stakeholders in case of 
violation/not adhering to standards set? Failure 
to implement? 
Can choose more than one answer:  
- Legal Sanctions 




- Regulatory Sanctions 
- Softer Sanctions, Specify: 
3.A.12 Who is entitled to impose sanctions? 
- Governmental bodies, Specify: 
- Others: Specify: 
   
3.A.13 Is there documentation of sanctions 
enforced? Y/N 
   
3.A.14 Are any of the following methods used to 
enable accountability? 
Can choose more than one answer:  
- Information System in place 
- Dissemination of information 
- Participation of Public/Civil 
organizations 
- Whistle blowing mechanisms 
- Watchdog organizations 
- Performance incentives for good 
performance 
- Enforcement of rules & regulations 
- Appeal mechanisms 
- Others, Specify: 
   
OVERALL COMMENTS on Evidence Based Questions for ACCOUNTABILITY: 
 
B. Perception Based Questions 
These questions will be asked to key informants 
through face-to-face interviews 
Relevant 
/Not Relevant 
Justifications Need Editing 
Kindly Suggest 
Alternative 
3.B.1 Are the various stakeholders held 
accountable for their roles in the policy 
formulation? How?  
   
3.B.2 Are the implementing bodies held 
accountable for their roles in the policy 
implementation? How? 
   
3.B.3 Are all participants held accountable in 
equal manner? How accountability is ensured? 
   
3.B.4 What you think of the accountability 
mechanisms (ethical, professional, legal, 
political, financial, functional) used? Are they 
sufficient?  
   
3.B.5 Is there transparent 
answerability/monitoring mechanism in place 
for policy formulation process? Explain 
   
3.B.6 Is there transparent 
answerability/monitoring mechanism in place 
for implementing bodies? Explain 
   
3.B.7 Are there enforcement of sanction 
decisions? Give examples 
   
3.B.8 What is the importance of holding 
stakeholders accountable in the policy 
formulation process?  
   
3.B.9 What is the importance of holding 
stakeholders accountable in the policy 
implementation process? 
   
3.B.10 What is the importance of having a 
transparent accountable mechanism in place?  
   
3.B.11 What you think of the methods 
(Information system, participation, 
whistleblowing mechanisms, watchdogs, etc) 
used to enable accountability? Which is most 





 3.B.12 What is the role of media in encouraging 
accountability? Siddiqi 2009* 
   
3.B.13 Does the MoH ensure that regulations, 
legislations and sanctions are fairly enforced? & 
How? Veillard, 2011** 
   
3.B.14 What is the role of MoH in 
promoting/establishing accountability at the 
policymaking level?  
   
3.B.15 Does the MoH provide incentives for 
implementing bodies when reach policy goals? 
   
3.B.16 Does the civil society have an active role 
as watchdogs over policy implementation? 
How? 
   
OVERALL COMMENTS on Perception Based Questions for ACCOUNTABILITY:  
*Siddiqi S., Masud T., Nishat S., Peters D., Sabri B., Bile K. & Jama M. 2009. Framework for assessing 
governance of the health system in developing countries: gateway to good governance. Health Policy, 90:13-
25.  
**Veillard J., Brown A., Baris E., Permanand G., Klazinga N. 2011. Health system stewardship of National 





SECTION FOUR. USE OF INFORMATION at the policymaking Level 
A. Evidence Based Questions 
Answers for these questions will be collected 
through desk review of relevant documents 
Relevant 
/Not Relevant 
Justifications Need Editing 
Kindly Suggest 
Alternative 
4.A.1 Is the MoH directly involved in the 
following:  
Can choose more than one answer: 
- Information Generation 
- Publication, Specify types of publications: 
- Dissemination of health information, Specify 
type of information disseminated: 
   
4.A.2 Is the MoH using the following? 
Can choose more than one answer: 
- Data Collection tools, specify: 
- Data Management technologies, specify: 
   
4.A.3 Is there an item/commitment in the 
strategic vision document of MoH to use 
research evidence in policymaking? Y/N 
   
4.A.4 Was the policy related to....been 
developed based on evidence-base? Y/N 
   
4.A.5 Were other types of information used in 
the policy formulation? 
Can choose more than one answer: 
- Health information (health determinants, health 
status, others), Specify: 
- Financial information 
- Governing laws 
- Political direction & commitment 
- Public Opinions 
- Others, Specify: 
   
4.A.6 How was evidence-based research utilized 
in the policy formulation/implementation? 
 - Instrumental 
- Conceptual 
- Symbolic use 
- Not used 
   
4.A.7 Did the MoH publish a summary on the 
research evidence used in the policy 
formulation? Y/N 
   
4.A.8 Does the evidence used in the policy 
formulation have the following criteria? Can 
choose more than one answer: 





- Easily Accessible 
   
4.A.9 Is the evidence used:  
- Global Evidence 
- National Evidence 
- Local/limited evidence 
   
4.A.10 Is there a specialized unit in the MoH 
who deals with research analysis for policy 
formulation? Y/N 
   
4.A.11 Does the MoH publish regularly progress 
reports on implementation plans of policy? Y/N 
   
4.A.12 Are the progress reports disseminated to 
all stakeholders? Y/N 
   
4.A.13 What are the objectives of progress 
reports? 
Can choose more than one answer: 
-Increase awareness 
- Judge the situation 
- Identify problems 
- Provide evidence 
- Locate responsibility 
- Others, specify: 




4.A.14 Who is the intended audience for the 
progress reports?  
Can choose more than one answer:  





- Others, specify:C 
   
4.A.15 Does the MoH fund policy related 
research? Y/N 
   
4.A.16 Does the MoH have any form of 
partnership/collaboration with research centers? 
Y/N 
   
4.A.17 Does the MoH provide direct incentives 
for researchers in the country? Y/N  
   
4.A.18 Was there an input from a 
researcher/academia to the policy formulation? 
Y/N 
   





B. Perception Based Questions 
These questions will be asked to key informants 
through face-to-face interviews 
Relevant 
/ Not Relevant 
Justifications Need Editing 
Kindly Suggest 
Alternative 
4.B.1 Was enough evidence used in the 
formulation of the policy? What type of 
evidence was used? 
   
4.B.2 Is the MoH leadership committed to use 
evidence base and other types of information in 
policy formulation? What is the evidence for 
this commitment? 
   
4.B.3 What type of information/evidence usually 
the MOH use in policy formulation process? Is 
this information readily available?  
   
4.B.4 Is the MoH encouraging proper 
information generation, collection, analysis and 
dissemination of information used in policy? 
How? 
   
4.B.5 Is MoH disseminating information related 
to the governance of the policymaking process? 
What Type of information is disseminated?  
   
4.B.6 What is the importance of using 
information/evidence-base in policymaking? 
   
4.B.7 What are the factors that influence the 
uptake of information/research into policies? 
   
4.B.8 Do participants from outside MoH have 
major influence on the use of research evidence 
at policy formulation level? 
   
4.B.9 Is MoH staff trained to use research 
evidence? What is the level of training? 
   
4.B.10 Is the process of how research evidence 
is used in policy formulation transparent? How? 
   
4.B.11 Can you describe the relationship 
between MoH leadership and researchers? 
   
4.B.12 Is research evidence use in policymaking 
a priority for MoH? What is the evidence for 
this claim? 
   
4.B.13 What other factors (other than evidence-
base) contributed to the formulation of policies?  
   





SECTION FIVE. RESPONSIVENESS TO THE NEEDS OF THE POPULATION 
at the policymaking level 
 
A. Evidence Based Questions 
Answers for these questions will be collected 
through desk review of relevant documents 
Relevant 
/ Not Relevant 
Justifications Need Editing 
Kindly Suggest 
Alternative 
5.A.1 Is there a public policy against 
discrimination in the health system? Y/N 
   
5.A.2 Does the policy document relate to 
....mention that it will not impose any 
discrimination? Y/N 
   
5.A.3 Does the action plan relate to 
implementation of ....mention that it will ensure 
respect to all? Y/N 
   
5.A.4 Is there a law in place to allow 
participation of lay people/public in policy 
formulation? Y/N 
   
5.A.5 Do the participants in the policy 
formulation include representatives of the 
public? Y/N 
Specify representing whom: 
   
5.A.6 How these representatives were selected?  
- Appointed by MoH 
- Self-selected 
- Nominated , specify 
- Others, specify 
   
5.A.7 Does the MoH disseminate information 
related to policy formulation and 
implementation to the public? Y/N 
   
5.A.8 Is dissemination done through: 




- Others, specify 
   
5.A.9 Did needs assessment was conducted as 
part of the policy formulation process? Siddiqi, 
2009 Y/N 
   
5.A.10 Are the results of the assessment needs 
published? Y/N 
   
5.A.11 Does the MoH conduct public 
polls/surveys on regular basis to explore public 
preferences in relation to policy related to....? 
Y/N 
   
5.A.12 Is there a Hotline where people can call 
and give their opinions regarding policies? Y/N 
   
5.A.13 Is there any online platform for public to 
express opinions and give feedback? Y/N 
   
5.A.14 Are the public free to express their 
opinions through media? Y/N 
   
5.A.15 Is there in place a public relation 
operation/department to promote the MoH work 
regarding policies and receive feedback? Y/N 
   
OVERALL COMMENTS on Evidence Based Questions for RESPONSIVENESS:  
 
B. Perception Based Questions 
These questions will be asked to key informants 
through face-to-face interviews 
Relevant 
/ Not Relevant 
Justifications Need Editing 
Kindly Suggest 
Alternative 
5.B.1 Is the policy developed on.... responsive to 
the needs of the population? How? 
   
5.B.2 Was the policy developed in timely 
manner to respond to the needs of the 
population? Explain 
   
5.B.3 How the needs of the population were 
expressed/collected/measured? 
   
5.B.4 Does the MoH have the institutional 
capacity to collect/gather public preferences? 




And adapt to the conflicting needs? 
5.B.5 How does the MoH overcome the 
influence of professionals/elite groups over 
public opinion? 
   
5.B.6 What are the mechanisms that MoH can 
use to increase policy responsiveness? in terms 
of listening to the needs of the public and 
responding to their expectations 
   
5.B.7 How does the MoH overcome inequality 
in representations of the public? 
   
5.B.8 What is the importance of MoH being 
responsive to the public need in the 
policymaking process? 
   
5.B.9 What are the factors that can influence the 
responsiveness of MoH to the public needs in 
the policymaking process? 
   
5.B.10 How the public can express their 
opinions and give feedback regarding policies 
implemented? 
   
5.B.11 Does the MoH respond to media reports 
regarding failure to implement policies? How? 
   
5.B.12 What is the role of encouraging 
participation and promoting transparency on the 
responsiveness of the MoH to the public needs? 
Explain 
   
5.B.13 Do you consider MoH responsiveness a 
valid outcome of the governance process? Why? 
   
5.B.14 How can we measure/assess 
responsiveness of MoH? 
   
OVERALL COMMENTS on Perception Based Questions for RESPONSIVENESS:  
 
GENERAL COMMENTS: 




Annex 5. List of Participants-Consultation Meeting 
Egypt 
Dr.Maha Rabbat 
Executive Director MENA Health Policy Forum 
Former Minister of Health 
 
Dr. Sameen Siddiqi 
Director, 





Deputy Acting Minister for International Affairs 
Ministry of Health and Medical Education 
 
Iraq 
Dr.Salih Mahdi Al Hasnawi 
Professor & Consultant Psychiatrist 
Parliament Member 
Former Minister of Health 
 
Jordan 
Dr. Hani Brosk Kurdi 
Secretary General 
High Health Council 
 
Lebanon  
Dr. Alissar Rady 
National Professional Officer 
WHO-Lebanon Office 
 
Dr. Nabil Kronfol 
Founder and President 
Lebanese Health Care Management Association 
 
Dr. Samer Jabbour 
Associate Professor of Public Health Practice 
Faculty of Health Sciences 
American University of Beirut 














Health System, Health policy and Planning Consultant 
Former-Staff of WHO 
 
Switzerland 
Dr. Maryam Bigdeli (via skype) 
Health System Adviser 




Dr Emma Kate Carmel (via skype) 
Associate professor (Senior Lecturer) 
Social and Policy Sciences 





Annex 6. Summary of Results: Pilot 
A. Summary of Evidence-based Question Analysis 
Total Number of KIs is 11 









Legal basis/requirement (Law/Regulation/Policy) to include various 




If No law, A commitment to ensure some degree of stakeholders 
participation in formulation & implementation 
Y:11 
 
A body or mechanism(s) was used to involve stakeholders in development 
of the Mental Health Policy 
Y: 11 
 
A national committee 0  
An advisory Board 1  
Working Group (s) 7 
KIs were confused 
about what to call the 
mechanism they were 
working in 
Others 3 
Task force, Focus 
group, Round table 
Formally Formulated 7 
KIs considered the 
invitation sent by 
email by the head of 
the program as a 
formal way to form 
the working group, 
which is not the case 
A written scope/mandate for stakeholders involvement in the formulation 
of the Mental Health Policy exists 
Y: 1, N:10 
 
Roles and the responsibilities of participants for the various stakeholders 
specified 
Y: 3, N: 8 
Who answered yes, 
said that it was 
mentioned verbally 
and not written  
Qualifications of participants for the various stakeholders specified Y: 4, N:6 
Who answered yes, 
said it was not written 
though  
Timetable for the work to be carried out set Y: 7, N: 4  




State Actors (Government, other than MoH, National, Local) 
Y:6, N:1, 
DK:4 
It means not all 
stakeholders were 
aware who are the 
others participating  
Health Service providers  Y:10, DK: 1  
Parliamentary members  N:10, DK:3  




Civil Society Y:11  




Not all KIs were 






funding the activities  
Academic Institutions/Researchers Y:10, N:1  




Most Vulnerable or Key affected populations N:10, DK:1  
Media N:5, DK:6  




Appointed 5  
Elected  4  
Self-selected 0  
Representing Themselves 1  
Representing their organizations 10 
It is important to 
know who they 
represent for 
accountability issues 
Gender balance /consideration (Male vs. Female) among the 
stakeholders participating in the formulation of the Mental Health 
Policy was taken into account 
Y:8, DK:3 
There were more 
females than males 
Dedicated resources made available by the MoH/Health Authority to 




Cost of meetings Y:9, DK:2  
Incentives for participants (Fee or Honoraria) N:11  
Transportation and lodging (Direct Payment or Reimbursement) N:11  




Final decisions were taken by participants:   
Majority Vote 0  
Consensus 8  
Other Procedures 2 
Consultation and 
Brainstorming  
Minutes published/made available to the public N:9, DK:2  




State Actors (Government) 
Y:9, N:1, 
DK:1 
Most of KIs are not 
aware about the 
implementation phase 
 Health Service providers  Y:10, DK:1  




Civil Society Y:9, DK:2  
Development Partners Y:9, DK:2  
Academic Institutions/Researchers Y:8, DK:3  
Private Sector (medical, pharmaceutical industry, insurance companies) 
Y:8, N:1, 
DK:2 
They were not 





They were not 
involved in the 
formulation, yet they 
have a role in the 
implementation  























throughout the policy 
making process 
Mechanism/strategies used by MOH/Health Authority to ENCOURAGE 




Opinion Polls/Surveys 0  
Focus groups 0  
Public Hearings/Public Comments 0  
Online platforms 0 
Although there is a 
council of minister 
decree abiding all 
ministries to public 
draft 
strategies/policies for 
at least 2 weeks on 
website to allow 
feedback and 
comments by the 
public, but not done 
Citizens juries 0  
Roundtables 0  
Voting 0  
Hotline 0  
Inter-governmental conferences 0  
Policy dialogues 3 
Done by academia 
and on a specific 












MoH/Health Authority require signature of contract/Memorandum of with 
various stakeholders before engaging them in 
  
Policy Formulation N:7, DK: 4  
Policy Implementation Y:6, N:2, DK: 
3 
MOUs are 
done but not 
with all 
stakeholders 
and not all are 
aware of this 
fact 
Formal mechanism (s) followed by MoH/Health Authorities to hold public 
officials and non-state stakeholders involved in the policy formulation of 
the Mental Health Policy accountable based on their contribution for 
decisions and policies borne out in case of false advice/failure to engage in 
appropriate action 







Stakeholders are held accountable as   
Institutions/organizations represented  Y:10, N:1  
Type of the accountability mechanisms/types used by MoH/Health 
Authority to hold various stakeholders accountable 
  
Ethical Y:10, DK: 1  
Professional/Performance NA  
Legal NA  
Financial NA  
MoH/Health Authority conduct the following as part of holding its staff 
accountable for implementing the Mental Health policy 
  
Evaluation of the performance of the individual staff on annual basis Y:2, N:1, 
DK:7, P:1 
Stakeholders 
are not aware 
of such process 
takes place, 
this reflect lack 
of transparency  












Financial auditing for personnel, operations, supplies, and others NA As all is based 
on funding 
from donors 
Contracts oversight Y:4, DK:6  It will be done 
based on 
MOUs signed 
Formal mechanism (s) to hold implementing bodies of Mental Health 
Policy accountable in-line with set timelines and targets exist 
Y:5, DK:6  
Internal within the health sector Y:5, N:1, DK:5 Most 
stakeholders 
do not know 
External by public NA  
Accountability Mechanism (s)/types used by MoH/Health Authority at all 
levels include the following components: 
NA  
Set Standards  NA  
Investigation & Answerability/Justifications  NA  








Enforcement NA  
Rewards for Performance  NA  
Appeals NA  
The following tools are used by MoH/Health Authority to foster 
accountability:  
  
Information System that generate key performance indicators Y:7, N:, DK:3  
Dissemination of information Y:9, DK:2  
Participation of Public/Civil organizations Y:8, N:2, DK:1  
Whistle blowing mechanisms Y:1, N:6, 
DK:3, P:1 
 
Watchdog organizations collaboration & Protection  Y:3, N:4, DK:4  




and visibility  
Enforcement of rules & regulations Y:5, N:4, 
DK:1, P:1 
 
Appeal mechanisms N:8, DK:3  
Monitoring & evaluation (M&E) of Mental Health Policy exist & 
include:  
Y:9, DK:2  
Compliance with Mental Health Policy by professionals/Private sector Y:3, N:2, DK:5  
Policy outcomes in terms of health improvement, efficacy, equity and 
quality 
Y:9, DK:2  
M&E process is formal Y:6, DK:5 Stakeholders 
are not aware 
of the process, 
who is doing it 
and how often 
 M&E conducted independently Y:2, N:4, DK:5  
Types of sanctions applied/might be applied to implementers and/or 
implementing bodies responsible for implementation of Mental Health 
Policy in case of violation/not adhering to standards set? Failure to 
implement  
NA  
Legal Sanctions NA  
Regulatory/Administrative Sanctions NA  
Using Media: Name & Shame NA  
Softer Sanctions NA  
None is applied Y:11  
Laws in place related to the Mental Health Policy Y:9, N:1, DK:1  
Enforced N:10, DK:1  














A law/mechanism that allow access by the general public to government 




A law/government policy in place to promote electronic government services 
to improve public access to government information and services 
Y:2, N:3, 
DK:6 
It is actually the 
government policy to 
simplify all 
administrative 
procedure and this 
include using 
electronic services, but 
people are not aware 
of it  
Official website for the MoH/Health Authority Y:11  
User-friendly Y:10, DK:1  
Updated on regular basis Y:8, DK:3  
Access to the website Open to all  Y:9, N:1, 
DK:1 
 
Decisions related to priority setting in relation to the Mental Health Policy 
made public 
Y:10, N:1  
Decisions related to resource allocation in relation to the Mental Health 
Policy made public 
N:10, DK:1  
Official, up-to-date (within last 5 years), detailed policy document regarding 
Mental Health Policy 
Y:11  
Publicly available Y:10, DK:1  
Easily accessible  Y:9, DK:2  
Available on the MoH/Health authority website Y:9, DK:2  
Available in the official/national language of the country Y:10, DK:1  
Document related to Mental Health Policy include the following 
information: 
  
Background on how the policy was formulated  Y:10, N:1  
Objectives, Purpose and goals based on priority problems Y:11  
Evidence used to inform policy formulation Y:8, N:2, 
DK:1 
 
Mechanisms to engage stakeholders participation  Y:6, N:5 Actually this is not 
mentioned 
Stakeholders (Names & Affiliation) who participated/consulted in policy 
formulation 
Y:11  
How decisions were made/Justifications for decisions  Y:3, N:7, 
DK:1 
 
Other factors that influenced the policy formulation: Specify: Y:6, N:5  
Responsible body for releasing or approving the policy Y:11  
Clear distribution of responsibility for implementation  N:11  
Contracting requirements for implementation if needed N:11  
Time frame for implementation Y:9, N:2  
Measurable Indicators & Targets Y:10, N:1 Only targets are 
indicated but not 
indicators  
Plans for monitoring & evaluation Y:5, N:6 It is included but not 
all know about it 
Funding requirements/allocation N:10, DK:1  
Intended audience of the document Y:5, N:5, 
DK:1 
Actually it is not 
mentioned  
Official publication (s) related to implementation of Mental Health Policy 
available:  
  








DK:6 published  
Program/Project Documents Y:3, N:2, 
DK:6 
 
Relevant MoH/Health Authority decisions Y:3, N:1, 
DK:7 
 
Progress reports Y:5, N:2, 
DK:3, P:1 
It is developed and 
shared but with some 
stakeholders NOT all  
Financial reports including how funds were generated/secured for 
implementation/source of funding 
N:4, DK:7  
Policy Evaluation Y:2, N:1, 
DK:5, P:3 
 
Scientific Publications Y:4, DK:5, 
P:2 
There are few but not 
all are aware of it  
Contracts made for implementation  N:2, DK:8, 
P:1 
 
Details about recruitment made to implement  Y:1, N:3, 
DK:7 
 
2. MoH/Health Authorities release information related to formulated and 
implemented policies in Periodic/regular manner 
Y:5, N:5, 
DK:1 
Not all stakeholders 
are receiving the 
progress 
reports/newsletters  
Participants declared any conflict of interest by signing an official form N:11  
A policy on conflict of interest management exist  N:11  
MoH/Health Authority is using or has used in the past 12 months, to 
INFORM/Disseminate to stakeholders (including the public) about policy 
formulation, development, implementation and progress of Mental Health 
Policy 
  
Use of mass media Y:10, N:1  
Wide Advertisement Y:5, N:6  
Bulletins  Y:6, N:5  
Targeted, Personal Invitations Y:11  
Contact by email, Telephone, Mail Y:10, DK:1  
















Number of KIs 
 
Comments  
MoH/Health Authority directly involved in the following in relation to 
policymaking:  
  
Information Generation Y:9, N:1, DK:1  
Dissemination of health information Y:10, N:1  
Publication Y:7, N:3, P:1  







MoH using:    
Data Collection tools Y:8, N:1, DK:1, 
P:1 
 
Data Management technologies, specify: Y:6, N:2, DK:1, 
P:2 
 
Validation of data sources Y:3, N:3, DK:4, 
P:1 
This is not 
being done  
MoH/Health Authority have a form of partnership/collaboration with 
research centers  
Y:8, DK:2, P:1  
MoH/Health Authority allocate funds in its yearly budget for research 
related to policy 
N:5, DK:6  
MoH/Health Authorities make Raw data generated at health facilities/health 
service delivery level accessible to researchers 
Y:2, N:4, DK:1, 
P:3, NA:1 
 
 A specialized unit/staff in the MoH/Health Authority that deals with 
research analysis for policymaking exist 




MoH/Health Authorities has a mechanism in place to check sources of 
funding of research to be used in policy 
Y:2, N:4, DK:3, 
P:2 
 
Mental Health Policy was informed by scientific evidence Y:11  
The scientific evidence used in policy formulation of the Mental Health 
Policy 
  
Reliable and of good quality source/Peer reviewed studies Y:11  
Up-to-date (published in the last 5 years) Y:9, N:2 Some 
national data 
are out of 




Comprehensive Y:8, N:2, DK:1  
Locally Appropriate Y:11  
Easily Accessible Y:9, N:1, DK:1  
Global Y:11  
National Y:8, N:2, DK:1  
Local evidence Y:7, N:2, DK:2  
Only Available evidence  Y:6, N:2, DK:3  
Other types of information utilized in the formulation of Mental Health 
Strategy 
  









Governing laws Y:8, N:1, DK:2  
Political direction & commitment Y:5, N:3, DK:3  
Public Opinions N:8, DK:3  
MoH/Health Authority publish periodic progress reports/M&E reports on 
policy implementation status of Mental Health Policy  





d to all, so 
not all are 
aware about 
it  
Progress reports are disseminated Only to stakeholders  Y:6, DK:5 Not to all  
Progress reports are disseminated Only to Public N:11  
The following are used to disseminate:   
Printed material; flyers 0  
Public Presentations 0  
Website 0  
Emails 6  
Objectives of progress reports   





reports are it 
is not clearly 
stated 








Provide evidence Y:1, N:4, DK:6  




B. Summary of Perception Based Questions Analysis 
Total Number of KIs is 8 
 







- MoH/Mental Health Team started a new initiative to involve all in strategy 
formulation, keen to involve all  
- Still Not full participation  
- Things are not structured, process not well defined 
- Need more infrastructure, resources, experienced staff and capacity  
- External funding which makes things not sustainable  
- All felt involved, and are supportive  
- Final decisions were based on consensus 
- It was an effective, inclusive process, but service users were excluded 
- Participants were representatives and qualified group; they were asked to join via an 
informal process using personal contacts and professional networks 
- Invitations to join were sent via email  
- Everyone identified a different powerful stakeholder, but all agreed that their role 
was facilitating  
-Stakeholders need to be involved in the implementation planning as well even if they 
do not have a direct role 
- Facilitators of the process included: leadership of the mental health team and the way 
discussions were handled, all stakeholders were motivated, almost all stakeholders 
knows each other. 
- Barriers to the process included: finding the right time and place for the meetings, 
was not an easy task to agree on same agenda, terminologies, etc, information given 
before the meeting was not enough  
- No coordination at the implementation 
- There were two consultation meetings (round table discussions) and follow up was 






- It is important to hold all stakeholders accountable, but hard to do so, and cannot 
hold them for something not clear 
- There was no evaluation or a process to assess feedback of stakeholders 
- Accountability is a cultural issue 
- Accountability issues need to be formalized and follow standardized practices 
- Watchdogs are needed and participation is also important as it generated good results 
- Media has a big/important/positive role in accountability, but they need to be 
sensitized and trained, and a toolkit for media is needed 
- NGOs has also a big and active role to put pressure on MoH and to implement 
policies  
- The public they do not have a role in holding the government accountable, they are 
not aware of this right, they need proper mechanisms to express their opinions 
- No clear idea about how to hold everyone accountable and enforce it 
- Enforcement of the law is an issue, MoH should be responsible for its 
implementation 
- Even if there is a good law, failure to implement comes due to lack of inclusion of all 
stakeholders especially who will be the most affected 
- No information about the internal process of MoH for accountability  




- The process was transparent, but not enough and not full transparency  
- Transparency can burden the process 
- Need to publish more documents on regular basis and make them available on the 
website, given that the documents are useful and short and there is a need to have 
regular discussions of problems that emerge 
- Documentation is an important issue and the process should be standardized and it 
needs commitment 
- Opinions of stakeholders should be disclosed since there is conflicting priorities and 
competing needs  
- The process was transparent to stakeholders but not to the public 




implementation plans  
- The strategy document is comprehensive enough and user friendly but it is not made 
for the public as it contains scientific terms. The document lacks implementation and 
costing plans and lacks needs assessment 
- Priorities setting process was not transparent, as the national team suggested the 
priorities and consensus followed and there were no justifications for the goals set 
- Roles and responsibilities of the various stakeholders are not defined and not 





- The MoH is committed to use evidence based in policy formulation, as the Mental 
health strategy was developed based on studies and statistics 
- All staff are qualified to access and use research based on their technical background 
(all are Master degree holders) 
- There is a close relationship with academia with regular discussion, but no funding is 
available 
- Mainly it was based on expert opinion and based on feedback from stakeholders 
working in the field 
- There is weak national evidence on mental health as no local data, no up-to-date 
prevalence data  
- Factors that influenced the development of the mental health strategy in addition to 
evidence base include: availability of funding from international donors, the Syrian 
refugees crisis and their influx to Lebanon, interest of stakeholders to work on this 






- There is no capacity for MoH to collect public needs and opinions 
- This needs networking with people, a survey can be done, NGOs working in the field 
with beneficiaries can help in this, also opening a space at the website and ask people 
to comment is a good idea 
- The factors that can influence the responsiveness of the MoH to public needs include: 
availability of resources, political implications, security and safety of staff, the 
leadership from the community and the flexibility of the administration  
- It is important to listen to all needs without taking sides, be open and fair, and 
coordinate between competitors, till a decision mature. 
- Need communication and advocacy strategies to target both levels; community and 
professionals 
- Need to empower people and increase awareness  
- The strategy is not patient centres as their opinions were not taken, but it is based on 
ethics and values based on pyramid of services, it was developed as a top bottom 
approach.  
- It highlights the importance of respect to patients and autonomy to empower patients  
- Mental health was not a priority and there were a lot of challenges; lack of resources, 
lack of updated evidence, and there was no national program or team, all of this caused 
delay in issuing a national strategy.  
- Even in the absence of a strategy, the MoH was providing services (medications and 
hospitalizations)  
- The Syrian crisis and the creation of a national program fasten the process to set a 




C. Summaries of Findings Per Principle & Characteristics 







- Legal framework  
 








- Financial Resources  
 




- Consensus orientation  
 
- Mechanisms used to 
enhance participation  
 




- Financial Resources & 
contextual factors   
 





- Leadership  
 
 




- There is no legal requirement to include various stakeholders in 
health policymaking  
- No participation of parliamentary members, the private sector or 
patient groups  
 
 
- There was a working group but not officially established  
 
- No mandate for the committee; roles, responsibilities and 
qualifications are not specified 
- No incentives were given for participation, but meeting costs 
were secured  
- Minutes of meetings are documented but not published 
- Role and the responsibilities of the implementation bodies were 
not set within the strategy 
 
- Decisions were taken by consensus 
 
- No strategies were used to encourage participation like opinion 
polls, focus groups, online platforms, etc 
 
- No participatory body was established to oversee the 
implementation of the strategy 
- No coordination regarding the implementation 
 
- Implementation will rely on external funding which will not be 
sustainable  
 
- Barriers to the process included: finding the right time and place 
for the meetings, was not an easy task to agree on same agenda, 
terminologies, etc, information given before the meeting was not 
enough  
 
- There is commitment of the national team to involve all in 
strategy formulation  
 
- Facilitators of the process included: leadership of the mental 
health team and the way discussions were handled, all stakeholders 









- Formal mechanisms 
for accountability  
 
- Types of 
accountability  
 





- External accountability 
by external  
 
- Stakeholders did not sign any MOU before their engagement in 
the policy formulation process  
 
- No formal mechanisms in place to hold public officials and non-
state stakeholders involved in the policy formulation accountable  
 
- Most used type of accountability is ethical, while others like 
legal, performance and financial are not enforced 
 
- MoH has an internal process to hold its staff responsible for 
implementation accountable using evaluation of performance, 
administrative audit and contacts oversight, but result of those are 
not published 
 
- No external independent audit takes place nor is accountability 





- Components of 
accountability  
 









- Types of sanctions  
 
 
- Rule of law  
 
 
- Role of media  
 
 
- Role of NGOs 
 
- All components of accountability are not in place: standards, 
investigation mechanisms, sanctions, enforcement nor appeals  
 
- MoH is involved in generating key performance indicators and 
dissemination of information 
- There are no mechanisms for whistle blowing and watchdog 
protection 
 
- Monitoring and evaluation (M&E) plans do not include 
evaluation for the compliance of the private sector when 
implementing the strategy 
 
- There are no set sanctions (legal, regulatory, softer sanctions) 
applied in cases of violation or failure to implement 
 
- Current law about mental health is not enforced and there are 
plans to amend it 
 
 - Media has an important role in accountability, but they need to 
be sensitised and trained, and a toolkit for them is needed 
 
- NGOs also has a big and active role to put pressure on MoH and 






- E-transparency  
 
 






















- COI declaration  
 
 








- Negative aspects of 
- There is no law in place to allow access to government 
information by the public  
- There is an official website that is updated, user friendly and is 
accessible to all public 
 
- Decisions related to priority setting are made public 
- Priorities setting process was not transparent, as the national team 
suggested the priorities and consensus followed and there were no 
justifications for the goals. Priorities setting process was not 
transparent, as the national team suggested the priorities and 
consensus followed and there were no justifications for the goals 
set 
 
- Decisions related to resource allocation are not made public  
- There is an official document about the strategy that is updated, 
publicly available, placed on website, and is available in the 
national language of the country, which is Arabic 
- The strategy documents include the following: Background on 
how the policy was formulated, objectives, purpose and goals 
based on priority problems, evidence used, stakeholders who were 
involved, responsible body for releasing the strategy, timeframe 
for implementation, and plans for M&E. 
- The strategy documents do not include: mechanisms used to 
engage the stakeholders, justifications for decisions that were 
made, clear distributions of responsibilities for implementation, 
funding requirements and intended audience of the document 
 
- Participants did not declare any conflict of interest before being 
engaged in the consultation process of developing the strategy 
 
- There are no official documents related to the five year strategic 
plan, relevant implementation decisions, financial reports, 
contracts made for implementation nor details about recruitment 
made to implement  
 
- MoH disseminated information about the strategy using mass 
media, newsletters, personal invitations, emails, and website  
 










- Documentation is an important issue and the process should be 
standardised as well as needing commitment 
 
- Opinions of stakeholders should be disclosed since there are 
conflicting priorities and competing needs  
 
- The process was transparent to stakeholders but not to the public 
 
- Stakeholders were informed on regular basis on the development 
process, but not on implementation plans  
 
- The strategy document is comprehensive enough and user 
friendly, but it is not made for the public as it contains scientific 
terms 
 
- Roles and responsibilities of the various stakeholders are not 
















- Institutional capacity  
 
 
- Mechanisms to check 






- Other types of 
information used  
 
 
- Dissemination of 
information  
 
- Factors affecting use 
of information  
- MoH use data collection tools like registries, surveys and other 
statistics and data management tools 
 
- MoH collaborates with research centres in the country, but there 
is no allocation of a budget for research 
 
- MoH has no specialised unit that deals with research analysis for 
policymaking nor making raw data generated at the service 
delivery level accessible to researchers 
 
- All staff are qualified to access and use research based on their 
technical background (all are masters degree holders) 
 
- There is no mechanism in place to check sources of funding nor 
validate data sources  
 
- The strategy was informed by scientific evidence that was up to 
date, reliable and of good quality, comprehensive and locally 
appropriate 
 
- Other types of information that influenced the strategy included 
existing laws and political will and commitment, while financial 
information and public opinion were not taken into consideration  
 
- Progress reports and M&E reports are generated but not 
published and are only shared with some stakeholders by email 
 
- Factors that influenced the development of the mental health 
strategy in addition to evidence base included: availability of 
funding from international donors, the Syrian refugees crisis and 
their influx to Lebanon, interest of stakeholders to work on this 







- Adequate health 
services 
 
- Respect for dignity & 
confidentiality  
 
- Adequate basic 
services and prompt 
attention  
- The strategy ensures that all will have access to quality services 
including disadvantaged/vulnerable groups  
 
- The strategy ensures that all health services related to mental 
health will respect the confidentiality and dignity of all 
 
- The strategy does not explicitly state the benefit package to be 
provided, how referral will take place from one level of care to 













- Institutional capacity  
 
 
- Factors that affect 




- Contextual factors  
services needed 
 
-  Needs assessment was not conducted as part of the strategy 
formulation process 
- The strategy did not set out that patient satisfactory surveys 
should be conducted 
 
- The strategy mentions only the rights of the patients and not their 
responsibilities  
 
- There is no capacity for the MoH to collect public needs and 
opinions 
 
- The factors that can influence the responsiveness of the MoH to 
public needs include: availability of resources, political 
implications, security and safety of staff, the leadership from the 
community and the flexibility of the administration  
 
- The Syrian crisis and the creation of a national programmewas 




























Annex 7. Final Tool 
Health Policymaking-Governance Guidance Tool (HP-GGT) 
 
HP-GGT is a Generic Tool  
 
 
Key Informants Information                                                       Date: 




KI works in: 
- Government (Public Sector) 
- Private Sector 
- Non-governmental organization 
- International organization 
- Academia 
- Media 
- Other (please specify):  
 












Y: Yes, N: No, P: In Process, D.K.: Don’t Know, N.A: Not Applicable 
 
Participation 
Evidence Based Questions; Answers for these questions will be 
collected through face-to-face interviews with KIs  
and answers to be validated by documented evidence  
 
    
I. A.1 
Is there a Legal basis/requirement (Law/Regulation/Policy) to include 
various stakeholders in health policymaking process? 
(Assessor: Read the response options and Circle the answer given by the 
Key Informant) 
Y 
N P DK NA 
 If Yes, Specify what is it?      
 
& in what phase of the policymaking process is it specified to consult 
with stakeholders  
(Assessor: Read the response options, allow Key Informant to reply, and 
check by adding (√)all options that Key Informants identifies) 
 
    
 In policy formulation      
 In policy implementation      
 Other, Specify:      
 Not Specified      
 
If No, is there still a commitment from the MoH/Health 
Authority/National Program to ensure some degree of stakeholders 
participation in formulation & implementation of national health 
policies? 
(Assessor: Read the response options and Circle the answer given by 
the Key Informant) 
Y 
N P DK NA 
I.A.2 
Was there a body or mechanism(s) used to involve stakeholders in 
policymaking process that was concerned with the development of the X 
Policy? (Assessor: Read the response options and Circle the answer 
given by the Key Informant) 
Y 
N P DK NA 
 
If Yes, what body or mechanism (s) was used to involve stakeholders in 
the policymaking process that was concerned with the X Policy?  
(Assessor: Read each response option, allow Key Informant to reply, and 
check by adding (√)all options that Key Informants identifies)  
 
    
 A national committee      
 An advisory Board      
 Working Group (s)      
 Other, Specify:      
 
How was this body /mechanism (mentioned above) formulated?  
(Assessor: Read each response option, allow Key Informant to reply, and 
check by adding (√)all options that Key Informants identifies) 
 
    
 Formally (in written format), Specify How & By Whom:      
 Informally, Specify How:      
 If it was Formally formulated,      
 
Was there a written scope/mandate for stakeholders’ involvement in the 
formulation of the X Policy? 
What is the scope/mandate for the stakeholders?  
Y 
N P DK NA 
 
Were the roles and the responsibilities of participants for the various 
stakeholders specified? 
Y 
N P DK NA 
I: PARTICIPATION at policymaking level 
Everyone should have a voice in decision-making for health, either directly or through legitimate intermediate 
institutions that represent their interests. Such broad participation is built on freedom of association and speech, 
as well as capacities to participate constructively. It is about empowering citizens to have a role in decisions that 
affect their lives, and reach common goals by participating in policymaking process. It is the responsibility of the 






Were the qualifications of participants for the various stakeholders 
specified? 
Y 
N P DK NA 
 Was there a timetable for the work to be carried out? Y N P DK NA 
I.A.3 
Were the following stakeholders represented in the FORMULATION 
that was concerned with X Policy?   
(Assessor: Read each response option, allow Key Informant to reply, and 
check by adding (√)all options that Key Informants identifies) 
 
    
 State Actors (Government, other than MoH, National, Local): Specify:      
 
Health Service providers (Professional Association/Unions/Orders & 
Health  Service Organizations/Hospital boards) Specify: 
     
 Parliamentary members       
 Beneficiaries (patients associations) &/or Public: Specify:      
 Civil Society: Specify:      
 Development Partners/International organizations: Specify:      
 Funders/Donors: Specify      
 Academic Institutions/Researchers: Specify:      
 
Private Sector (medical, pharmaceutical industry, insurance companies):   
Specify: 
     
 Most Vulnerable or Key affected populations: Specify:      
 Media      
 Others: Specify:       
 
Were representatives from local/regions within X Country represented? 
 How? 
Y 
N P DK NA 
I.A.4 
For each category of stakeholders identified above, how were the 
participants involved in formulation of X Policy selected?  
(Assessor: Read each response option, allow Key Informant to reply, 
and check by adding (√)all options that Key Informants identifies) 
 
    
 Appointed, Nominated was there a set criteria for the selection?       
 Elected, by whom?       
 Self-selected      
 Others:      
 Was their participation:      
 Voluntary       
 Mandatory       
 
Are participants: (Assessor: Read each response option, allow Key 
Informant to reply, and check by adding (√)all options that Key 
Informants identifies) 
 
    
 Representing Themselves: Specify:      
 Representing their organizations: Specify:      
 Other, Specify:      
I.A.5 
1. Is there a gender balance /consideration (Male vs. Female) among the 
stakeholders participating in the formulation of the X Policy? (Assessor: 
Read the response options and Circle the answer given by the Key 
Informant) 
Y 
N P DK NA 
I.A.6 
Are there dedicated resources made available by the MoH/Health 
Authority to enable and facilitate participation during the policy 
development process of X Policy?  
(Assessor: Read the response options and Circle the answer given by 
the Key Informant) 
Y 
N P DK NA 
 
If Yes, what type of resources is made available?  
(Assessor: Read each response option, allow Key Informant to reply, and 
check by adding (√)all options that Key Informants identifies) 
 
    
 Cost of meetings (venues, coffee breaks, etc)       
 Cost of Administrative work (print outs, etc)      






Transportation, lodging and/or meals (Direct Payment or 
Reimbursement): Specify: 
     
 Other, Specify:      
I.A.7 
Is there documentation (Minutes of meetings) on the recommendations 
submitted for final decisions in relation to the formulation of the X 
Policy? (Assessor: Read the response options and Circle the answer 
given by the Key Informant) 
Y 
N P DK NA 
 
Are the minutes published/made available to the public?  
(Assessor: Read the response options and Circle the answer given by 
the Key Informant) 
Y 
N P DK NA 
I.A.8 
How final decisions were taken by participants: 
(Assessor: Read each response option, allow Key Informant to reply, and 
check by adding (√)all options that Key Informants identifies) 
 
    
 Majority Vote      
 Consensus      
 Dissenting Opinions      
 Other Procedures      
 Not Specified      
 Is there documentation of this?  Y N P DK NA 
I.A.9 
Are the roles and responsibilities of the various stakeholders in the 
implementation process specified in the formulation document of the X 
Policy? (Assessor: Read the response options and Circle the answer 
given by the Key Informant) 
Y 
N P DK NA 
 If NO, are they defined by law or by any other formal means? Y N P DK NA 
I.A.10 
Is there a participatory body to oversee the implementation of the X 
Policy? 
(Assessor: Read the response options and Circle the answer given by 
the Key Informant) 
Y 
N P DK NA 
 If Yes, What is its composition?      
I.A.11 
Are other mechanism/strategies used by MOH/Health Authority/National 
Program to ENCOURAGE participation (express opinions/preference 
and encourage feedback) of different stakeholders in priority setting and 
in policymaking process of X Policy? (Assessor: Read the response 
options and Circle the answer given by the Key Informant) 
Y 
N P DK NA 
 
If YES, which mechanisms are used (Assessor: Read each response 
option, allow Key Informant to reply, and check by adding (√)all options 
that Key Informants identifies) 
 
    
 Opinion Polls/Surveys      
 Focus groups      
 Public Hearings/Public Comments/Citizens Juries      
 Online platforms      
 Voting      
 Hotline      
 Inter-governmental conferences      
 Policy dialogues      
















Evidence Based Questions; Answers for these questions 
will be collected through face-to-face interviews with KIs  
and answers to be validated by documented evidence 
 
Y N P DK NA 
II.A.1 
Does the MoH/Health Authority/National Program require signature of 
contract/Memorandum of understanding/Terms of Reference (that 
include incentives, sanctions, timeline, deliverables, etc) with 
stakeholders before engaging them in:  
(Assessor: Read the response options, allow Key Informant to reply, 
and check by adding (√)all options that Key Informants identifies) 
     
 Policy Formulation      
 Policy Implementation      
II.A.2 
Are the different stakeholders (public officials & non-state actors) 
involved in the policy formulation related to X Policy formally held 
accountable for their contribution for decisions and policies in case of 
false/bad advice/failure to engage in appropriate action?  
(Assessor: Read the response options, allow Key Informant to reply, 
and check by adding (√)all options that Key Informants identifies) 
     
 To their institutions/organizations      
 To the public      
 
If Yes, who are the stakeholders held accountable from within 
institutions/organizations they represent in policy formulation?  
(Assessor: Read the response options, allow Key Informant to reply, 
and check by adding (√)all options that Key Informants identifies) 
     
 Governmental Staff       
 Professionals      
 Private Sector      
  NGO Representatives      
 All       
 Others: Specify      
II.A.3 
What is the type of the accountability mechanisms/types used by 
MoH/Health Authority/National Program and various 
institutions/organizations involved in policy towards their 
representatives? * 
(Assessor: Read the response options, allow Key Informant to reply, 
and check by adding (√)all options that Key Informants identifies) 
     
 Ethical      
 Professional/Performance      
 Legal      
 Financial      
 Others, Specify:       
II.A.4  
Does the MoH/Health Authority/National Program conduct any of the 
following as part of holding its staff accountable for their role in 
implementing the X Policy?  
     
 II. ACCOUNTABILITY at policymaking Level 
Is about assuring that those who are responsible for designing and implementing policies are held 
accountable for their performance. Decision-makers in government, the private sector and civil society 
organizations involved in health are accountable to the public, as well as to institutional stakeholders. This 
accountability differs depending on the organization and whether the decision is internal or external to an 
organization. It is about having the right checks and balances put into place. It is ensuring that all health 




(Assessor: Read the response options, allow Key Informant to reply, 
and check by adding (√)all options that Key Informants identifies) 
 Evaluation of the performance of the individual staff on annual basis      
 
Administrative/Performance audit of the relevant department(s) on 
annual basis 
     
 Financial auditing for personnel, operations, supplies, and others      
 Contracts oversight      
 Are the results of the above made public?  Y N P DK NA 
II.A.5 
Are any of the following tools used by MoH/Health Authority to foster 
accountability?**  
(Assessor: Read the response options, allow Key Informant to reply, 
and check by adding (√)all options that Key Informants identifies) 
     
 Information System that generate key performance indicators      
 Dissemination of information      
 Participation of Public/Civil organizations      
 Whistle blowing mechanisms      
 Watchdog organizations collaboration & Protection       
 Performance incentives for good performance      
 Enforcement of rules & regulations      
 Others, Specify:      
II.A.6 
Is there monitoring & evaluation (M&E) of implementation of X 
Policy?  
(Assessor: Read the response options and Circle the answer given by 
the Key Informant) 
Y N P DK NA 
 
If Yes, does the M&E include the following: 
(Assessor: Read the response options, allow Key Informant to reply, 
and check by adding (√)all options that Key Informants identifies) 
     
 Compliance with X Policy by professionals/Private sector      
 
Policy outcomes in terms of health improvement, efficacy, equity and 
quality 
     
 None      
 Are the results made public?  Y N P DK NA 
II.A.7 
If Question II.A.6 is YES, Is the M&E process formal?  
(Assessor: Read the response options and Circle the answer given by 
the Key Informant) 
Y N P DK NA 
 If Yes,       
 Is the M&E conducted independently, by whom: Y N P DK NA 
 How often M&E take place?      
II.A.8 
Did the MoH/Health Authority/National Program set a formal 
mechanism (s) to hold implementers and/or implementing bodies from 
the private sector/non-state actors responsible for implementation of 
various components of X Policy accountable in-line with set timelines 
and targets? 
(Assessor: Read the response options and Circle the answer given by 
the Key Informant) 
Y N P DK NA 
 
If Yes, Are the following components set? ? 
(Assessor: Read the response options, allow Key Informant to reply, 
and check by adding (√)all options that Key Informants identifies) 
     
 
Standards (accreditation, benchmarking, rules and procedures, 
guidelines, etc) , Specify:  
     
 Investigation & Answerability/Justifications Mechanisms       
 Sanctions      
 Enforcement Mechanisms       
 Rewards for Performance       





* If the answer to this question is Not Applicable, you can formulate the question as follows: What is the 
most suitable accountability mechanism/type that can be applied to hold the various stakeholders accountable 
in their role in the context of your country?  
** If the answer to this question is Not applicable, you can formulate the question as follows: What of the 
following tools is best to be used to foster/encourage accountability in the context of your country?  
 
II.A.9 
If Question II.A.8 is Yes, Who is authority responsible for holding 
implementers and/or implementing body accountable?  
(Assessor: Read the response options, allow Key Informant to reply, 
and check by adding (√)all options that Key Informants identifies) 
     
 Internal within the health sector, Specify:      
 External by independent bodies, Specify      
 External by public: Specify:      
 Others: Specify:       
 Are the results of the above made public? Y N P DK NA 
II.A.10 
What are the types of sanctions applied/might be applied to 
implementers and/or implementing bodies responsible for 
implementation of X Policy in case of violation/not adhering to 
standards set? Failure to implement?  
(Assessor: Read the response options, allow Key Informant to reply, 
and check by adding (√)all options that Key Informants identifies) 
     
 Legal Sanctions      
 Regulatory/Administrative Sanctions      
 Using Media: Name & Shame      
 Softer Sanctions, Specify:      
II.A.11 
Are there any law(Assessor: Read the response options and Circle the 
answer given by the Key Informant)s in place related to the X Policy? 
What does the law(s) cover? 
 
Y N P DK NA 
 
If Yes, is it enforced? How?  
(Assessor: Read the response options and Circle the answer given by 
the Key Informant) 
Y N P DK NA 
 
Is there a plan to develop a new law? Why? 
(Assessor: Read the response options and Circle the answer given by 
the Key Informant) 










Y: Yes, N: No, P: In Process, D.K.: Don’t Know, N.A.: Not Applicable 
 
Transparency 
Evidence Based Questions; Answers for these questions will be 
collected through face-to-face interviews with KIs  
and answers to be validated by documented evidence 
     
III.A.1 
Is there a law/mechanism about "access to information" that allow 
access by the general public to government information and 
documents? 
(Assessor: Read the response options and Circle the answer given by 
the Key Informant) 
Y N P DK NA 
 
If Yes, Does the law allow: 
(Assessor: Read the response options, allow Key Informant to reply, 
and check by adding (√)all options that Key Informants identifies) 
     
 Full Access      
 Partial Access/Restricted Access      
 Access to Information on Health      
III.A.2 
Is there a law/government policy in place to promote "cyber 
transparency”(availability of information online) electronic 
government services to improve public access to government 
information and services? 
(Assessor: Read the response options and Circle the answer given by 
the Key Informant) 
Y N P DK NA 
III.A.3 
Is there an official website for the MoH/Health Authority?  
(Assessor: Read the response options and Circle the answer given by 
the Key Informant) 
Y N P DK NA 
 If Yes,       
 Is it user-friendly? Y N P DK NA 
 Is it updated on regular basis/has up to date news, documents, etc? Y N P DK NA 
 Is access to the website open to all? Y N P DK NA 
 If No, Why? who is allowed to access it?      
III.A.4 
Are decisions related to priority setting in relation to the X Policy 
made public? 
(Assessor: Read the response options and Circle the answer given by 
the Key Informant) 
Y N P DK NA 
 How?      
III.A.5 
Are decisions related to resource allocation (general resource 
allocation decisions, focused on overall budgets) in relation to the X 
Policy made public? 
(Assessor: Read the response options and Circle the answer given by 
the Key Informant) 
Y N P DK NA 
 How?       
 Are the Cost estimates clearly explained and justified? Y N P DK NA 
III.A.6 
Is there official, up-to-date (within last 5 years), detailed policy 
document regarding X Policy?  
(Assessor: Read the response options and Circle the answer given by 
the Key Informant) 
Y N P DK NA 
 If Yes, Is it:      
 Publicly available? Y N P DK NA 
 Easily accessible?  Y N P DK NA 
III. TRANSPARENCY at the Policymaking Level 
It is actively disclosing information on how decisions are made, implemented and evaluated. It is built on the 
free flow of information for all health matters. Processes, institutions, and information should be directly 




 Available on the MoH/Health authority website?  Y N P DK NA 
 
Is the document available in the official/national language of the 
country?  
What other languages is it available?  
Y N P DK NA 
III.A.7 
Does the document related to X Policy include the following 
information: 
 (Assessor: Read the response options, allow Key Informant to reply, 
and check by adding (√)all options that Key Informants identifies) 
     
 
Background on how the policy was formulated (based on international 
guidelines, best practices, etc) 
     
 Objectives, Purpose and goals based on priority problems      
 Evidence used to inform policy formulation      
 Mechanisms to engage stakeholders participation       
 
Stakeholders (Names & Affiliation) who participated/consulted in 
policy formulation 
     
 How decisions were made/Justifications for decisions       
 Other factors that influenced the policy formulation: Specify:      
 Responsible body for releasing or approving the policy      
 Contracting requirements for implementation if needed      
 Time frame for implementation      
 Measurable Indicators & Targets      
 Plans for monitoring & evaluation      
 
Funding requirements/allocation (including costs of human resources, 
medicines, management, infrastructure and costs for activities and 
stakeholders beyond the public health sector) 
     
 Intended audience of the document      
III.A.8 
Is there plans to publish/already published any of the following 
documents that are related to implementation of X Policy?  
(Assessor: Read the response options, allow Key Informant to reply, 
and check by adding (√)all options that Key Informants identifies) 
     
 Five year strategic plan/Operational Plan/Implementation Plans       
 Program/Project Documents      
 Relevant MoH/Health Authority decisions      
 Policy Evaluation Reports      
 
Financial reports including how funds were generated/secured for 
implementation/source of funding 
     
 Scientific Publications      
 Contracts made for implementation       
 Details about recruitment made to implement       
 Others: Specify      
III.A.9 
3. Does the MoH/Health Authorities/National Program release 
information related to formulated and implemented X policy in 
"predictable manner"/Periodic/regular manner?  
4. (Assessor: Read the response options and Circle the answer given by 
the Key Informant) 
Y N P DK NA 
III.A.10 
Did participants declared any conflict of interest by signing an 
official form?  
(Assessor: Read the response options and Circle the answer given by 
the Key Informant) 
     
 In the policy formulation     Y N P DK NA 
 In the policy implementation   Y N P DK NA 
 If Yes, Is there a policy on conflict of interest management? Y N P DK NA 






Which of the following methods, if any, the MoH/Health 
Authority/National Program is using or has used in the past 12 
months, to INFORM/Disseminate to stakeholders (including the 
public) about policy formulation, development, implementation and 
progress of X Policy?  
(Assessor: Read the response options, allow Key Informant to reply, 
and check by adding (√)all options that Key Informants identifies) 
     
 Use of Mass Media (TVs, Radios, etc)      
 Wide Advertisement (Newspapers, Billboards, etc)      
 Bulletins/Newsletters      
 Targeted Personal Invitations by email, mail, Telephone, etc..      
 Social Media      
 Smart Phones Applications      
















Evidence Based Questions; Answers for these questions will be 
collected through face-to-face interviews with KIs  
and answers to be validated by documented evidence 
     
IV.A.1 
Is the MoH/Health Authority/National Program directly involved in 
the following in relation to policymaking:  
(Assessor: Read the response options, allow Key Informant to reply, 
and check by adding (√)all options that Key Informants identifies) 
     
 Information Generation      
 
Dissemination of health information, Specify type of information 
disseminated: 
     
 Publication, Specify types of publications:      
 Knowledge Translation to policy      
IV.A.2 
Is the MoH/Health Authority/National Program using any of the 
following?  
(Assessor: Read the response options, allow Key Informant to reply, 
and check by adding (√)all options that Key Informants identifies) 
     
 
Data Collection tools (vital registries, surveys (population, facilities, 
etc), health statistics), Specify:  
     
 Data Management technologies, Specify:      
 Validation of Data sources      
 Checking sources of funding of research to be used in policy      
IV.A.3 
Does the MoH/Health Authority/National Program have any form of 
partnership/collaboration with research centers inside as well as 
outside the country?  
(Assessor: Read the response options and Circle the answer given by 
the Key Informant) 
Y N P DK NA 
 
If Yes, Does the MoH/Health Authority/National Program allocate 
funds in its yearly budget for research related to policy?  
Y N P DK NA 
IV.A.4 
Does MoH/Health Authorities make Raw data generated at health 
facilities/health service delivery level accessible to researchers?  
(Assessor: Read the response options and Circle the answer given by 
the Key Informant) 
Y N P DK NA 
IV.A.5 
 Is there a specialized unit/staff in the MoH/Health Authority/National 
Program that deals with research analysis for policymaking? 
(Assessor: Read the response options and Circle the answer given by 
the Key Informant) 
Y N P DK NA 
IV.A.6 
Was the developed X Policy informed by scientific evidence? 
(Assessor: Read the response options and Circle the answer given by 
the Key Informant) 
Y N P DK NA 
IV.A.7 
If Questions IV.A.6 is YES, Which of the following criteria were 
used for the inclusion of scientific evidence in policy formulation of 
the X Policy?  
(Assessor: Read the response options, allow Key Informant to reply, 
and check by adding (√)all options that Key Informants identifies) 
     
 Reliable and of good quality source/Peer reviewed studies      
 IV. USE OF INFORMATION at the policymaking Level 
Is essential for a good understanding of health system without which it is not possible to provide evidence for 
informed decisions that influences the behavior of different interest groups that support, or at least do not 
conflict with, the strategic vision for health. It includes; information generation, collection, analysis and 
dissemination. Sound and reliable information is essential for health system policy development and 
implementation, governance and regulation. Availability of information includes accessibility, user-friendly, 















 Up-to-date (published in the last 5 years)      
 Comprehensive/Extensive      
 Locally Appropriate      
 Easily Accessible      
 Global/International       
 National      
 Local Evidence/Community level       
 Only Available evidence       
IV.A.8 
Were other types of information utilized in the policy formulation of 
X Policy, Like:  
(Assessor: Read the response options, allow Key Informant to reply, 
and check by adding (√)all options that Key Informants identifies) 
     
 Experts opinion       
 Financial information      
 Governing laws      
 Political direction & commitment      
 Others, Specify:      
IV.A.9 
Does the MoH/Health Authority/National Program publish/plan to 
publish periodic progress reports/M&E reports on policy 
implementation status of X Policy?  
Y N P DK NA 
 
If Yes, Does progress reports include: 
(Assessor: Read the response options, allow Key Informant to reply, 
and check by adding (√)all options that Key Informants identifies) 
     
 Follow Up Plans      
 Impact of the policy      
 Recommended review of the policy considering results obtained      
 If Yes, Are the progress reports disseminated? Y N P DK NA 
 If Yes, is it disseminated to      
  Public      
 Only for stakeholders      
 What media/means are used to disseminate the results?      
 Printed material      
 Public Presentations      
 Website      
 -  Others, Specify      
IV.A.10 
If Questions IV.A.10 is YES, What are the objectives of progress 
reports?  
(Assessor: Read the response options, allow Key Informant to reply, 
and check by adding (√)all options that Key Informants identifies) 
     
 Increase awareness      
 Evaluate the situation      
 Identify problems      
 Provide information       















Evidence Based Questions; Answers for these questions will be collected 
through face-to-face interviews with KIs 
and answers to be validated by documented evidence 
 






Does the X Policy include an objective/goal that MoH/Health 
Authority/National Program will ensure access to adequate Quality of care 
services to ALL the population/patients including disadvantaged/vulnerable 
groups to be covered by the policy? (Assessor: Read the response options and 
Circle the answer given by the Key Informant) 






Does the X Policy include an objective/goal that the health services will 
respect the confidentiality and the dignity of the population/patients? 
(Assessor: Read the response options and Circle the answer given by the Key 
Informant) 






Does the X Policy include an objective/goal that the health providers will 
respect the rights of the patients in terms of: 
(Assessor: Read the response options, allow Key Informant to reply, and check 
by adding (√)all options that Key Informants identifies) 
     
 Autonomy to participate in health related decisions 
     
 Freedom of choice of health care provider 
     
 
Provide all information related to the patients’ medical conditions in an 
understandable manner 
     
 Others: Specify:  
     
V.A
.4 
Does the X Policy refer to the explicit package of benefits to be provided to 
patients at the different levels of care?  
(Assessor: Read the response options and Circle the answer given by the Key 
Informant) 






Does the X Policy include an objective/goal that the health services will be 
provided to population/patients within reasonable timeframe?  
(Assessor: Read the response options and Circle the answer given by the Key 
Informant) 




 If Yes, is the timeframe specified?  






Does the X Policy refer to how referral of patients will take place from one 
level of care to the other?  
(Assessor: Read the response options and Circle the answer given by the Key 
Informant) 




 If Yes, is the timeframe for referral specified?  
     
V.A Does the X Policy include an objective/goal to set in place an official 




V. RESPONSIVENESS TO POPULATION NEEDS at the policy making level 
 
Institutions and processes should try to serve all stakeholders to ensure that the policies and programs are 
responsive to the health and non-health needs of its users. Governments are obliged to listen to the needs of 





.7 complaint mechanism?  




Was a needs assessment (targeting the public)/Public Opinion surveys 
conducted as part of the X Policy formulation process? 
(Assessor: Read the response options and Circle the answer given by the Key 
Informant) 





 If Yes, Is there evidence that the identified population needs were 
incorporated in the X Policy?  






Do the monitoring & evaluation plans of the X Policy include a component to 
assess whether the policy is meeting the population needs through conducting 
patients satisfaction surveys/exit surveys? 
(Assessor: Read the response options and Circle the answer given by the Key 
Informant) 




 If Yes, is it recommended to be done on regular basis?  






Did the MoH/Health Authority/National Program develop a communication 
strategy to inform the public about the X Policy? (Assessor: Read the response 
options and Circle the answer given by the Key Informant) 







SECTION B: Perception-based Questions 










KI Interviews Questions; These questions will be asked to key informants through face-to-face 
In-depth interviews 
I.B.1 
How do you view the role of MoH/Health Authorities/National Program in encouraging 
stakeholders’ participation in policy formulation and implementation in general? & in the X Policy 
development in specific? Does the MoH/Health Authority/National Program has the institutional 
capacity and needed resources to facilitate the participation process? In terms of leadership? 
Planning? Needed information? Institutional arrangements? Database of key stakeholders? 
I.B.2 
To what extent was the formulation process of the X Policy inclusive of the key stakeholders? 
Were they “Effectively “consulted? Were all relevant voices taken into account? Which 
stakeholders were missing?   
I.B.3 
What type of process was applied for the selection/identification of participants in the X Policy 
formulation? Do You consider that it was a fair/effective process to ensure a qualified group? A 
representative group? Why? 
I.B.4 
Who were the powerful stakeholders in the decision making/formulation of the X Policy? Was 
their influence hindering or facilitating the formulation process of X Policy? What their influence 
led to?  
I.B.5 
What are the barriers and/or facilitators to the participatory process? For MoH/Health 
Authorities/National program? For stakeholders? 
I.B.6 
What are the mechanisms used to enable stakeholder participation in policymaking process? Do 
they include mechanisms to give voice to the traditionally voiceless groups (homeless, 
migrants/refugees, unemployed, minorities, disabled, elderly, etc?? How do you view the 




KI Interviews Questions; These questions will be asked to key informants through face-to-face 
in-depth interviews 
II.B.1 
To what extent do you agree that all stakeholders should be held accountable for their role in the 
policymaking process including formulation?  
What is the best way to hold the various stakeholders accountable for their role in policymaking? 
How to ensure that they know they will be held accountable prior to their involvement?  
II.B.2 
What is the role of media in accountability in policymaking in your setting? Is media playing a 
positive or negative role in Policy X? Give examples 
II.B.3 
Does the civil society have an active role as watchdogs over policy formulation and 
implementation of Policy X? How? Give examples 
II.B.4 
How the public can hold various stakeholders accountable for their role in policymaking in 
general and in relation to Policy X? 
II.B.5 
How the implementing bodies are held accountable for their roles in the policy implementation 
process of X Policy? Are all held accountable in equal manner? Give examples 
II.B.6 
How is the law (s) related to X Policy translated into rules, regulations and procedures? Who is 
responsible for this? How does the MoH/Health Authority/National Program ensure that 
regulations, legislations and sanctions are fairly enforced in relation to the implementation of the 
















KI Interviews Questions; These questions will be asked to key informants through face-to-face 
in-depth interviews 
III.B.1 
Does the MoH/Health authority/National Program have the interest/willingness/Commitment to 
achieve better transparency? What is the type of this willingness/commitment? How can the 
MoH/Health Authority/National Program increase its transparency in the policymaking process? 
Does the MoH/Health Authority/National Program have the needed capacity/means to achieve 
better transparency?  
III.B.2 5. How the MoH/Health Authorities/National Program can ensure that the opinions of the different 
stakeholders are documented & disclosed/published as part of a transparent policymaking process?  
III.B.3 6. How transparent was the policy formulation process of X Policy as perceived by stakeholders? by 
public? What made it transparent? What could have been done to make it more transparent? 
III.B.4 7. How comprehensive is the X Policy? Is the policy document user-friendly& easily accessible? 
How useful? What is missing? 
III.B.5 8. How transparent was the process of priority setting during the development of X Policy? How this 
process can be improved? 
III.B.6 9. How transparent is/was the process of resource allocation for implementing the X Policy? Are 




KI Interviews Questions; These questions will be asked to key informants through face-to-face 
in-depth interviews 
IV.B.1 
How committed is the MoH/Health Authority/National Program leadership to use evidence-based 
(scientific evidence) and other types of information in policymaking process? What is the evidence 
for this commitment? Is it documented?  
IV.B.2 
How can the capacity of staff at the MoH/Health Authority/National Program be improved in terms 
of to access/use and analysis of research evidence?  
IV.B.3 
Can you describe the relationship between MoH/Health Authority/National Program leadership and 
researchers? Is their regular interaction? 
IV.B.4 
Do you consider the scientific evidence used in the formulation of X Policy pertinent/adequate? 
Why? What factors influenced the uptake of evidence-based/research findings into X Policy? What 
additional evidence would have been necessary?  
IV.B.5 
How national evidence is generated? What is the role of MoH/Health Authority/National Program in 
adapting research findings to local context? Give Examples in relation to the X Policy.  
IV.B.6 
What other factors (other than evidence-base political context for example, ) contributed to the 









KI Interviews Questions; These questions will be asked to key informants 
through face-to-face in depth interviews 
V.B.1 
How do you view MoH/Health Authority/National Program institutional capacity to collect/gather 
public needs/preferences to be incorporated into policymaking process? What Mechanisms can be 
used to improve policy responsiveness to the population needs?  
V.B.2 
What are the factors that can positively or negatively influence the responsiveness of MoH/Health 
Authorities/National Program to the public needs in the policymaking process? 
V.B.3 
How does the MoH/Health Authority/National Program balance the competing 
interests/conflicting needs and influence of professionals/elite groups with public opinion 
(if there is any conflict present between the two opinions)? And between different groups 
of elites, or different publics or different social groups? 
V.B.4 
Does the MoH/Health Authorities/National Program usually respond to media and/or civil societies 
reports regarding failure to implement policies? How the response is formulated? Please Give 
Examples 
V.B.5 
How responsive is the X Policy to the population needs in general? And to the vulnerable 
population needs in particular? Is the policy patient-centered? Please explain 
V.B.6 
How do you perceive the timeliness as well as the promptness of developing the X Policy in 
response to population legitimate needs? 
 
 
Exit Interview Questions: 
• If you were in High level authority, what would have you done differently?  
• Please provide any additional comments if you like 
Thank you for your participation in this guidance tool.  
 
Your responses will help to better guide MOHs/Health Authorities/National Program 
to strengthen governance of the policymaking process that they lead at the national 
level.  
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About this Manual:  
 This manual is intended to serve like a general guide to standardize the process of gathering 
the evidence for desk review and conduct the interviews as well as how to present and 














WHO defines governance as "ensuring strategic policy frameworks exist and are combined 
with effective oversight, coalition-building, provision of appropriate regulations and 
incentives, attention to system-design, and accountability" (WHO, 2007B). According to 
WHO, Governance in health is an essential element for achievement of health millennium 
development goals (Siddiqi et al., 2009) as well as the post development goals; since 
Governance is considered one of six building blocks of any health systems (WHO, 2010). Yet, 
governance is the least understood aspect of these (Siddiqi et al., 2009), most difficult to 
measure and its implementation the least evaluated (Alliance HPSR, 2008). It was reported 
that poor governance in health systems contributes to poor performance and poor health 
outcomes in low and middle income countries (LMG, 2012). This is due to the fact that weak 
health governance affects negatively utilization of resources and service delivery (Siddiqi et 
al., 2009). While practicing effective governance can improve health outcomes in those 
countries (Ciccone et al., 2010). . This can be achieved by overcoming poor accountability and 
transparency, weak responsiveness, limited engagement of various stakeholders and lack of 
data and evidence (Siddiqi et al., 2009). To improve governance and subsequently 
performance of health systems it is believed to be important to identify weak points that 
contribute to poor governance. Thus, good governance is considered an indicator for 
performance of any health system (Alliance-HPSR,2008). Similarly, health system reforms are 
also dependant on good governance in terms of establishing standards, using information and 
enforcing accountability among others (Lewis et al., 2009).  
In addition, international organization reported that weaknesses in health system governance 
(HSG) can pose a threat to effective use of external funds (USAID,2008) , thus these 
organizations pose a pressure on governments to improve HSG as way to better manage 
limited resources and funds in a transparent manner to demonstrate accountability (Alliance-
HPSR,2008, Lopez.et.al,2011) .  
In an attempt to simplify and clarify what governance is; various organizations proposed lists 
of principles for what constitute "effective" good governance. Siddiqi et al. proposed 10 core 
principles that are relevant to the health system governance. These are: strategic vision, 
participation & consensus orientation, rule of law, transparency, responsiveness, equity and 
inclusiveness, effectiveness and efficiency, accountability, intelligence & information and 
ethics (Siddiqi et al., 2009). 
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To improve something, there is a need to assess it first to identify gaps in practice as well as to 
identify gaps in knowledge about how to improve it (WHO, 2009). Assessing and 
understanding governance at all levels of the health system is crucial in order to understand 
how to improve its performance.  
Previously several assessment tools of health system governance have been proposed, but for a 
range of reasons, they are not widely used (Lopez et al., 2011). Thus, there is a need to 
develop practical tools that are based on academic rigor.  
Rational for Development of HP-GGT: 
 
The rational to develop HP-GGT was based on the importance of assessing HSG as a way of 
detecting weakness in it that will enable policymakers and researchers to identify possible 
ways and interventions to improve them accordingly, thus leading to improved health system 
performance (Kaufman et al., 1999). Another important reason for assessing governance is to 
raise awareness among public officer, policymakers and others about role of effective 
governance in the development of health system at all levels by communicating the results of 
the assessment and to promote common understanding of it and its role and advocate to adopt 
it and implement it (Siddiqi et al., 2009).  
The development of this tool followed a methodological approach to develop a SMART 
governance guidance tool, with aim to have a tool which is capable of analysing health 
governance in developing countries in a Specific, Measurable, Achievable, Realistic and in a 
Timely manner.  
This work will make a contribution to transform theoretical knowledge on health system 
governance into more practical application.  
 
Process of Development of HP-GGT: 
The development of this tool came as part of the research required to gain a professional 
doctorate in Health. The research focus was on conducting methodological work to develop a 
valid and useful tool that is suitable and practical for the assessment of the application and 
implementation of governance principles at the health policy level. The development of the 
tool went through 4 different phases.  
 
Phase I: The initial tool was developed based on and building upon existing research to 
identify key governance principles based on literature review and previous work on health 
governance, and following academic processes of assessment tools development (Devellis R, 
2003). The starting point for the development of this tool is based on a previous work done by 
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Dr. Sameen Siddiqi "Framework for assessing governance of health system in developing 
countries: Gateway to good governance" (Siddiqi et al., 2009).  
Phase II of the development of tool was to evaluate the developed tool with "Governance 
Experts" within the health sector to seek informed "expert" opinion on the rigor, content, 
relevance and conceptual organization of the tool as well as its feasibility and practicality in 
order to maximize its content validity. The governance experts were consulted using an 
iterative Delphi-method consultation (which is a flexible group method that does not require 
panel of experts to meet face-to-face instead through virtual meetings) (Okali C. et al., 2004, 
Keeny S.el al, 2001). Thus, consultation was done via email and it included 3 rounds of 
consultations and 25 experts from 16 countries around the world participated in at least one 
round of consultation (14 experts participated in all 3 rounds). The first round of consultation 
focused on assessing the comprehensiveness, relevance, and report on any missing aspect as 
well as providing feedback on wording of questions and the suggested structure of the tool. 
The first draft of the tool that was sent to experts constituted a long “laundry list” of concepts 
identified in literature related to selected governance principles. The experts were asked to 
review at least two sections out of the five sections of the tool. The second round focused on 
narrowing down the original list to the most important aspects to be assessed. The revised draft 
of the tool based on Round 1 consultation was sent to experts to revise and validate the 
revisions implemented from Round 1 responses and to Rate items to be kept in the tool. The 
final round focused on getting a final feedback on the tool. The third revised version based on 
Round 2 was sent for final feedback on items retained and to be rated again and ranked, and to 
give feedback on the practicality and feasibility of the tool. The overall aim of the three rounds 
of consultations was to generate consensus between experts on final tool to be pilot tested that 
is a short and practical. Another phase of evaluation was planned before the pilot testing. 
Phase III: The methodology and the content of the tool needed to be further refined based on 
experience and feedback of policymakers. Thus, a consultative one day meeting was planned to 
be held in presence of high level policymakers from the EMRO region. The specific objectives 
of the consultative meeting were to finalize the tool to be ready for pilot testing, agree on most 
user-friendly structure and design and agree on the data presentation of the results of the tool. 
The consultation meeting was attended by 10 participants from Egypt, Iran, Iraq, Jordan, 
Lebanon, and Morocco. 2 of the participants were former ministers of health (one of them is a 
current parliamentary member), 3 general directors at ministry of health/high health council, 2 
WHO high level staff, 2 former WHO staff (one of them is currently working in academia) and 
1 independent expert. The meeting was funded by WHO.  
After the consultation meeting, tool was finalized and was ready for pilot testing.  
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Phase IV: It was pilot tested in Lebanon and the mental health strategy that was recently 
developed was used an example for the pilot.  
The pilot included face to face interviews with11 KIs who were directly involved in the 
development of the mental health strategy. The KIs interviewed represented almost all 
stakeholders who were involved in the formulation phase; 3 from ministry of health, 2 from 
international organizations, 1 from international NGO, 1 from local NGO, 2 from academia 
(different institutions), 1 from scientific society, and 1 from a private hospital.  
After the pilot, tool was further adjusted and now it is in its final format and ready to be used 
by developing countries as a way to improve their governance practices at the health 
























Chapter II: Overview of HP-GGT 
 
Overall Objectives of HP-GGT: 
• To identify the main characteristics/aspects of key good governance principles and 
highlight their significance in health policymaking process 
• To have a suitable and practical guidance tool to gather data to identify if these 
characteristics are evident in health policymaking  
• To identify strengths and weakness in practicing good governance principles by 
Ministries of Health/Health Authorities while developing health policies  
• To raise awareness of need to have "Good Practices" of good governance in place to 
improve the quality of governance practiced by Ministries of Health/Health Authorities  
 
Scope of HP-GAT:  
 
What will be assessed? The HP-GAT is developed in a way to be a valid and practical 
assessment tool to examine whether key governance principles are practiced at the 
policymaking level. The KEY principles, as identified from existing research, are: 
participation, transparency, accountability, use of information and responsiveness. Extensive 
literature review was conducted to reveal various components, major characteristics and 
relevant concepts of the selected governance principles that are identified to be directly 
relevant to the health system to gain better understanding of these principles that contribute to 
the quality of HSG at all levels. The purpose of this step was to go beyond traditional approach 
of only listing relevant principles of governance by exploring their main 
characteristics/components for better conceptualization, in other words to unpack these 
principles. The main characteristics of the principles are readily available in literature but not 
used comprehensively. Characteristics identified for each governance principle provided a 
definition of that principle and thus was used as guideline for best practices to be followed to 
achieve good governance. In this way, concepts will be simplified, understandable and 
concrete.  See Diagram 1: Framework of HP-GGT.  
 
The level of analysis: The selected governance principles will be assessed at the health 
policymaking process level, where the processes of decision-making at all levels of the health 
system and the wider influences that underpin the prioritisation of policy issues, the 
formulation of policies, the processes of implementing policies in practice and their evaluation 
take place. The tool will be focusing on formulation mainly and to lesser extent on 
implementation ONLY. For the implementation part, the tool does not cover details of 
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arrangements of implementation at the local/decentralized levels (i.e service delivery, 
financing health services, contracting, performance assessment, etc). It mainly will evaluate if 
implementation arrangements were thought about/planned for well during the policy 
development.  
 Thus, the analysis of the governance of health policymaking will take place at the 
NATONAL decision making level. One limitation of the tool is that it will not cover all levels 
of policymaking process.  
The intention for the HP-GGT to be a generic guidance tool, as it was designed to be 
flexible enough to analyse governance processes of policymaking of ANY TYPE of health 
policy (from National Health Strategy, Universal Health Coverage, to NCDs, AIDS, Mental 
Health and any other policy in between). Health policy is all formal written documents, rules, 
and guidelines that present policymakers’ decisions about what actions are deemed legitimate 
and necessary to strengthen the health system and improve health (Blank et al., 2010, p:2). 
Thus, this tool can be used to assess any type of health policies that were recently formulated 
and implemented in a country within the last year. Based on the assessment, recommendations 
can be made on how to improve the policymaking process in the future. The tool includes 
questions about the policymaking process in general in relation to good governance, and other 
questions go into details of policymaking process of the specific policy.  
 
The Unit of analysis: Since, governance is considered a function of MoHs/Health Authorities 
specifically where they are responsible for promoting and maintaining well-being of 
population through their role in regulation and policymaking. The HP-GGT is designed to 
assess abilities of Ministries of Health (MoHs)/Health Authorities (at the central level as well 
at the peripheral level if applicable as the tool is designed to be flexible enough to be adapted 
to country context) to practice and adhere to key governance principles at the policymaking 
process level in developing countries. Thus, the unit of analysis is Ministries of Health/Health 
Authorities in developing countries. The tool can be used as an entry point by policymakers 
and/or international organizations to examine the extent to which key governance principles 
are applied in health policymaking and thus assist Ministries of Health (MOHs)/Health 
Authorities to better govern their health systems as the tool can be used as a checklist of 
“Good Practices”. The governance tool is developed to be a practical, robust and adaptable for 
stakeholders to use in diverse developing country health contexts. Thus, this tool serves like a 
guidance tool and not just as assessment tool. 
 
The Intent of analysis: the focus of the tool is normative/evaluative in nature. The tool will 
evaluate HOW a policy was formulated not WHAT was formulated. Thus, it will be a 
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retrospective evaluation of a policy that was developed in the past 12 months. The purpose of 
guidance tool is to document successes, identify weaknesses, challenges, and recommend ways 
by which health governance can be strengthened in the future at the policymaking level and 
thus the recommendations will NOT propose to produce a new policy.  
It will be sufficient to conduct assessment at least once (as a learning/diagnostic tool) and not 
for every type of policy that is being developed.  
Who can conduct the tool? It should be conducted as a country demand driven, thus it should 
be MOHs/Health Authorities led/endorsed. The MOHs/Health authorities can nominate a team 
from within led by a senior staff to conduct the tool OR nominate someone from academia 
with a counterpart of a senior staff at the MOHs/Health authorities. Another option is to ask 
for an external independent body to conduct it. 
 
Structure of the HP-GGT:  
The guidance tool is a structured questionnaire and has TWO separate sections (Section 
A&B); one that contains all evidence-based questions for all the five principles, and another 
section will contain all the perception-based questions for all the five principles. The 
relationship between the evidence-based and the perception-based questions is that the latter 
should help in filling gaps in knowledge and facilitate in-depth interpretation of the data 
obtained from the evidence based.  
Each section is divided into five parts (I-V) and each is concerned with one of the key 
governance principles: participation, transparency, accountability, use of information and 
responsiveness. Each principle is assessed separately in relation to how it is applied in 
policymaking process mainly at formulation level. For each principle, the assessment tool has 
two sets of question.  
The first section is Evidence-based questions that evaluate the existence of certain structures, 
procedures, guidelines, legislation that indicate the application of the governance principle. 
Answering these questions is done by face to face interviews with Key Informants (KIs) and 
asking these KIs to provide documents and evidence to validate their answers.  
The KIs will be given 5 options to answer these questions and these are: Yes, No, In Process, I 
Don’t Know, and Not Applicable or will be asked to choose answers from a list of sub-answers 
(can choose more than one answer). A content analysis of the relevant documents identified by 
KIs and through desk-based research will be conducted. Answers in this part of the assessment 
questionnaire can be used to evaluate progress or changes over time. The long lists of sub-
answers to select from are like indicators/examples (and not limited to) of good practices to be 
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followed/practiced. The questions are developed with the purpose to be practical and 
operational.  
The second section is perception-based that evaluates the perceptions of KIs about practices of 
good governance. This would be done via face-to-face semi-structured interviews. 
Thus, the KIs should be interviewed twice. See Diagram2: See overview of the structure of the 
tool.  
 
In summary, the HP-GGT is based on current and previous work done by others, it is a generic 
tool and can be adjusted based on country context, it will cover only one level of analysis; the 
National policymaking level, it contains a baseline list of questions that will be used to identify 
key issues; list of “good practices “to reflect if we have good “enough” governance in place. It 
can be considered an educational/guidance tool as well as a diagnostic tool as negative answers 
will signal deficiency that need to be addressed.  
The HP-GGT is not an end by itself and defiantly not a panacea, it is not a comprehensive 
toolkit to assess governance of the health system at all levels, it does not cover an exhaustive 
analysis of the good governance principles, and not all questions are relevant or applicable to 


















Chapter III: Methodology of conducting the HP-GGT 
Users of the HP-GGT 
As it was mentioned earlier, the HP-GGT should be conducted as a country demand driven, 
thus the MOHs/Health Authorities should initiate or request for the assessment to be 
conducted in the country.  
A team (a minimum of 2 persons) conducting the tool within ministries can be junior staff or 
from academia who are working under the supervisor of a senior staff at the MoHs/Health 
Authorities who is experienced and where KIs can cooperate and respond to and have the 
influence to improve the quality of governance and accordingly can have a key role in carrying 
out the recommendations of the assessment to higher management levels to decide with 
relevant stakeholders on the priority areas to be tackled for improvement. In addition, 
international organizations/donors can conduct the tool in various countries to have a baseline 
on governance practices, share experiences and advice on what can be done to improve 
governance quality as well as provide help and support to progress health system governance 
of these countries.  
 
Steps to conduct the HP-GGT 
Before the conduction of the assessment tool, the assessors need to decide on the policy that 
they want to evaluate its process of development. The policy should be a recently formulated 
(within the last 12 months) and implementation started in the country.  
Then the team of assessors needs to adapt the questions based on the country context and 
policy type. For example, is the unit of analysis is the MOH or is there an independent health 
authority at central or district level or is it a national program that is responsible for the 
formulation for the policy in question.  
A mapping of stakeholders is important to be conducted to identify who will be the KIs to be 
approached for interviews. KIs to be interviewed should include high level officials/senior 
staff as well as other stakeholders who are knowledgeable about, and were directly involved in 
the policy formulation of the health policy in question. The selected KIs should be 
representative of various stakeholders. The KIs number will depend on the number of relevant 
KIs who were involved and who will accept to participate in the assessment.  
 
Data Collection: Desk Review and KIs interviews 
The data collection process has 3 stages:  
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First, general desk review to compile background material and data collection from various 
documents should be done and reviewed to have a clear understanding of the specific country 
context and health system structure in general as the final report of the guidance tool should 
include an introductory chapter with the following information: country context; geographic 
location and political context, legislative process and local administration, economic profile, 
demographic profile and health status indicators. Also, it should include the description of the 
health sector in general in terms of health sector overview, reform efforts, levels of decision 
making, decentralization, policymaking process, health care financing and expenditure on 
health (national health accounts), health workforce, and service delivery, role of private sector 
as well as role of NGOs in health. This information can be collected as part of the desk review 
process. Following the desk review, KIs should be identified to prepare a list of contacts to be 
approached. 
Second, the first set of interviews to be conducted with KIs to collect data related to the 
evidence based questions using a structured questionnaire and questions will be asked in 
relation to a specific health policy in terms of formulation and implementation plans.  
During this set of interviews, KIs will be asked to provide evidence and documents to validate 
their answers whenever possible. Also, they will be asked for a SECOND Interview to 
complete the perception based part of the tool.  
Third, the second set of interviews is carried out to collect data for the perception based 
questions also via face-to-face semi-structured interviews with same KIs (if they agreed to 
participate in the second interview). The semi-structured interviews will generate in-depth 
information about the process of policy development.  
The reason for having two interviews with the same KIs; is the lengthy questionnaire and to 
avoid burdening the KIs with a long interview given their limited schedule and fear to loss 
their interest in the interview. Another reason is to give time to the assessors to read and 
analyse the documents provided during the first set of interviews. The suggested time between 
the two interviews is 1 to 2 weeks. Confidentiality and anonymity of the answers will be 
ensured for all KIs during both interviews and they will be asked to fill an informed consent 
before the interviews and will be provided with an information sheet. (See Annex 1: B&C).  
Questionnaires and notes of the interviews should be kept in secure location and under lock for 






Suggested documents to be reviewed:  
Ministry publications, administrative and legal records, health laws and policies, statistics, 
health sector strategy reports, media reports, official web sites, other health system 
assessments and others. Reports and evaluations carried out by other 
development/international organizations and partners. NGO reports and websites, Private 
sector documents and websites, as well as Individuals who are likely to be able to provide 
insights and access to the documents needed.  
 
Suggested list of KIs to be interviewed: 
- MOH leadership (minister, general director) & MoH staff, from all levels of 
management (senior, middle and junior level) and from various departments  
- Staff from other ministries: finance, social affairs, etc.. 
- Parliamentarians involved in the health sub-committee and others who have interest on 
health 
- Representative of NGOs (local and international)  
- Representative of Patient groups relevant to the policy  
- Professionals from the private sector 
- Representatives of private sector: hospitals, pharmaceutical companies, insurance 
companies & others 
- Representatives of professionals associations, societies and orders 
- International organizations working in the country  
- Media persons interested in the health sector 
- Academia and/or research institutions  
- Independent experts/think tanks 
- Members of national committees 
- Any other relevant stakeholder that is not mentioned above 
 
General Tips for the HP-GGT users: 
- Read carefully the questions before data collection and interviews and adjust the 
questions based on the country context and the policy type to be evaluated.  
- Prepare the list of potential stakeholders to be interviewed with contact details (phone 
numbers and emails) 
- Interview as much as possible of KIs till you reach saturation in answers and themes that 
might emerge  
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- Approach the potential KIs by contacting them first via email (if appropriate) to request 
their participation and to brief them about the guidance tool (see Annex 1: A draft 
letter/email) 
- In the email you need to set a deadline for potential KIs to respond to your email, indicate 
that the interviews are done on two phases and each phase will require one hour. It is up to 
the KIs to choose to make the two sets of interviews together.  
- Send a reminder email to potential KIs who did not respond.  
- Take the following with you to the Interview: informed consent (if not signed and sent by 
email), copy of the questionnaire (both sections), a recorder, a pen, a copy of the 
policy/strategy in question. 
- Ask the KIs about his/her acceptable to be interviewed and tell them why they were 
chosen to be interviewed.  
- Ask the KIs about the available time for the interview and if they would like to conduct 
both sections together or only one section at a time. If they prefer a second interview, ask 
them at the end of the interview to set a suitable time for them.  
- Introduce yourself at the beginning and the purpose of the tool briefly and highlight the 
fact that the intent of the tool is not to evaluate the content of the policy but rather to 
evaluate the process followed to develop the policy, and the tool serve as a guidance tool 
for the future.  
- Ask the KIs for the permission to record the interview during both sections, even the 
close ended; since there is so much space for elaboration by the KIs 
- Highlight that all of the interview will be confidential in terms of identity of the KI and 
the answers.  
- Add a code on the questionnaire and take some notes of key ideas/key words mentioned 
while the KI answers even if the interview is recorded. Write down exactly what the KI is 
saying to avoid subjective interpretation if you are not recording.  
- Use some probing techniques whenever you feel that the KI did not understand the 
question or reluctant to answer. Try to ask the question in another way and/or give 
examples and give some time for the KI to think and answer.  
- Ask questions in relation to the KI position/role (academia, NGO, professional). 
- Ask KIs to provide you with documents and relevant evidence on what was discussed 
during the interview.  
- Enter the results to the excel sheet immediately after the interviews and start the thematic 
analysis of the open ended questions. 
258 
- Review all notes and complete as needed and write a summary of interview notes 
including your impression, observations and findings on regular basis and not wait till the 
end of the interviews are all done.  
 
 Displaying Results, Analysis of Findings and Recommendations:  
The first part of the data analysis is based on the review of the secondary data compiled as 
a description of the health system and the policy developed then it should be combined 
with data collected through interviews and discussions with KIs.  
The results of the first section of the tool/first set of interviews (the evidence based 
questions) can simply be entered using an excel sheet (see annex 2 for a sample excel 
sheet).  
 There should be a sheet for each of the five principles: participation, accountability, 
transparency, use of Information and responsiveness.  
The analysis will be a simple statistical analysis; for example how many answered Yes vs. 
how many answered No for a certain question or sub-question. 
The results of this section can be summarized using a traffic light symbol system (used by 
WHO for pharmaceutical sector profile at country level, WHO, 2014) and NOT a score; as 
red will be used for NO answers, green will be used for YES answers and yellow will be 




*still under translation 
 
See what traffic light symbol means and an example on how it can be used. 
 
Color Code Meaning Applies to 




 In Process Or it Exist 
but Not applied 
Main and sub-
questions 






As for the second section; the open ended questions, a thematic analysis should be 
conducted by transcribing all the answers of KIs with respect to same questions and then 
identify common or striking themes that might emerge.  
The final analysis of the findings of both sections should be presented in the format of 
SWOT analysis (Strengths, Weaknesses, Opportunities and Threats) for each of the five 
principles and then compare and triangulate SWOT and cross-checking findings for all the 




Is there official, up-to-date (within last 5 years), detailed policy 
document regarding National Health Strategy?  
 
If Yes,  
 
 
Publicly available?  
 Easily accessible?  
 Available on the MoH/Health Authority website?   
 Is it available in the local language?*   
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Description of SWOT analysis*  
A* Source: The Health System Assessment Approach: A How-to Manual, Version 2.0, September 2012. LT 
(Principle) 
Strengths Weaknesses 
Strengths are elements of the health system that 
work well, contributing to the achievement of 
system objectives and thereby to good system 
performance. 
 
Example: Having a national Committee that was 
issued by a decree assigned the development of 
Policy X 
 
Recommendations should build on the 
strengths of the system 
Weaknesses are attributes of the health system 
that prevent achievement of system objectives 
and hinder good system performance. 
 
Example: Minutes of Meetings of the National 
Committee were not documented.  
 
Recommendations should suggest how to 
resolve system weaknesses. 
Opportunities Threats 
Opportunities are conditions external to 
the health system that can facilitate the 
achievement of system objectives. 
 
Example: The refugees’ crisis in the country 
was the reason behind initiating work on a new 
national policy for X. 
 
These factors can be leveraged when 
planning interventions. 
Threats are external conditions that can hinder 
achievement of health system objectives. 
 
Example: Resources used to facilitate and 
enable participation process of all stakeholders 
are donor based, thus there is no sustainability.  
 
Recommendations should suggest how to 
overcome these threats. 
SYSTEM 
Based on the SWOT analysis, identification of potential recommendations for 
improvement should be done and thus a list of recommendations should be developed.  
After the analysis and the recommendations are finalized, it is suggested that the team of 
assessors hold a consultation meeting with relevant stakeholders including the KIs and the 
MOH/Health Authority staff to review and validate the findings and conclusions as well as 
to prioritize the recommendations with the relevant stakeholders.  
 
 
 Final Assessment Report:  
 
The final assessment report should include the following sections:  
- Executive summary: maximum of 2 page summary,  
- Introduction: objectives and methodology of the tool,  
- Overview of the health system in the country with focus on the policy sector,  
- Data presentation/findings of the assessment: summary tables and brief description of 
total results for each of the five principles in addition to the traffic light symbol summary 
sheets,  
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- Data analysis and interpretation: for both sections of the tool; close ended and the open 
ended,  
- SWOT analysis: to highlight the strengths, diagnose weaknesses, and identify key 
opportunities and threats 
- Recommendations: based on the findings, identify potential solutions and 
recommendations for improvement 
- Priority list of recommendations based on the discussion of the consultation meeting  
- Conclusions  
- References 
- Annexes: Including list of evidence obtained  
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Chapter IV: The HP-GGT: Questions & Explanations of the Questions  
 
Section A of HP-GGT: Evidence-based questions: 
This section will include listing of the questions for the 5 principles with Explanation s for 
each question.  
I: PARTICIPATION at policymaking level 
Definitions: Everyone should have a voice in decision-making for health, either directly or 
through legitimate intermediate institutions that represent their interests. Such broad 
participation is built on freedom of association and speech, as well as capacities to 
participate constructively (Siddiqi S et al. 2009). It is about empowering citizens to have a 
role in decisions that affect their lives, and reach common goals by participating in 
policymaking process (Labonte R, 2010). It is the responsibility of the government to 
create mechanisms and spaces for participation (Cornwall A et al., 2001).  
There are many benefits in involving all stakeholders in the policy development process 
and these benefits are to participants (stakeholders) as well as to policymakers and these 
include:  
- To Participants 
Is considered an end by itself, considered a virtue, give a sense of control (self-
development process)  
Participation as a “Human Right” and reflect a "positive Freedom" 
Increase level of policy acceptance by health professionals 
Enable citizens to demand accountability, transparency and responsiveness from 
government institutions.  
- To policymakers (governments) 
It is a mean to have better/good governance, a mean to enhance other principles/ 
dimensions of governance, a sign of democracy.  
(Charles C et al., 1993, Cornwall A et al., 2001, Gaveta J, 2002)  
 
Many governments, organizations recognize the importance of public engagement in 
policymaking (Oxman A et al., 2009).  
More efficient policy making process due to contribution of knowledgeable actors about 
policy issue which will result in minimizing errors in policy decisions and actions to be 
taken and to take into account the different inputs of various stakeholders.  
 
Participation process is also associated with negative impact and these include:  
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Poorly designed process, time consuming, produce confusing data, conflict of interest, 
representation issues & legitimacy of representation, informal influence which can affect 
stakeholders voice inadequate input, hard to reach consensus and manipulative 
participation.  
(Mitton C. et al., 2009; Lopez I. et al., 2011; Gaveta J, 2002) 
 
Questions and Explanations for the questions:  
I. A.1 Is there a Legal basis/requirement (Law/Regulation/Policy) to include various 
stakeholders in the health policymaking process? 
Explanation: 
Legal framework for participation to be involved in decision making to encourage 
participation across all stages of policy cycle should be in place (Cornwall A et al., 2000).  
It is considered a human right; WHO: "people have the right and duty to participate 
individually and collectively in the planning and implementation of their health care" Alma 
Ata 1978. 
If it is not legally required, there still should be a commitment to ensure some degree of 
stakeholder participation in formulation and/or implementation (Delphi Expert).  
It is important to contextualize a legal basis or framework to support participation in health 
governance as it opens a space for participation in policymaking processes (Delphi 
Expert).   
Participation in itself is a human right that is commonly neglected by different authorities 
particularly health authorities. Having a law and regulations which spell out the 
government commitment is a good evidence for this commitment (Delphi Expert).  
I.A.2 Was there a body or mechanism(s) used to involve stakeholders in policymaking 
process that was concerned with the development of the X Policy? How this 
body/mechanism formulated? Is there a written scope/mandate? Is roles and 
responsibilities specified?  
Explanation:   
There should be a national committee/an advisory board/working group or any other type 
of body or mechanism to deal with policy development and formulation to facilitate the 
participation process from all stakeholders. This committee should be officially formed to 
have an official entity and it can be formed by a law (parliamentary legislation, presidential 
ordinance, ministerial decree, administrative decision or any other way. This 
body/mechanism should have a written mandate. Existence of SOPs, by laws, decision 
rules, conflict resolution mechanisms are a must as it is important to have 
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awareness/transparency on roles and responsibilities. Need to have shared commitment, 
motivation, and shared set of values or goals set from the beginning (Cornwall A et al., 
2001, Emerson K et al., 2011).  
Having this body formally established gives a form of authority (Delphi Expert).  
Informal mechanisms to include various stakeholders can be as important given the 
transparency and accessibility of the process and this need to be looked at (Delphi Expert).  
Having a mechanism (formal or informal) is important to ensure a multi-stakeholder 
perspective and consensus building in the decision making process of policymaking 
(Delphi Expert).  
Roles and responsibilities for each member of the policymaking body should be defined. 
As long as there are explicit roles, tasks, and responsibilities outlined for participation, 
each member is therefore accountable and responsible for his/her participation and level of 
effort (Delphi Expert).  
The presence of a body through which participation of different stakeholders are carried 
out is of utmost importance. However, the regularity of meetings of this body is also very 
important (Delphi Expert).  
I.A.3 Were the various stakeholders represented in the FORMULATION that was 
concerned with X Policy?   
Explanation:   
All types of actors in the health sector should be represented at the formulation level to 
achieve a broad consultation ant to obtain the views of all stakeholders;  
- State actors: Politicians, government officials (can be high or middle level officials, 
policymakers, public health sector agencies: ministry of health, health and social insurance 
agencies, and public pharmaceutical procurement and distribution entities. Other state 
actors include: parliamentary health committees, regulatory bodies, ministry of finance, 
other ministries, various oversight and accountability entities and judicial system.  
-Health Service providers: mix of public, private and voluntary sector providers working 
in: hospitals, clinics, laboratories, and educational institutions, insurance companies, health 
maintenance organizations, pharmaceutical industry, equipment manufacturers and 
suppliers 
-Beneficiaries, users, recipient: patient, guardians of patients, lay people, service users, 
interest groups, advocacy groups, policy audience, citizens, tax payers, non-governmental 
organizations, civil society,  poor and marginalized groups, Consumer associations, 
Patients associations, Commercial stakeholders (whose interest may be affected by set 
policies). 
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(Labonte R, 2010, Smith K et al., 2013, Brinkerhoff D et al., 2008, Oxman A et al., 2009).  
- Most vulnerable groups should also be included in the policymaking process including 
women 
- Others: journalists (media, academia, researchers, think tanks, champions, donor (Mutale 
W et al., 2013, Bennett S et al. 2012). 
There is a need to have a balance between public vs. private and public representation and 
professionals and other participants to avoid dominance by one group over the other and 
information imbalance 
I.A.4 For each category of stakeholders identified above, how were the participants 
involved in formulation of X Policy selected?  
Explanation: 
Participants can be appointed/nominated, elected, self-selected or selected by any other 
mean but for all of these and for transparency issues there is a need to have set inclusion 
and diversity criteria. It is also important to clarify where the participation of the various 
stakeholders is done on voluntary basis or mandatory since this will reflect on 
accountability of these participants (Brugha R et al. 2000, Charles C et al., 1993, Emerson 
K et al., 2011).  
Also participants can represent:  
- Themselves 
- Client 
- Public Agency 
- NGO 
- Community 
- Private sector 
(Emerson K et al., 2011).  
This should be identified and declared to others to avoid any conflict of interest. 
 
Ensuring a good mix of stakeholders representing industry groups and non-state actors 
such as NGOs and academia will enhance the discussions during the policy formulation. 
The NGOs provide for the pragmatic and implementation approach, while academia can 
provide for the policy framework and evidence-base and private industry groups can 
provide for the markets’ experience. These are essential perspectives that help government 
shape their policies (Delphi Expert).  
I.A.5 Is there a gender balance /consideration (Male vs. Female) among the stakeholders 
participating in the formulation of the X Policy?  
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Explanation: 
It is important to highlight the importance of women participation in the policymaking 
process.  
It would be interesting to know if there is a balance between male vs. females (Delphi 
Expert).  
It is important to have gender balance in participation for fair representation issues (Delphi 
Expert).  
In some countries females are highly discriminated and their voices are not being heard, 
while in others this is not the case. So, identifying whether this is the case with regard to 
policy formulation in a certain country reflects in stakeholder participation (Delphi 
Expert).  
I.A.6 Are there dedicated resources made available by the MoH/Health Authority to 
enable and facilitate participation during the policy development process of X Policy?  
Explanation: 
Resources need to be available to facilitate and pay for costs of meetings (venues, coffee 
breaks and other meals) and administrative work (print outs, etc) related to meetings 
(Smith K et al., 2013, Matthews A et al. 2008).  
Also, it is recommended to provide incentives for participation in the form of fee or 
honoraria or at least provide reimbursement for transportation and lodging as a way to 
encourage participation and commitment (Emerson K et al., 2011).  
Lack of participation could be due to lack of dedicated resources, thus there is a need for 
dedicated resources to cover for cost of meetings, travelling, etc. (Delphi Expert).  
I.A.7 Is there documentation (Minutes of meetings) on the recommendations submitted 
for final decisions in relation to the formulation of the X Policy?  
Explanation: 
Participation process should be recognized by documentation and minutes of meetings 
need to be made public for transparency (Charles C et al., 1993, Oxman A et al., 2009). 
Documentation of the process is very important and should be stressed. It is evidence and 
is important for learning and lessons to be discerned (Delphi Expert).  
I.A.8 How final decisions were taken by participants? 
Explanation: 
Final decisions can be reached by Majority vote, consensus, and dissenting opinions or by 
any other procedure. In order to have ‘effective participation” there is a need to reach 
consensus; as stakeholders and citizens positions/voices should be taken into account not 
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just allow free expression of opinions and not by majority or by elite (Cornwall A et al., 
2001, Emerson K et al., 2011, Gaveta J, 2002). 
Documentation of how decisions were made is crucial; for transparency and accountability 
issues to minimize as much as possible the power struggle and competition between 
different stakeholders (Lopez I et al., 2011). 
I.A.9 Are the roles and responsibilities of the various stakeholders in the implementation 
process specified in the formulation document of the X Policy?  
Explanation:  
For transparency as well as for accountability issues, it is very important to specify the 
roles and the responsibilities of the various stakeholders in the implementation phase. 
Having these specified in the policy document will reflect a well-planned (thought of) 
implementation phase.  
It is important to clearly define the roles and the responsibilities of various stakeholders in 
the policy implementation. Especially if non-state stakeholders will be receiving grants or 
monetary compensation by the state for implementing such policy and this should be 
clearly stated in the policy document. Then there should be a clear mechanism for 
accountability of roles as well as public funds (i.e open call through competitive bidding, 
signing of contracts, and reimbursement of implemented activities) (Delphi Expert).  
Implementation phase need to be thought of very clearly and deeply, otherwise the strategy 
might not be translated properly (Delphi Expert).  
I.A.10 Is there a participatory body to oversee the implementation of the X Policy? 
Explanation: 
Participation should continue through all the policymaking cycle and phases and thus 
continuing the participation is essential to ensure ownership and success of the policy 
implementation (Emerson K et al., 2011).  
Oversight role of stakeholders’ in implementing policies and strategies is very crucial to 
the process (Delphi Expert).  
I.A.11 Are other mechanism/strategies used by MOH/Health Authority/National Program 
to ENCOURAGE participation (express opinions/preference and encourage feedback) of 
different stakeholders in priority setting and in policymaking process of X Policy?  
Explanation: 
It is the responsibility of the government to create and facilitate mechanisms, spaces and 
places to encourage citizen participation of all who are interested. Engaging the public 
requires planning and resources from the government (Bishop B et al. 2009). 
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Different Methods/mechanism/strategies can be used to encourage participation of citizens 
and these include: opinion poll, need/ impact assessments, attitude surveys, focus groups, 
public hearings, citizens’ juries, roundtables, voting, inter-governmental conferences, 
policy dialogues, third-party facilitated conflict resolution and committees and online 
platforms for the public engagement is also recommended (Papadopoilos Y et al. 2007, 
Charles C et al., 1993, Mitton C et al., 2009, Oxman A et al., 2009). 
 
II. ACCOUNTABILITY at policymaking Level 
Definitions: Is about assuring that those who are responsible for designing and 
implementing policies are held accountable for their performance (Dieleman M et al. 
2011). Decision-makers in government, the private sector and civil society organizations 
involved in health are accountable to the public, as well as to institutional stakeholders. 
"This accountability differs depending on the organization and whether the decision is 
internal or external to an organization" (Siddiqi S et al. 2009). "It is about having the right 
checks and balances put into place" (Dieleman M et al. 2011). It is ensuring that all health 
system actors are held publicly accountable (WHO, 2007a, ch:6).  
To assess accountability, it is important to assess whether formal accountability 
mechanisms are in place, the effectiveness of these mechanisms, and evidence that these 
mechanism are being used (Delphi Expert).  
 
Questions and Explanations for the questions:  
II.A.1 Does the MoH/Health Authority/National Program require signature of 
contract/Memorandum of understanding/Terms of Reference (that include incentives, 
sanctions, timeline, deliverables, etc) with various stakeholders before engaging them in 
policy formulation and implementation.  
Explanation: 
Various stakeholders should be informed before being engaged in policy formulation and 
implementation about what their roles and responsibilities will be; this is to ensure 
accountability of all (Delphi Expert).  
II.A.2 Are the different stakeholders (public officials & non-state actors) involved in the 
policy formulation related to X Policy formally held accountable based on their 
contribution for decisions and policies borne out in case of false advice/failure to engage in 
appropriate action?  
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Explanation:  
Usually accountability focus on public health sector, but it should include accountability of 
private sector, donors, NGOs, and citizens.  
Decision-makers in government, the private sector and civil society organizations and 
other stakeholders involved in health policy formulation should be held accountable to the 
public, as well as their institutions (WHO, 2007a, ch:6).  
Accountability of participants is important; they should be held accountable for their 
position while participating and for not actively involved (Delphi Expert). 
Each stakeholder should be accountable to their institutions (Delphi Expert).  
Governance is a shared responsibility and not only the responsibility of the government 
(Delphi Expert).  
II.A.3 What is the type of the accountability mechanisms/types used by MoH/Health 
Authority/National Program and various institutions/organizations involved in policy 
towards their representatives?  
Explanation:  
There are various types of accountability mechanisms and these include: Ethical, 
Professional and/or performance, legal, financial and other types (Saltman R, 1997, 
Emanuel E et al., 1996).  
This question highlights the fact that various accountability measures and safeguards can 
be used and not only the legal one (Delphi Expert).  
II.A.4  Does the MoH/Health Authority/National Program conduct any of accountability 
evaluation as part of holding its staff accountable for their role in implementing the X 
Policy?  
Explanation:  
Internal accountability is as important as external accountability. Internal accountability is 
about having the" right checks and balances" put into place. It is ensuring that all 
components of the system are held publicly accountable (Murthy R, 2008, Ebrahim A, 
2003). 
Internal accountability can be conducted in the form of evaluation of performance of 
individual staff and it is usually done on annual basis, administrative/performance audit of 
the relevant department also done on annual basis, financial auditing for personnel, 
operations, supplies and others, and contract oversight (Delphi Expert).  
There should be in place institutional mechanism for accountability (Delphi Expert).  




Many tools can be used to enable accountability and these include: information System in 
place, Dissemination of information, Participation of Public/Civil organizations, Whistle 
blowing mechanisms, Watchdog organizations, and Performance incentives for good 
performance, Enforcement of rules & regulations, appeal mechanisms (Taryn V, 2008, 
Brinkerhoff D et al., 2008, Ebrahim A, 2003). 
Mechanisms to generate and share publicly information are essentials although Information 
system is important but might be costly. Clear responsibilities of all participants are 
important to ensure accountability (Tuohy C, 2003). 
II.A.6 Is there monitoring & evaluation (M&E) of implementation of X Policy? 
Explanation:   
Monitoring and Evaluation are important to measure/assess level of adherence to or 
compliance (Emanuel E et al., 1996) by professionals/private sector with the criteria for 
specific policy issue as well as monitoring and evaluation policy outcomes in terms of 
health improvement, efficacy, equity and quality.  
Monitoring and evaluation is a tool for oversight (Delphi Expert).  
It is important to have M&E as a follow through on the policies in effect to see if they are 
relevant, effective and efficient or whether these policies are implemented due to 
compliance only (Delphi Expert).  
II.A.7 If Question II.A.6 is YES, Is the M&E process formal? 
Explanation:  
It is advised to have a formal process of M&E and it can be conducted by independent 
body (can be either internal within the health sector or external) or it can be done as a self-
responsibility. The M&E should be done on regular basis at least once per year.  
It is important to know if the process of M&E follows a structured format (Delphi Expert).  
II.A.8 Did the MoH/Health Authority/National Program set a formal mechanism (s) to 
hold implementers and/or implementing bodies from the private sector/non-state actors 
responsible for implementation of various components of X Policy accountable in-line 
with set timelines and targets? 
Explanation:  
To have meaningful accountability, you need to have the following components: setting 
standards, Investigation and Answerability including allowing justifications, Sanctions, 
Enforcement mechanisms as well as Rewards for Performance and an independent appeal 
mechanism (Brinkerhoff D, 2004, Murthy R, 2008).  
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The presence of all the components together is essential to have accountability. 
Answerability can reveal "illegal or inappropriate actions and behaviors" that should be 
followed by sanctions (Brinkerhoff D, 2004). On the other hand, enforcement is about 
ensuring compliance with sanction decisions (Murthy R, 2008). 
Accountability is not only about having sanctions it is as much about giving incentives and 
rewards (WHO, 2007a, ch:6).  
This question will give an indicator whether accountability mechanism is established and 
operates in accordance with good governance (Delphi Expert).  
II.A.9 If Question II.A.8 is Yes, Who is authority responsible for holding implementers 
and/or implementing body accountable?  
Explanation:  
It can be internal within the health sector, external by independent bodies or external by the 
public. It can be the MoH/Health authority itself or an audit office. "Accountability differs 
depending on the organization and whether the decision is internal or external to an 
organization" (Siddiqi et al., 2009). 
 It is about having the "right checks and balances put into place" (Dieleman M et al., 2011). 
It is ensuring that all health system actors are held publicly accountable (WHO, 2007a, 
ch:6). 
It is important to identify who is responsible for accountability mechanisms and if formally 
recognized and has a mandate and authority to perform its role and impose sanctions 
according to predefined rules (Delphi Expert).  
II.A.10 What are the types of sanctions applied/might be applied to implementers and/or 
implementing bodies responsible for implementation of X Policy in case of violation/not 
adhering to standards set? Failure to implement?  
Explanation:  
Sanctions: include Legal sanctions through judicial system, Regulatory/administrative 
sanctions:(like licensing and accreditation standards, quality assurance guidelines and 
compliance mechanisms, code of conduct, etc) and/or Softer sanctions include: negative 
publicity (name and shame) (Brinkerhoff D, 2004, Murthy R, 2008).  
II.A.11 Are there any laws in place related to the X Policy? What does the law(s) cover? 
Explanation:  
Rule of law is another dimension of governance and it is related to accountability as well. 
"It is about having legal frameworks pertaining in health that should be fair and enforced 
impartially, particularly the laws on human rights related to health" (Siddiqi S. et al., 
2009).  
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"Enforcement of health-related legislations is important as it shows the extent to which 
various health-related laws are applied at all levels of health system (and government)" 
(Kirigia J et al., 2011).  
  
III. TRANSPARENCY at the Policymaking Level 
Definitions: It is actively disclosing information on how decisions are made (Taryn V, 
2008, implemented and evaluated. It is built on the free flow of information for all health 
matters. Processes, institutions, and information should be "directly accessible to those 
concerned with them, and enough information is provided to understand and monitor 
health" (Siddiqi S et al. 2009). 
Transparency is about ensuring that all relevant information and processes are documented 
and are publicly available and easily accessible. Most of the time a lot of information is 
available, but the MoH/Health Authorities need to have the right balance as information 
overload is confusing while essential information is not easy to find (Delphi Expert).  
Questions and Explanations for the questions:  
III.A.1 Is there a law/mechanism about "access to information" that allow access by the 
general public to government information and documents? 
Explanation:  
There should be Existence of access to information law as a method to increase 
transparency (Oxman A et al., 2009).  
III.A.2 Is there a law/government policy in place to promote "cyber transparency” 
electronic government services to improve public access to government information and 
services? 
Explanation:  
Having a law to enforce the use of electronic government services will increase 
transparency and improve public access to government information and services (Oxman 
A et al., 2009).  
III.A.3 Is there an official website for the MoH/Health Authority?  
Explanation:   
Using E-Government is another method for increasing transparency (Oxman A et al., 
2009).  
The downside of E-transparency is information overload and not finding easily the 
information needed. Thus, user-friendly and easy access should go hand in hand with 
transparency (Delphi Expert).  
III.A.4 Are decisions related to priority setting in relation to the X Policy made public? 
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Explanation:  
Availability of such decisions is a sign of transparency (Otenyo D et al., 2004) 
III.A.5 Are decisions related to resource allocation in relation to the X Policy made public? 
Explanation:   
Availability of such decisions is a sign of transparency (Relly J et al., 2009).  
III.A.6 Is there official, up-to-date (within last 5 years, detailed policy document regarding 
X Policy?  
Explanation:  
It is not enough to make information available, it is the speed of making the information 
available is the critical aspect of transparency. Documentation of all policy stages should 
be done by policymakers, and the policy document should be updated every 5 years. 
To have full transparency, need to make all policy documents publicly available and enable 
ease of access to all information (example to place it on the website) and make the 
available information in an understandable language to the public (make documents 
available in national language of the country) (NAO, 2012, Otenyo D et al., 2004, Taryn 
V, 2008).  
Publicly available and easily accessible are signs of transparency (Delphi Expert).  
III.A.7 Does the document related to X Policy include various types of information?  
Explanation:  
Content of the information is another important criteria for transparency. policy document 
should include: background on how the policy was formulated, evidence used in policy 
formulation, stakeholders who participated in policy formulation, other factors that 
influenced the policy formulation, responsible body for releasing the policy, budget and 
funding requirements, timeframe for implementation, indicators and targets, M&E plans 
and intended audience for the document.  
As availability of all of these information in the policy document is a sign of transparency 
(Delphi Expert).  
III.A.8 Is there plans to publish/already publish documents that are related to 
implementation of X Policy?  
Explanation:  
As a sign of transparency, the MoH/Health Authority should publish information related to 
implementation and these might include: Five year strategic plan/operational 
plan/Implementation plans, Program documents, relevant official decisions to guide 
implementation, policy evaluation repots, financial reports, contracts made for 
implementation (if applicable), scientific publications and others.  
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It is important for transparency to demonstrate the intent and/or progress made in policy 
implementation (Delphi Expert).  
III.A.9  Does the MoH/Health Authorities/National Program release information related to 
formulated and implemented X policy in "predictable manner"/Periodic/regular manner?  
Explanation: Predictability is one factor to be included in transparency. It means that the 
relevant stakeholders and the public can expect when to receive information in a 
predictable manner. This means that there should be published timelines which include 
what to expect (Delphi Expert).  
III.A.10 Did participants declared any conflict of interest by signing an official form?  
Explanation:  
Participants declaring their affiliation and any relationship and/or remuneration that might 
influence their participation and contribution to the policy development and 
implementation is a sign of transparency and this declaration does not mean that they do 
not have the right to provide their feedback (Delphi Expert).  
Most stakeholders will have conflict of interest; it is inherent to them being actors in the 
health system. If only neutral parties are consulted, then we miss capturing stakeholders’ 
real positions. It is just a matter of declaring these conflicts to everyone around the table 
(Delphi Expert).  
III.A.11 Which of the following methods, if any, the MoH/Health Authority/National 
Program is using or has used in the past 12 months, to INFORM/Disseminate to 
stakeholders (including the public) about policy formulation, development, implementation 
and progress of X Policy?  
Explanation:  
It is the "right of the public to seek, receive and impart information" (Gostin et al., 2003). 
 It is the responsibility of the government to inform all the stakeholders as well as the 
public on developments of policies and their implementations and this should be done 
using various channels like mass media (TVs, radios, wide advertisement (newspapers, 
billboards, bulletins/newsletters, emails, social media, smart phone applications and any 
other appropriate mean (Oxman A et al., 2009).  
It is important for the MoH/Health Authority to disseminate information about new 
policies once they are finalized and adopted as a sign of transparency (Delphi Expert).  
How decisions are made public is important to participation, transparency and 
accountability (Delphi Expert).  
Dissemination of health policies to the general public (who are the direct beneficiaries in 
Health) should be done on regular basis (Delphi Expert).  
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IV. USE OF INFORMATION at the policymaking Level 
Definitions: "Is essential for a good understanding of health system without which it is not 
possible to provide evidence for informed decisions that influences the behavior of 
different interest groups that support, or at least do not conflict with, the strategic vision for 
health. It includes; information generation, collection, analysis and dissemination" (Siddiqi 
S et al. 2009). Sound and reliable information is essential for health system (WHO, 2007a, 
ch:3). 
Questions and Explanation s/Explanations for the questions:  
IV.A.1 Is the MoH/Health Authority/National Program directly involved in information 
generation, dissemination, and publications in relation to policymaking?  
Explanation:  
The MOH/|Health authority should have a role in generation of information as well as in 
use of information in policy making (Siddiqi S et al., 2009, WHO, 2007a, ch:3). 
IV.A.2 Is the MoH/Health Authority/National Program using data collection tools, data 
management technologies, validation of data sources, checking sources of funding of 
research to be used in policy?  
Explanation:  
MOH/Health Authority should ensure the use of appropriate tools to have proper 
information generation/production, collection, & analysis of information needed to 
decision making (WHO, 2007a, ch:3). 
It is important for MoH/Health Authority to have a mechanism in place to double check if 
research used is financed by private or any other entity that has conflict of interest in 
relation to the policy in question (Delphi Expert).  
IV.A.3 Does the MoH/Health Authority/National Program have any form of 
partnership/collaboration with research centers inside as well as outside the country?  
Explanation:  
Collaborating with academia and or research institutions is an important way to promote 
information/research uptake into policies (Oxman A et al., 2009). Also allocating funds on 
yearly budget for research related to policy can promote information/research uptake into 
policies and encourage knowledge driven approach (WHO, 2007a, ch:6). 
Regular interaction between researches and policymakers will increase the possibility of 
using evidence in the policymaking (Delphi Expert).  
IV.A.4 Does MoH/Health Authorities make Raw data generated at health facilities/health 
service delivery level accessible to researchers?  
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Explanation:  
Part of governance is sharing the information that is needed to inform policies and to 
conduct relevant research. Data generated at the health facilities level should be easily 
accessible by researchers (Delphi Expert).  
IV.A.5  Is there a specialized unit/staff in the MoH/Health Authority/National Program that 
deals with research analysis for policymaking? 
Explanation:  
MOH/health Authority needs to have institutional capacity for research analysis for policy 
formulation (WHO, 2007a, ch:3).  
For better generation, use and analysis of information, institutional capacity as well as 
resources and regulatory support are required (Delphi Expert).  
IV.A.6 Was the developed X Policy informed by scientific evidence? 
Explanation:  
Research findings are needed to support arguments, justify choice of policies, and inform 
decisions. Scientific evidence use in policy formulation can help in finding solutions that 
are effectiveness and cost-effectiveness (Policy Innovation for Health, Ch:2, Lavis J et al., 
2004). 
IV.A.7 If Questions IV.A.6 is YES, Which of the following criteria were used for the 
inclusion of scientific evidence in policy formulation of the X Policy?  
Explanation:  
Evidence based used in policy formulation need to be reliable and of good quality, up-to-
date, extensive and comprehensive enough, and locally appropriate (WHO, 2007a, ch:3).  
Evidence used can be international, national or based on community level (Lavis J, 2006).  
IV.A.8 Were other types of information utilized in the policy formulation of X Policy? 
Explanation:  
Other types of information like expert opinion, financial information, governing laws, 
political direction, and others can be used in policy formulation in addition to scientific 
evidence. They can be used on regular basis and in emergencies at all levels of 
policymaking process and should be available to all interested stakeholders (WHO, 2007a, 
ch:3).  
IV.A.9 Does the MoH/Health Authority/National Program publish/plan to publish periodic 
progress reports/M&E reports on policy implementation status of X Policy?  
Explanation:  
MoH/Health Authority should publish regularly progress reports on implementation of 
policy as well as reports of M&E. This is as part of its role in generating information and 
277 
promoting transparency. Such reports should be disseminated widely and all stakeholders 
should have access to such information to encourage transparency, accountability and 
responsiveness. 
It is important to disseminate relevant information to M&E results. It is a sign of 
transparency as well (Delphi Expert). 
It is very important to disseminate such information as it will ensure the right 
accountability through ensuring visibility and transparency (Delphi Expert).  
 
IV.A.10 If Questions IV.A.10 is YES, What are the objectives of progress reports?  
Explanation:  
The objectives of the progress reports should be clearly stated at the beginning of the 
report. The purpose of producing and generating progress reports on implementation 
should include all of the following: increase awareness, evaluate the situation, identify 
problems, provide information and assign responsibilities (Cornwall A et al., 2000).  
 
V. RESPONSIVENESS TO POPULATION NEEDS at the policy making level 
Definitions: "Institutions and processes should try to serve all stakeholders to ensure that 
the policies and programs are responsive to the health and non-health needs of its users" 
(Siddiqi et al., 2009). Responsiveness is how well the health system meets the legitimate 
expectations of the population for non-health enhancing aspects/dimensions of their 
interaction with the health system (Darby et al., 2000).  
Also, according to WHO, responsiveness is important for many reasons: 
- "Addressing the legitimate expectations of people is at the heart of the stewardship 
function of health systems"  
- Responsiveness is "fundamental because it relates to basic human rights".  
- A health system can "improve some of the elements of responsiveness without 
large investments" as it does not necessarily require new legislations to authorize it. 
- "Responsiveness can be improved much faster than health" (Darby C et al., 2000, 
Gostin L et al., 2003).  
The interactions of people with a responsive health system will improve their well-being, 
irrespective of improvements to their health (Gostin L et al., 2003). By ensuring that 
people are treated in ways that correspond to their needs; they will be empowered to lead 
healthier lives (Gostin L et al., 2003).  
Responsiveness is classified as a principle of good governance and is also considered as a 
DIRECT outcome of good governance. Unlike other outcomes (like equity, efficiency and 
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effectiveness) that might be the results of other factors all working together in addition to 
good governance.  
WHO defined 8 domains for health responsiveness as well as a strategy for measuring it. 
Health responsiveness was tackled at the service delivery level only. The 8 domains 
include: respect for the dignity of persons, confidentiality, autonomy to participate in 
health related decisions, prompt attention, access to social support networks, basic 
amenities of adequate quality of care, choice of health care provider and communication 
(Darby C et al., 2000, Gostin L et al., 2003).  
 
Questions and Explanation s/Explanations for the questions:  
V.A.1 Does the X Policy include an objective/goal that MoH/Health Authority/National 
Program will ensure access to adequate Quality of care services to ALL the 
population/patients including disadvantaged/vulnerable groups to be covered by the 
policy? 
Explanation: 
The MOH/Health Authority should ensure that the population will have access to adequate 
quality of health care services. As this is one of the domains of responsiveness (Gostin L et 
al., 2003).  
V.A.2 Does the X Policy include an objective/goal that the health services will respect the 
confidentiality and the dignity of the population/patients? 
Explanation: 
Confidentiality and respect for the dignity of patients are two of the domains of 
responsiveness (Gostin L et al., 2003).  
There should be guidelines and standards at the health facility level to respect 
confidentiality and the dignity of patients (Delphi Expert).  
V.A.3 Does the X Policy include an objective/goal that the health providers will respect 
the rights of the patients in terms of autonomy to participate in health related decisions, 
freedom of choice of health care provider, provide all information related to the patients’ 
medical conditions in an understandable manner.  
Explanation: 
Autonomy to participate in health related decisions, choice of health care provider and 
right to get all information related to patients’ medical condition are domains of 
responsiveness (Gostin L et al., 2003).  
V.A.4 Does the X Policy refer to the explicit benefit package to be provided to patients at 
the different levels of care?  
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Explanation: 
It is the right of the patient to know his rights and responsibilities and these should be 
clearly stated and this will reflect how the health system is responsive (Delphi Expert).  
V.A.5 Does the X Policy include an objective/goal that the health services will be 
provided to population/patients within reasonable timeframe?  
Explanation:  
Providing prompt attention to the patients is another domain of responsiveness (Gostin L et 
al., 2003).  
V.A.6 Does the X Policy refer to how referral of patients will take place from one level of 
care to the other?  
Explanation: 
Patients should know what to expect in terms of referring their medical cases from one 
level to another and how this referral will take place with stating time frame for this 
referral and these should be clearly stated and this is a again a sign of a responsive health 
system (Delphi Expert). 
V.A.7 Does the X Policy include an objective/goal to set in place an official complaint 
mechanism?  
Explanation: 
Part of being responsive to the needs of people is to have a complaint mechanism in place 
to allow the public to report any violation or raise concerns about services provided to 
them (Delphi Expert).  
In order to encourage people to use such mechanisms it is crucial to ensure follow up on 
complains reported.  
The investigation on complains should be done in a timely manner and the results should 
be published (actions and justifications) (Delphi Expert).  
 
V.A.8 Was a needs assessment (targeting the public)/Public Opinion surveys conducted as 
part of the X Policy formulation process? 
Explanation: 
Assessing responsiveness of the health system should be based on consumers/users 
feedback as they are the best source of information. As it is important for policymakers to 
understand the perception of people about responsiveness of the health system to their 
needs and assess factors that contribute to this perception as well as understand the 
preferences of people about the health system and allow them to express their needs to 
address them appropriately (Darby C et al). Most of the time this is not the case, as 
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population health needs are usually determined by the health professionals with little 
involvement of the public (Siddiqi S et al., 2012). Thus, it is crucial to have needs 
assessment targeting the public during the policy formulation process (Siddiqi S et al., 
2009). It could take the form of surveys, public forums, telephone hotline or any other 
appropriate mean (Delphi Expert).  
V.A.9 Do the monitoring & evaluation plans of the X Policy include a component to 
assess whether the policy is meeting the population needs through conducting patients 
satisfaction surveys/exit surveys? 
Explanation: 
It is important to be able to assess the various elements of responsiveness as part of the 
specific policy under evaluation. This will give a valuable input on the policy for 
improvement if needed.  
It is a governance issue to see if the policy in question is meeting the people’s expectations 
and thus it is important to be included in the evaluation phase (Delphi Expert).  
V.A.10 Did the MoH/Health Authority/National Program develop a communication 
strategy to inform the public about the X Policy?  
Explanation: 
Communication is another element of responsiveness (Darby C et al., 2000).  
The communication strategy is needed to ensure that information is freely available and 
directly accessible to the public. It also should ensure that enough information is provided 
and that it is provided in easily understandable forms and media (Delphi Expert). 
 
Section B of HP-GGT: Perception-Based Questions 
I. Participation at the policymaking level  
Questions and Explanation s/Explanations for the questions:  
I.B.1 How do you view the role of MoH/Health Authorities/National Program in 
encouraging stakeholders’ participation in policy formulation and implementation in 
general? & in the X Policy development in specific? Does the MoH/Health 
Authority/National Program has the institutional capacity and needed resources to facilitate 
the participation process? In terms of leadership? Planning? Needed information? 
Institutional arrangements? Database of key stakeholders? 
Explanation: 
MoH/Health Authority should encourage participation and creating appropriate spaces for 
that.  
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To have a successful participation process, the MoH/Health Authority should have the 
needed resources and skills to bring partners together; thus need technical & institutional 
capacity (Emerson K et al., 2011).  
 
I.B.2 To what extent was the formulation process of the X Policy inclusive of the key 
stakeholders? Were they “Effectively “consulted in? Were all relevant voices taken into 
account? Which stakeholders were missing?   
Explanation: 
All stakeholders should be represented at the formulation phase. State actors are usually 
are responsible for formulating health policies. Health service providers can have a role at 
the formulation phase with technical input (Brinkerhoff D et al., 2008). Beneficiaries can 
be involved at the end of the policy development phase (determining details of 
implementation rather than broad policy formulation) (Charles C et al., 1993).  
To have effective and fruitful participation process; there should be: 
consensus orientation, informed participation, existence of written documents about SOPs, 
by laws, decision rules, conflict resolution mechanisms, awareness/transparency on roles 
and responsibilities, shared commitment, motivation, and shard set of values or goals 
(Cornwall A et al., 2001, Emerson K et al., 2011). 
I.B.3 What type of process was applied for the selection/identification of participants in the 
X Policy formulation? Do you consider that it was a fair/effective process to ensure a 
qualified group? A representative group? Why? 
Explanation: 
The process of selection/identification should be transparent and influence free 
(Papadopoulos Y et al., 2007).  
The process of selection should be fair, transparent and effective (Delphi Expert).  
I.B.4 Who were the powerful stakeholders in the decision making/formulation of the X 
Policy? Was their influence hindering or facilitating the formulation process of X Policy? 
What their influence led to?  
Explanation: 
There will always be powerful stakeholders and it is important to identify them and know 
their influence (Lopez I et al., 2011). There will always be a complex interaction between 
various stakeholders with different objectives, power levels & how policy decisions may 
affect them and these need to be identified given the context of the policymaking process.  
This question will give an insight about the power matrix and how this can be mitigated 
(Delphi Expert).  
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I.B.5 What are the barriers and/or facilitators to the participatory process? For MoH/Health 
Authorities/National program? For stakeholders? 
Explanation: 
There are many facilitators as well as barriers to the participation process to take place, 
some are listed below:  
- Political will & commitment 
- Level of interest of policymakers & stakeholders 
- Power struggle & competition between stakeholders 
- Values and ethics 
- Evidence, access to information 
- Availability of resources 
- Trust in policymaking process 
- Supportive environment & context 
- Public satisfaction in implementation  
-Legal framework for participation in decision making  
-Generate capacity to participate: including; procedures & institutional arrangements, 
leadership, information, and resources 
- Incentives & contracts 
(Smith K, 2013, Matthews A et al. 2008).  
I.B.6 What are the mechanisms used to enable stakeholder participation in policymaking 
process? Do they include mechanisms to give voice to the traditionally voiceless groups 
(homeless, migrants/refugees, unemployed, minorities, disabled, elderly, etc?? How do you 
view the effectiveness of these mechanisms? 
Explanation: 
There should be mechanisms in place to give a chance for vulnerable groups to participate 
in decision making related to their health or at least be consulted and heard (Delphi 
Expert).  
MoH/Health Authorities should make some kind of investments to help enable and 
facilitate the participation of most vulnerable as they may not have formal education or 
skills to amplify their voice (Delphi Expert).  
 
II. Accountability at the policymaking level 
Questions and Explanation s/Explanations for the questions:  
II.B.1 To what extent do you agree that all stakeholders should be held accountable for 
their role in the policymaking process including formulation?  
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What is the best way to hold the various stakeholders accountable for their role in 
policymaking? How to ensure that they know they will be held accountable prior to their 
involvement?  
Explanation: 
All stakeholders should be held accountable; public health sector, private sector, donors, 
NGOs, and citizens if they are taking a part in the health policy making process. Various 
stakeholders should be held accountable by their institutions and by the public (WHO, 
2007a, ch:6).  
Holding everyone accountable in an equal manner is a sign of good governance. This will 
result in control the misuse and abuse of public resources and/or authority (Taryn V, 2008). 
II.B.2 What is the role of media in accountability in policymaking in your setting? Is 
media playing a positive or negative role in Policy making process? Give examples 
Explanation: 
Media has an important role in holding the various stakeholders accountable. Media can 
play a positive role as well as a negative role and thus media needs to be well informed.  
Some countries cite media as a good ally for accountability “shame and sensationalism”, so 
it will be good to see how effective the role of media as an accountability mechanism is 
perceived (Delphi Expert).  
II.B.3 Does the civil society have an active role as watchdogs over policy formulation and 
implementation of Policy X? How? Give examples 
Explanation: 
Civil societies can have an active role as watchdogs’ organizations (Taryn V, 2008).  
It is important to get insights on how influential the civil society organizations voice in the 
country (Delphi Expert).  
II.B.4 How the public can hold various stakeholders accountable for their role in 
policymaking in general and in relation to Policy X? 
Explanation: 
There is a need to establish mechanisms for citizen oversight (Brinkerhoff D et al., 2008) 
through health boards or other mechanisms to enable civil organizations to demand 
explanations for certain health issues or decisions.  
II.B.5 How the implementing bodies are held accountable for their roles in the policy 




There should be a body responsible for holding all implementing bodies accountable for 
their role in implementing the policy whether it is the MoH/Health authority or an 
independent body (Murthy R, 2008, Ebrahim A, 2003).  
Holding all implementing bodies accountable in an equal manner is a sign of good 
governance. This will provide assurance that resources are used and authority is exercised 
according to legal procedures, professional standards, and social values (Taryn V, 2008). 
II.B.6 How is the law (s) related to X Policy translated into rules, regulations and 
procedures? Who is responsible for this? How does the MoH/Health Authority/National 
Program ensure that regulations, legislations and sanctions are fairly enforced in relation to 
the implementation of the X Policy in both public and private sector? 
Explanation: 
There is a need to establish clear procedural rules and use authority to enforce those roles 
(Brinkerhoff D et al., 2008). 
Enforcement is ensuring compliance with policies and sanction decisions (Murthy R, 
2008). 
 
III. Transparency at the Policymaking level 
Questions and Explanation s/Explanations for the questions:  
III.B.1 Does the MoH/Health authority /National Program have the interest/ willingness/ 
Commitment to achieve better transparency? What is the type of this willingness/ 
commitment? How can the MoH/ Health Authority/National Program increase its 
transparency in the policymaking process? Does the MoH/Health Authority/National 
Program have the needed capacity/means to achieve better transparency?  
Explanation: 
The MoH/Health Authority can increase its transparency in various ways, among which is 
existence of access to information law, availability of publications (public service reports, 
government documents or decisions, Public databases, Public meetings, Financial 
monitoring reports, etc., availability of written standards on operating procedures, decision 
making process, minutes of meetings, availability of written criteria for choosing 
participants & terms of reference, practice of E-Government: existence of official website, 
online services, having a freedom of press, and dissemination through media and finally 
having communication strategies with media and reports published in media (NAO, 2012, 
Oxman A et al., 2009). 
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III.B.2  How the MoH/Health Authorities/National Program can ensure that the opinions 
of the different stakeholders are documented & disclosed/published as part of a transparent 
policymaking process?  
Explanation: 
Transparency of the participation process is important; stakeholders’ positions should be 
transparent to be held accountable (Labonte R, 2010). 
The formulation process should be transparent at all levels; the internal level between the 
various stakeholders and at the external level to the public (Gaveta J, 2002). Thus, 
documentation of various positions of various stakeholders is recommended through 
minutes of meetings that need to be published or through any other way (NAO, 2012).  
III.B.3 How transparent was the policy formulation process of X Policy as perceived by 
stakeholders? by public? What made it transparent? What could make it more transparent? 
Explanation: 
Transparency contributes to having good governance and improves quality of governance 
of policy making process. Thus, "the policymaking process should be transparent to all 
stakeholders as well as to the public, since access to information is a public right, it 
empower citizens, it is a sign of democracy and it increase public trust in government 
decisions" (NAO, 2012). 
III.B.4  How comprehensive is the X Policy? Is the policy document user-friendly& easily 
accessible? How useful? What is missing? 
Explanation: 
It is not enough to publish information; the quality of the information will affect the 
transparency. It have full transparency, the information should be easily accessible to all 
including the public and should be useful and understandable to all (Otenyo D et al., 2004, 
Taryn V, 2008).  
Policy document should be intended for all; Public, different policy actors and participants, 
media; can have different documents depending on the intended audience (IHP, 2013).  
How information is presented is also an important criterion of transparency (Delphi 
Expert).  
III.B.5  How transparent was the process of priority setting during the development of X 
Policy? How this process can be improved? 
Explanation: 
It is a sigh of transparency (Otenyo D et al., 2004).  
III.B.6  How transparent is/was the process of resource allocation for implementing the X 
Policy? Are criteria applied for allocating resources known to all? 
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Explanation: 
It is a sigh of transparency (Relly J et al., 2009). 
 
IV. Information at the policymaking level  
Questions and Explanation s/Explanations for the questions:  
IV.B.1 How committed is the MoH/Health Authority/National Program leadership to use 
evidence-based (scientific evidence) and other types of information in policymaking 
process? What is the evidence for this commitment? Is it documented?  
Explanation: 
MoH/Health Authority should be committed and should encourage linking evidence to 
policy (WHO, 2007a, ch:3). 
MoH/Health Authority should follow policy driven model where policymakers should 
demand knowledge to solve specific problems and develop relevant policies (Choi B et al., 
2005). 
IV.B.2 How can the capacity of staff at the MoH/Health Authority/National Program be 
improved in terms of to access/use and analysis of research evidence?  
Explanation: 
MoH/Health Authority should have institutional capacity for generation and use of 
information in policy (Hanney S et al., 2003).  
IV.B.3 Can you describe the relationship between MoH/Health Authority/National 
Program leadership and researchers? Is their regular interaction? 
Explanation: 
A good relationship with researchers and academia are important to encourage use of 
research findings in policy development (Davis P et al., 1996). As research findings are 
needed to support arguments, justify choice of policies, & inform decisions and it can help 
in finding solutions that are effectiveness and cost-effectiveness. In addition, research 
findings are needed to demonstrate best way to implement policies, guide investment 
decisions in resource constrained settings, improve service delivery and health outcomes 
(Policy Innovation for Health, Ch:2, Lavis J et al., 2004). 
IV.B.4 Do you consider the scientific evidence used in the formulation of X Policy 
pertinent/adequate? Why? What factors influenced the uptake of evidence-based/research 
findings into X Policy? What additional evidence would have been necessary?  
Explanation: 
Several factors might affect the use of evidence-base information in policymaking, and 
these can be categorized into 4;  
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1. External Influence: Encouragement & influence of donors & international agencies 
&Global evidence 
2. Context: Consistency with governing party political views, Politics, Economic 
Resources, Incentives for researchers & policymakers, Opinion of mass media and public, 
Demand for evidence base, Ways of knowledge transfer/translation, knowledge brokers, 
Publicly funded research, Government encouragement & commitment for linking evidence 
to policy , Institutional capacity for research analysis & policy formulation 
3. Type of evidence: Technical Content & Quality: reliability, timeliness, specific, 
comprehensiveness, Practicality, issue complexity, how results communicated: summaries, 
via media, Feasibility, National significance  
4. Stakeholders: Relationship between researchers & policymakers, Acceptability of key 
stakeholders, Public engagement, Power of pressure groups, Successful advocacy, 
Partnership, synergy & coordination with academia/research centers. 
(Lavis J et al., 2004, Hanny S et al., 2003, Davis P et al., 1996, Choi B et al., 2005, Orem J 
et al., 2012, Siddiqi S et al., 2012).  
All types of Information can be used on regular basis and in emergencies at all levels of 
policymaking process and should be available to all interested stakeholders. 
 
IV.B.5 How national evidence is generated? What is the role of MoH/Health 
Authority/National Program in adapting research findings to local context? Give Examples 
in relation to the X Policy.  
Explanation: 
It is a governance issue on how evidence is encouraged and generated at the national level 
and what factors affects its generation (Delphi Expert).  
IV.B.6 What other factors (other than evidence-base) contributed to the formulation of X 
Policy? 
Explanation: 
The availability of other factors like: financial resources availability, restricting or 
encouraging governing laws, political situation and commitment, public opinions can 
influence the formulation process (Jansen M et al., 2010).  
Other factors might include catastrophic or crisis situations (natural or man-made) that are 
common in developing countries (Delphi Expert).  
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V. Responsiveness at the policymaking level 
Questions and Explanation s/Explanations for the questions:  
V.B.1 How do you view MoH/Health Authority/National Program institutional capacity 
to collect/gather public needs/preferences to be incorporated into policymaking process? 
What Mechanisms can be used to improve policy responsiveness to the population needs?  
Explanation: 
The MoH/Health Authority should develop mechanisms to improve its responsiveness and 
this comes of course with a financial cost and a need for human resources (Gaveta J, 2002).  
Responsiveness is not regularly assessed. Population health needs are usually determined 
by the health professionals with little involvement of the public (Siddiqi S et al., 2012). 
Thus, needs assessments and/or public pools might be used to collect public opinions. 
Public and patient representation is essential in policymaking process.  
V.B.2 What are the factors that can positively or negatively influence the responsiveness 
of MoH/Health Authorities/National Program to the public needs in the policymaking 
process? 
Explanation: 
Factors that can influence responsiveness include: 
"National Mood”, nature of the policy issue, urgency of the and the degree of 
seriousness/level of priority, costs to be responsive, involvement of changing an old 
established policy, media coverage, informed public, Informed policymakers, Social 
movements and pressure, availability of "open window of opportunity", influence of elite, 
contradictory public opinions, Timing, Government commitment to be responsive to the 
needs of the population, Inequality in representation (Powell B, 2004, Ura J et al., 2008, 
Wlezien C et al., 2009, Manza J et al., 2002).  
 
V.B.3 How does the MoH/Health Authority/National Program balance the competing 
interests/conflicting needs and influence of professionals/elite groups with public opinion 
(if there is any conflict present between the two opinions)? 
Explanation: 
It is common that public opinions are manipulated by the elite (interest groups) (Martin D 
et al., 2002). Thus, the MoH/Health Authority should have access to trusted information on 
public preferences. Having effective participation is a key in this area. The public/citizens 
need to be well represented in the policy development process as inequality in 
representation will lead to inequality in responsiveness (Ura J et al., 2008). 
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This question is important as it help identify the problem and reflect on action as that can 
be taken to address potential issues that might arise with “powerful stakeholders” and how 
the MoH/Health Authority can do better manage and balance their influence against the 
public needs (Delphi Expert).  
V.B.4 Does the MoH/Health Authorities/National Program usually respond to media 
and/or civil societies reports regarding failure to implement policies? How the response is 
formulated?  
Explanation: 
It is important to MoH/Health Authorities to respond to media and NGO reports when 
needed as part of being responsive and this should be done on timely manner (Delphi 
Expert).  
V.B.5 How responsive is the X Policy to the population needs in general? And to the 
vulnerable population needs in particular? Is the policy patient-centered? Please explain 
Explanation: 
MoH/Health authorities should pay attention to developed policies to address legitimate 
expectations of the people (including the vulnerable population) as this is one of the 
outcomes of the governance function of the health systems. "Responsiveness of health 
system can be improved much faster than health without large investments" (Darby C. et 
al., 2000).  
Having responsive health polices can improve people well-being irrespective of 
improvements to their health just by their interaction with the health system. Ensuring that 
people are treated in ways that correspond to their needs can lead to healthier lives (Darby 
C et al., Gostin L et al., 2003).  
V.B.6 How do you perceive the timeliness as well as the promptness of developing the X 
Policy in response to population legitimate needs? 
Explanation: 
Prompt attention to the needs of the population in a timely manner is another element of 









Chapter V: Limitations 
 
The HP-GGT is not a perfect tool. Like with any other tool it has some limitations.  
The findings of the assessment will depend greatly on the existence of relevant documents 
to be reviewed as the culture of documentations in some countries might be poor. Also 
identifying the relevant KIs to be interviewed is critical. Identifying relevant KIs is a key 
success for the assessment; as the results obtained will depend on the number of KIs who 
will accept to be interviewed, KIs’ level of knowledge about the policy process being 
evaluated, and their openness in responding to the questions. It is crucial to have a mix of 
KIs to obtain multi-perspective reflection on the policy development process. Thus, KIs 
should include government officials, representatives of private sector, NGOs, academia, 
professional societies and others with relevant involvement in the policy development.  
Translating the tool into other languages (especially Arabic) might be a problem since the 
translation might create some inaccuracies.  
The tool is long and it needs a minimum of 2 hours to conduct both sections (around one 
hour for each). This might result in low rate of acceptance by KIs when they know about 
the time needed to complete the assessment given their tight schedule, that is why it is 
suggested to conduct two separate interviews with the same KIs given they will accept this 
option. Some KIs will accept to cover only one section of the tool. While others will not 


















- Conflict of Interest: means that the participant or his/her partner including a spouse 
or other person with whom s/he has a similar close personal relationship) has a 
financial or other interest that could unduly influence the participant's position with 
respect to the subject matter being considered (WHO, 2009).  
- Delphi Experts: are “Governance” experts who participated in reviewing the tool and 
giving their feedback via Delphi consultation process that took place via email over 
three rounds of review.  
- Easily Accessible: Obtained effortlessly with no delay or any bureaucratic obstacle as 
needed and/or upon request (WHO, 2009).  
- Ethical accountability: mostly related to health professionals & abiding by code of 
conduct (Emanuel E, 1996, Brinkerhoff D., 2004).  
- Financial accountability: concerns tracking and reporting on allocation, 
disbursement and utilization of financial resources using tools of auditing, budgeting 
and accounting. (Emanuel E, 1996, Brinkerhoff D., 2004).  
- Formal Mechanism/Body: If it defined by a law or other mechanism then it is 
formal.  
- Informal Mechanism/Body: Not defined by a law or something formal, asking 
opinion of a stakeholder via email is considered informal mechanism.  
- Legal accountability: related to violation of laws (Emanuel E, 1996, Brinkerhoff D., 
2004).  
- Patient-centered: is when individuals, families and communities are served by and 
are able to participate in trusted health systems that respond to their needs in humane 
and holistic ways. The health system is designed around stakeholder needs and enables 
individuals, families and communities to collaborate with health practitioners and 
health care organizations in the public, private and not-for-profit health and related 
sectors in driving improvements in the quality and responsiveness of health care 
(WHO, 2007c). 
- Performance accountability: refers to demonstrating and accounting for performance 
in light of agreed-upon performance targets (Emanuel E, 1996, Brinkerhoff D., 2004).  
- Publicly available: to be found openly, widely and with no restrictions and to be 
found in usually in more than one media (Soft copy: website, hard copy: at 
governmental office, or documentation center or in national gazette (WHO, 2009).  
- Whistle blowing: is when a person who exposes any kind of information or activity 
that is deemed illegal, unethical, or not correct within an organization that is either 
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private or public. The information of alleged wrongdoing can be classified in many 
ways: violation of company policy/rules, law, regulation, or threat to public 
interest/national security, as well as fraud, and corruption. Those who become 
whistleblowers can choose to bring information or allegations to surface either 
internally or externally. Internally, a whistleblower can bring his/her accusations to the 
attention of other people within the accused organization. Externally, a whistleblower 
can bring allegations to light by contacting a third party outside of an accused 
organization. Whistleblowers can reach out to the media, government, law 
enforcement, or those who are concerned but also face stiff reprisal and retaliation 
from those who are accused or alleged of wrongdoing (Wikipedia).  
 
- Watchdogs’ organizations: are usually non-profit groups that view their role as 
critically monitoring the activities of governments, industry, or other organizations 
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Diagram 2: Structure of the HP-GGT 
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Annex 1-Manual:  
A. Letter/Email addressed to KIs 
Request to participate in the Assessment of Governance at the Health Policymaking 
Level-XXXX Health Strategy using a Guidance Tool  
 
Dear Dr. …. 
Greetings. Hope this email finds you well. 
You are being invited to take part in conduction of Governance Guidance Tool. The conduction of the tool 
will be done in relation to the newly developed National XXXX Health Strategy.  
I am sure that you have many questions before you consider saying YES to this request, and I hope that I will 
be able to answer most of your questions by the below: 
  
What’s the project? Assessment of Governance at the health policymaking level of XXX Health Strategy 
 
What is the project aims? The tool will enable health ministries/health authorities or other international 
organizations and others to examine the extent to which key governance principles are applied in health 
policymaking. The governance tool is organized around five key governance principles: participation, 
transparency, accountability, use of information & responsiveness.  
 
What is the project output? The governance guidance tool is a practical, robust and adaptable for 
stakeholders to use in diverse developing country health contexts. The final report of the assessment should 
document successes, identify weaknesses, challenges, and recommend ways by which health governance can 
be strengthened at the policymaking level.  
Who is leading this project? My name is……., I am the principle investigator. I work in ……… 
 
Why me and what do you want from me as a participant? Since you were actively involved in the 
National XXXX Health Strategy development, thus you are considered as a Key Informant and your 
informed opinion about the process of development of the strategy is essential for this assessment.  
Thus, we would like you to take part in face-to-face interviews (one or two) with principle investigator.  
Your contribution is central to the assessment process.  
 
What is involved? The tool has Two Sections; one with close ended questions and the other contains open 
ended questions. Thus, you will be asked various questions in relation to the National XXXX Health Strategy 
in terms of formulation and implementation plans.  
 
How much time will it take & when? If you accept to participate in the piloting, you are kindly asked to 
assign TWO separate meeting times (if possible) at your convenience to conduct face-to-face interviews to 
cover the two sections of the tool. Each interview might take around 50 minutes to be completed. You may 
wish to have one interview to conduct both sections of the tool. Interviews will be conducted in a place 
convenient for you.  
 
I would like more information, where can I find it? For more information, kindly see the Information 
Sheet attached. Also you can contact me via: …….. 
 
When do you need to know whether I could be involved? If you agree to participate, kindly return by 
email by……… with your approval & consent to be part of the assessment (or you can sign during our 
meeting before we start the interview). Informed consent attached.  
 






B. Participant Information Sheet  
 
Title of the Study: Assessment of Governance at the Health Policymaking Level-XXXX 
Health Strategy using a Guidance Tool 
 
Investigators:  
- Principle Investigator (PI): XXXXX 
                     e-mail:  
 
                     Telephone:  
Introduction: 
 
WHO defines Governance as "ensuring strategic policy frameworks exist and are combined 
with effective oversight, coalition-building, provision of appropriate regulations and 
incentives, attention to system-design, and accountability”. Governance is considered one of 
the six building blocks of any health systems. Yet, governance is the least understood aspect of 
these, most difficult to measure and its implementation the least evaluated. There are 10 core 
principles that are relevant to the health system governance. These are: strategic vision, 
participation & consensus orientation, rule of law, transparency, responsiveness, equity and 
inclusiveness, effectiveness and efficiency, accountability, intelligence & information and 
ethics. 
Purpose & Value of the Study:  
 
The aim of this research is to identify/examine if characteristics of selected governance 
principles (participation, transparency, accountability, use of information & responsiveness) 
exist/practiced at the policymaking level. The selected governance principles will be assessed 
at policymaking process due to importance of policymaking in shaping health of population, 
and as major practice of Ministries of Health (MOHs)/Health Authorities in governance 
process. The selected principles will be assessed at the main stage of health policy process; 
formulation and implementation plans, as this is the most important for evaluating governance 
quality. Since health system governance is considered to be a function of MOHs specifically 
where they are responsible for promoting, and maintaining well-being of population through 
its role in regulatory and policymaking. Thus, unit of analysis for this study will be MOHs. 
Undertaking such analysis will assist in assessing ability of MOHs to formulate and implement 




The assessment will be flexible enough to be used to analyse process of policymaking of any 
type of health policy and to be adapted to country context. It can be used as an entry point to 
be used by policymakers to assist MOHs in countries to better govern their health systems. 
 
Description of the Process of Participation in this Study: 
For Key Informants (KIs) taking Part in the Assessment  
You are selected as a Key Informant as you were identified as knowledgeable about, directly 
involved, and interested in the National XXXX Health Strategy that was recently developed.  
If you agree to participate, kindly set TWO separate meeting times (if possible) and a meeting 
place that is convenient to you to conduct face-to-face interviews with you where you will be 
asked various questions in relation to the National XXXX Health Strategy in terms of 
formulation and implementation plans.  
The reason for having two interviews with you; is that the tool has two sections. One section 
contains close ended questions and might take around 50 minutes to complete and the other 
section contains open ended questions (for better understanding of the process that was 
followed during the policy formulation) and it might take another 50 minutes to complete.  
If you wish, the two sections can be covered within the same interview.  
 
We would like to tape-record the interview if you agree and you are free to refuse to answer 
any question and it is your right to stop at any time.  
Confidentiality will be respected in all stages of study, your name and your responses will be 
anonymous as all will be coded and you will be asked to sign a written informed consent.  
Raw data will be available only to the PI and all related documents of the study will be stored 
under lock for at least 3 years.  
You may be contacted by the PI after the interviews for any follow up or clarifications.  
If you have any questions, clarifications about this study or about the objectives of this 
research before the interview or during, please contact the PI for this research project.  
There is no direct benefit to you for participating in this study. No risks of any kind will be 











C. Informed Consent 
 
Title of the Study: Assessment of Governance at the Health Policymaking Level-
XXXX Health Strategy using a Guidance Tool  
 
- Principle Investigator (PI):  XXXX 
                     e-mail:                    Telephone:  
Purpose of the Study:  
The aim of this research is to conduct an assessment to identify/examine if characteristics 
of selected governance principles (participation, transparency, accountability, use of 
information & responsiveness) exist/practiced at the policymaking level.  
The developed tool will assess abilities of Ministries of Health/Health Authorities (in 
developing countries) in applying principles of good governance at the health 
policymaking level and it can be used as an entry point to be used by policymakers to 
assist MOHs/Health Authorities in countries to better govern their health systems. 
 
Consent: 
I, ......................................................., agree to take part as a Key Informant in the 
assessment using the guidance tool that is part of this study. I agree to participate in ONE / 
TWO (circle your choice) face-to-face interview (s) and answer various questions and I 
approve that I might be contacted again by the Principle Investigator as a follow up on the 
study if needed.  
I declare, that I have read the participant information sheet that was provided to me about 
the study and what will be my role in it, and all my questions and concerns were answered 
by the PI.  
I understand that it is my right to ask any question during the interview and refuse to 
answer any question and stop the interview at any time. I agree that the interview may be 
recorded using a digital recorder for an accurate record of the interview and that notes may 
also be taken. 
I understand that my words may be quoted in published work, but that I will not be 
identified, and that all identifying information will be removed before publication. 
I was informed that the confidentiality will be respected in all stages of study, and my 
name and responses will be anonymous as all will be coded and personal as well as raw 
data will be available only to the PI and all related documents of the study will be stored 
under lock for at least 3 years.  
Name of Participant:                    Date:                 Signature:   
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Annex 2-Manual: Sample of Excel Sheet for Data Entry 
Section A: I Participation  
 
  1 2 3 4 5 6 7 
Type of KI* P G I INGO A NGO SS 
I.A.1               
Policy formulation               
Policy implementation               
Other               
Not Specified               
If No, is there still a 
commitment                
I.A.2                
 A national committee 
              
Advisory Board               
Working Group (s)               
Other               
Formally               
Informally               
Written Mandate/scope               
Roles & 
Responsibilities                
Qualifications               
Timetable                
I.A.3               
State Actors: Other 
than MOH               
Health Service 
providers                
Parliamentary members                
Beneficiaries &/or 
Public               
Civil Society/NGOs               
International 
organizations               
Funders/Financiers               
Academic 
Institutions/Researchers               
Private Sector               
Most Vulnerable 
populations               
Media               
Others               
I.A.4               
Appointed                
Elected                
Self-selected               
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Voluntary               
Mandatory               
Representing 
Themselves                
Representing their 
organizations               
I.A.5               
I.A.6               
Cost of meetings               
Cost for administrative 
work               
Incentives for 
participants                
Transportation, lodging 
and/or meals                
I.A.7 
        Publicly Available  
       I.A.8               
 Majority Vote               
Consensus               
Dissenting Opinions               
Other Procedures               
Not Specified               
Is it documented?               
I.A.9               
Defines by Law               
I.A.10               
I.A.11               
Opinion Polls/Surveys               
Focus groups               
Public Hearings/Public 
Comments               
Online platforms               
Voting               
Hotline               
Inter-governmental 
conferences               
Policy dialogues               
*P: Private Sector                                           SS: Scientific Society                                      
G: Government                                               I: International Agency 
NGO: Nongovernmental organization 





Annex 9. Sample Comparison on How Siddiq et al. are Proposing to 
Assess Participation vs. How HP-GGT Is Proposing to Be Assessed 
 
Siddiqi et al., 2009 Assessment of 
Participation 
HP-GGT Assessment of Participation 
- - Are the private sector, civil society, 
line departments and other 
stakeholders consulted in decision 
making? 
-  
- - How are decisions related to health 
finalized: cabinet, parliament, head 
of government or state?  
-  
- - How are the inputs solicited from 
stakeholders for health policy?  
-  
- - How does government reconcile the 
different objectives of various 
stakeholders in health decision-
making? 
-  
- - Are other state ministries involved in 
by the MOH in policies and 
programs to tackle health 
determinants? 
 
- Is there a Legal basis/requirement (Law/Regulation/Policy) to 
include various stakeholders in health policymaking process? 
If Yes, Specify what is it? 
& in what phase of the policymaking process is it specified to 
consult with stakeholders  
If No, is there still a commitment from the MoH/Health 
Authority/National Program to ensure some degree of 
stakeholders participation in formulation & implementation of 
national health policies? 
 
- Was there a body or mechanism(s) used to involve stakeholders in 
policymaking process that was concerned with the development of 
the X Policy?  
If Yes, what body or mechanism (s) was used to involve 
stakeholders in the policymaking process that was concerned with 
the X Policy?  
A national committee 
An advisory Board 
Working Group (s) 
Other, Specify: 
 
- How was this body /mechanism (mentioned above) formulated?  
Formally (in written format), Specify How & By Whom: 
Informally, Specify How: 
If it was Formally formulated, 
 
- Was there a written scope/mandate for stakeholders’ involvement 
in the formulation of the X Policy? 
What is the scope/mandate for the stakeholders?  
Were the roles and the responsibilities of participants for the 
various stakeholders specified? 
Were the qualifications of participants for the various stakeholders 
specified? 
Was there a timetable for the work to be carried out? 
 
- Were the following stakeholders represented in the 
FORMULATION that was concerned with X Policy?   
State Actors (Government, other than MoH, National, Local): 
Specify: 
Health Service providers (Professional Association/Unions/Orders 
& Health  Service Organizations/Hospital boards) Specify: 
Parliamentary members  
Beneficiaries (patients associations) &/or Public: Specify: 
Civil Society: Specify: 
Development Partners/International organizations: Specify: 
Funders/Donors: Specify 
Academic Institutions/Researchers: Specify: 
Private Sector (medical, pharmaceutical industry, insurance 
companies):   Specify: 
Most Vulnerable or Key affected populations: Specify: 
Media 
Others: Specify:  
Were representatives from local/regions within X Country 
represented? 
 How? 
- For each category of stakeholders identified above, how were the 
participants involved in formulation of X Policy selected?  
Appointed, Nominated was there a set criteria for the selection?  
Elected, by whom?  
Self-selected 
Others: 





- Are participants:  
Representing Themselves: Specify: 
Representing their organizations: Specify: 
Other, Specify: 
 
- Is there a gender balance /consideration (Male vs. Female) among 
the stakeholders participating in the formulation of the X Policy?  
 
- Are there dedicated resources made available by the MoH/Health 
Authority to enable and facilitate participation during the policy 
development process of X Policy?  
 
If Yes, what type of resources is made available?  
Cost of meetings (venues, coffee breaks, etc)  
Cost of Administrative work (print outs, etc) 
Incentives for participants (Fee or Honoraria): Specify: 




- Is there documentation (Minutes of meetings) on the 
recommendations submitted for final decisions in relation to the 
formulation of the X Policy?  
- Are the minutes published/made available to the public?  
 






Is there documentation of this?  
 
- Are the roles and responsibilities of the various stakeholders in the 
implementation process specified in the formulation document of 
the X Policy?  
If NO, are they defined by law or by any other formal means? 
 
- Is there a participatory body to oversee the implementation of the 
X Policy? 
If Yes, What is its composition? 
 
- Are other mechanism/strategies used by MOH/Health 
Authority/National Program to ENCOURAGE participation 
(express opinions/preference and encourage feedback) of different 
stakeholders in priority setting and in policymaking process of X 
Policy?  
If YES, which mechanisms are used ( 
Opinion Polls/Surveys 
Focus groups 








-How do you view the role of MoH/Health Authorities/National 
Program in encouraging stakeholders’ participation in policy 
formulation and implementation in general? & in the X Policy 
development in specific? Does the MoH/Health Authority/National 
Program has the institutional capacity and needed resources to 
facilitate the participation process? In terms of leadership? 
Planning? Needed information? Institutional arrangements? 
Database of key stakeholders? 
 
- To what extent was the formulation process of the X Policy 
inclusive of the key stakeholders? Were they “Effectively 
“consulted? Were all relevant voices taken into account? Which 
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stakeholders were missing?   
 
 - What type of process was applied for the selection/identification 
of participants in the X Policy formulation? Do You consider that it 
was a fair/effective process to ensure a qualified group? A 
representative group? Why? 
 
- Who were the powerful stakeholders in the decision 
making/formulation of the X Policy? Was their influence hindering 
or facilitating the formulation process of X Policy? What their 
influence led to?  
 
- What are the barriers and/or facilitators to the participatory 
process? For MoH/Health Authorities/National program? For 
stakeholders? 
 
- What are the mechanisms used to enable stakeholder participation 
in policymaking process? Do they include mechanisms to give 
voice to the traditionally voiceless groups (homeless, 
migrants/refugees, unemployed, minorities, disabled, elderly, etc?? 
How do you view the effectiveness of these mechanisms? 
 
